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When l'm in the middle of a dream 
Stay in bed, float up stream 
Please, don 't wake me, no, don 't shake me 
Leave me where 1 am ... 
''l'm Only Sleeping" by LennonIMcCartney 
(Album Revolver, The Beatles, 1966) 
ABSTRACT 
The basal forebrain (BF) plays multiple and divergent roI es in the 
modulation of cortical activity and the control of sleep-wake states. BF neurons 
project to cortex, where they promote cortical activation during wakefulness (W) 
and paradoxical sleep (PS). Other neurons may conversely promote the 
appearance of slow wave activity (SW A) that occurs during slow wave sleep 
(SWS). BF neurons also send projections to the lateral hypothalamus (LH), a 
wake- and arousal-promoting region and whose inhibition by the BF is thought to 
facilitate the appearance ofbehavioral quiescence and sleep. It is likely that these 
multiple roles are carried out by the heterogeneous population that comprises the 
BF, which include cholinergic, GABAergic and as yet putative glutamatergic 
neurons which, as shown by retro grade tracing, innervate these areas. To better 
understand the mechanisms through which BF neurons modulate cortical activity 
and sleep-wake states, research was carried out to determine the numbers of 
cholinergic, GABAergic and putative glutamatergic neurons in the BF, and to 
examine their respective efferent projections to the cortex and LH. Following 
stereological quantification of immunohistochemically identified ACh-, GABA-
and glutamate-synthesizing neurons, anterograde transport ofbiotinylated dextran 
amine 10,000 MW (BDA) in magnocellular BF neurons was combined with 
immunohistochemistry for vesicular transporter proteins (VTPs) for ACh 
(VAChT), GABA (VGAT) or glutamate (VGluT) for identification ofBF 
terminaIs in prefrontal cortex (PFC) and LH. Subsequent stereological analysis 
was used to determine contributions of cholinergic, GABAergic and newly 
identify glutamatergic BFaxon terminaIs to these areas. There, triple fluorescent 
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staining was perfonned to describe the innervation by BF tenninals of pyramidal 
and intemeuronal cell groups in the PFC and of the orexin/hypocretin cell 
population in the LH. Additional triple staining with postsynaptic markers was 
used to provide evidence for synaptic contacts. Together, these findings 
demonstrate the existence of at least three neuronal contingents ofBF neurons, 
which may have the capacity to modulate the activity of cortical or LH neurons 
and thus, to control different aspects of cortical activity and sleep-wake states. 
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RÉSUMÉ 
Le télencéphale basal (TB) joue des rôles multiples et divergents dans la 
modulation de l'activité corticale et le contrôle des états de veille-sommeil. 
Certains neurones du TB projètent dans le cortex cérébral, où ils promeuvent 
l'activation corticale durant l'éveil et le sommeil paradoxal alors que d'autres 
neurones peuvent au contraire promouvoir l'apparition de l'activité à ondes lentes 
qui se produit durant le sommeillent. Par ailleurs, des neurones du TB envoient 
des projections dans l'hypothalamus latéral, une région promouvant l'éveil et dont 
l'inhibition par le TB semble faciliter l'apparition de la passivité comportementale 
et du sommeil. Il est probable que ces multiples rôles sont exécutés par la 
population neuronale hétérogène que comprend le TB et qui inclut des neurones 
cholinergiques, GABAergiques et encore présumés glutamatergiques dont on sait 
par des techniques de traçage rétrograde des voies nerveuses qu'ils innervent le 
cortex cérébral et l'hypothalamus latéral. Afin de mieux comprendre les 
mécanismes à travers lesquels ces neurones modulent l'activité corticale et les 
états de veille-sommeil, nous avons cherché à déterminer le nombre de neurones 
cholinergiques, GABAergiques et présumés glutamatergiques dans le TB et à 
examiner leurs projections respectives dans le cortex cérébral et de 
l'hypothalamus latéral. Ainsi, après avoir quantifié par stéréologie les neurones 
identifiés par immunohistochimie dans le TB comme synthétisant l'acétylcholine, 
le GABA ou le glutamate, le transport antérograde du dextran amine biotinylé de 
10000 Da dans les neurones magnocellulaires du TB a été combiné avec une 
détection immunohistochimique des transporteurs vésiculaires de l'acétylcholine, 
du GABA ou du glutamate afin d'en identifier les axones terminaux dans le cortex 
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préfrontal et 1 'hypothalamus latéral. Ultérieurement, une analyse stéréologique 
dans ces régions a été utilisée pour déterminer la contribution des axones 
terminaux cholinergiques, GABAergiques et nouvellement identifiés 
glutamatergiques. En outre, des triples marquages fluorescents ont été effectués 
pour décrire l'innervation par les axones du TB des cellules pyramidales et des 
intemeurones dans le cortex préfrontal et des neurones à orexine/hypocrétine dans 
1 'hypothalamus latéral. Enfin, d'autres triples marquages avec des marqueurs 
postsynaptiques ont été utilisés pour indiquer de possibles contacts synaptiques. 
En conclusion, nos travaux démontrent l'existence d'au moins trois contingents de 
neurones du TB qui peuvent avoir la capacité de moduler l'activité des neurones 
du cortex cérébral ou de 1 'hypothalamus latéral et ainsi de contrôler les différents 
aspects de l'activité corticale et des états de veille-sommeil. 
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INTRODUCTION 
Mammals continuously alternate between three unique and distinctive 
behavioral states: wakefulness (W), slow wave sleep (SWS) and paradoxical sleep 
(PS). Each ofthese states is characterized by a particular combination of 
behavioral features and physiological correlates. W is behaviorally characterized 
by alertness, responsiveness, movement and goal directed behavior, which are 
physiologically paralleled by a low sensory threshold, high muscle tone, a 
relatively high sympathetic tone and, as indicated by the electroencephalogram 
(EEG), the presence oflow voltage/high frequency activity. Conversely, SWS 
(also known as non-rapid eye movement sleep, NREM) is distinguished by 
behavioral quiescence, higher sensory thresholds, lower muscle tone, increased 
parasympathetic tone and an EEG comprised by high amplitude/low frequency 
activity (~0.5 to 4 Hz), generally known as slow wave activity (SWA). PS (also 
called rapid eye movement sleep, REM) is also characterized by behavioral sleep, 
higher sensory threshold, absence of muscle tone (or atonia) and yet, by an 
activated EEG exhibiting low voltage/high frequency activity, "paradoxically" 
resembling that ofW (Jouvet, 1965; Jones, 2005b, c; Steriade, 2005). 
The generation of these states and associated phenomena are controlled by 
different regions and systems within the central nervous system (CNS) and whose 
dysfunction has been proposed to underlie the appearance of sleep- or sleep 
related-disorders including insomnia, restless legs syndrome, REM sleep behavior 
disorder and narcolepsy (Mignot et al., 2002; Jones, 2005b). Therefore, the study 
of the mechanisms by which these CNS regions promote and coordinate their 
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occurrence is relevant in the design of therapies and drugs aimed to treat them 
(Mignot et al., 2002; Jones, 2005a). 
Among CNS regions, the basal forebrain (BF, Figure 1) has been shown to 
play a critical role in the expression of cortical activation that occurs during W 
and PS (Buzsaki et al., 1988; Bemtson et al., 2002; Jones, 2004) as weIl as on the 
direct promotion of sleep (Sterman and Clemente, 1962a, 1962b; Szymusiak and 
McGinty, 1986a; Jones, 2005a). Through widespread projections to the cortical 
mantle (Kievit and Kuypers, 1975; Luiten et al., 1987; Gritti et al., 1997) BF 
neurons promote theta (-5 to 10 Hz) and gamma activity (>30 Hz) (Stewart et al., 
1984; Lee et al., 1994; Cape and Jones, 2000; Bemtson et al., 2002; Jones, 2004), 
both correlates of cortical activation and associated with other various cortical 
functions including neuronal pl asti city, sensory processing, sensory binding, 
memory formation and consciousness (Llinas and Ribary, 1993; Buzsaki and 
Chrobak, 1995; Jefferys et al., 1996; Sarter et al., 2003; Jones, 2004). 
ReciprocaIly, the BF promotes the appearance of cortical SW A that occurs 
during SWS as well as the generation of sleep itself, as stimulation of the BF 
leads to SW A and sleep (Sterman and Clemente, 1962a, 1962b; Szymusiak and 
McGinty, 1986a; Jones, 2005a), and conversely, lesions of the BF are associated 
with sleep loss and insomnia (von Economo, 1930; Nauta, 1946; McGinty and 
Sterman, 1968; Szymusiak and McGinty, 1986a). 
It is likely that these various and divergent roI es are carried out by 
chemically differentiated groups of neurons that populate the BF (Jones, 2005a). 
As suggested by several early studies (Krnjevic, 1967; Shute and Lewis, 1967; 
J ohnston et al., 1979; Lehmann et al., 1980), and confirmed by many others 
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(Kimura et al., 1980; Rye et al., 1984; Wainer and Rye, 1984; Gritti et al., 1997), 
there is a population of cholinergic neurons in the BF which send prominent 
projections to the cortex (Figure 2). These neurons have been shown to 
participate in cortical activation that occurs during W and PS (Jasper and Tessier, 
1971; Stewart et al., 1984; Manns et al., 2000a; Bemtson et al., 2002; Lee et al., 
2005b), as well as in cognitive and behavioral pro cesses that are mediated by the 
cortex (Everitt and Robbins, 1997; Sarter et al., 2003), as most evidently 
demonstrated by the deficits of cortical and cognitive function seen in 
Alzheimer's disease, which is associated with loss of cholinergic activity in the 
cortex (Davies and Maloney, 1976; Rossor et al., 1982) and a decrease in cortical 
activation (Jeong, 2004). 
Another major population of neurons that project to the cortex is 
GABAergic (Figure 2) (Zaborszkyet al., 1986; Fisher et al., 1988; Gritti et al., 
1997), which is part of a numerous population of GABAergic neurons that exist in 
the BF (Young et al., 1984; Brashear et al., 1986; Gritti et al., 1993). Although 
less is known about their role in cortical function, anatomical and physiological 
studies have suggested that subgroups of GABAergic BF neurons may play 
divergent roles in cortical activity, either by promoting cortical activation ofW 
and PS (Freund and Gulyas, 1991; Manns et al., 2000b, 2003a) or SWA ofSWS 
(Manns et al., 2000b; Jones, 2005a). 
In addition to cortical projections, GABAergic and a few cholinergic 
neurons provide a descending projection to the 1ateral hypothalamus (LH, Figure 
3) (Gritti et al., 1994). It has been proposed that this inhibitory projection may 
facilitate the appearance ofbehavioral quiescence and sleep (Gritti et al., 1994; 
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Manns et al., 2003b; Jones, 2005a), given the long known role of the LH in the 
behavioral display of arousal and the promotion of wakefulness (N auta, 1946; 
Hess, 1957; Lin et al., 1989; Sakai et al., 1990). Critically, it has been recently 
shown that neurons in the LH, which contain the peptide Orexin (Orx, or 
Hypocretin), play a cardinal role in the maintenance ofW, as their absence leads 
to narcolepsy (de Lecea et al., 1998; Peyron et al., 1998; Sakurai et al., 1998; 
Chemelli et al., 1999; Lin et al., 1999). Thus, it is plausible that the sleep 
promoting role of the BF may be carried out by direct inhibition of the LH and 
Orx neurons (Jones, 2005a). 
In spite this relatively vast knowledge about BF organization, there are 
several aspects of its anatomy that remain unsolved and may be relevant to our 
understanding of the mechanisms by which the BF modulates cortical activity and 
sleep-wake states. 
Retrograde tracing studies have estimated that cholinergie and GABAergic 
neurons represent ~25% and ~45% of the total contingent ofBF neurons 
projecting to the cortex (Gritti et al., 1997) and ~3% and ~20% ofthose projecting 
to the LH (Gritti et al., 1994), respectively. These results indicate that another 
non-cholinergie, non-GABAergic population must also participate in these 
projections and thus be part of the influence that the BF has over the cortex and 
LH (Figures 2 and 3). As recently proposed, they may comprise glutamate-
synthesizing neurons given the presence of the enzyme phosphate activated 
glutaminase (P AG), which is thought to participate in the synthesis of the 
neurotransmitter glutamate (Bradford et al., 1978; Kaneko and Mizuno, 1988) in a 
large, yet unknown, number ofBF neurons and in ~80% ofthose projecting to the 
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cortex (Manns et al., 2001). However, it is not known whether BF neurons may 
have the actual mechanisms to release glutamate from their axon terminaIs. 
Moreover, since P AG is also coexpressed in the vast majority of cholinergic 
(-95%) and a large proportion ofGABAergic (-60%) neurons, these results also 
indicate that in addition to pure1y glutamatergic neurons, cholinergic and 
GABAergic neurons might synthesize glutamate as well (Manns et al., 2001). 
Similarly, whether cholinergic and GABAergic neurons have the capacity to 
re1ease glutamate is as yet unknown. 
In addition, while the proportions of cholinergic, GABAergic and putative 
glutamatergic neurons that participate in these projections are known, the 
proportions ofaxon terminaIs that each of these groups provides to cortex and LH 
are not. This is a critical point since the pattern of innervation, in terms ofaxonal 
collateralization and density of synaptic terminaIs per volume may differ 
considerably among components and therefore may not necessarily reflect the 
proportion of neurons from which they appear. 
Finally, the innervation that each of these contingents provide to specific 
cortical cell groups, inc1uding principal and intemeuronal cell types is re1ative1y 
unknown. Likewise, the innervation that cholinergic, GABAergic and putative 
glutamatergic neurons provide to LH neurons, inc1uding Orx neurons, has not 
been established. 
To c1arify these important issues about BF organization, research was 
carried out to study in detail the BF neurochemical groups and their projections to 
cortex and LH. In this aim, the main of objectives of this project were: 1) to 
determine the number of glutamate-synthesizing neurons, as well as those 
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synthesizing ACh and GABA in the BF, 2) to assess in those neurons the presence 
ofmarkers for glutamate release, 3) to examine the presence ofmarkers for ACh, 
GABA and glutamate release in BF terminaIs innervating the cortex and LH, as 
well as their proportions and 4) to study the innervation that these groups provide 
to cortical and hypothalamic cclI groups. 
In the first place, the number of BF neurons immunohistochemically 
positive for choline acetyltransferase (ChAT, the synthetic enzyme for ACh), 
glutamic acid decarboxylase (GAD, the synthetic enzyme for GABA) and PAG, 
was determined by stereological analysis in seriaI sections of the rat BF. In 
addition, the presence of the recently identified vesicular transporter proteins 
(VTPs) for glutamate (VGluTs), as definitive markers for glutamatergic neurons 
(Bellocchio et al., 2000; Fremeau et al., 2001; Herzog et al., 2001; Fremeau et al., 
2002; Gras et al., 2002; Kaneko and Fujiyama, 2002; Schafer et al., 2002) was 
assessed in each BF population by dual immunohistochemical fluorescent 
staining. 
Second, axonal transport of the anterograde neuronal tracer biotinylated 
dextran amine 10,000 MW (BDA) from magnocellular BF neurons was combined 
with immunohistochemistry for the VTPs for ACh, V AChT (Gilmor et al., 1996; 
Arvidsson et al., 1997), GABA, VGAT (McIntire et al., 1997; Chaudhry et al., 
1998) or glutamate, VGluT (subtypes 1, 2 or 3) (Bellocchio et al., 2000; Fremeau 
et al., 2001; Fujiyama et al., 2001; Fremeau et al., 2002), as markers for 
neurotransmitter-specific releasing terminaIs, and examined in prefrontal cortex 
(PFC). There, estimates of the contribution of cholinergie, GABAergic and 
glutamatergic BFaxon terminaIs were determined by unbiased sampling 
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procedures in seriaI sections of the rat PFC. By using triple fluorescence staining 
for BDA, VTPs and the postsynaptic proteins (PSPs) gephyrin (Geph), as a 
marker for inhibitory synapses (Sassoe-Pognetto and Fritschy, 2000; Sassoe-
Pognetto et al., 2000) and PSD-95, as a marker for excitatory synapses (Komau et 
al., 1995; Sheng and Pak, 2000; Sassoe-Pognetto et al., 2003), the capacity ofBF 
terminaIs to form synapses was assessed. Finally, triple fluorescence staining for 
BDA, VTPs and the cell-specific markers non-phosphorylated neurofilament 
(NPNF) for pyramidal cells (Campbell and Morrison, 1989; Kirkcaldie et al., 
2002), and the calcium binding proteins (CBP) parvalbumin (PV) and calbindin 
(CB) for intemeurons (Celio, 1986, 1990) was used to examine the relation ofBF 
terminaIs to subpopulations of cortical neurons. 
Third, by single staining ofBDA and dual fluorescence staining ofBDA 
and VTPs, the projection to LH was also studied. Proportions ofLH neurons 
innervated, as weIl as the number and proportions of BF cholinergic, GABAergic 
and glutamatergic terminaIs present in the LH, were estimated by stereological 
analysis. Additionally, triple fluorescence staining ofBDA, VTPs and PSPs was 
used to examine the capacity of BF GABAergic and glutamatergic axons to form 
synapses with LH neuronal elements. 
FinaIly, the specific innervation ofthe orexin/hypocretin (Orx) neuronal 
population in the hypothalamus was analyzed. By dual staining for BDA and 
Orx, the innervation of Orx neurons by BF afferents was examined and 
quantitatively described. Then, triple fluorescent staining ofBDA, VTPs and Orx 
was used to examine the innervation of Orx neurons and determine quantitatively 
the contribution of each BF contingent to it. FinaIly, triple fluorescent stained 
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material for BDA, PSPs and Orx was performed to assess the synaptic nature of 
the innervation. 
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Figure 1: Basal forebrain nuclei. Depicted are five antero-posterior levels (~9.8 
to ~7.0 anterior to interaural zero) across the forebrain of the rat. The basal 
forebrain (BF, orange contours) consists of several telencephalic nuclei (blue 
contours) which include the medial septum (MS), the nucleus of the diagonal 
band (DBB), the magnocellular preoptic nucleus (MCPO), the anterior (or 
subcommissural) and posterior (or sublenticular) parts of the substantia 
innominata (SIa and SIp, respectively) and the gtobus pallidus (OP). What is 
common to these nuclei and here defines the BF is the presence of cortically 
projecting cholinergic neurons. BF nuclei also send prominent projections to 
subcortical regions (see text). Other abbreviations: A, amygdala; ac, anterior 
commissure; Acb, accumbens nucleus; BST, bed nucleus of the stria terminalis; 
cc, corpus callosum; CPu, caudate putamen; Cx, cerebral cortex; EP, 
entopeduncular nucleus; f, fornix; ic, internaI capsule; 10, lateral olfactory tract; 
LPO, lateral preoptic area; LS, lateral septum; ot, optic tract; OTu, olfactory 
tubercle; Rt, reticular thalamic nucleus. 
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Figure 2: Ascending projections ofthe basal forebrain. As part of an ascending 
activating system which originates in the reticular formation (grey arrows), the 
basal forebrain (BF, here represented by the substantia innominata, SI) provides a 
prominent innervation to the cerebral cortex (Cx) through which it promotes 
cortical activation during wakefulness (W) and paradoxical sleep (PS), as 
exemplified in the activated (low voltage, fast) EEG on the upper left. 
Constituents ofthis projection are BF neurons that synthesize acetylcholine (ACh, 
in blue), GABA (in red) and possibly glutamate (in green contours), as evident 
from the presence ofthe synthetic enzymes, choline acetyltransferase (ChAT, 
blue circle), glutamic acid decarboxylase (GAD, red triangle) and phosphate 
activated glutaminase (PAG, green open rhombus), respectively. Sorne 
GABAergic neurons may also promote slow wave activity during slow wave 
sleep (SWS). Other abbreviations: ac, anterior commissure; CPu, caudate 
putamen; Gi, gigantocellular reticular formation; GiA, gigantocellular reticular 
formation, alpha part; GiV, gigantocellular reticular formation, ventral part; GP, 
globus pallidus; Hi, hippocampus; ic, internaI capsule; LC, locus coeruleus; 
LDTg, laterodorsal tegmental nucleus; LH, lateral hypothalamus; Mes RF, 
mesencephalic reticular formation; ot, optic tract; PnC, pontine reticular 
formation, caudal part; PnO, pontine reticular formation, oral part; POA, preoptic 
area; PPTg, pedunculopontine tegmental nucleus; Rt, reticular thalamic nucleus; 
SN, substantia nigra; Sol, solitary tract nucleus; Th, thalamus; TM, 
tuberomammillary nucleus; VTA, ventral tegmental area. Modified with 
permission from Jones BE (2005a), Figure 1. 
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Figure 2. Ascending projections of the basal forebrain 
Figure 3: Descending projections of the basal forebrain. As part of a descending 
system involved in the suppression of arousal, the basal forebrain (BF, here 
represented by the substantia innominata, SI) provides a prominent innervation to 
the lateral hypothalamus (LH) and brainstem. The activity of this system would 
be involved in the promotion of sleep, along with the disfacilitation of muscle 
tone, which occurs during SWS, and its suppression, which occurs during 
paradoxical sleep (PS), as exemplified by the decreasing amplitude of 
electromyographic activity (EMG) on the lower right. This projection is 
comprised by neurons that synthesize GABA (in red) as indicated by the presence 
of glutamic acid decarboxylase (GAD, red triangles) in neurons retrogradely 
labeled from the LH. In addition, a few cholinergie (in blue) and a large number 
ofneurons that are neither GABAergic nor cholinergie (non-ChAT/non-GAD, 
green open rhombus) which could use glutamate (Glu, in green contours) 
contribute to this projection. Other abbreviations: ac, anterior commissure; 
ChAT, choline acetyltransferase; CPu, caudate putamen; Gi, gigantocellular 
reticular formation; GiA, gigantocellular reticular formation, alpha part; GiV, 
gigantocellular reticular formation, ventral part; GP, globus pallidus; Hi, 
hippocampus; ic, internaI capsule; LC, locus coeruleus; LDTg, laterodorsal 
tegmental nucleus; Mes RF, mesencephalic reticular formation; ot, optic tract; 
PnC, pontine reticular formation, caudal part; PnO, pontine reticular formation, 
oral part; POA, preoptic area; PPTg, pedunculopontine tegmental nucleus; Rt, 
reticular thalamic nucleus; SN, substantia nigra; Sol, solitary tract nucleus; Th, 
thalamus; TM, tuberomammillary nucleus; VT A, ventral tegmental area. 
Modified with permission from Jones BE (2005a), Figure 1. 
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REVIEW OF THE LITERATURE 
The BF has been proposed to play a role in the modulation of cortical 
activity and in the control ofbehavioral states. Through its direct projections to 
cortex and descending projections to LH, the diverse populations of cells that 
comprise the BF might contribute and regulate these processes. In this part, the 
most relevant anatomical and physiological data supporting a direct role of the BF 
in cortical activation and SW A, as well as on the direct control over the 
generation of sleep and re1ated phenomena are reviewed. Special attention is paid 
to unsolved issues and open questions, which are summarized in a separate 
section. The review is then finalized by a brief revision of the literature on the 
core basic techniques used in this project. 
1. General description 
Historically, the term basal forebrain has referred to a group of structures located 
in the medio-ventral aspect of the te1encephalon, often including cell groups of 
rather diverse anatomical as well as functional identity (Alheid and Heimer, 
1988). More recently, however, the term basal forebrain has been applied to the 
forebrain region that contains a population of cortically projecting cholinergic 
neurons (Butcher and Semba, 1989). In the rat, these te1encephalic structures 
form a continuum that from rostral to caudal includes the medial septum (MS), 
the nucleus ofthe diagonal band of Broca (DBB), the magnocellular preoptic 
nucleus (MCPO), the anterior (or subcommissural) and posterior (or 
sublenticular) parts ofthe substantia innominata (SIa and SIp, respectively) and 
the globus pallidus (GP). These structures share many anatomical and functional 
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characteristics, yet as we will see later, differ in the preponderance to which they 
project to different cortical structures. Here and in most of the chapters (II, III 
and IV) and unless specified, we generally use the term BF to refer to the 
magnocellular region of the MCPO, SI and GP, from where the major projections 
to the neocortex originate (Mesulam et al., 1983b; Mesulam et al., 1983a; Gritti et 
al., 1997). 
Limited dorsally by the striatum, laterally by the piriform cortex and 
medially by the lateral preoptic area, the BF lays within or just adjacent to the 
path ofthe medial forebrain bundle (MFB), the most important communicating 
pathway of the anterior brain (Nieuwenhuys et al., 1982; Veening et al., 1982; 
Geeraedts et al., 1990). This criticallocation allows BF neurons to receive 
multiple inputs arising from the ascending reticular activating system of the 
brainstem to relay such inputs to the cerebral cortex and promote cortical 
activation (Jones and Cuello, 1989; Gritti et al., 1997). It is through this pathway 
too, that the BF can influence reciprocally the LH and brainstem regions to 
promote, as seen previously and discussed more extensively in the next section, 
behavioral quiescence and sleep (Swanson, 1976; Grove, 1988; Gritti et al., 
1994). 
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2. Role of the basal forebrain in modulation of cortical activity 
2.1 Central mechanisms responsible for arousal and cortical activation 
Experiments done during the tirst half of the last century showed that ascending 
signaIs of the brainstem are critical for the appearance of cortical activation, a 
phenomenon that occurs in association with aroused states and wakefulness and 
characterized by the presence of low voltage and high frequency activities in the 
EEG (Jones, 2005b). As clearly shown by Bremer in his pioneering cerveau isolé 
preparation (Bremer, 1929), transections at the level of the mesencephalon 
eliminate cortical activation and leave the forebrain in a continuous sleep state, 
similar to that normally observed during SWS, as indicated by the presence of 
SWA in the cortical EEG. This observation led to the conclusion that afferent 
sensory signaIs, which enter or travel through the brainstem, were responsible for 
the appearance and maintenance of a waking and aroused state, and conversely, 
that their absence was the cause of sleep. Subsequent experiments showed, 
however, that the generalized activation of the EEG was evoked by stimulation of 
the brainstem reticular formation (RF) and could occur independently of sensory 
inputs, as lesions of the sensory pathways that ascend through the brainstem did 
not eliminate its occurrence (Moruzzi and Magoun, 1949). These results clearly 
indicated that wakefulness and the phenomenon of cortical activation (later also 
shown to occur during PS (Dement, 1958; Jouvet, 1965)) depended upon the 
brainstem reticular formation. 
The ascending pathways by which the RF stimulates the cortex were 
thought to rely in part on the so-called diffuse thalamic projection system, formed 
bya collection ofmidline and intralaminar thalamic nuclei that, by mean oflong 
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and widespread projections, would activate the cortical mantle (Moruzzi and 
Magoun, 1949). Nonetheless, since thalamic ablations did not completely 
eliminate cortical activation, either evoked by stimulation ofthe RF (Starzl et al., 
1951) or occurring spontaneously across the sleep-wake cycle (Villablanca and 
Salinas-ZebaIlos, 1972), the existence of another, extrathalamic pathway involved 
in this phenomenon was suggested (Starzl et al., 1951). This alternative pathway 
to the cortex was shown to involve a ventral route, through the hypothalamus and 
up to the BF from where signaIs were then transmitted to the cortex (Jones, 
2005b). 
2.2 Basalforebrain projections to cortex 
Although previously suggested by several studies (Starzl et al., 1951; Shute and 
Lewis, 1967), the requisite of a direct projection from the BF neurons to the 
cortex was first proven by Kievit and Kuypers (Kievit and Kuypers, 1975) using 
injections ofthe retro grade tracer horseradish peroxidase (HRP) into frontal and 
parietal cortices. They accordingly described a large group of cortically 
projecting neurons that were distributed ventrally across the BF as weIl as the 
hypothalamus. These projections, as subsequently shown by anterograde tracing 
from BF neurons, travel in association with subjacent white matter to then provide 
innervation to aIl corticallayers, yet clear regional differences in the laminar 
distribution of BFaxons have been observed (Saper, 1984; Gaykema et al., 1990; 
Freund and Gulyas, 1991). The projections from the BF to cortex were shown to 
present sorne degree of topography, in that more anterior regions of the BF project 
to more anterior and medial cortical areas, whereas more posterior levels of the 
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BF project to more caudal and lateral cortical areas (Lamour et al., 1982; Saper, 
1984; Luiten et al., 1987). Still, the basalo-projection was also shown to be 
widespread since single neurons were found to innervate different cortical regions 
(Adams et al., 1986) and reciprocally, specific cortical regions may be innervated 
by BF neurons 10cated in different nuclei (Price and Stem, 1983; Fisher et al., 
1988; Gritti et al., 1997). Through widespread projections, the BF and other 
extrathalamic forebrain regions may promote the simultaneous activation of the 
EEG in several and distant cortical areas as occurring during cortical activation 
(Moruzzi and Magoun, 1949; Starzl et al., 1951; Cape and Jones, 2000). 
In parallel to anatomical evidence, projections from BF neurons to cortex 
were shown to be critical for the appearance of cortical activation, as electrolytic 
(Lo Conte et al., 1982) or neurotoxic (Stewart et al., 1984; Buzsaki et al., 1988) 
lesions of the BF resulted in EEG changes from high frequency activity (over -20 
Hz) toward lower frequency activity (in the delta range, -0.5 to 4 Hz). This 
evidence supported thus the view of the BF as an anatomical and functional 
extrathalamic extension of the ascending reticular activating system (Buzsaki et 
al., 1988; Jones, 2005b), as originally inferred by Magoun and colleagues 
(Moruzzi and Magoun, 1949; Starzl et al., 1951). Consonant with this concept, 
microinjections in the BF of glutamate agonists (Cape and Jones, 2000) or 
noradrenaline (Cape and Jones, 1998), two important neurotransmitters used by 
the brainstem arousal system (Jones, 1991, 1995), were accompanied by increases 
in high frequency activity and active waking, with concomitant decreases in SW A 
and total suppression of sleep. 
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2.3 Cholinergie mechanisms in cortical activity and function 
2.3.1 Morphological aspect of the BF cholinergic population and their innervation 
to cortex 
Several neuronal groups carry out the influence of the BF over cortical 
activity, ofwhich the most known is that formed by neurons that synthesize ACh. 
The existence of this population was suggested almost 40 years ago by Shute and 
Lewis (Lewis and Shute, 1967; Shute and Lewis, 1967) who using histochemical 
staining for the catabolic enzyme for ACh, AChE, described eells of the MS, 
DBB, MCPO and GP, as well as other forebrain areas. However, as evidenee 
indicated that the sole presence of AChE did not necessarily indieate a cholinergic 
phenotype (Butcher, 1995), it was only with the advent of antibodies against the 
synthetic enzyme for aeetylcholine, ChAT, that the presence of ACh-synthesizing 
neurons in the BF was unequivoeally demonstrated (Kimura et al., 1980; Houser 
et al., 1983; Butcher, 1995). 
BF cholinergic neurons, as determined by ChAT immunohistochemistry 
(Kimura et al., 1981; Mesulam et al., 1983a; Wainer and Rye, 1984; Brashear et 
al., 1986; Gritti et al., 1993), distribute across BF nuc1ei where they can be 
generally classified as bipolar or multipolar cells, with a small number of 
radiating dendrites that, as for reticular neurons in the brainstem, are oriented 
perpendicular to the major passing fiber systems in the forebrain (Gritti et al., 
1993; Jones, 1995). As intermingled with other non-cholinergie cells (see below), 
cholinergie neurons represent only a portion of the total neuronal BF population, 
being estimated as -15,000 across BF nuc1ei (inc1uding the MS and DBB) (Gritti 
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et al., 1993). More recently, studies based on stereology estimated their number to 
be -26,000 (Miettinen et al., 2002). 
The projection that BF cholinergie neurons provide to the cortex was also 
proposed based on the existence ofneurons and emerging axons stained for AChE 
(Shute and Lewis, 1967), findings that were confirmed by subsequent studies 
combining ChAT immunostaining with retro grade tracing (Rye et al., 1984; 
Wainer and Rye, 1984). The cholinergie projection was also shown to present 
sorne degree of topography since cholinergie neurons of different BF areas 
innervated preponderantly, yet not exclusively, certain cortical areas (Rye et al., 
1984; Gritti et al., 1997). Thus, cholinergie neurons of the medial septum and 
verticallimb of the DBB provide innervation mainly to the hippocampal 
formation; cholinergie neurons in more ventral aspects ofDBB innervate 
retrosplenial as well as occipital cortex; whereas cholinergie neurons of the 
magnocellular area, including MCPO, SI and GP gave rise to projections to 
neocortex (Rye et al., 1984; Zaborszky et al., 1986; Gritti et al., 1997). Neurons 
in the MCPO also provide a prominent projection to olfactory bulb and olfactory 
cortices (Rye et al., 1984; Zaborszky et al., 1986). Cholinergie neurons are 
intermingled with other cortically projecting neurons (see below) and represent 
only a portion of the cortically projecting cells. Indeed, BF cholinergie neurons 
represent -20% of the projection to neocortex (Gritti et al., 1997). 
In the cortex, cholinergie axons have been observed that form a dense mesh 
innervating alllayers, as shown by a large number of studies using 
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immunohistochemistry for ChAT in cortical structures*. Differences in laminar 
distribution have been observed yet they are largely dependent on the cortical 
region studied (Lysakowski et al., 1986; Eckenstein et al., 1988; Lysakowski et 
al., 1989; Mechawar et al., 2000), and as proposed, they may reflect the functional 
role of ACh in each particular functional system (Lysakowski et al., 1986; 
Lysakowski et al., 1989; Beaulieu and Somogyi, 1991). Regional differences in 
density of innervation also exist, with frontal cortex presenting a higher density of 
cholinergic axons than parietal or occipital cortices (Mechawar et al., 2000). 
Cholinergic axons in the cortex have a relatively small diameter with small 
varicosities (Houser et al., 1985; Stichel and Singer, 1985; Mechawar et al., 
2000). They have been reported to forrn synaptic complexes, most often of the 
syrnrnetric type (Wainer et al., 1984; Houser et al., 1985; Beaulieu and Somogyi, 
1991). While synapses have been shown to be forrned on dendrites of pyramidal 
cells and intemeurons (Wainer et al., 1984; Houser et al., 1985; De Lima and 
Singer, 1986), detailed analysis of postsynaptic elements has indicated that 
cholinergic axons provide a richer innervation to dendrites of intemeurons, as 
identified by the presence of GABA irnrnunostaining, than to pyramidal cells 
(Beaulieu and Somogyi, 1991), indicating that part oftheir control over principal 
cell activity may be inhibitory. Yet, discrepancies exist conceming the frequency 
• In most mammals, cholinergie axons originate subcortically in the BF (Semba, 2004). However, 
an intrinsic population of cholinergie neurons has been described in the cortex of the rat (Houser et 
al., 1983; Houser et al., 1985), a portion ofwhich has been shown to belong to the group ofbipolar 
interneurons which express the vasoactive intestinal polypeptide (VIP) (Bayraktar et al., 1997). 
Still, it has been considered that their contribution to cortical cholinergie innervation should be 
relatively minor in comparison to subcortical afferents, as neurotoxic lesions in the cortex (which 
would only eliminate cortical cells but not subcortical axons), produced a decrease ofless than 
-8% in ChAT activity (Lehmann et al., 1980). 
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with which cholinergie axon terminaIs form synapses and therefore the main 
mechanism through which they influence cortical neurons of either type. Thus, 
whereas sorne authors have claimed that most cholinergie varicosities form 
synapses (Turrini et al., 2001), others have reported that they do so infrequently 
(De Lima and Singer, 1986; Mechawar et al., 2000), suggesting a prominent 
contribution of non-synaptic released of ACh (Descarries et al., 2004). 
2.3.2 Cholinergie neurons in the basal forebrain modulate cortical activity 
As shown by early studies, ACh had a facilitatory effect on cortical activity, since 
intracerebroventricular injections of muscarinic or nicotinic agonists (Domino et 
al., 1968) promoted the appearance ofhigh frequency as well as theta activity in 
the cortex and conversely, injections of muscarinic antagonists produced SW A 
(Domino et al, 1968; Stewart et al., 1984). Moreover, ACh was shown to be 
released maximally during W and PS (Jasper and Tessier, 1971), two states 
distinguished by the presence ofhigh frequency as well as theta activity on the 
EEG (Jones, 2005b). This facilitatory action of ACh could be in part explained 
by the slow and persistent excitatory effect that ACh had on pyramidal cells 
(Krnjevic, 1967), which as shown later depended on slow muscarinic currents 
(McCormick and Prince, 1985; McCormick, 1993). Similarly, this effect may 
also involve excitation of intemeurons, whose high frequency spiking might 
contribute to fast EEG activity (McCormick and Prince, 1985; McCormick, 
1993). 
Another determinant on the influence that the cholinergie system has on 
cortical activity may be the activity ofBF cholinergie neurons per se, which as 
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shown by recordings of immunohistochemically identified cholinergic neurons 
from BF slices in vitro, have the intrinsic capacity to discharge in high frequency 
burst of action potentials, which appear rhythmically at slow frequencies (Khateb 
et al., 1992), similar to those of theta activity. This activity has also been 
recorded from cholinergie neurons in in vivo anaesthetized rats, and shown to 
occur in parallel with high frequency and theta activity recorded on the EEG 
(Manns et al., 2000a). Recently, it has also been shown that in unanaesthetized 
rats BF cholinergie neurons discharge similarly during active W and PS (Lee et 
al., 2005b). 
The influence of the cholinergie system in the cortex has been shown to be 
critical for various processes that depend on the cortex, in particular those related 
to cognitive pro cesses such as attention, learning and memory (Everitt and 
Robbins, 1997; Sarter et al., 2003). These influences may relate to the role of the 
cholinergie system in promoting cortical fast activity, as the most clear hallmark 
in patients suffering from Alzheimer' s disease is a decrease in cortical fast 
activity (Jeong, 2004), which has been attributed to loss of cholinergie activity in 
both the BF (Rossor et al., 1982) and the cortex (Davies and Maloney, 1976). 
2.4 GABAergic neurons in the basal forebrain in the control of cortical activity 
2.4.1 Existence of a GABAergic population in the BF with ascending projections 
to cortex 
Another group ofBF neurons which provide massive projections to cortex 
is that comprised by GABA-synthesizing neurons. Following the development of 
antibodies against the synthetic enzyme for GABA, GAD, and their availability 
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for immunocytochemical studies in brain tissue (McLaughlin et al., 1974; Oertel 
et al., 1981), it was soon found that a large population of neurons in the BF were 
immunopositive for GAD (Young et al., 1984; Brashear et al., 1986). Although 
GABAergic and cholinergie neurons present similar morphology and distribution 
through the BF, it was determined that ChAT+ and GAD+ cells form two 
mutually exclusive groups with no (Gritti et al., 1993) or only minimal (Brashear 
et al., 1986) numbers of neurons showing colocalization of cholinergie and 
GABAergic markers. GAD+ cells in the BF represented approximately twice the 
number for ChAT + neurons (Brashear et al., 1986; Zaborszky et al., 1986), 
according to their number estimated as -31,000 (including those in the MS and 
DBB) (Gritti et al., 1993). 
Like cholinergie neurons, GAD+ neurons contribute significantly to cortical 
projections (Zaborszky et al., 1986; Fisher et al., 1988). Cortically projecting 
GABAergic neurons intermingle with and are also structurally and 
morphologically similar to cortically projecting cholinergie neurons (Fisher et al., 
1988; Gritti et al., 1997). As for their numbers, cortically projecting GABAergic 
neurons outnumber cholinergie ones in projections to cortex (Fisher et al., 1988; 
Gritti et al., 1997), as they represent -30% of the total projecting population, in 
contrast to the -20% originated from cholinergie neurons (Gritti et al., 1997). 
Whereas most studies have relied on retro grade transport to examine the BF 
GABAergic projection to cortex, yielding knowledge about the distribution, 
number and proportions ofGABAergic neurons in the BF, oruy a few have 
attempted to reveal the GABAergic cortical projection by use of anterograde 
tracing techniques. By combining transport of Phaseolus vulgaris leucoagglutinin 
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(PHA-L) from BF neurons with immunohistochemistry for GABA, ultrastructural 
analysis as weIl as morphological criteria, Freund and colleagues (Freund and 
Gulyas, 1991; Freund and Meskenaite, 1992) reported a population ofBFaxon 
terminaIs of relativelylarge size that were immunoreactive for GABA and formed 
symmetrical synapses. Although immunohistochemical staining for ChAT was 
not performed, this axonal type was assumed to represent non-cholinergic axons, 
since the cholinergic type was previously suggested to be formed by thin fibers 
and varicosities (Nyakas et al., 1987; Gaykema et al., 1990). The GABA stained 
axons formed synapses on morphologically identified intemeurons, manyof 
which also contained GABA. As assessed by light microscopic analysis and 
relying on morphological criteria, these axons were found, in the cat, to innervate 
intemeurons that expressed the calcium binding proteins (CBP) parvalbumin (PV) 
or the peptide somatostatin. Contrastingly, in the rat brain, BFaxons innervated 
only intemeurons containing the CBP calbindin (CB) and also those containing 
the peptide somatostatin. 
2.4.2 Role ofbasal forebrain GABAergic neurons in cortical activity 
Based on the prominent innervation of intemeurons by GABAergic BF neurons 
(see above), Freund and colleagues proposed that a major role ofGABAergic BF 
neurons could be the disinhibition of pyramidal cells (Freund and Meskenaite, 
1992) and thus, in synergism with cholinergic neurons, the promotion of cortical 
activation. 
However, neurons in the BF that have been recorded, labeled and identified 
immunohistochemically as GABAergic in the in vivo anaesthetized rat, form a 
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heterogeneous group in their discharge profiles in relation to cortical activity 
(Manns et al., 2000b). One of the main groups comprises neurons that increase 
their discharge during cortical activation induced by somatosensory stimulation. 
These neurons, sorne of which could be antidromically activated from the 
prefrontal cortex, discharge tonically at frequencies in the gamma range and 
simultaneously with gamma activity in the EEG. Therefore, these neurons have 
been proposed to promote cortical activation (Manns et al., 2000b, 2003a). 
However, another main group, which also includes neurons antidromically 
activated from the prefrontal cortex, comprises neurons that discharge maximally 
in association with irregular SWA and actually decrease their firing with cortical 
activation. Sorne ofthese neurons discharge phasically in bursts of action 
potentials at low «1 Hz) frequencies, similar to the SWA recorded in the EEG. 
Given the profile of activity, and that similar units have been recorded in the 
freely moving rat during SWS, this group has been proposed to comprise SWS-
active neurons (Lee et al., 2004; Jones, 2005a). 
2.5 Glutamatergic neurons in the basalforebrain 
Retrograde tracing studies from olfactory bulb (Zaborszky et al., 1986) or cortex 
(Fisher et al., 1988; Gritti et al., 1994) have shown that the number ofprojecting 
neurons is larger than the sum of cholinergie and GABAergic projecting neurons, 
indicating the existence of another population of neurons in the BF whose identity 
is unknown. Based on the presence of phosphate activated glutaminase (P AG) in 
a large proportion (~80%) ofBF neurons projecting to entorhinal cortex, it has 
been proposed that this population may be glutamatergic (Manns et al., 2001). 
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P AG, which is thought to participate in the synthesis of the neurotransrnitter pool 
of glutamate (Bradford et al., 1978), is present in identified glutamatergic 
neurons, including pyramidal as well cortically projecting thalamic cells (Kaneko 
and Mizuno, 1988). Hence, P AG neurons in the BF rnight also synthesize and use 
glutamate for neurotransrnission. However, P AG is also coexpressed in a high 
proportion of ChAT (~95%) and GAD (~60%) BF neurons, suggesting that 
cholinergie and sorne GABAergic neurons could synthesize and re1ease glutamate 
as well (Manns et al., 2001). 
Putative glutamatergic neurons, which are positive for P AG and negative 
for ChAT and GAD, have also been recorded in vivo in the anaesthetized rat 
(Manns et al., 2003a). These neurons, which by antidrornic activation were 
shown to project to cortex or olfactory bulb, increase their firing rate with cortical 
activation and dis charge rhythmically at slow theta-like frequencies in clusters of 
action potentials (with intracluster frequencies in the beta, ~20 Hz, range). 
Interestingly, the rhythmic activity ofthese neurons is coherent with slow 
rhythmic activity recorded frorn olfactory bulb and prefrontal cortex. These 
results thus show that putative glutamatergic neurons rnight contribute, in parallel 
to cholinergie and sorne GABAergic neurons, to cortical activation by prornoting 
cortical synchronization at theta and/or beta frequencies. 
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3. Role of the basal forebrain in sleep-wake states 
3.1 Forebrain regions involved in sleep promotion 
Following the epidemic of Encephalitis lethargica that spanned Europe during the 
second and third decade of the last century, Constantin von Economo documented 
disruption in the sleep-wake organization of a group of patients previously 
affected by Encephalitis (von Economo, 1930). Based on the post-mortem 
observation that lesions located in the preoptic are a, which included part of the 
BF, were associated with severe insomnia, whereas lesions located caudally in the 
posterior hypothalamus and upper brainstem were associated with somnolence, he 
postulated the existence of a sleep-controlling center formed by an anterior sleep-
promoting zone and a posterior wake-promoting one (von Economo, 1930). 
Years later, N auta studied experimentally the location and functional 
interconnections ofthese two areas in the rat, by performing transections at levels 
from the preoptic area down to the posterior hypothalamus, while leaving the 
connections between the RF and the thalamus intact. By these means, he allowed 
sensory inputs to reach the thalamus and cortex. Like von Economo, he observed 
that transections isolating the preoptic region from the rest of the hypothalamus 
resulted in severe insomnia and hyperactivity. Conversely, transections that 
isolated the posterior hypothalamus from anterior portions, lead to somnolence, 
adynamia and increases in behavioral sleep (Nauta, 1946). These results 
supported the hypothesis that sleep is an active process requiring of an intact 
anterior hypothalamic/preoptic region to appear and not resulting simply from the 
absence of sensory input. 
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In line with Nauta's observations, Hess, who was studying autonomic as 
well as motor functions of the forebrain and brainstem (Hess, 1957), found that 
electrical stimulation of anterior hypothalamus and preoptic region results 
consistently in parasympathetic responses, such as pupil contraction and decreases 
in heart rate, arterial blood pressure and muscle tone with the appearance of 
quiescent behaviors, including most commonly adynamia and sleep. In contrast, 
stimulation of the posterior-lateral hypothalamus produced arousal and autonomic 
responses associated with a sympathetic activation. 
3.2 Basalforebrain raie in sleep 
3.2.1 Lesions of the basal forebrain leads to insomnia 
To localize more precisely the forebrain regions that elicited sleep in the cat, 
Sterman and Clemente mapped the full extent of the BF and preoptic region, and 
found that brief periods of electrical stimulation in these regions triggered 
behavioral quiescence and sleep (Sterman and Clemente, 1962b). The appearance 
of sleep was also accompanied by cortical SW A of the same characteristics as 
those observed during normal SWS (Sterman and Clemente, 1962a). 
Accordingly, subsequent studies involving electrolytic (McGinty and Sterman, 
1968) or neurotoxic lesions (Szymusiak and McGinty, 1986a) of the BF were 
associated with sleep loss. 
3.2.1 Sleep active neurons in the basal forebrain 
The sleep promoting action of the BF could be carried out by neurons that have 
been recently shown to be selectively active during sleep, as indicated by the 
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expression of c-Fos in BF neurons following sleep deprivation and rebound 
(Modirrousta et al., 2004). Even more, since many ofthese neurons also express 
GAD, they could directly participate in the inhibitory processes that, as discussed 
in the next section, permit sleep to appear. Hence, this sleep active population 
may correspond to neurons that in the BF discharge maximally with SWS 
(Szymusiak and McGinty, 1986b, 1989; Lee et al., 2004; Jones, 2005a) and that, 
as SW A-active GABAergic neurons (Manns et al., 2000b), project to cortex and 
may be involved in the promotion of cortical SW A during SWS (Manns et al., 
2000b; Jones, 2005a). 
Sleep active GABAergic neurons may also correspond to neurons that in the 
BF increase their discharge rates continuously from W to SWS to be maximally 
active with PS (Lee et al., 2004; Jones, 2005a). The discharge ofthese sleep 
active neurons is negative1y correlated with muscle tone amplitude, and they may 
accordingly participate in the decrease and suppression ofmuscle tone which 
occur during SWS and PS (Jones, 2005a). In fact, a role ofthe BF in promoting 
suppression of muscle tone along with promotion ofPS has been previously 
suggested from experiments showing that stimulation of the BF with cholinergie 
agonists is able to evoke PS in cats (Hemandez Peon and Chavez Ibarra, 1963) or 
loss of muscle tone in dogs (Nishino et al., 1995). Similarly, selective stimulation 
of the BF cholinergie system with the peptide neurotensin evokes quiet waking 
state and PS, which occurs along with increases in theta activity and reduction of 
muscle tone (Cape et al., 2000). 
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3.2.3 Descending projections of the basal forebrain to the posterior and lateral 
hypothalamus 
One of the mechanisms through which the BF may promote sleep is through their 
massive descending projections to the LH which, as pointed out previously and 
discussed extensively in the next section, is important for arousal and generation 
ofW. As known from many studies, the BF sends prominent projections to 
subcortical regions, which include the hypothalamus and brainstem (Swanson, 
1976; Grove, 1988). By using the autoradiographic method, Swanson described 
fibers that descended through the MFB and gave rise to collaterals to the LH on 
their way to more posterior regions, such as the supramammillary bodies, ventral 
tegmental area and locus coeruleus (Swanson, 1976). These results were also 
confirmed by Grove, who by using anterograde and retro grade tracing techniques, 
described projections that reached posterior lateral hypothalamus, 
supramammillary regions and the brainstem (Grove, 1988). 
In contrast to the cortical projection, almost the totality of the BF 
subcortical projection arises from non-cholinergic neurons (Grove, 1988; Semba 
et al., 1989; Gritti et al., 1994). Importantly, this projection was shown to 
comprise a significant proportion of GABAergic neurons, as indicated by the 
presence of GAD staining in ~20% ofBF neurons retrogradely labeled from the 
posterior lateral hypothalamus (Gritti et al., 1994). 
3.3 The lateral hypothalamus in the control ofwakefulness 
As described, Nauta attributed a wake-promoting role to the posterior 
hypothalamus and Hess found this region to promote arousal. Subsequent studies 
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have confinned these observations by showing that electrolytic lesions of the 
posterior hypothalamus lead to a somnolent state (Swett and Hobson, 1968) and 
similarly, that chemical inactivation of the posterior hypothalamus pro duces sleep 
(Lin et al., 1989). The neurochemical identity of the neurons that may be 
responsible for these functions was unknown until the recent discovery of two 
excitatory neuropeptides, called orexin-1 and -2 (Orx, or also hypocretin-A and-
B). These peptides are expressed in a discrete population ofneurons in the tuberaI 
hypothalamus, including LH, perifomical region (PF) and dorsomedial 
hypothalamus (DMH) (de Lecea et al., 1998; Sakurai et al., 1998) and innervate 
most of CNS regions (Peyron et al., 1998). Orx neurons have been shown to be 
critical for arousal and W, since their absence, or that of the peptide, or the 
receptor resulted in narcolepsy in experimental animaIs (Chemelli et al., 1999; Lin 
et al., 1999). Narcolepsy is a human, equine and canine disease characterized by 
excessive sleepiness and is in most cases present together with cataplexy 
(narcolepsy-cataplexy), a sudden loss of muscle tone that in humans is triggered 
by strong emotions (Nishino and Mignot, 1997). In humans, narcolepsy-
cataplexy is the results of a degeneration of orexin-containing neurons whereas in 
dogs it is the result of a mutation in the receptor for Orexin 2 (Lin et al., 1999; 
Siegel, 1999; Peyron et al., 2000). The orexinergic system has been shown to 
have a strong facilitatory role on sympathetic (Kayaba et al., 2003; Zhang et al., 
2006) and hypothalamo-pituitary-adrenal (HP A) (Winsky-Sommerer et al., 2005) 
systems, as weIl as on muscle tone (Lin et al., 1999; Yamuy et al., 2004). 
Consonant with these findings, Orx neurons have been shown to discharge 
maximally during active W and to be silent during behavioral quiescence, SWS 
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and PS (Lee et al., 2005a). As Orx neurons have been shown to be endowed with 
mechanisms that allow them to be continuously active (Eggennann et al., 2003), it 
is therefore inferred that they must be under strong inhibition during behavioral 
quiescence and sleep. Part of this inhibitory drive may come from BF 
GABAergic neurons that provide a prominent innervation to the LH (Gritti et al., 
1994). 
41 
4. Unsolved issues and open questions 
In the previous sections, we have reviewed the organization of the BF and 
constitutive cellular groups and discussed their involvement in regulation of 
cortical activity and sleep wake states. Although our knowledge about the BF 
anatomy and function is vast, it is evident that many critical issues about BF 
neuronal constituency and organization of its projection system are still unsolved 
and therefore open for investigation. First, what type of cells constitute the BF? 
Are cholinergie and GABAergic cells the only efferent contingents of the BF? Is 
there another neuronal population that contributes to BF output? Secondly, do BF 
axons have the capacity to re1ease the neurotransmitters they are supposed to 
synthesize? Can they release more than one neurotransmitter? Finally, are BF 
projecting contingents organized in the same way? Do they project to the same 
regions, and within regions, do they form contacts with different cell types? 
These and other re1ated questions form the core of this thesis project. We 
believe that by answering them we will significantly contribute to the knowledge 
of BF organization and function. 
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5. Methodologies in the study of BF cell groups and projections 
The ascending and descending projections ofthe BF have been examined in great 
detail with the use ofanterograde and retro grade transport oftracers (Saper, 1984; 
Zaborszkyet al., 1986; Luiten et al., 1987; Grove, 1988; Gritti et al., 1994). 
Although providing detailed infonnation on morphology and spatial distribution 
of efferent fibers, anterograde tracing studies have generally not been able to 
unequivocally identify the neurochemical phenotype ofthose fibers, nor their 
neurochemically-specific distribution, morphology, number or targeted cell 
populations (Luiten et al., 1987; Grove, 1988; Gaykema et al., 1990). In fact, it is 
only from the use of retro grade tracing methods that, in combination with 
immunohistochemistry, most of the knowledge about neurochemical identity and 
contribution of cortically or caudally projecting BF cell groups has come (Rye et 
al., 1984; Zaborszkyet al., 1986; Gritti et al., 1994; Gritti et al., 1997; Manns et 
al., 2001). In spite ofthese advances, the lack of more definitive markers for 
neurotransmitter usage by BF neurons, along with the apparent overlap in cell 
body phenotype, makes necessary the examination and identification of the 
neurochemical identity ofBFaxon tenninals. 
Following this rationale, the core ofthis project has relied on the use of 
anterograde tracing techniques in combination with immunohistochemistry for 
definitive neurochemical markers of neurotransmitters in BFaxon tenninals. 
5.1 Anterograde transport of biotinylated dextran amines for axonal tracing 
Biotinylated dextran amine 10,000 MW (BDA-l 0,000; BDA) is a highly stable 
and non-toxic hydrophilic polysaccharide (dextran) conjugated to biotin and an 
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amme group. In its 10,000 MW fonn, BDA is a reliable anterograde tracer, which 
as PHA-L, labels axon fibers and tenninals with a Golgi-like quality with 
preservation of morphology at both the light microscopie and ultrastructurallevel 
(Veenman et al., 1992; Wouterlood and Jorritsma-Byham, 1993; Reiner et al., 
2000). However, the most critical advantage ofBDA is that in contrast to PHA-L, 
it does not require an immunohistochemical procedure for revelation, but only the 
avidin-biotin reaction, which may be done with a routine ABC protocol 
(Veenman et al., 1992; Wouterlood and Jorritsma-Byham, 1993). In addition to 
providing quicker and simpler means of revelation, the single staining of BDA 
does not require the use ofhigh concentrations of detergent for penneabilization, 
given the high affinity between avidin and biotin molecules and the relatively 
small size of the ABC complex (180,000 MW). Due to these advantages, BDA 
has been reliably used in combination with other staining techniques, including 
immunohistochemistry, for double or triple staining (Lanciego et al., 2000; Reiner 
et al., 2000; Wouterlood et al., 2002a). 
5.2 Vesicu/ar transporter pro teins as neurochemically specifie markers. 
Vesicular transporter proteins (VTPs) are recently identified molecules involved 
in the uptake ofneurotransmitter (or in sorne cases its substrate) from the cytosol 
to the synaptic vesicle lumen (Roghani et al., 1994; Peter et al., 1995; McIntire et 
al., 1997; Reimer et al., 1998; Bellocchio et al., 2000; Fremeau et al., 2001). As 
differentiated by their protein structure, uptake mechanism and substrate affinity, 
they represent markers for neurochemical phenotype and most notably, capacity 
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for neurotransmitter-specific synaptic release (Reimer et al., 1998; Fremeau et al., 
2004) 
The vesicular ACh transporter, V AChT, was originaIly identified from the 
unc-17 gene in Caenorabhditis elegans (Alfonso et al., 1993; Roghani et al., 
1994). This gene expresses a protein involved in the vesicular uptake of ACh and 
shows homology with the vesicular transporter for mono amines (VMAT) (Peter et 
al., 1995; Reimer et al., 1998). In the rat, the V AChT protein is present in aIl 
cholinergie ceIls groups described previously to express ChAT and localizes in 
somatic, dendritic as weIl as axonal compartments of cholinergic neurons in the 
CNS and peripheral ganglia (Gilmor et al., 1996; Arvidsson et al., 1997; Garzon 
and Pickel, 2000). In the cortex, YAChT has been found to be present in axonal 
varicosities forming synapses onto pyramidal ceIls which, as also observed with 
ChAT immunohistochemistry, are often of the symmetric type (Turrini et al., 
2001). Since it is involved in the vesicular release of ACh, YAChT represents a 
marker for cholinergic axon terminaIs. 
The vesicular GABA transporter (VGAT, or vesicular inhibitory amino acid 
transporter, VlAAT) was originally identified from the unc-47 gene in C. elegans, 
as a protein involved in the uptake of GABA and glycine for synaptic release and 
found to present no homology to VMAT or V AChT (McIntire et al., 1997; Sagne 
et al., 1997). In mammals, VGAT is expressed at symmetric synapses where it 
colocalizes with GABA and/or glycine (Chaudhry et al., 1998). In contrast to the 
synthetic enzyme for GABA, GAD, VGAT is absent in most ceIl bodies within 
the CNS. 
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~- The vesicular glutamate transporters (VGluTl, 2 or 3, VGluTs) were 
identified and cloned recently (Bellocchio et al., 2000; Fremeau et al., 2001; 
Herzog et al., 2001; Fremeau et al., 2002; Gras et al., 2002; Schafer et al., 2002). 
In contrast to VMAT, YAChT or VGAT, VGluTs do not show homology with 
any of previously identified VTPs (Fremeau et al., 2004). Indeed, VGluTI and 2 
had been already described in the brain as proteins involved in the transport of 
phosphate (as the brain-specific Na(+)-dependent inorganic phosphate co-
transporter (BNPi) and the differentiation-associated Na(+)-dependent inorganic 
phosphate cotransporter (DNPi), respectively) without a direct role in glutamate 
uptake (Ni et al., 1994; Ni et al., 1995; Aihara et al., 2000; Hisano et al., 2000; 
Fujiyama et al., 2001). VGluTI and VGluT2 neurons are profuse within the CNS 
and, as identified by in situ hybridization, exhibit a complementary distribution 
throughout the CNS. In the forebrain, VGluTl neurons are abundant in the cortex 
and hippocampus, whereas VGluT2 neurons appear predominant in subcortical 
structures. Like VGAT, neither VGluTl nor VGluT2 accumulate in cell bodies 
but are found exclusively in axon terminaIs (Fremeau et al., 2001; Fujiyama et al., 
2001). Both VGluTl and VGluT2 have been found present in axon terminaIs 
forming synapses of the asymmetric type (Bellocchio et al., 1998; Fremeau et al., 
2001; Fujiyama et al., 2001). VGluT3, on the other hand, was originally 
described as being expressed by restricted populations of neurons in the CNS, 
which surprisingly included cholinergic neurons in the striatum and serotonergic 
neurons of raphe nuclei (Fremeau et al., 2002; Gras et al., 2002; Kaneko and 
Fujiyama, 2002; Herzog et al., 2004). Yet, as recent reports suggest, VGluT3 
may be expressed more ubiquitously (Harkany et al., 2003; Harkanyet al., 2004). 
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In contrast to VGluTI and VGluT2, VGluT3 is not only found in axon terminaIs 
but also in cell bodies and dendrites (Fremeau et al., 2002; Harkanyet al., 2004). 
Remarkably, somato-dendritic VGluT3 has been shown to participate in the 
release of glutamate from the soma and dendrites of pyramidal cells (Harkany et 
al., 2004). 
These markers were accordingly utilized for the definitive identification of 
BFaxon terminaIs and varicosities that have the capacity to release ACh, GABA 
or glutamate. 
Contingent upon the presence of these markers, additional evidence for 
synaptically mediated transmission was sought by the presence of postsynaptic 
proteins in association with identified BFaxon terminaIs. To this end, the 
presence of PSD-95, a protein constituent of postsynaptic densities of excitatory 
synapses and involved in the anchoring ofNMDA and AMPA glutamate 
receptors at these synapses (Komau et al., 1995; Chen et al., 2000; Sheng and 
Pak, 2000; Sassoe-Pognetto et al., 2003) was examined in relation to BFaxons 
having the capacity to release glutamate, ACh or GABA. Similarly, the presence 
of Gephyrin, (Geph) a protein involved in the synaptic clustering of GABAAR and 
glycine receptors and present at inhibitory synapses (Giustetto et al., 1998; 
Sassoe-Pognetto and Fritschy, 2000; Sassoe-Pognetto et al., 2000) was examined 
in relation to GABAergic, cholinergie and glutamatergic terminaIs. 
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PREFACE TO CHAPTER 1 
The numerous roles that the BF plays in modulating cortical function and 
behavioral state are like1y carried out by neurochemically differentiated groups of 
neurons that comprise the BF. ACh- and GABA-synthesizing cell groups have 
been well described in the BF, yet together they do not account for the total BF 
neuronal population, nor for those contingents projecting to cortex or caudally to 
the hypothalamus. It has been recently proposed that a third population ofBF 
neurons might comprise glutamate-synthesizing neurons, based on the expression 
ofPAG in the cell bodies of a large proportion ofBF neurons. As a tirst step in 
identifying and characterizing this putative population, the total number of 
neurons, inc1uding those containing PA G, plus those containing ChAT and GAD, 
was quantitied in the BF using unbiased sampling procedures. In addition, the 
presence of a newly described family of proteins involved in the vesicular uptake 
and release of glutamate was examined in cells containing ChAT, GAD and P AG, 
as an independent, yet functionally complementary indication of a glutamatergic 
phenotype. 
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the rat, comprising neurons containing choline acetyltransferase, 
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Abbreviations: 
A amygdala 
ac anterior commissure 
Acb accumbens nucleus 
ACh acetylcholine 
AD anterodorsal thalamic nucleus 
AHA anterior hypothalamic area 
AM anteromedial thalamic nucleus 
Arc arcuate hypothalamic nucleus 
AV anteroventral thalamic nucleus 
BF basal forebrain 
BST bed nucleus of the stria terminalis 
ChAT choline acetyltransferase 
Cl claustrum 
CM central medial thalamic nucleus 
CPu caudate put amen 
DBB diagonal band of Broca nucleus 
En endopiriform nucleus 
EP entopeduncular nucleus 
f fornix 
FStr fundus striati 
G gelatinosus thalamic nucleus 
GAD glutamic acid decarboxylase 
Glu glutamate 
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GP globus pallidus 
IAM interanteromedial thalamic nucleus 
ic internaI capsule 
LD laterodorsal thalamic nucleus 
LH lateral hypothalamic area 
10 lateral olfactory tract 
LOT nucleus of the lateral olfactory tract 
LPO lateral preoptic area 
LS lateral septal nucleus 
MCPO magnocellular preoptic nucleus 
MD mediodorsal thalamic nucleus 
MPO medial preoptic nucleus 
MS medial septal nucleus 
NR neutral red 
oc optic chiasm 
ot optic tract 
OTu olfactory tubercle 
Pa paraventricular hypothalamic nucleus 
PAG phosphate-activated glutaminase 
PC paracentral thalamic nucleus 
Pe periventricular hypothalamic nucleus 
Pir piriform cortex 
PT paratenial thalamic nucleus 
PV paraventricular thalamic nucleus 
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Re reuniens thalamic nucleus 
Rh rhomboid thalamic nucleus 
Rt reticular thalamic nucleus 
SCh suprachiasmatic nucleus 
SFi septofimbrial nucleus 
SI substantia innominata 
SIa substantia innominata anterior 
SIp substantia innominata posterior 
sm stria medullaris of the thalamus 
SO supraoptic nucleus 
st stria terminalis 
TT tenia tecta 
YAChT vesicular acetylcholine transporter 
VGAT vesicular GABA transporter 
VGluT vesicular glutamate transporter 
VL ventrolateral thalamic nucleus 
VM ventromedial thalamic nucleus 
VMH ventromedial hypothalamic nucleus 
ZI zona incerta 
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ABSTRACT 
The basal forebrain (BF) plays an important role in modulating cortical activity 
and influencing attention, leaming and memory. These activities are fulfilled 
importantly yet not entirely by cholinergie neurons. Noncholinergic neurons also 
contribute and are comprised by GABAergic neurons and other possibly 
glutamatergic neurons. The aim of the present study was to estimate the total 
number of cells in the BF of the rat and the proportions of that total represented 
by cholinergie, GABAergic and glutamatergic neurons. For this purpose, cells 
were counted using unbiased stereological methods within the medial septum, 
diagonal band, magnocellular preoptic nucleus, substantia innominata and globus 
pallidus in sections stained for Nissl substance and/or the neurotransmitter 
enzymes, choline acetyltransferase (ChAT), glutamic acid decarboxylase (GAD) 
or phosphate-activated glutaminase (P AG). In Nissl-stained sections, the total 
number ofneurons in the BF was estimated as ~355,OOO and the numbers of 
ChAT-immuno-positive (+) as ~22,OOO, GAD+ ~119,OOO and PAG+ ~316,OOO, 
corresponding to ~5%, ~35% and ~90% of the total. Thus, of the large population 
ofBF neurons, only a small proportion has the capacity to synthesize 
acetylcholine (ACh), one third to synthesize GABA and the vast majority to 
synthesize glutamate (Glu). Moreover, through the presence ofPAG, a 
proportion of ACh- and GABA-synthesizing neurons also have the capacity to 
synthesize Glu. In sections dual fluorescent immunostained for vesicular 
transporters, VGluT3 and not VGluT2 was present in the cell bodies of most 
PAG+ and ChAT+ and halfthe GAD+ cells. Given previous results showing that 
VGluT2 and not VGluT3 was present in BFaxon terminaIs and not colocalized 
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with YAChT or VGAT, we conclude that the BF cell population influences 
cortical and subcortical regions through neurons which release ACh, GABA or 
Glu from their tenninals but which in part can also synthesize and release Glu 
from their soma or dendrites. 
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INTRODUCTION 
As evident from the devastating effects of lesions, the basal forebrain (BF) plays 
a critical role in cortical and state modulation, which influences sleep-wake 
states, attention, learning and memory (Damasio et al., 1985; Dunnett et al., 
1991; Wenk, 1997; Sarter et al., 2003; Jones, 2004). This role has been 
attributed particularly to the cholinergic neurons and their widespread 
projections to the allo- and neo-cortex. Yet, selective neurotoxic lesions of the 
cholinergic neurons have not produced the same overwhelming effects as the 
totallesions of the BF (Lee et al., 1994; Baxter et al., 1995; Gerashchenko et al., 
2001a), indicating that other BF neurons participate in cortical and state 
modulation. It is thus important to characterize and quantify the noncholinergic 
as well as cholinergic constituents of the BF cell population. 
Acetylcholine (ACh)-synthesizing neurons are distributed across BF nuc1ei 
ofthe medial septum-diagonal band of Broca (MS-DBB), from where they give 
rise to prominent projections to hippocampus, and the magnocellular preoptic-
substantia innominata-globus pallidus (MCPO-SI-GP), from where they give rise 
to prominent projections to neocortex (Rye et al., 1984). Another well-defined 
contingent of the BF cell population contains the synthetic enzyme for GABA. 
Neurons containing glutamic acid decarboxylase (GAD) are codistributed with 
the those containing choline acetyltransferase (ChAT), and large GAD-positive 
(+) neurons project in parallel with ChAT+ neurons from the MS-DBB to the 
allocortex and from the MCPO-SI-GP to the neocortex (Kohler et al., 1984; 
Brashear et al., 1986; Zaborszky et al., 1986; Fisher et al., 1988; Freund and 
Antal, 1988; Freund and Meskenaite, 1992; Gritti et al., 1993; Gritti et al., 1997). 
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In contrast to ChAT + neurons, GAD+ neurons also give rise to important 
descending projections to the hypothalamus and brainstem (Semba et al., 1989; 
Gritti et al., 1994), and they likely also include local intemeurons. In the BF, the 
GAD+ plus the ChAT + neurons do not account for all the cortically projecting, 
nor for all the caudally projecting BF neurons (Gritti et al., 1997; Gritti et al., 
2003). It was thus proposed that the nonGABAergic, noncholinergic BF neurons 
are likely glutamatergic neurons. 
The synthesis of glutamate (Glu) as a neurotransmitter in neurons occurs 
from the substrate glutamine, which is taken up from glia, and by the 
mitochondrial enzyme phosphate-activated glutaminase (P AG) (Bradford et al., 
1978). In immunohistochemical studies in the neocortex, P AG was found to be 
contained predominantly in pyramidal neurons and rarely in GABAergic 
intemeurons (Donoghue et al., 1985; Kaneko and Mizuno, 1988; Akiyama et al., 
1990; Kaneko et al., 1992; Kaneko and Mizuno, 1994; Van der Gucht et al., 
2003). In a previous study, we thus utilized P AG to label Glu-synthesizing 
neurons in the BF (Manns et al., 2001). In that study, we found that a major 
proportion of neocortically projecting BF neurons contained P AG and would 
accordingly have the capacity to synthesize Glu as a neurotransmitter. By 
applying stereology, we sought in the present study to determine the total 
numbers ofChAT+, GAD+ and PAG+ neurons along with the total number of 
all, Nissl-stained, neurons in the BF of the rat. 
Given that the numbers and proportions ofPAG+ cells exceeded that of the 
ChAT -negative (-) and GAD- cells in the present study and that a proportion of 
ChAT + and GAD+ cells were found to be P AG+ in a previous study (Manns et 
56 
al., 2001), we also examined in the present study whether ChAT+, GAD+ and/or 
P AG+ cells contained the vesicular transporters for Glu (VGluT) and could thus 
store and release Glu as a neurotransmitter (Fremeau et al., 2001; Fujiyama et 
al., 2001; Fremeau et al., 2002). Using RT-PCR or in situ for mRNA or 
immunohistochemistry for protein, VGluT2 has been found to be synthesized in 
BF neurons and transported along their axons to terminaIs from where it is 
released as a neurotransmitter and VGluT3 to be contained in BF nerve cell 
bodies and dendrites from where it can be released to act as a retro grade signal 
(Harkany et al., 2003; Hajszan et al., 2004; Colom et al., 2005; Danik et al., 
2005; Hur and Zaborszky, 2005; Henny and Jones, 2006a). Employing 
colchicine treatment to block axonal transport, we examined dual 
immunostaining by fluorescence for the enzymes and VGluTs to determine the 
proportion of each cell type that would have the capacity to release Glu. 
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EXPERIMENTAL PROCEDURES 
Animais and surgery 
Results from six adult male Wistar rats (Charles River Canada, St. Constant, 
Quebec, Canada), weighing approximately 250 grams, are reported in this study. 
AH procedures were approved by the McGill University Animal Care Committee 
and conform to standards of the Canadian Council on Animal Care. For surgery 
or euthanasia, the rats were anesthetized with sodium pentobarbital (Somnotol, 65 
mg/kg, i.p.). Three rats were operated ~24 hours prior to killing for injections of 
colchicine (50 J-lg in 25 J-li saline) into the lateral ventricle, as previously applied 
(Gritti et al., 1993; Gritti et al., 1997) for enhancing levels of GAD in ceH bodies 
and here for also enhancing levels ofVGluTs within dual-immunostained tissue 
(below). AH rats were killed by perfusion with a fixative through the ascending 
aorta. 
Perfusion and fIXation 
Brains were fixed with Zamboni's solution, according to a slight modification of 
the procedure developed by Kaneko for immunostaining of the P AG enzyme 
(Kaneko and Mizuno, 1988; Kaneko et al., 1989; Manns et al., 2001). FoHowing 
a brief rinse with phosphate buffered saline, the animaIs were perfused through 
the ascending aorta with 500 ml ofa modified Zamboni's solution of 0.3% 
paraformaldehyde and 75% saturated picric acid in 0.1 M sodium phosphate 
buffer (pH 7.0, over ~30 minutes). The brains were post-fixed overnight at 4°C in 
a solution of3% paraformaldehyde with 75% saturated picric acid (pH 7.0). They 
58 
were subsequently immersed in a solution of 30% sucrose at 4°C for ~ 72 hours 
for cryoprotection. Brains were then frozen at -50°C and stored at -80°C. 
Immunohistochemistry 
Coronal sections were cut on a freezing microtome with a thickness of 20 Jlm, 
which was established as the thickest that allowed full and even penetration of 
antibodies (particularly for P AG). The sections were collected at 400 Jlm 
intervals in twenty adjacent series used for different immunostaining. For random 
starting and ordering of the series, a random number generator was employed to 
determine which series would be immunostained with ChAT, GAD or P AG in 
each brain. The sections were collected in phosphate buffer (pH 7.4; O.IM). 
For peroxidase immunostained series (from 3 untreated rats, Gl, G2 and 
G3), sections were tirst incubated in a Tris-saline solution (TS, 0.1 M) containing 
bovine serum albumin (BSA) at 3% for prior blocking and at 1 % for all other 
applications. As previously employed (Gritti et al., 2003), antisera for ChAT 
(from rabbit, 1 :2000) were obtained from Chemicon International (Temecula, CA, 
USA: ABI43). Also previously employed (Manns et al., 2001), antisera for PAG 
(from rabbit, 1 :6000) were kindly supplied by Dr. T. Kaneko (Kyoto, Japan) who 
originally showed that the antisera recognizes two bands of peptides at 62 and 65 
kD, corresponding to the two isoforms of rat brain PAG (Akiyama et al., 1990). 
Aiso previously employed (Gritti et al., 2003), antisera for GAD (from rabbit, 
1 :3000) were obtained from Chemicon (AB 1 08) and shown by them using 
Western Blot to recognize a 67 kD band of protein from rat brain, corresponding 
to GAD67. Sections were incubated overnight at room temperature with primary 
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antibodies for ChAT and PAG or for three nights at 4° C with those for GAD. 
The sections were subsequently incubated with donkey anti-rabbit antiserum 
(1:100, Jackson ImmunoResearch Laboratories, West Grove, PA, USA) followed 
by rabbit peroxidase-antiperoxidase (P AP, 1 :200, Jackson). P AP was revealed 
using diaminobenzidine (DAB) in the presence of 0.1 % glucose oxidase in Tris-
buffer (pH 7.4) during 15 min for ChAT, 13 min for PAG and 17 min for GAD. 
For the PAG series, DAB was intensified with nickel (DAB-Ni), and the sections 
were counterstained for Nissl using Neutral Red (NR). 
For dual fluorescent immunostained series (from 3 colchicine treated rats, 
G5, G6 and G7), sections were incubated in a Tris-saline solution (0.1 M) 
containing Triton x-1 00 at 0.1 % and normal donkey serum (NDS) at 3% for prior 
blocking and at 1 % for the rest of the procedure. The primary antibodies for 
VGluT2 and VGluT3 (both from guinea pig) were obtained from Chemicon 
(AB5907 and AB5421, respectively) and were found in previous studies (Henny 
and Jones, 2006a) to provide staining similar to that published with other 
antibodies for these proteins (Fremeau et al., 2001; Fremeau et al., 2002). The 
primary antibody for GAD (from mouse) was obtained from Chemicon 
(MAB5406) and shown by them to recognize a 67 kD band in rat brain. Sections 
were co-incubated ovemight at room temperature with the primary antibodies 
against 1) VGluT2 (1:5000) and PAG (as above), 2) VGluT3 (1:1000) and PAG 
(as above), 3) VGluT3 and ChAT (as above), or 4) VGluT3 and GAD67 (1 :500). 
The sections were then co-incubated for 2 hours with Cy3-conjugated donkey 
anti-guinea pig (1: 1 000, Jackson, for VGluT2 or VGluT3) and Cy2-conjugated 
60 
donkey anti-rabbit (1 :200, Jackson, for ChAT or PAG) or Cy2-conjugated donkey 
anti-mouse (1 :200, Jackson, for GAD67). 
Controls were routinely carried out by replacing the primary antisera with 
normal sera from the same species and at the same concentration to insure that 
nonspecific staining did not OCCUf. After processing, all sections were washed in 
phosphate buffer, mounted out of TS, dehydrated through graded alcohols, 
delipidated in xylene and coverslipped using Permount (Fisher, Fair Lawn, NJ, 
USA). 
Stereological analysis 
Sections were viewed using a Leica DM LB microscope equipped with an x/y/z 
movement-sensitive stage and video camera connected to a computer. Cells were 
plotted and images acquired for figures using Neurolucida software 
(MicroBrightField, MBF, Williston, VT, USA). In three brains processed for 
peroxidase immunostaining, cells were counted using StereoInvestigator software 
(MBF). Plotting and counting were done using a computer resident atlas of the 
forebrain, which was designed according to cytoarchitectonic and 
chemoarchitectonic principles (Geeraedts et al., 1990; Gritti et al., 1993). For this 
purpose, outlines of sections and contours of the major nuc1ei were drawn in 
Neurolucida from series of sections which were collected at 400 !lm intervals and 
stained for Nissl, Klüver-Barrera, ChAT and GAD. The levels of the atlas 
correspond approximately to those of the Paxinos and Watson atlas (Paxinos and 
Watson, 1986), although from anterior (A) 8.6 (from interaural zero), at which 
level our sections are matched to the Paxinos and Watson atlas, extending 
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rostrally and caudally, they differ slightly (~1 0% difference). For stereological 
estimates, cell counts were performed within the atlas contours of the BF nuclei in 
12 sections at 400 Ilm intervals from A 7.0 to A1l.0. For plotting and illustrating 
the distribution of cells in the BF nuclei, cells were plotted in 6 sections at 800 Ilm 
intervals. In each case, histological sections of each series were matched to 
computer atlas templates using low magnification (5 or 10x) objectives. When 
necessary the contours of the atlas were slightly adjusted to fit the nuclei of the 
histology section. Plotting or counting was then performed within the contours at 
high magnification using a 63x Oil objective with a 1.4 numerical aperture and an 
oil condenser. For plotting cells for illustration oftheir distribution in figures 
using Neurolucida, alliabeled neuronal cell profiles in the BF nuclei contours 
were marked through the full depth of individual (20 Ilm thick cut) sections. 
In each series ofthree brains (G1, G2 and G3) immunostained by 
peroxidase, immuno-positive (+) or NR+ cells were counted by applying 
systematic unbiased sampling using the Optical Fractionator probe of 
StereoInvestigator. The cells were counted within 6 nuclei in the BF: MS, DBB, 
MCPO, SIa, SIp and GP. For each nucleus, labeled cells were counted on one 
si de of the brain in at least 4 sections (4 - 7, depending upon the length of each 
nucleus) at 400 Ilm intervals (1120 sections sampled). A counting frame of 89 x 
89 Ilm (7921 Ilm2) and a sampling grid of200 x 200 Ilm (40,000 Ilm2) were 
employed. Since the average thickness of the mounted sections was ~ 10 Ilm 
across series and brains, a dissector height of 8 Ilm below the surface was 
employed. From the top surface of each section, cells were counted if the top of 
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the cell came into focus beneath the surface and within the dissector height. The 
sampling thus included 5% ofthe sections, -20% of the area of each nucleus and 
-80% of the height of the section for an overall sampling of -0.8% of the volume 
of each nucleus through the BF. Accordingly, an average of -894 sampling sites 
were employed for counting cells in an average total volume for the six BF nuclei 
of -11.34 mm3• In initial sampling and for the duration of the counting, the 
precision of the estimates was checked by referring to Gundersen's Coefficient of 
Error (CE, ml). The average CE (in 3 brains) for the total number of cens across 
the BF was 0.08 for the ChAT+ cells, 0.04 for the GAD+ cens, 0.02 for the 
PAG+/NR+ cens and 0.06 for the PAG-/NR+ cens. 
Additional series processed for dual fluorescent immunostaining for 
VGluTs and PAG, ChAT, or GAD were analyzed under epifluorescent 
microscopy on the Leica DMLB microscope equipped with filters appropriate for 
Cy2 (FITC) and Cy3 (rhodamine) detection. In each dual immunostained series 
ofthree brains (G5, G6 and G7), immuno-positive cens were counted by applying 
systematic unbiased sampling using the Optical Fractionator probe of 
Stereolnvestigator for estimates of proportions of double-Iabe1ed cens within the 
MCPO at one leve1 (-A8.2). The probe was run twice in each series, so as to 
sample the same population of cells but with different (Cy3 or Cy2) filters. A 
counting frame of 89 x 89 ~m (7921 ~m2) and a sampling grid of 200 x 200 ~m 
(40,000 ~m2) were employed, such as to sample an average of -30 sites in each 
series. A dissector height of 8 ~m was used in this series of mounted sections 
which had an average thickness of 8 ~m. 
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Color photographs were prepared using Adobe Photoshop and schematic 
figures from the computer atlas images from Neurolucida using Adobe Illustrator 
(Adobe Systems, San Jose, CA, USA). 
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RESULTS 
Distribution and estimates of ChAT +, GAD+ and P AG+ neurons 
As evident in the MCPO (Fig. 1), ChAT+, GAD+ and PAG+ neurons were 
codistributed through the nuclei of the BF cholinergic cell area. Darkly stained 
with DAB, ChA T+ cells were most commonly medium to large in size, fusiform 
to polygonal in shape and in sorne regions grouped in clusters (Fig. lA). Also 
darkly stained with DAB, GAD+ cells were variable in size from small to large, 
oval to polygonal in shape and relative1y densely distributed through all areas 
where cholinergic cells were present (Fig. lB). In sorne places, large GAD+ cells 
also formed small aggregates. Stained in a punctate manner with black DAB-Ni, 
P AG+ neurons were also variable in size from small to large, oval to polygonal in 
shape and more numerous than the ChAT+ or GAD+ cells (Fig. lC). PAG+/NR+ 
cells were codistributed with less numerous NR+ cells that did not contain PAG+ 
punctate staining and were thus considered PAG-/NR+ cells. Like the 
PAG+/NR+, these were also variable in size and shape. Along with GAD+ celIs, 
the P AG+ cells were evident across aIl the BF nuclei where cholinergic cells were 
located, including the MCPO (Fig. 1), the DBB (Fig. 2A), the SIa (Fig. 2B), the 
SIp (Fig. 2C) and the GP (Fig. 2D). In each ofthese areas, the PAG+/NR+ ceIls 
were codistributed with less numerous PAG-/NR+ cells (Fig. 2). AlI cell types 
were also present in the olfactory tubercle (OTu), but were not included in the 
present survey. 
From rostral to caudal, ChAT + cells were distributed through the MS, 
DBB, MCPO, SIa, SIp and GP (Fig. 3), in sorne places in aggregates, as described 
previously (Gritti et al., 1993). Ubiquitously, though not evenly, intermingled 
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with the ChAT + cells, GAD+ cells were densely distributed through the same 
regions (Fig. 4). Throughout, P AG+/NR + cells were present in the highest 
density along with less numerous PAG-/NR+ (Fig. 5). 
Using the Optical Fractionator probe of StereoInvestigator, total cell 
numbers were estimated for each cell type across the BF nuclei from three rats 
(G 1, G2 and G3; Table 1). The average total numbers of cells estimated in this 
manner were -22,000 ChAT+ cells, -119,000 GAD+ cells, -315,000 PAG+ cells 
and 350,000 (PAG+/ and PAG-I) NR+ cells. According to these estimates the 
cell densities were -2000 ChAT+, 11,000 GAD+ cells, 28,000 PAG+ and 31,000 
NR+ cells per mm3• The relative proportions of cells were -5% ChAT+, 35% 
GAD+ and 90% PAG+ of the total (NR+) cell population. Except within the GP, 
these proportions were similar across nuclei of the BF. 
Proportions ofPAG+, ChAT+ and GAD+ neurons containing VGluT 
In order to determine ifPAG+, ChAT+ and/or GAD+ cells contained VGluTs, 
dual fluorescent immunostained series were examined from colchicine treated rats 
(G5, G6 and G7). In series dual immunostained for P AG and VGluT2 (Fig. 6A), 
the VGluT2 staining was prominent within axon terminaIs and varicosities (Fig. 
6A2). In contrast, it was not evident at levels above background in cell bodies of 
neurons in the BF, despite colchicine pretreatment. Under these conditions, 
P AG+ nerve cell bodies were judged to be negative for VGluT2 immunostaining 
(Fig. 6Al and A2). 
In series dual immunostained for the synthetic enzymes and VGluT3 (Fig. 
6B-D), the VGluT3 staining was prominent in a small number ofaxon terminaIs 
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and in many nerve cell bodies. In sections dual irnrnunostained for P AG and 
VGluT3, most P AG+ cells contained VGluT3 (Fig. 6B 1 and B2). Using unbiased 
estimates through the MCPO, approximately 70% of P AG+ cells were judged to 
be immuno-positive for VGluT3 (mean ± standard deviation from three rats, SD: 
70.3% ± 26.7%). Reciprocally, almost all VGluT3+ neurons were positively 
stained for PAG (96.3% ± 4.4%). In sections dual immunostained for ChAT and 
VGluT3, the vast majority ofChAT+ neurons were judged irnrnuno-positive for 
VGluT3 (Fig. 6Cl and C2). Indeed, VGluT3 was present in -90% of the ChAT+ 
cells (88.9% ± 19.2%). In sections dual irnrnunostained for GAD and VGluT3, 
about half of the GAD+ neurons were judged to be irnrnuno-positive for VGluT3 
(46.8% ± 21.6%) (Fig. 6Dl and D2). 
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DISCUSSION 
The present stereological estimates reveal a very large cell population in the BF of 
the rat that is comprised of only a small proportion of ACh-synthesizing neurons 
together with a significant proportion of GABA-synthesizing neurons and major 
proportion of Glu-synthesizing neurons. Given the overlapping numbers, a 
proportion of ACh- and GABA-synthesizing neurons could also synthesize Glu. 
The vast proportion of Glu-synthesizing neurons also appear to have the capacity 
to store and release Glu either through VGluT2, which is present in axon 
terminaIs, or through VGluT3, which is present in most Glu- and ACh- and about 
halfthe GABA-synthesizing nerve cell bodies. These results indicate that 
glutamate can be synthesized in the cell bodies of a major proportion of BF cells 
and if not released from terminaIs, re1eased from the soma or dendrites of 
glutamatergic but also many cholinergie and GABAergic neurons to contribute to 
the local processing as well as efferent output and consequential functional 
influence of the BF. 
Numbers and proportions of neurons able to synthesize ACh, GABA and/or 
Glu 
We employed stereological analysis for estimating total cell numbers through the 
volume of the BF nuc1ei in the present study. We first had to determine 
appropriate immunohistochemical processing and stereological procedures for 
counting immunostained cells. We leamed that we could not use sections thicker 
than 20 !lm in order to have full and even penetration ofthe antibodies for ChAT, 
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GAD and P AG through the full depth of the sections. We subsequently found that 
these sections were reduced to an average 10 /lm thickness once they were 
dehydrated, delipidated and coverslipped. We were thus not able to apply what 
are otherwise considered to be optimal conditions for stereological counts which 
set guard zones at the top and bottom of the sections and count through more than 
10 /lm through the middle ofthe section (West, 1993). We adopted a strategy 
instead of counting the tops of cells which came into focus beneath the surface of 
the section and through 8 /lm of the z axis. We moreover had to count cells based 
upon their immunostaining and thus of the cytoplasm, not the nucleus, which we 
thus did for the NR staining ofthe cytoplasm as weIl. Given several adjacent 
series of sections that were stained from each brain, we randomized the start of 
each series and collected sections at every 400 /lm. This collection procedure 
thus provided for sampling of each series, 12 sections through the BF cholinergic 
cell area and 4 to 7 sections through each individual nucleus, depending upon its 
length. We subsequently selected a counting frame size that would provide >3 
cells on average to be counted per frame per series across the BF. And finally we 
selected a grid size that provided > 100 cells of each type to be counted per series 
across the BF. In practice, the sampling proved to be just adequate for the ChAT + 
cells and more than adequate for the other cells, particularly the P AG+ cells. 
We obtained an average estimate ofChAT+ cells of ~22,000 which is 
higher than the average estimate, ~ 15,000 (excluding the OTu), we previously 
calculated using counts corrected for double counting according to estimates of 
cell size and section thickness by the Abercrombie method (Abercrombie, 1946). 
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However, these two estimates are not statistically significantly different when 
compared between the two groups and thus support the contention that 
Abercrombie corrected counts can be successfully used to estimate cell numbers if 
applied appropriate1y (Guillery and Herrup, 1997). In the present sample, the 
variation across brains was re1atively high with a coefficient of variation (CV: 
SD/mean) of 0.33. It is not known ifthis variation is due to sampling ofwhat is 
an inhomogeneously distributed population of cens that tend to c1uster in groups 
or to individual variation in the number of cens across rats. To our knowledge, 
there is one other published estimate of the total number of ChAT + cens in the rat 
BF which is 26,390 (Miettinen et al., 2002). 
The number of GAD+ cens, ~ 119,000, estimated here by stereology 
significantly and greatly exceeds the number, ~30,000 (exc1uding the OTu), 
previously estimated by us using Abercrombie corrected counts (Gritti et al., 
1993). This three fold difference cannot be attributed to differences in counting 
method. It is undoubtedly due to the use of a different antibody for staining GAD. 
In our previous study, we employed the original sheep anti-GAD antiserum 
(Oerte1 et al., 1981), whereas in the current study we employed the more recent 
rabbit anti-GAD antiserum directed against the GAD67 isoform of the enzyme 
(Chemicon), which is present in the soma ofmost GABAergic cens and appears 
to provide greater sensitivity for staining cen bodies at least in the BF. We did 
also find a re1atively large variation in the number of GAD+ cells across brains 
with a CV of 0.39. As for the ChAT+ cens, it could be due to the somewhat 
uneven distribution of GAD+ cells. It could also be due to individual differences 
in numbers of GAD+ cens. Such variation for GAD+ neurons (stained for 
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GAD67) has been noted by others using stereological estimates in the dentate 
gyrus and associated with a CV of 0040 (Muller et al., 2001). In those studies, the 
variation was actually attributed to individual variation in the number of GAD+ 
cells across rats (see be1ow). For comparison, we know ofno other estimates for 
GAD+ cell numbers across the BF. 
The number ofPAG+ neurons was estimated here at ~316,000. This 
estimated number had the smallest CV of 0.14, indicating possibly that the large 
number and density as well as more even distribution of the P AG+ neurons was 
associated with more similar estimates across brains. Or it indicates that there is 
less variation in the number of P AG+ neurons. By adding the number of P AG-
/NR+ neurons to those of the PAG+/NR+ neurons, we estimated the total 
population of cells in the BF as ~355,000 with a CV of 0.15. We know of no 
other published estimates ofPAG+ or total BF cell population. 
The PAG+ neurons represented ~90% of the BF cell population. Given 
that the ChAT+ cells represent ~5% and the GAD+ ~35%, it appears that there is 
an overlap in the three populations. We first employed P AG based upon 
immunohistochemical studies showing that it selectively labe1ed glutamatergic 
pyramidal cells and rare1y labe1ed GABAergic intemeurons in the cortex 
(Donoghue et al., 1985; Kaneko and Mizuno, 1988; Akiyama et al., 1990; Kaneko 
et al., 1992; Kaneko and Mizuno, 1994). On the other hand, in our previous study 
we found that P AG was present in ~95% of ChAT + cells and ~60% of GAD+ 
(also >50% of parvalbumin+) cells in the BF (Manns et al., 2001; Gritti et al., 
2003). As discussed in that original study on cortically projecting neurons, the 
colocalization of these neurotransmitter enzymes could indicate that Glu could be 
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synthesized and utilized together with ACh and GABA in the same neurons. 
P AG can also serve to provide Glu for the synthesis of GABA (Pow and 
Robinson, 1994). The clear presence ofPAG- neurons in the BF, indicates that 
certain neurons do not contain this enzyme for the conversion of glutamine to 
Glu. In the cortex, evidence was presented that GABAergic intemeurons do not 
contain P AG and contain instead high concentrations of soluble aspartate 
arninotransferase (sAA T) through which they could utilize a-ketoglutarate to 
produce Glu as a precursor for GABA (Kaneko and Mizuno, 1994). The nurnbers 
ofthe PAG-/NR+ cells (-39,000) correspond to approxirnately40% of the GAD+ 
cell population that was the proportion of GAD+ cells found to be negative for 
PAG in our previous study (Manns et al., 2001). Together with our previous 
results, the present results suggest that sorne neurons contain P AG and GAD and 
have the capacity to synthesize both Glu and GABA or to utilize Glu synthesized 
by P AG for GABA synthesis, whereas others have the capacity to synthesize 
GABA alone through a different rnetabolic pathway for Glu. Perhaps the capacity 
for sorne PAG+ neurons to synthesize GABA frorn Glu through the presence of 
GAD is realized under certain conditions, as has been found for what are 
glutamatergic neurons in the dentate gyms, which in addition to P AG, express 
GAD, and synthesize and release GABA following kindling (Kaneko and 
Mizuno, 1988; Sloviter et al., 1996; Gornez-Lira et al., 2005). 
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Proportions of neurons able to release Glu through VGluTs 
Since implementation of immunohistochemical staining of the synthetic enzymes 
for ACh, GABA and Glu, the vesicular transporter proteins have been identified, 
which are responsible for the uptake, storage and release of ACh (V AChT) 
(Gilmor et al., 1996), GABA (VGAT) (Chaudhry et al., 1998) and Glu (VGluT 1 
and 2) from nerve terminaIs (Fremeau et al., 2001; Fujiyama et al., 2001). 
Presence of specifie vesicular transporters in terminaIs of neurons thus indicates 
use of the substrate as a neurotransmitter. Whereas YAChT is present in the soma 
and dendrites of cholinergie neurons, VGAT and VGluTl12 are only found in the 
axonal varicosities and terminaIs. Sorne investigators have visualized VGluT2 in 
nerve cell bodies of neurons in the MS-DBB using very high doses (3 times those 
used in the present study) of colchicine (Hajszan et al., 2004; Colom et al., 2005), 
yet such doses also stimulate mRNA for many enzymes and peptides (Cortes et 
al., 1990). Using previously established and approved doses of colchicine which 
block axonal transport (Gritti et al., 1993), we were unable to detect VGluT2 in 
nerve cell bodies ofneurons in the BF. It was thus not possible to employ 
immunohistochemical staining of cell bodies for this vesicular transporter to 
determine which BF neurons utilize Glu. In situ hybridization for mRNA of the 
vesicular transporters has been successfully employed in BF and revealed that 
sorne neurons contain mRNA for VGluT2 (Hur and Zaborszky, 2005). From RT-
PCR studies, it also appeared that mRNA for VGluT2 can be colocalized with 
mRNA for ChAT and/or GAD in young and adult rats (Sotty et al., 2003; Danik et 
al., 2005). Thus, as for the presence of P AG, the presence of mRNA for VGluT2 
in ChAT and GAD expressing neurons suggested that BF neurons have the 
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potential to synthesize Glu and the vesicular transporters necessary for its 
utilization along with ACh or GABA as neurotransmitters. In contrast, by 
immunohistochemical study of the vesicular transporters contained in 
anterogradely labeled BF terminais, we have found that the BF fibers are 
phenotypically distinct, containing YAChT, VGAT or VGluT2 in their terminais, 
and thus functionally cholinergie, GABAergic or glutamatergic (Henny and Jones, 
2006a). In the descending projections to the hypothalamus, the VAChT+ 
terminaIs represented a small proportion (-10%), the VGAT+ terminaIs the 
largest proportion (-50%) and the VGluT2+ terminais -25%. The estimate of 
glutamatergic BF projection neurons in our studies is similar to that recently 
estimated for the MS-DBB, though using different techniques, as representing 20-
25% (Colom et al., 2005). On the other hand, these similar estimates leave in 
further question why such a large proportion ofBF neurons contain PAG, 
induding ChAT + and GAD+ neurons. 
In addition to VGluTl and 2, a third type ofVGluT was discovered and 
found to be present in cell bodies as weIl as terminais of neurons and moreover to 
be present within cholinergie neurons in the striatum (Gras et al., 2002) and 
GABAergic intemeurons in the cortex (Fremeau et al., 2002; Herzog et al., 2004). 
VGluT3 was also reported to be present in many BF neurons, induding both 
cholinergie and presumed GABAergic, parvalbumin-immunostained, neurons 
(Harkany et al., 2003). In the present study, we found that VGluT3 is present in 
the soma ofBF neurons dual-immunostained for ChAT, GAD or PAG. In our 
previous studies, we did not find VGluT3 to be contained in terminaIs ofBF 
projecting fibers to either hypothalamus (Henny and Jones, 2006a) or cortex 
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(Henny and Jones, in preparation). Its presence in the cell bodies thus presumably 
does not indicate that the cells have the capacity to release Glu from axon 
terminaIs. On the other hand, VGluT3 has been shown to endow the soma and 
dendrites of cells with the capacity to release Glu that Can act as a retro grade 
signal upon afferent inputs (Fremeau et al., 2002; Harkany et al., 2003; Harkany 
et al., 2004). Here, the vast majority ofChAT+ cells and about halfthe GAD+ 
cells were judged immuno-positive for VGluT3. These proportions are very 
similar to those estimated for the ChAT+ and GAD+ cells that respectively 
contained PAG (Manns et al., 2001), indicating together with our previous results 
showing a lack ofVGluT3 in BF terminaIs (above, (Henny and Jones, 2006a», 
that these neurons would have the capacity to synthesize and release Glu not from 
axon terminaIs but from their cell bodies or dendrites. A large proportion (~70%) 
of P AG+ neurons were immunostained for VGluT3 and virtually all VGluT3+ 
neurons were immunostained for P AG, indicating that most Glu-synthesizing 
neurons would have the capacity to release Glu from their cell bodies or dendrites. 
It is thus possible that the presence of P AG in ChAT + and GAD+ neurons (Manns 
et al., 2001) does reflect the capacity to synthesize Glu as a neurotransmitter or 
modulator, however one which is released through VGluT3 from the soma and 
dendrites of neurons which otherwise release ACh or GABA through V AChT or 
VGAT respectively from their axon terminaIs. The presence ofPAG in ChAT-
and GAD- neurons likely reflects the capacity ofthose neurons to synthesize Glu 
as a neurotransmitter that Can be released from axon terminaIs presumably 
through VGluT2 and/or from cell bodies through VGluT3. Accordingly, the 
presence ofPAG in the major proportion ofBF neurons indicates that in addition 
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to ACh and GABA, Glu plays a major part in the distant and local influences of 
the BF neurons. 
Given the large population of BF neurons and the small percentage 
comprised by the cholinergie cells, it is not surprising that nonselective lesions of 
the BF have had much more devastating effects upon cortical activity and 
behavioral state than selective cholinergie celliesions (Damasio et al., 1985; 
Dunnett et al., 1991; Wenk:, 1997; Sarter et al., 2003; Jones, 2004). Thus the 
important role played by the cholinergie cells must be viewed as contingent upon 
the influence of the predominant GABAergic and glutamatergic cells along with 
the potential modulation exerted by Glu, which can be synthesized and released 
from such a large proportion of BF neurons. 
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Table 1. Stereological estimates ofnwnbers and proportions ofChAT+, GAD+, PAG+ and total (NR+) cells in basal forebrain. 
Sections Sampled Sites Sampled 
Nucleus 
ChAT+ cells 
MS 
OBB 
MCPO 
Sla 
Slp 
GP 
Total BF 
GAO+cells 
MS 
OBB 
MCPO 
SIa 
SIp 
GP 
TotalBF 
PAG+cells 
MS 
OBB 
MCPO 
SIa 
SIp 
GP 
Total BF 
NR+ cells (Total) 
4 
5 
7 
4 
6 
12 
4 
5 
7 
4 
6 
12 
4 
5 
7 
4 
6 
12 
MS 5 
OBB 4 
MCPO 5 
SIa 7 
SIp 4 
GP 6 
Total BF 12 
Mean ± SO 
78.7 ± 1.5 
64.0 ± 5.3 
104.7 ± 8.1 
187.0 ± 19.7 
100.0 ± 7.9 
359.3 ± 10.2 
893.7 ± 23.0 
79.7 ± 4.0 
66.0 ± 8.7 
106.3 ± 7.5 
181.7 ± 12.5 
101.3 ± 4.7 
358.7 ± 10.5 
893.7 ± 13.6 
78.3 ± 2.3 
62.0 ± 7.8 
103.7 ± 6.0 
185.0 ± 12.2 
100.7 ± 7.2 
356.3 ± 4.7 
886.3 ± 15.0 
78.3 ± 2.3 
62.0 ± 7.8 
103.7 ± 6.0 
185.0 ± 12.2 
100.7 ± 7.2 
356.3 ± 4.7 
886.3 ± 15.0 
Volume (mm3) 
Mean ± SO 
0.939 ± 0.044 
0.738 ± 0.109 
1.310 ± 0.112 
2.241 ± 0.245 
1.200 ± 0.094 
4.941 ± 0.140 
11.369 ± 0.316 
0.940 ± 0.046 
0.765 ± 0.136 
1.313 ± 0.092 
2.173 ± 0.197 
1.210 ± 0.087 
4.932 ± 0.135 
11.334 ± 0.276 
0.939 ± 0.044 
0.738 ± 0.109 
1.328 ± 0.088 
2.193 ± 0.163 
1.197 ± 0.096 
4.910 ± 0.069 
11.304 ± 0.235 
0.939 ± 0.044 
0.738 ± 0.109 
1.328 ± 0.088 
2.193 ± 0.163 
1.197 ± 0.096 
4.910 ± 0.069 
11.304 ± 0.235 
Cells Counted 
Mean ± SO 
16.3 ± 15.0 
45.7 ± 13.2 
43.0 ± 21.9 
17.0 ± 1.7 
21.7 ± 13.8 
33.7 ± 13.7 
177.3 ± 57.7 
120.7 ± 78.8 
62.7 ± 34.4 
131.0 ± 78.1 
216.0 ± 130.0 
63.0 ± 26.5 
353.0 ± 47.5 
946.3 ± 369.6 
309.0 ± 56.6 
287.0 ± 64.0 
470.0 ± 60.5 
653.3 ± 54.2 
292.0 ± 64.0 
494.7 ± 115.9 
2,506.0 ± 347.4 
342.3 ± 65.3 
321.7 ± 74.5 
508.0 ± 76.5 
769.7 ± 115.6 
324.7 ± 73.0 
544.7 ± 124.1 
2,811.0 ± 432.2 
CellNumber 
Mean ± 
2,062 ± 
5,765 ± 
5,429 ± 
2,146 ± 
2,735 ± 
4,250 ± 
22,388 ± 
SO 
1,891 
1,667 
2,769 
219 
1,742 
1,723 
7,290 
15,234 ± 9,946 
7,911 ± 4,347 
16,538 ± 9,860 
27,269 ± 16,411 
7,954 ± 3,347 
44,565 ± 5,992 
119,471 ± 46,657 
39,010 ± 7,149 
36,233 ± 8,080 
59,336 ± 7,639 
82,481 ± 6,848 
36,864 ± 8,083 
62,450 ± 14,632 
316,374 ± 43,860 
43,218 ± 
40,609 ± 
64,133 ± 
97,168 ± 
40,988 ± 
68,762 ± 
354,879 ± 
8,245 
9,411 
9,663 
14,591 
9,216 
15,672 
54,558 
Cell Oensity 
Mean ± SO 
2,158 ± 1,954 
7,740 ± 1,379 
4,147 ± 2,122 
969 ± 180 
2,275 ± 1,484 
866 ± 364 
1,976 ± 661 
16,279 ± 10,473 
9,891 ± 4,581 
12,806 ± 8,074 
12,652 ± 8,138 
6,508 ± 2,429 
9,052 ± 1,351 
10,528 ± 4,107 
41,384 ± 5,832 
49,811 ± 12,461 
44,571 ± 3,007 
37,881 ± 5,594 
30,979 ± 7,744 
12,713 ± 2,920 
28,006 ± 3,992 
45,832 ± 6,829 
56,222 ± 16,845 
48,129 ± 4,243 
44,777 ± 9,677 
34,438 ± 8,759 
13,995 ± 3,113 
31,433 ± 5,132 
% Total 
Mean ± 
4.4 ± 
14.5 ± 
8.5 ± 
2.2 ± 
6.3 ± 
6.1 ± 
6.2 ± 
SO 
3.7 
4.2 
4.3 
0.2 
3.4 
1.9 
1.3 
36.9 ± 24.1 
20.6 ± 12.4 
26.2 ± 15.6 
29.2 ± 17.9 
20.6 ± 10.1 
65.7 ± 6.8 
34.1 ± 12.8 
90.5 ± 5.7 
89.6 ± 5.8 
92.7 ± 2.0 
85.6 ± 7.8 
90.0 ± 0.7 
90.8 ± 2.3 
89.4 ± 3.7 
100.0 ± 
100.0 ± 
100.0 ± 
100.0 ± 
100.0 ± 
100.0 ± 
100.0 ± 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
Cells were counted and total cell numbers estimated using the Optical Fractionator probe of Stereolnvestigator in the number of sections (every 
400 /lm) and sites (89 x 89jtm by 8 jtm depth counting blocks) indicated along with the estimated volume and corresponding cell density (per 
mm
3) pernucleus. The % total represents the proportion that each cell type represents ofthe Nissl-stained (NR+) cells per nucleus, which was 
calculated as the total number ofNR+ (PAG+INR+ plus PAG-/NR+) cells. 
Fig. 1. Images ofChAT+ (A), GAD+ (B) and PAG+ with NR+ (C) neurons in 
the magnocellular preoptic nucleus (MCPO, ~A8.5). ChAT and GAD are 
revealed with DAB (brown), and PAG is revealed with DAB-Ni (black) along 
with Nissl stained by Neutral Red (NR) (on right side in adjacent series from rat 
G3). Many cells are immuno-positive for PAG (PAG+/NR+, black arrowheads), 
evident as black granules over the cytoplasm, and are codistributed with fewer 
cells which are immuno-negative for PAG and stained for NR (PAG-/NR+, white 
arrowheads). Scale bar = 25 ~m. 
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Fig. 1. Images of ChAT + (A), GAD+ (B) and PAG+ with NR+ (C) neurons in the 
magnocellular preoptic nucleus (MCPO, -A8.S) 
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Fig. 2. Images ofPAG+/NR+ and PAG-/NR+ neurons in different BF nuclei. 
PAG+/NR+ cells (black arrowheads) are codistributed with PAG-/NR+ cells 
(white arrowheads) (on right side in same series from rat G3) in the nucleus ofthe 
diagonal band of Broca (DBB, -A9.4, in A), the substantia innominata, pars 
anterior (SIa, -A8.6 in B), the substantia innominata, pars posterior (SIp, A7.8 in 
C) and the globus pallidus (GP, -A7.8 in D). Very small NR stained cells were 
judged to be glia and not counted as neurons. Scale bar = 25 Ilm. 
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Fig.2. Images of PAG+/NR+ and PAG-/NR+ neurons in different BF nuclei 
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Fig. 3. Distribution ofChAT+ neurons in the BF. Each symbol marks one 
ChAT+ cell plotted in one 20 Ilm thick section (from rat 03) on computer-based 
atlas templates. See list for abbreviations. 
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Fig. 3. Distribution of ChAT + neurons in the BF 
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Fig. 4. Distribution ofGAD+ neurons in the BF. Each symbol marks one GAD+ 
cell plotted in one 20 J!m thick section (from rat G3) on computer-based atlas 
templates. See list for abbreviations. 
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: ... GAO+ neurons: 
Fig.4. Distribution of GAD+ neurons in the BF 
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Fig. 5. Distribution ofPAG+/NR+ and PAG-/NR+ neurons in the BF. Each 
symbol marks one PAG+/NR+ or PAG-/NR+ cell plotted in one 20 f..lm thick 
section (from rat G3) on computer-based atlas templates. See list for 
abbreviations. 
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Fig. S. Distribution of PAG+/NR+ and PAG-/NR+ neurons in the BF 
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Fig. 6. Presence ofVGluT2 or VGluT3 in PAG+, ChAT+ or GAD+ cens in the 
MCPO of colchicine treated rats. A. PAG+ cens (in Cy2, solid arrowheads in Al) 
were not immunostained for VGluT2 (open arrowheads in A2), which was 
prominent in axon terminaIs (in Cy3, A2). B. Most P AG+ cens (in Cy2, solid 
arrowheads in BI) were positively immunostained for VGIuT3 (in Cy3, solid 
arrowheads in B2). C. Most ChAT+ cens (in Cy2, solid arrowheads in Cl) were 
immunostained for VGIuT3 (in Cy3, sol id arrowhead in C2). D. About haif of 
GAD+ cells (in Cy2, solid arrowheads in Dl) were judged immuno-positive (solid 
arrowheads in D2) and haifimmuno-negative (open arrowheads in D2) for 
VGIuT3 immunostaining (in Cy3, D2). Scaie bar = 25 /lm. 
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Fig.6. Presence ofVGluT2 orVGluT3 in PAG+, ChAT+ or GAD+ cells in the 
MCPO of colchicine treated rats 
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PREFACE TO CHAPTER II 
In the previous chapter we showed that a large number of neurons in the BF 
contain PAG, and are thus able to synthesize glutamate. We also showed that 
P AG neurons also expressed VGluT3, indicating their capacity to take up and 
release glutamate. Critically, most of ChAT + and half of the GAD+ cell 
population also contained VGluT3, in line with previous results showing the 
presence ofPAG in these two neuronal populations. Nonetheless, the presence of 
PAG and VGluT3 in BF cell bodies leave many unanswered questions about the 
use of glutamate as a neurotransmitter by BF neurons. As discussed previously, 
VGluT3 expressed in the somato-dendritic compartment of neurons has been 
implicated in the retro grade signaling of glutamate (Harkany et al., 2004). Yet, if 
expressed in axon terminaIs, VGluT3 may also mediate axonal release of 
glutamate (Fremeau et al., 2004). Therefore, is VGluT3 only expressed in cell 
bodies and dendrites of BF neurons, or may it be also present in axon terminaIs 
and participate in the axonal release of glutamate? Second, based on the presence 
ofPAG and VGluT3 in cholinergie and GABAergic neurons, may that be an 
indication of co-release of ACh or GABA with glutamate from axon terminaIs of 
those neurons? Finally, given the presence of a fraction ofPAG neurons that do es 
not express VGluT3, are other VGluTs used by BF neurons to release glutamate? 
In the next two chapters, these questions will be addressed by combining 
anterograde transport from BF neurons with immunohistochemistry for YAChT, 
VGAT and VGluTs in order to assess the capacity ofBF terminaIs for 
neurotransmitter release and/or co-release. We examined these terminaIs in the 
pre frontal cortex (PFC, chapter II) and the lateral hypothalamus (LH, chapter III), 
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two areas known to receive prominent projections and be critically influenced by 
the BF region. 
Following the identification of cholinergie, GABAergic and glutamatergic 
contingents in PFC, their contribution to total innervation was estimated by 
unbiased sampling procedures. In addition, the capacity to form synapses as well 
as the relation of each contingent with cortical pyramidal and interneuronal cell 
populations was examined. 
Given the diverse roles ofthe PFC in autonomie regulation, cognition and 
generation of SW A during sleep, the influence of cortically projecting BF neurons 
on these pro cesses is discussed. 
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Chapter II 
Basal Forebrain Axon TerminaIs Containing Vesicular 
Transporters for Acetylcholine (V AChT), GABA (VGAT) or 
Glutamate (VGluT) in Rat Prefrontal Cortex 
Pablo Henny and Barbara E. Jones 
Montreal Neurological Institute, McGill University, 
Montreal, Quebec, Canada H3A 2B4 
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ABSTRACT 
Through projections to cerebral cortex, the basal forebrain (BF) plays important 
roles in the modulation of cortical activity and function. Retrograde tracing 
studies have established that this projection comprises cholinergic, GABAergic 
and other unidentified neurons. Recent evidence suggests the latter could be 
glutamatergic. To examine the existence, contribution and organization ofBF 
neurons that can release glutamate, the presence of vesicular transporters proteins 
(VTPs) for glutamate (VGluT), as weIl as for acetylcholine (ACh, YAChT) and 
GABA (VGAT), was examined in BFaxon terminaIs innervating the prefrontal 
cortex (PFC). Following small injections of the anterograde tracer biotinylated 
dextran amine 10,000 MW (BDA) into the magnocellular region of the BF, brain 
seriaI sections were processed for dual and triple fluorescent staining. BDA-
labeled axons were seen in the PFC, with a high density in the infralimbic cortex 
(IL), where they innervated deep layers. Axonal varicosities formed three 
independent populations containing VGluT2, YAChT or VGAT. In the IL, they 
accounted for ~ 15%, ~ 19% and ~52% of the total number of BF terminaIs, 
respectively. Glutamatergic and GABAergic axons appeared to form synapses, as 
assessed by the relation of the terminaIs with the postsynaptic proteins (PSPs) 
PSD-95 and Gephyrin (Geph), respectively. Sorne cholinergie axons were also 
associated with postsynaptic Geph profiles. Finally, it was found that PFC 
intemeurons expressing the calcium binding protein (CBP) calbindin (CB) were 
apposed by glutamatergic, cholinergic and GABAergic axonal varicosities. 
VGAT + varicosities also apposed intemeurons containing the CBP parvalbumin 
(PV) as well as principal cells, as identified by non-phosphorylated 
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neurofilaments (NPNF). Through three independent cortically projecting 
contingents and specifie efferent projections, the BF can modulate cortical activity 
in a diverse and complex manner. 
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INTRODUCTION 
Through widespread projections to the cerebral cortex, the basal forebrain (BF) 
plays important and diverse roles in the modulation of cortical activity in 
association to behavioral states, cognitive processes and autonomie function 
(Buzsaki et al., 1988; Groenewegen and Uylings, 2000; Van Eden and Buijs, 
2000; Sarter et al., 2001; Jones, 2004). The projections are comprised by 
heterogeneous yet not fully characterized populations of neurons that could 
contribute to different aspects of BF function. 
Based on the presence of choline acetyltransferase (ChAT) and glutamic 
acid decarboxylase (GAD), the synthetic enzymes for acetylcholine (ACh) and 
GABA respectively, retrograde tracing studies have established that large 
contingents of ACh- and GABA-synthesizing BF neurons innervate the cortex 
(Zaborszkyet al., 1986; Fisher et al., 1988; Gritti et al., 1997). They have 
nonetheless evidenced the existence of another non-cholinergie, non-GABAergic 
group ofprojecting neurons, since the proportions of ChAT (-20% to -30%) and 
GAD (-40 to 45%) neurons retrogradely labeled from prefrontal or parietal cortex 
did not account for the total number oflabeled cells (Gritti et al., 1997). This 
additional contingent might comprise glutamate-synthesizing neurons, since a 
prominent number of cortically projecting BF neurons (-80%) shows 
immunoreactivity for phosphate-activated glutaminase (PAG) (Manns et al., 
2001), the enzyme involved in the synthesis of the neurotransmitter glutamate 
(Bradford et al., 1978; Kaneko and Mizuno, 1988). However, P AG is also present 
in a vast majority (-95%) ofChAT+ and large proportion (-60%) ofGAD+ 
neurons, suggesting that in addition to purely glutamate-releasing neurons, 
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cholinergic and sorne GABAergic neurons rnight also synthesize and re1ease 
glutamate (Manns et al., 2001). 
In order to identify, quantify and describe the contribution of cholinergic, 
GABAergic and as yet putative glutamatergic BF neurons to the cortical 
projection, the presence ofthe vesicular transporter proteins (VTP) for ACh 
(VAChT) (Gilrnor et al., 1996; Arvidsson et al., 1997), GABA (VGAT) (McIntire 
et al., 1997; Chaudhry et al., 1998) and glutamate (VGluTs) (Bellocchio et al., 
2000; Frerneau et al., 2001; Fujiyama et al., 2001; Fremeau et al., 2002) as 
rnarkers for neurotransrnitter specific uptake and release, was examined in BF 
axon terminaIs in the prefrontal cortex (PFC), one of the major cortical targets of 
BF neurons (Luiten et al., 1987; Gaykerna et al., 1990). 
Following discrete deposits ofbiotinylated dextran amine 10,000 MW 
(BDA-I0,000) in the rnagnocellular preoptic nucleus (MC PO) and substantia 
innorninata (SI) and anterograde transport of the tracer, series were processed for 
dual staining ofBDA and YAChT, VGAT or VGluT (1, 2 or 3) and examined in 
PFC. Additional series were processed for double-staining ofVTP to assess 
colocalization ofVTPs within the same varicosities. Subsequent stereological 
analysis was carried out to determine the nurnber and proportion of terminaIs, in 
addition to their laminar distribution in the infralirnbic cortex (IL). To assess 
whether the terminaIs formed synapses, sections were triple stained for BDA, 
VTPs and postsynaptic proteins (PSPs) gephyrin, a rnarker for inhibitory synapses 
(Sassoe-Pognetto and Fritschy, 2000; Sassoe-Pognetto et al., 2000), or PSD-95, a 
rnarker for excitatory synapses (Komau et al., 1995; Sheng and Pak, 2000; 
Sassoe-Pognetto et al., 2003). Finally, triple stained rnaterial for BDA, VTP and 
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the cortical neuron mark ers non-phosphorylated neurofilament (NPNF) (Campbell 
and Morrison, 1989; Kirkcaldie et al., 2002) for pyramidal cells or the calcium 
binding proteins (CBP) parvalbumin (PV) or calbindin (CB) for intemeurons 
(Celio, 1986, 1990) was examined to determine the relation with different cortical 
cell populations. 
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MATERIALS AND METHODS 
Animais and Surgery 
Procedures were in agreement with the guidelines of the Canadian Council on 
Animal Care and the U.S. NIH and were approved by the McGill University 
Animal Care committee. 
As described previously (Henny and Jones, 2006a), Long-Evans rats (200-
250 g, Charles River Canada, St. Constant, Quebec, Canada) were anaesthetized 
with ketamine/xylazine/acepromazine (65/5/1 mg/kg, i.p.) and placed in a 
stereotaxic frame (David KopfInstruments, Tujunga, CA, U.S.A.) for surgery and 
holes were drilled in the skull on each si de over the BF. Glass micropipettes (tip 
diameter 15 to 25 /lm) were back-filled with a 0.5 M NaCI solution containing 2% 
10,000 MW BDA (BDA-10,000, Molecular Probes, Eugene, Oregon, U.S.A.) and 
lowered into the BF on each si de aimed at the magnocellular preoptic nucleus 
(MCPO, from Bregma: anterior-posterior (AP), -0.5 mm; Lateral (L), +/- 2.5 mm; 
Vertical (V), 8.5 mm) with the aid of a micropositioner (Model 660, David Kopf 
Instruments). A holding CUITent of -300 nA was maintained (using a 
Microiontophoresis Dual CUITent Generator 260, World Precision Instruments 
(WPI), Sarasota, FL, U.S.A.) during the descent to avoid leakage ofthe solution. 
Microinjection ofBDA was performed by iontophoresis applying positive CUITent 
pulses (5 to 10 /lA) in a dut y cycle of 1 sec (0.5 son, 0.5 s off) for a period of25 
to 30 min through a stimulator (Pulsemaster A300, WPI) and stimulus isolation 
unit (Iso-Flex, A.M.P.I., Israel). After the injection, the micropipette was held in 
place for 10 min and removed during renewed application of the holding CUITent. 
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Rats were maintained for 5 or 6 days with food and water ad libitum to 
allow anterograde transport of the tracer. They were subsequently perfused 
transcardially under deep sodium pentobarbital anesthesia (100 mg/k:g, i.p.) with 
-500 ml 4% paraformaldehyde fixative solution. The brains were removed and 
put in a 30% sucrose solution for 2 to 3 days or until they sunk:, after which they 
were frozen at -500 C and stored at -800 C for subsequent processing. 
Immunohistochemistry 
Forebrains, including cortex and BF, were eut in sections of25 J.lm thickness and 
collected in eight series, using intervals of 200 J.lm between sections. The first 
series was processed for evaluation of the BDA injection site location and general 
BDA fiber distribution in the forebrain under light microscopy. For this purpose, 
sections were incubated and processed with the Vectastain ABC Elite kit (Vector 
Laboratories, Burlingame, CA, V.S.A.) with nickel-intensified diaminobenzidine 
(DAB-Ni) and counterstained with neutral red (NR). 
Adjacent series containing PFC were processed for dual or triple fluorescent 
staining of BDA, VTPs, PSPs or cortical markers (see Table 1). Prior pilot 
studies were performed to determine the conditions necessary for antibody as weIl 
as streptavidin penetration through the full depth of the sections. As assessed 
under epifluorescent and confocal microscopy, we established that 0.1 % and 0.3 % 
Triton X -100 (TX) allowed full penetration of antibodies and streptavidin through 
the sections in double and triple fluorescent material, respectively. Free floating 
sections from each series were rinsed for 30 min in Trizma saline buffer (TS, 0.1 
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M, pH 7.4) followed by incubation for 30 min with a blocking solution ofnorrnal 
donkey serum (NDS, 6% in TS) containing 0.1 % or 0.3% Triton X-1 00 (TX). 
Sections were subsequently incubated ovemight at room ternperature with one or 
two primary antibodies in TS containing NDS 1 % and TX (0.1 % or 0.3%). The 
sections were then rinsed for 30 min and incubated for three hours in appropriate 
secondary antibodies in NDS 1 % and TX (0.1 % or 0.3%) (Table 1). With the 
exception of double staining oftwo VTPs (see below), sections were then rinsed 
for 30 min and incubated for three hours in streptavidin for BDA revelation 
(Table 1). 
For double labeling ofBDA and one ofthe VTPs, sections were incubated 
(using 0.1 % TX) first with primary antibodies against YAChT, VGAT or 
VGluT1, 2 or 3 (from Goat, Gt or Rabbit, Rb) and then with Cy3-conjugated 
secondary antibodies (from Donkey, Dky) followed by Cy2-conjugated 
streptavidin for revelation ofBDA (see Table 1, Double BDANTP). 
For double labeling of two VTPs, sections were incubated (using 0.1 % TX) 
with two primary antibodies against YAChT, VGAT or VGluT2 (from different 
host species) and then with corresponding Cy2- and Cy3-conjugated secondary 
antibodies (from Dky) (see Table 1, Double VTPNTP). 
For triple labeling ofBDA, YAChT and VGAT, sections were incubated 
(using 0.3% TX) with primary antibodies (from different host species) against 
V AChT and VGAT and then with corresponding Cy3 or Cy5 secondary 
antibodies (from Dky), respectively. The sections were subsequently incubated 
with Cy2-conjugated streptavidin for revelation ofBDA (see Table 1, Triple 
BDANTPNTP). 
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For triple labeling ofBDA, the VTPs and PSPs, sections were incubated 
(using 0.3% TX) with two primary antibodies (from different host species) against 
YAChT, VGAT or VGluT2 and Geph or PSD-95 and then with corresponding 
Cy3 or Cy5 secondary antibodies (from Dky). Then, sections were subsequently 
incubated with Cy2-conjugated streptavidin for reve1ation ofBDA (see Table 1, 
Triple BDANTPIPSP). 
For triple labeling ofBDA, the VTPs and the cortical markers, sections 
were incubated (using 0.3% TX) with two primary antibodies against YAChT, 
VGAT or VGluT2 and NPNF, PV or CB, respectively (from different host 
species) and then with appropriate Cy3 or Cy5 secondary antibodies (from Dky). 
They were subsequently incubated with Cy2-conjugated streptavidin for 
revelation ofBDA (see Table 1, Triple BDANTP/Cortical markers). 
AH sections were mounted out of Trizma water, and the mounted sections 
dehydrated through alcohols, cleared in xylene and coverslipped with Pennount. 
Conventional microscopy and stereological analysis 
Sections were examined under light and epifluorescent microscopy with a Leica 
DMLB microscope or Nikon Eclipse E800 which were equipped with x-y-z 
motorized stages, video or digital camera and filters appropriate for FITC (or 
Cy2), Rhodamine (or Cy3) fluorescence. Single as weH as composite images 
were acquired using Neurolucida software (MicroBrightField, MBF, Colchester, 
VT, U.S.A.). 
Injection sites from 8 rats (BDA 14, 15, 16, 18, 19,20,21 and 22) were 
examined under brightfie1d illumination in DAB-NiINR stained material. In 14 
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injection sites ('cases' on left and lor right sides), the labeled cells were centered 
in the MCPO-SI (on the left and/or right sides) and were used for analysis with 
double and triple fluorescent staining for BDA, VTP, PSPs or cortical markers. 
From these, 6 cases from 3 rats (BDA 16, 18 and 19) were selected for 
quantitative estimate of the proportions and layer distribution of BDAlVTP 
varicosities in PFC in fluorescent stained material (see text and Table 1). 
Double labeling for V AChT, VGAT or VGluT2 was assessed under 
epifluorescent illumination on the Leica microscope (in 3 brains, Table 1). 
Under epifluorescent illumination, fluorescent stained BDA-positive (+) 
varicosities were examined for double labeling with the VTPs in the PFC. 
Finding double labeling with YAChT, VGAT or VGluT2 (see Results), unbiased 
estimates of the total numbers of single BDA+ and double-Iabeled 
BDA+NGluT2+, BDA+I VAChT+ or BDA+NGAT+ varicosities from 5 cases 
were estimated in the IL, a region from where projections from the BF have 
previously been described (Gritti et al., 1997). In all cases analyzed 
stereologically, all VTPs were stained using antibodies from Rabbit (Rb-Anti-
YAChT, -VGAT and -VGluT2, see Table 1). Counts were performed under a 
100x Oil objective (with 1.40 numerical aperture) using the Optical Fractionator 
probe of the Stereo Investigator software (MBF) on the Leica microscope. 
Varicosities were sampled in the IL, as delimited cytoarchitectonically by others 
(Krettek and Price, 1977), including all corticallayers, through 3 levels separated 
by 400 f.!m intervals (11.8, 11.4 and 11.0 f.!m anterior (A) to interaural zero 
(lAO)). The grid size (150 f.!m x 150 f.!m) was set to be larger than the counting 
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frame (75 Jlm x 75 Jlm) so as to sample 25% of the area in each ofthe regions. 
Counting was performed through ~8.5 Jlm ofthe section thickness (starting 1 Jlm 
from the surface of the mounted sections having an average thickness of ~ 10 Jlm). 
ln each counting block, aIl BDA+ varicosities (in green, Cy2) were counted, 
inc1uding those which were or were not double-labeled for VTP (in red, Cy3) to 
aIlow an estimate of the proportion of double-labeled varicosities for each VTP. 
Additional estimations were performed at the same levels for the ventrolateral and 
lateral (VLO, LO) orbitofrontal cortex (OF), where a 900 x 900 Jlm2 square was 
used as a sampling area. 
To examine the distribution ofBDA+ and BDA+NTP+ axons across 
corticallayers, contours of the IL containing the mapped varicosities during the 
stereological procedure were overlaid on Nissl-stained rat brain sections. 
Molecular (1), superficial (II-III) and deep (V-VI) layers were delineated within 
the contours based onto cytoarchitectonic criteria (Krettek and Price, 1977; 
Hurley et al., 1991) and maps ofthe rat brain (Swanson, 1992), and the proportion 
ofBDA+ and of each type ofBDA+NTP+ per layer over total BDA+ or 
BDA +NTP+ in each series was estimated. 
Confocal microscopy and image processing 
To assess the presence of VGAT in BDA +N AChT +, or the association of 
BDA +NTP+ varicosities with postsynaptic elements or cortical neurons, triple 
stained sections for BDANAChTNGAT, BDANTPs/PSPs or 
BDANTPs/Cortical markers were analyzed by confocal microscopy with a Zeiss 
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LSM 510 laser scanning microscope equipped with Argon 488 nm, helium-neon 
543 nm and helium-neon nm 633 lasers for Cy2, Cy3 and Cy5 excitation as well 
as with appropriate filters for detection of Cy2 (bandpass 500 to 530 nm, green), 
Cy3 (bandpass 565 to 615 nm, red) and Cy5 (bandpass 697 to 719 nm, infrared). 
Scanning was performed through a Plan-Apochromat 100x (with 1.4 numerical 
aperture) objective and pinhole size of 1 (Airy Vnits) for each of the three 
channels. Images were acquired for the three chromo gens using the resident LSM 
510 software and consisted of stacks taken through the z-axis in optical slices of 
~0.33 /lm for PSP series or ~0.50 /lm for cortical markers series. 
Rendered 3D views ofthe image stacks were obtained using the image 
software Volocity 3.5.1 (Improvision Inc, Lexington, MA, V.S.A., 
www.improvision.com). which allowed interactive visualization, magnification 
and rotation ofthe 3D images in order to determine the relative location of each of 
the elements from the three channels. 
Adjustments for brightness and contrast in brightfield images and tonal 
range for each individual ROB channel ("Adjust/levels" command) in fluorescent 
images were performed with Adobe Photoshop Creative Suite (Adobe System, 
San Jose, CA, V.S.A). Figures were mounted in Adobe Illustrator Creative Suite 
(Adobe). 
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RESULTS 
BDA injection site and axonallabeling in the cortex 
As described previously (Henny and Jones, 2006a), iontophoretic application of 
BDA-lO,OOO into the region of the MCPO-SI (Fig. lA) produced a weIl restricted, 
round injection site (Fig. lB) containing labeled cell bodies and dendrites (Fig. 
1C). The average number ofBDA-labeled neurons per injection was -1400 
(mean ± SEM, 1430.6 ± 315, n = 5), trom which -90% were located at the MCPO 
and -6% at the SI (Henny and Jones, 2006a). 
BDA-lO,OOO was found in axons within regions previously described to 
receive abundant projections trom MCPO-SI, including cortical and subcortical 
regions (Luiten et al., 1987; Grove, 1988; Gritti et al., 1994; Gritti et al., 1997; 
Henny and Jones, 2006a). BDA-Iabeled axons reached the cortex through lateral 
and medial pathways, as previously described (Saper, 1984; Gaykema et al., 
1990). In the lateral path, axons coursed laterally to reach and innervate piriform, 
entorhinal and perirhinal cortices caudaIly, and piriform cortex, the rhinal aspect 
of the agranular insular cortex, the claustrum and OF rostraIly. Through the 
medial path, axons run rostrally through the diagonal band of Broca and medial 
septum, to innervate the tenia tecta, IL and prelimbic (PL) cortices. 
Most prominently, the IL as weIl as VLO and LO cortices received 
abundant BDA-Iabeled axons, which could be seen across corticallayers yet more 
abundant in deep ones. Axonal fibers were morphologically diverse and bore 
both boutons en passant, as weIl as boutons terminaux (not shown). 
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YAChT, VGAT or VGluT within BDA-labeled varicosities in prefrontal 
cortex 
Series that were double stained for BDA and the VTPs were examined to 
determine if BFaxonal varicosities in the PFC were immunopositive (+) for 
YAChT, VGAT or VGluT!, 2 or 3. 
In series processed for BDA and V AChT, a portion ofthe BDA-!abe!ed 
terminaIs were double-Iabeled for YAChT (Fig. 2A and B). The BDA+N AChT+ 
varicosities were relatively small and most often located along axons (Fig. 2A), 
yet at times they could be located at the end of axons as boutons terminaux (Fig. 
2B). 
In series stained for BDA and VGAT, VGAT was found in a large number 
ofBDA+ axon terminaIs (Figure 2C, D). The BDA+NGAT+ varicosities 
appeared somewhat larger and rounder than BDA+N AChT+ ones and could be 
seen at the end of axons as boutons terminaux (Fig. 2C), yet most commonly 
along the axons as boutons en passant, (Fig. 2D). 
In series processed for BDA and VGluT!, 2 or 3, only VGluT2 (Fig. 2E and 
F), and not VGluT! or VGluT3 (not shown), was found to be present in BDA-
labeled varicosities. The BDA+NGluT2+ varicosities were most frequently seen 
as boutons en passant (Fig. 2E and F) though also seen as boutons terminaux. 
To find evidence of colocalization ofVGluT2 with YAChT or VGAT in 
BF terminaIs, dual stained material for VTPs was subsequently examined in IL 
and OF (Fig. 3). In dual-stained material for YAChT and VGluT2, no evidence 
for colocalization ofthe two markers was found (Fig. 3A). Similarly, in dual-
stained material for VGAT and VGluT2 there was no evidence for colocalization 
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between these two populations (Fig. 3B). Thus, the results suggest that 
cholinergie or GABAergic BFaxons do not express a glutamatergic phenotype in 
their tenninals. Series dual stained for V AChT and VGAT were also examined. 
Most ofVAChT+ varicosities were found to be negative for VGAT, and 
reciprocally, the vast majority ofVGAT+ varicosities were found negative for 
V AChT (Fig. 3C). Yet, a very small proportion was found to be double labeled 
for V AChT and VGAT. To assess whether this small proportion could 
correspond to BDA-labeled cholinergie fibers coming from MCPO-SI neurons, 
triple staining was perfonned for BDA, V AChT and VGAT and analyzed in 
confocal microscopy. Of>290 BDA+N AChT+ varicosities from several axons 
from 3 cases analyzed, less than 4% presented sorne staining for VGAT (not 
shown). 
Proportion and laminar distribution ofVAChT+, VGAT+ and VGluT2+ 
BDA-labeled varicosities 
Having established the lack of colocalization by the different VTPs in BFaxonal 
varicosities, the proportions of cholinergie, GABAergic and glutamatergic BF 
axon tenninals were detennined by stereological estimations of the total numbers 
ofBDA+ and ofBDA+NTP+ varicosities in the IL and OF at three levels 
(-A11.8, A 11.4 and A11.0, Fig. 1, Table 2). In IL (n = 5), -19% ofBDA+ 
varicosities in the YAChT series were found BDA+N AChT+, -52% ofthe 
BDA+ varicosities in the VGAT series were BDA+NGAT+ and -15% of the 
BDA+ varicosities in the VGluT2 series were BDA+NGluT2+ (see Table 2). In 
the OF (n = 6), -23% ofBDA+ varicosities in the YAChT series were found 
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BDA+NAChT+, ~49% of the BDA+ varicosities in the VGAT series were 
BDA+NGAT+ and ~8% of the BDA+ varicosities in the VGluT2 series were 
BDA+NGluT2+. A two-way analysis ofvariance (ANOVA) for region and 
proportions ofVTP (Region x VTP) yielded significant effects ofVTP, but not 
for Region or the interaction (F = 0.078, P > 0.05 for Region; F = 18.042, P < 
0.001 for VTP; F = 0.291, p > 0.05 for the interaction). Accordingly, raw data for 
both regions were pooled together (PFC), resulting in V AChT +, VGAT + and 
VGluT2+ proportions of ~21 %, ~50% and ~ Il % of the BDA+ varicosities. The 
proportions ofVTP differed significantly according to one-way ANOVA 
(F=19.793, P < 0.001). 
To examine the laminar distribution ofBF fibers, the proportions of 
BDA+ and BDA+NTP+ varicosities located in layers l, II-III or V-VI ofIL was 
determined. Of the total number ofBDA+ varicosities sampled stereologically in 
the three series (see Methods), ~5 8% of them were found in layers V-VI, ~ Il % in 
layers II-III and ~31 % in layer I. These proportions differed significantly (as 
assessed by one-way ANOVA, F = 29.10, P < 0.001) followed by post-hoc 
Bonferroni pairwise comparisons (p < 0.05 for each comparison). Of the total 
number of BDA +NTP+ varicosities sampled in each series, proportions for each 
BDA+NTP+ group were significantly higher in deep V-VI (~73%, ~ 71 % and 
~75% for BDA+N AChT+, BDA+NGAT+ and BDA+NGluT2+ respectively) 
when compared to molecular 1 (~18%, ~27% and ~1O%) or II-III (~9%, ~2%, and 
~ 15%) layers (as assessed by two-way ANOVA, with Layer and VTP as factors: 
F=23.4, p < 0.001 for Layer; F = 0.336, P > 0.05 for VTP; F = 0.416, P > 0.05 for 
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the interaction and post-hoc Bonferroni pairwise comparisons, p< 0.05 for layer 
V-VI vs.layers l or II-III). 
Presence of postsynaptic proteins Gephyrin or PSD-95 in relation to V AChT, 
VGAT or VGluT2 BDA-Iabeled terminais 
To assess whether BFaxon terminaIs might form synapses with postsynaptic 
elements in PFC, series were processed for triple staining of BDA, the VTPs and 
the PSPs Geph or PSD-95 (see Table 1). Material was examined and z-stacks of 
images (taken at 0.33 Jlm steps) acquired under confocal microscopy, to be 
subsequently analyzed as single raw images and 3D rendered reconstructions (Fig. 
4). In series stained for BDA, YAChT and Geph (Fig. 4A), it was found that a 
moderate proportion ofBDA+N AChT+ profiles were found in association with 
Geph+ profiles (29.6% or 32 out of 108 varicosities observed). In series stained 
for BDA, VGAT and Geph (Fig. 4B), it was found that most ofBDA+NGAT+ 
varicosities were associated with Geph+ profiles (72.2% or 57 out of 79 
varicosities observed). In contrast, only a relatively minor proportion of 
BDA+NGluT2+ varicosities were associated with Geph profiles (16.7% or 2 out 
of 10 varicosities observed) in series stained for BDA, VGluT2 and Geph (Fig. 
4C). 
In series stained for BDA, V AChT and PSD-95 (Fig. 4D), only a small 
proportion ofBDA+N AChT+ varicosities were found associated with PSD-95+ 
profiles (13.9% or 5 out of36 varicosities analyzed). Similarly, in series stained 
for BDA, VGAT and PSD-95 (Fig. 4E) a small proportion ofBDA+NGAT+ 
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varicosities were in association with PSD-95 (13.3% or 2 out of 15 varicosities). 
In contrast, most ofBDA+NGluT2+ varicosities were associated with PSD-95+ 
profiles (53.3% or 16 out of30 varicosities analyzed) in series stained for BDA, 
VGluT2 and PSD-95 (Fig. 4F). 
VAChT+, VGAT+ and VGluT2+ BDA-Iabeled terminais in relation to NPNF 
pyramidal ceUs and PV or CB interneurons 
Series that were triple-stained for BDA, the VTPs and cortical markers (n = 3 for 
each combination) were examined and acquired under confocal microscopy to 
examine if different BF contingents were located close to or in apposition to 
cortical neurons in PFC (Table 1, Fig. 5). 
In BDANAChTINPNF material, BDA+NAChT+ axonal varicosities were 
often detected in the vicinity ofNPNF+ cell bodies or dendrites (Fig. 5A), but not 
in direct apposition to the NPNF+ profiles. In BDAN AChTIPV series, 
BDA+N AChT+ varicosities could be seen in close proximity to PV+ cells (Fig. 
5B). In BDAN AChT/CB series, BDA+N AChT+ terminals were seen in the 
vicinity of and sometimes in direct apposition to CB+ cells bodies (Fig. 5C). 
In BDANGATINPNF material, BDA+NGAT+ axonal varicosities were 
often detected in the vicinity of NPNF+ cell bodies or dendrites as well as in 
apparent contact with cell bodies (not shown) or dendrites (Fig. 5D). In 
BDANGATIPV series, BDA+NGAT+ varicosities could be seen in close 
proximity to PV+ cells and occasionally innervating perisomatically PV+ cell 
bodies (Fig. 5E). In BDANGAT/CB series, it was found that BDA+NGAT+ 
varicosities could form appositions with CB+ cell bodies (Fig. 5F). 
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In BDAlVGluT2INPNF series, BDA+NGluT2+ varicosities were detected 
only in the vicinity ofNPNF+ (Fig. 5G). Similarly, in BDAlVGluT2IPV series, 
BDA+NGluT2+ varicosities were only seen in the vicinity ofPV+ cells (Fig. 
SR). In BDAlVGluT2/CB series, it was found that BDA+NGluT2+ varicosities 
could fonn appositions with CB+ cell bodies (Fig. SI). 
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DISCUSSION 
The present study shows that the BF projection to PFC is fonned by cholinergic, 
GABAergic and glutamatergic contingents. Through this projection, the BF may 
have a triple influence in the PFC and contribute differentially to cognitive, 
autonomic and behavioral functions executed by the PFC. 
Glutamatergic BF cortically projecting neurons 
The existence of glutamatergic neurons in the BF with projections to the cortex 
was postulated after retro grade tracing studies established that cholinergic and 
GABAergic neurons could not account for the total contingent of cortically 
projecting neurons (Gritti et al., 1997) and that a large proportion ofBF neurons, 
incIuding those with cortical projections, would have the capacity to synthesize 
neurotransmitter glutamate based on the presence of the enzyme P AG (Bradford 
et al., 1978; Kaneko and Mizuno, 1988; Manns et al., 2001). With the recent 
identification ofVTPs for glutamate (VGluT1, 2 and 3) as proteins involved in 
the specifie uptake of glutamate into synaptic vesicIes, definitive mark ers for 
glutamatergic neurons have become available (Fremeau et al., 2001; Fujiyama et 
al., 2001; Fremeau et al., 2002). We report here that a set of cortically projecting 
BF neurons express the VGluT2 protein in their axon tenninals, thus 
demonstrating the capacity of BF neurons to take up and release glutamate from 
their axon tenninals in the cortex. 
The presence ofVGluT2 in axon tenninals ofBF neurons is in line with 
previous reports using in situ hybridization showing the presence of the mRNA 
for VGluT2 in BF neurons (Lin et al., 2003; Hur and Zaborszky, 2005). These 
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findings also confonn to the principle that in contrast to VGluTl, VGluT2 
expressing neurons predominate in subcortical regions (Fremeau et al., 2001; 
Kaneko and Fujiyama, 2002). On the other hand, neurons in the BF (Harkany et 
al.,2003), have also been shown to contain VGluT3 in their cell bodies. Yet,like 
BF neurons innervating the lateral hypothalamus (Henny and Jones, 2006a), 
cortically projecting glutamatergic neurons did not appear to express VGluT3 in 
their axon tenninals. Since VGluT3 has been proposed to have a role in the 
somato-dendritic release of glutamate, our results indicate that BF neurons might 
release glutamate from axon tenninals, using VGluT2, or from cell bodies and 
dendrites using VGluT3. Whether VGluT2 and VGluT3 could be expressed and 
utilized by the same neuronal population is as yet unknown. 
Based on the colocalization of the synthetic enzymes ChAT and GAD 
with that ofPAG in BF neurons, previous studies had suggested that cholinergie 
and GABAergic neurons might co-release glutamate (Manns et al., 2001). Given 
the lack of colocalization ofVGluT2 with YAChT or VGAT, our results do not 
support the possibility of co-release of glutamate with ACh, or with GABA from 
the same tenninals of BF neurons in the adult rat cortex. However, they do not 
exc1ude the possibility that cholinergie and sorne GABAergic neurons may 
synthesize glutamate and release it from their somato-dendritic compartments, 
indeed confinned by the presence ofVGluT3 protein in BF cholinergie and PV+, 
likely GABAergic, neurons (see ab ove) (Harkany et al., 2003). Nor do the results 
exc1ude the rather unconventional idea that single neurons may give rise to axon 
tenninals expressing different VTPs. 
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Previous studies have established that cholinergic and GABAergic BF 
populations do not overlap to a significant extent. We nonethe1ess examined the 
possibility of co-expression ofVAChT and VGAT in BF tenninals innervating 
the cortex, as it has been reported that -8% of cholinergic synaptic tenninals in 
the visual cortex of the cat present significant amounts of GABA 
immunoreactivity (Beaulieu and Somogyi, 1991). We found that ofBF tenninals 
expressing V AChT, less than 4% contained VGAT, indicating that whereas the 
BF may contribute sorne double-Iabeled tenninals, another contribution must 
come from cortical cholinergic interneurons that are described in the rat, and are 
known to present both cholinergic and GABAergic phenotypes (Bayraktar et al., 
1997). Together, these results show that in the adult rat, the BF projection to PFC 
is comprised by three independent, for the most part, non-overlapping, 
phenotypically distinct contingents. 
Proportions and laminar distribution of cholinergie, GABAergic and 
glutamatergic BFaxon terminaIs in PFC 
We have found that cholinergic, GABAergic and glutamatergic BF tenninals 
represent -19%, -52% and -15% of the total BF tenninals in their respective 
series in IL and similar proportions in OF. The proportions of cholinergic and 
GABAergic tenninals are similar to the proportions of ChAT (23%) and GAD 
(43%) neurons retrogradely labe1ed in the MCPO after injections in the medial 
prefrontal cortex (Gritti et al., 1997). The proportion of glutamatergic tenninals 
in IL (-15%) could not account for the total proportion of cortically projecting 
non-cholinergic, non-GABAergic neurons (-34%, from (Gritti et al., 2003», 
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suggesting that another contingent, neither VAChT+, VGAT+, nor VGluT+, 
might be part ofthis projection. 
In agreement with previous studies showing layer distribution of BF 
afferents to cortex (Saper, 1984), we found here that in IL all three contingents 
were mostly concentrated in deep layers. By innervating deep layers, cholinergie, 
GABAergic and glutamatergic BF fibers might influence the corticofugal output 
to BF itself (Gaykema et al., 1991), as well as subcortical autonomie and limbic 
areas (through layer V) to which IL projects (Vertes, 2004; Gabbott et al., 2005). 
Postsynaptic proteins in relation to cholinergie, GABAergic and 
g1utamatergic BF terminais 
We have shown in this study that BF cholinergie, GABAergic and glutamatergic 
axon terminaIs, as identified by presynaptic VTPs, associate differentially with 
the PSPs Geph and PSD-95. Geph is a microtubule-associated protein that forms 
part of the molecular scaffolding ofboth glycine and GABAA receptors and is 
present at inhibitory synapses (Sassoe-Pognetto and Fritschy, 2000; Sassoe-
Pognetto et al., 2000). PSD-95 is a scaffolding protein isolated from postsynaptic 
densities and shown to concentrate at asymmetrical excitatory synapses (Sheng 
and Pak, 2000; Sassoe-Pognetto et al., 2003). In addition, PSD-95 has been 
shown to interact directly and indirectly with NMDA and AMP A receptors, 
respectively. We have recently used both Geph and PSD-95 to show their 
association with BF GABAergic and glutamatergic descending axons in the 
lateral hypothalamus, respectively (Henny and Jones, 2006a). 
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Surprisingly, we observed a rnoderate incidence of cholinergic BF 
terminais with Geph. Although Geph has been shown not to associate with any 
known ACh receptor (AChR) type or play any known role in the assernbling or 
clustering of AChR in avian peripheral ganglia (Allaire et al., 2000) , it should be 
noted that nicotinic receptors belong to the same family of glycinergic and 
GABAAR (OrteIls and Lunt, 1995), both ofwhich present association with Geph 
(Sassoe-Pognetto and Fritschy, 2000). Also of note is that cholinergic axon 
terminais in the cortex have been shown to form symrnetric synapses (Houser et 
al., 1985; Beaulieu and Sornogyi, 1991; Mechawar et al., 2000), which generally 
indicate inhibitory synapses. We observed that a large rnajority of BF 
GABAergic terminais were associated with Geph, thus confirming the capacity of 
BF neurons to form inhibitory synapses with cortical neuronal elernents (Freund 
and Gulyas, 1991). In contrast, only a rninor proportion of glutamatergic 
terminais were seen associated with Geph. Given the lack of colocalization 
between VGluT2 and VGAT in PFC, it is difficult at present to hypothesize what 
the functionality of that association rnight be. It should be noted, nonetheless, that 
CNS glutamatergic neurons have the capacity to change their phenotype to that of 
a GABAergic one under certain conditions (Gornez-Lira et al., 2005), ofwhich 
the presence of Geph in association with sorne glutamatergic axons rnight be 
indicative. 
Sorne cholinergic axon terminais were seen in association with PSD-95 but 
this proportion was rninor as cornpared to those associated with Geph. PSD-95 
has been reported to be present in peripheral nicotinic synapses and PSD-93, a 
close related protein, interacts directly with synaptic nicotinic receptors (Conroy 
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et al., 2003), suggesting that central cholinergic neurons may also do it. However, 
as far as we are concerned, the presence ofPSD-95 in association with cholinergic 
central synapses has not been reported. Of note is that sorne, yet in marginal 
proportions, central cholinergic synapses have been shown to form asymmetrical 
synapses (Houser et al., 1985). Similarly, a very small proportion ofBF 
GABAergic terminaIs presented sorne association with PSD-95. As no 
association of GABAAR with PSD-95 has been reported, the functional 
significance of this finding is difficult to interpret. In contrast, and in agreement 
with the prevalence of PSD-95 in glutamatergic synapses (Sheng and Pak, 2000; 
Sassoe-Pognetto et al., 2003), a majority of the VGluT2 BF varicosities associated 
with PSD-95, as was also previously shown for BFaxonal varicosities in the 
lateral hypothalamus (Henny and Jones, 2006a). 
Relation of cholinergie, GABAergic and glutamatergic BF terminais with 
cortical pyramidal and interneuronal cell populations 
BF terminaIs innervated cortical pyramidal as weIl as interneurons identified by 
the cell-specific mark ers NPNF, PV and CB. 
NPNF are neurofilaments in a non-phosphorylated state that have been 
reported to be present in pyramidal cell axons, dendrites and soma (Sternberger 
and Sternberger, 1983; Campbell and Morrison, 1989). In spite the relatively low 
intensity ofNPNF staining in preffontal cortex of the rat (Kirkcaldie et al., 2002), 
we were positively able to detect pyramidal cell profiles in both IL and OF with 
high magnification under confocal microscopy, indicating the feasibility of using 
the NPNF to detect pyramidal cells in this study. PV and CB are two calcium 
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binding proteins that together with calretinin have been shown to represent three, 
mostly non-overlapping, populations of cortical intemeurons (Hendry et al., 1989; 
Celio, 1990; Kubota et al., 1994). It is assumed that both PV and CB intemeurons 
modulate the activity of pyramidal neurons by direct inhibition, although through 
differential innervation of pyramidal cellular domains (Wang et al., 2004). Thus, 
evidence suggests that PV is generally present in basket or chandelier type of 
intemeurons (DeFelipe, 1997), which encompass the group of neurons that 
provide somatic and proximal dendrite, as weIl as axonal innervation to pyramidal 
cens (Markram et al., 2004). Although CB may also be present in sorne basket 
cens (Markram et al., 2004) and a few layer III pyramidal cens (DeFelipe, 1997) 
it is usually present in double bouquet, Martinotti and/or Cajal-Retzius cells 
(DeFe1ipe, 1997), which in tum represent the group ofneurons that provide 
dendritic innervation to pyramidal cens (Markram et al., 2004). In contrast to 
these cell populations, the action mode of calretinin neurons onto pyramidal cens 
is thought to occur indirectly through disinhibition, as they comprise intemeuron-
targeting intemeurons (Wang et al., 2004). 
BF cholinergie axons could be detected in apposition only to CB 
intemeurons. They were seen close, but not in apposition, to pyramidal cens or 
PV intemeurons. These results agree in general with studies showing a 
preferential innervation ofintemeurons (Beaulieu and Somogyi, 1991), in this 
case represented by CB cells, versus pyramidal cens by ChAT axons. The low 
incidence of appositions onto other cen types may also be indicative of the low 
incidence of synaptic specializations that cholinergie axons in the cortex have 
been reported to form (Mechawar et al., 2000). In that case, the cholinergie 
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influence may be by diffusion and thus more involved in modulation, rather than 
the driving of postsynaptic cell activity (Mechawar et al., 2000; Descarries et al., 
2004). Among BF neurons, identified cholinergie neurons have been shown to 
discharge in association with cortical activation and during active wakefulness 
and paradoxical sleep (PS) (Manns et al., 2000a; Lee et al., 2005b). They have 
been shown to do so in bursts of action potentials at a theta frequency and in 
synchrony with cortical theta activity recorded in prefrontal and retrosplenial 
cortices (Manns et al., 2000a). In addition, ACh has been shown to pro duce a 
slow depolarization on pyramidal cells through muscarinic action. This effect is 
preceded by a fast inhibition mediated by fast muscarinic and nicotinic mediated 
excitation of intemeurons which in tum inhibit the pyramidal cells (McCormick 
and Prince, 1985; McCormick, 1993). By excitation ofCB intemeurons, which 
can target soma/proximal dendrites of pyramidal cells, BF cholinergie neurons 
might indirectly pace their activity, to make them discharge in a theta frequency 
during cortical activation. 
In contrast to cholinergie terminaIs, GABAergic terminaIs were seen in 
apposition with pyramidal as well as PV and CB intemeurons. Given the 
association ofBF GABAergic axons with the postsynaptic marker Geph, it is 
likely that the appositions on these cells represent synaptic specializations. If so, 
these results contrast with previous studies using anterograde tracing in 
combination with GABA immunohistochemistry and morphological criteria in 
EM, which showed an almost exclusive innervation by GABAergic BF afferents 
ofCB intemeurons, but not PV intemeurons in the rat (Freund and Gulyas, 1991), 
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or of PV and somatostatin intemeurons in the cat (Freund and Meskenaite, 1992), 
in both cases with no innervation of pyramidal cells. 
GABAergic neurons in the BF comprise a physiologically heterogeneous 
group in the way they discharge in relation to cortical activity (Manns et al., 
2000b,2003a). On one hand, an important proportion ofBF GABAergic neurons 
have been shown to increase their dis charge during cortical activation induced by 
somatic stimulation under urethane anesthesia. These neurons, which as shown 
by antidromic activation also project to PFC, discharge tonically at frequencies in 
the gamma range. Innervating directly pyramidal neurons, GABAergic BF 
neurons of this type might pace high frequency firing of pyramidal cells during 
cortical activation. This influence might also be mediated through PV 
intemeurons, which provide strong innervation of pyramidal cells, and have been 
suggested to contribute to the generation of gamma activity (Buzsaki and 
Chrobak, 1995; Jefferys et al., 1996) and do not adapt to high frequency input 
(Kawaguchi and Kubota, 1993), such as those which might be provided by BF 
high frequency spiking GABAergic neurons. By providing innervation to CB 
neurons, BF GABAergic neurons could also reduce the level of inhibition on 
pyramidal distal dendrites, in tum contributing to pyramidal cell excitability 
(Freund and Gulyas, 1991). 
On the other hand, most of the GABAergic neurons identified under 
urethane anesthesia have been found to discharge maximally in association with 
irregular slow wave activity (offrequencies in the delta band, -0.5 up to 4 Hz) 
and decrease their firing during cortical activation, and thus proposed to represent 
a population of neurons that could promote slow wave activity (Manns et al., 
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2000b). Sorne ofthese neurons, which could be also activated antidromically 
from PFC, were shown to discharge phasically in bursts of action potentials at low 
«1 Hz) frequencies, similar to the activity recorded in the cortex. By innervating 
pyramidal neurons, BF GABAergic neurons could promote the appearance of 
slow wave activity in PFC (see below). Innervation ofintemeurons may subserve 
a similar role in generation of slow wave activity, for example, by pacing activity 
of pyramidal cells through PV intemeurons. 
We found no evidence for a glutamatergic innervation of pyramidal or PV 
neurons in PFC. Glutamatergic axons could only be detected in apposition to CB 
intemeurons. These appositions likely represent synaptic contacts given the 
association of glutamatergic axons with postsynaptic protein PSD-95. Putative 
glutamatergic neurons in the BF, as identified by the PAG enzyme and the lack of 
ChAT and GAD, have been shown to discharge in association with cortical 
activation in c1usters of action potentials (Manns et al., 2003a). BF glutamatergic 
neurons might modulate the activity of pyramidal cells by reducing the influence 
of distal inputs if acting on dendrite-targeting CB intemeurons or to pace 
pyramidal cell activity if representing CB soma- and proximal dendrite-targeting 
neurons. 
Functional considerations 
Acting as an extrathalamic relay from the reticular activating system to the cortex, 
the BF has been shown to promote cortical activation (Starzl et al., 1951; Kievit 
and Kuypers, 1975; Buzsaki et al., 1988; Jones, 2003). Yet, the variable and 
dissimilar influences that the BF imposes upon cortical activity (Sterman and 
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Clemente, 1962a; Manns et al., 2000b, 2003a; Jones, 2004) suggest that non-
cholinergic inputs must also be of critical importance in other types of cortical 
activities and functions. We show here that the control the BF may have over 
PFC activity is carried out by three independent contingents of neurons, which 
may influence cortical activity through cholinergic, GABAergic or glutamatergic 
mechanisms. 
The relevance of this varied influence of the BF over cortical, particularly 
PFC, activity is reflected in the effects that lesions of the BF have on cognitive 
processes, such as attention, short and long term memory and leaming (Everitt 
and Robbins, 1997; Sarter et al., 2001; Sarter et al., 2003; Smith et al., 2004). 
These processes have been shown to depend on both cholinergic and non-
cholinergic neurons, as the effect of total BF excitotoxic lesions are different, and 
commonly more deleterious, than those only targeting cholinergic neurons 
(Everitt and Robbins, 1997). In this regard, disruption of the cholinergic 
innervation ofPFC primarily affects attention mechanisms, while having less 
direct influence on other processes, such as leaming and memory (Sarter et al., 
2003). It is suggested that those aspects primarily unaffected by cholinergic 
lesions might be carried out by the GABAergic system yet, as shown here, could 
also depend upon glutamatergic BF projection systems. OK 
In relation to its influence over PFC cognitive processing, the BF may 
influence other aspects of PFC function. The PFC has been long known to play 
an important role in autonomic regulation, particularly in the control of the 
cardiovascular system (Verbeme and Owens, 1998; Groenewegen and Uylings, 
2000; Van Eden and Buijs, 2000; Resstel and Correa, 2006). In this regard, it is 
124 
interesting to note that ACh in the PFC has been shown to have a parasympathetic 
action, producing a significant decrease in arterial blood pressure when injected in 
the PFC of unanaesthetized rats (Crippa et al., 1999). This effect may be related 
to the parasympathetic activation that has been observed during attentive states, 
such as those during presentation of a conditioned stimulus (Hunt and Campbell, 
1997), indicating that the role of ACh in attention (Sarter et al., 2003) may also be 
in part mediated through autonomic mechanisms. In contrast, microinjections of 
glutamate under the same behavioral conditions have been shown to elicit 
sympathoexcitatory pressor and tachycardic responses (Resstel and Correa, 2005, 
2006), which suggest that the role of glutamate in PFC may be related to 
behavioral arousal. Although the sources of glutamate might also be other than 
the BF, glutamatergic BF neurons have been previously proposed to promote 
behavioral arousal through innervation of Orx neurons in the LH (Henny and 
Jones, 2006b). Through release of ACh or glutamate in deep layers ofthe PFC, 
BF neurons may mediate these autonomic effects by influencing the activityof 
PFC neurons that project to CNS areas involved in autonomic regulation, 
including the lateral hypothalamus, the nucleus of the tractus solitarius, the 
ventrolateral medulla and the thoracic spinal cord (Hurley et al., 1991; Vertes, 
2004; Gabbott et al., 2005). 
Finally, through innervation of the PFC, the BF may also promote sleep-
related processes such as the appearance of slow wave activity that occurs during 
slow wave sleep (Sterman and Clemente, 1962a, 1962b). Exclusively sleep-
related units have been identified in the subgenual prefrontal cortex of the 
monkey, which is homologous to IL in the rat (Rolls et al., 2003). The PFC has 
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been shown to be the cortical region where slow oscillations start in the course of 
SWS (Massimini et al., 2004). AIso, anterior cortical regions, which would 
inc1ude the PFC show a maximal rebound in delta activity after SWS deprivation, 
suggesting a critical role in generation of these activities (Schwierin et al., 1999). 
It is proposed that these roles might depend, in part, on the activity of BF 
GABAergic neurons in the BF that project to the PFC and have been found to 
discharge during SW A at frequencies similar to those of the slow oscillation and 
of delta activity (Manns et al., 2000b). 
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Table 1. Primary antibodies (AB) for immunostaining of vesicular transporter proteins (VTPs), 
postsynaptic proteins (PSPs) or neuronal markers 
Antigen 
VTPs 
YAChT 
YAChT 
VGAT 
VGluTl 
VGluT2 
VGluT2 
VGluT3 
PSPs 
Geph 
PSD-95 
Neuronal markers 
NPNF 
PV 
CB 
Host Sp. 
Rb 
Gt 
Rb 
Rb 
Rb 
GP 
GP 
Ms 
Ms 
Ms 
Ms 
Ms 
Source l Cat. # 
Sigma V5387 
Chemicon ABl578 
Chemicon AB5062P 
Gift RHE 
Gift RHE 
Chemicon AB5907 
Chemicon AB542 1 
SV-SV 147011 
ABR MAI-045 
Stern berger SMI32 
Sigma 
Sigma 
P3088 
C8666 
'ABR: Affinity BioReagents, Golden, CO, V.S.A.; Chemicon International, Temecula, CA, V.S.A; Gift 
RHE: Gift from Robert H. Edwards, Fremeau et al (2001) "The expression of vesicular glutamate 
transporters defines two classes of excitatory synapse", Neuron 31 (2):247-260; Sigma: Sigma, St. Louis, 
MO, V.S.A.; Sternberger: Sternberger Monoclonals Inc., Lutherville, MD, VSA; SV-SV: Synaptic 
Systems, Gôttingen, Germany. Abbreviations: GP, guinea pig; Gt, goat; Ms, mouse (monoclonal); Rb, 
rabbit. 
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/"- Table 2. Combination and sequential processing ofprimary and secondary antibodies along with streptavidin (SA) 
used for triple fluorescent staining ofvesicular transporter proteins (VTPs), postsynaptic proteins (PSPs), neuronal 
markeTS and biotinylated dextran amine (BOA) 
1 ry AB (overnight}1 2ry AB (3 hours} SA!3 hours~ 
Series Antigen Host sI! Dilution IgG (Dkd,3 Dilution SA Dilution n4 
Double BDAIVTP 
BDA/VAChT YAChT Rb 1:1000 Anti-Rb-Cy3 1:800 SA-Cy2 1:800 6 
BDA/VGAT VGAT Rb 1:250 Anti-Rb-Cy3 6 
BDA/VOluTl VOluTl Rb 1:1000 Anti-Rb-Cy3 3 
BDA/VOluT2 VOluT2 Rb 1:5000 Anti-Rb-Cy3 6 
BDA/VOluT3 VOluT3 GP 1:1000 Anti-GP-Cy3 1:800 3 
Double VTPIVTP 
VAChT/VGAT YAChT Gt 1:5000 Anti-Gt-Cv3 1:800 3 VGAT Rb 1:250 Anti-Rb-CV2 1:200 
VAChT/VGluT2 YAChT Gt 1:5000 3 VGluT2 Rb 1:5000 
VGluT2/VGA T VOluT2 GP 1:1000 Anti-GP-Cv3 1:800 3 VGAT Rb 1:250 Anti-Rb-Cv2 1:200 
Triple BDAIVTP/VTP 
BDA/V AChT/VGAT YAChT Gt 1:5000 Anti-Gt-Cv3 1:800 SA-Cy2 1:800 3 VGAT Rb 1:250 Anti-Rb-Cv5 1:800 
Triple BDA/VTP/PSP 
BDA/V AChT/Geph YAChT Rb 1:1000 Anti-Rb-Cv3 1:800 SA-Cy2 1:800 3 Geph Ms 1:100 Anti-Ms-Cv5 1:800 
BDA/V AChT/PSD-95 YAChT Rb 1:1000 3 PSD-95 Ms 1:100 
BDA/VGAT/Geph VGAT Rb 1:250 3 Geph Ms 1:100 
BDA/VGAT/PSD-95 VGAT Rb 1:250 3 PSD-95 Ms 1:100 
BDA/VOluT2/Geph VGluT2 Rb 1:5000 3 Geph Ms 1:100 
BDA/VOluTZ/PSD-95 VOluT2 Rb 1:5000 3 PSD-95 Ms 1:100 
Triple BDA/VTP/Neuronal markers 
BDA/V AChTINPNF YAChT Rb 1:1000 Anti-Rb-Cv3 1:800 SA-Cy2 1:800 3 NPNF Ms 1:800 Anti-Ms-Cv5 1:800 
BDA/V AChT/PV YAChT Rb 1:1000 3 PV Ms 1:1000 
BDA/V AChT/CB YAChT Rb 1: 1000 3 CB Ms 1:200 
BDA/VGATINPNF VGAT Rb 1:250 3 NPNF Ms 1:800 
BDA/VGAT/PV VGAT Rb 1:250 3 PV Ms 1:1000 
BDA/VGAT/CB VGAT Rb 1:250 3 CB Ms 1:200 
BDA/VOluT2INPNF VOluTZ Rb 1:5000 3 NPNF Ms 1:800 
BDA/VOluTZ/PV VOluT2 Rb 1:5000 3 PV Ms 1:1000 
BDA/VOluT2/CB VOluT2 Rb 1:5000 3 CB Ms 1:200 
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1 For sources and specificity of primary antibodies from different species refer to Table 1. 
2 Jackson Immuno Research Laboratories, West Grove, PA. 
3 For multiple labeling (ML) with minimal cross-reactivity (min X) to other species. 
4 n: number of cases (each case referring to an injection site and series from the same side of the brain, thus 1 or 2 
per brain from 9 rats for a total of 16 injection sites se1ected for their placement in the MCPO/SI). 
Abbreviations: AB, antibody; AMCA, aminomethy1coumarin acetate; Cy2, cyanine; Cy3, indocarbocyanine; CyS, 
indodicarbocyanine; Dky, donkey; Geph, gephyrin; Gt, goat; Ms, mouse (monoclonal); Rb, rabbit; sp, species. 
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Table 3. Number (W) and proportion of VAChT+, VGAT+ and VGluT2+ BDA-Iabeled BFaxonal 
varicosities (var.) in in&alimbic area (IL) based on stereologyl. 
IL 
N° BDA+ var. 
N° BDA+NTP+ var. 
% VTP+ var. 
YAChT 
6832 ± 1386 
1168±381 
19.2 ± 5.4 
VGAT 
3344 ± 787 
1728 ± 442 
51.6 ± 9.9 
VGluT2 
5456 ± 1508 
816 ± 334 
14.6 ± 7.1 
INumbers ofvaricosities were estimated by sampling &om 3 levels per series per case in IL (see Fig. 1 and 
Methods). Mean values for estimated numbers of BDA+ var., for estimated numbers of double labeled 
BDA+NTP+ var. and for percentages ofBDA+VTP+ &om 5 cases for IL (l or 2 sides &om 3 rat brains) 
are presented together with SEM. The proportions of the three VTP+ varicosities differed significantly (p < 
0.05 according to one-way ANOV A) but not so the number of BDA+ sampled varicosities among cases. 
Post-hoc Bonferroni-corrected comparisons showed a significant difference (p < 0.01) between percentages 
for BDA+NGAT+ and BDA+NAChT+ or BDA+NGluT2+ var. Abbreviations: Est., estimated; var., 
varicosities; VTP, vesicular transporter proteins. 
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Fig. 1. Localization of injection site and region of analysis in prefrontal cortex. 
A: Atlas ofthe basal forebrain area where biotin dextran amine (BDA) 10,000 
MW was placed by microiontophoretic application into the MCPO-SI region. B: 
Image of one injection site containing BDA-Iabeled cells in MCPO. The small 
rectangle indicates the location of three labeled neurons shown at high 
magnification in C. C: High magnification image ofthree BDA-1abeled neurons 
ofthe injection site. D: Contours ofthe rat forebrain at the level of the pre frontal 
cortex (~11.8, Il.4 and 11.0 mm anterior to interaural zero) where BFaxons were 
observed in large amounts. The dashed contours depict the IL, where most of the 
quantitative analysis was carried out (see Table 2 and text). Abbreviations: AI, 
agranular insular cortex; ac, anterior commissure; Cg, cingulate cortex; Cl, 
claustrum; FS, fundus stratium; Fr, frontal cortex; IL, infralimbic cortex; LO, 
lateral orbital cortex; LPO, lateral preoptic area; MCPO, magnocellular preoptic 
nucleus; MPO, medial preoptic area; OTu, olfactory tubercle; Pir, piriform cortex; 
PL, prelimbic cortex; oc, optic chiasm; SI, substantia innominata; sa, supraoptic 
magnocellular nucleus; TI, taenia tecta; VLO, ventrolateral orbital cortex. Scale 
bar: B = 0.5 mm; C = 25 !-lm. 
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Fig. 1. Localization of injection site and region of analysis in prefrontal cortex 
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/'-- . Fig. 2. Cholinergie, GABAergic and glutamatergic BFaxons in prefrontal cortex. 
A, B: Epifluorescent microscopy images in the prefrontal cortex showing BDA-
labeled axons (green A' and B') with varicosities (arrowheads) that are positive for 
the vesicular transporter for acetylcholine, YAChT (red in A" and B" and yellow 
in the merged image in Alli and Bill). C, D: Epifluorescent microscopy images of 
the prefrontal cortex that show BDA-labeled axons (green C' and D') with 
varicosities (arrowheads) that are positive for the vesicular transporter for GABA, 
VGAT (red in C" and D" and yellow in the merged image in CIII and Dili). E, F: 
Epifluorescent microscopy images of the prefrontal cortex ofBDA-labeled axons 
(green E' and F') with varicosities (arrowheads) that are positive for the vesicular 
transporter for glutamate, VGluT2 (red in E" and Fil and yellow in the merged 
image in EIII and FIII). Scale bar = 5 J.lm in F for aU images. 
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Fig. 2. Cholinergie, GABAergie and glutamatergie BFaxons in prefrontal cortex 
135 
136 
Fig. 2. Cholinergie, GABAergie and glutamatergie BFaxons in prefrontal cortex (continued) 
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Fig. 3. Lack of colocalization ofvesicular transporter proteins for ACh (VAChT), 
glutamate (VGluT2) or GABA (VGAT) in prefrontal cortex. A: Merged 
epifluorescent image from dual-stained material for YAChT (in red, Cy3) and 
VGluT2 (in green, Cy2) in prefrontal cortex. As shown by the open arrowheads, 
VAChT+ and VGluT2+ varicosities do not colocalize with each other. Sorne 
varicosities may appear close, but still appear distinguishable of each other, as 
seen in the two opposite arrowhead on the upper right. B: Merged epifluorescent 
image from dual-stained material for VGluT2 (in red, Cy3) and VGAT (in green, 
Cy2) in prefrontal cortex. As shown by the open arrowheads, VGluT2+ and 
VGAT+ varicosities do not colocalize with each other. C: Merged epifluorescent 
image from dual-stained material for YAChT (in red, Cy3) and VGAT (in green, 
Cy2) in prefrontal cortex. As shown by the open arrowheads, most ofVAChT+ 
and VGAT+ varicosities do not colocalize with each other. Only few 
VAChT+NGAT+ varicosities could be detected (solid arrowhead). Scale bar = 
10 /-lm in C, for the three images. 
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Fig. 3. lack of colocalization of vesicular transporter proteins for 
ACh (VAChT), glutamate (VGluT2) or GABA (VGAT) in prefrontal cortex 
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Fig. 4. Postsynaptic proteins (PSPs) Gephyrin or PSD-95 in relation to 
cholinergie, GABAergic and glutamatergic BF terminaIs in prefrontal cortex. A-
C: Rendered 3D confocal images (0.33 /lm thick optical sections) ofBDA-labeled 
axons (in blue, Cy2) that are positive for the VTPs (in red, Cy3) V AChT (A), 
VGAT (B) or VGluT2 (C) in relation to Geph (in green, Cy5). A: In the rendered 
3D confocal image, sorne of the BDA+N AChT+ varicosities appear in relation 
with Geph+ profiles (small and large solid arrowheads), whereas the majority do 
not (small and large open arrowheads), as evident in the insets (open and solid 
large arrowheads in panel). B: In the rendered image, most of the varicosities of 
the BDA+NGAT+ axon (aIl solid arrowheads) associate with Geph+ profiles, as 
also evident in the varicosities shown in the inset (large arrowheads in the panel). 
C: Geph+ profiles do not usually associate with the BDA+NGluT2+ axonal 
varicosities (open arrowhead), as evident in the rendered image at the inset (open 
arrowhead in the panel). D-F: Rendered 3D confocal images (0.33 /lm thick 
optical sections) ofBDA-labeled axons (in blue, Cy2) that are positive for the 
VTPs (in red, Cy3) YAChT (D), VGAT (E) or VGluT2 (F) in relation to PSD-95 
(in green, Cy5). D: PSD-95+ profiles do not usually associate with the 
BDA+N AChT+ axonal varicosities (aIl open arrowheads), as evident in the 
rendered image shown at the inset (open large arrowhead in the panel). E: As 
shown in the rendered 3D image, PSD-95+ profiles are not generally seen in 
association with the BDA+NGAT+ axonal varicosities (open arrowheads), as 
evident in the rendered image at the inset (open arrowheads in large panel). F: As 
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Fig. 4. Postsynaptic proteins (PSPs) Gephyrin or PSD-95 in relation to 
cholinergie, GABAergic and glutamatergie BF terminais in prefrontal cortex 
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shown in the rendered 3D image in F (solid arrowheads), many ofthe varicosities 
ofBDA+NGluT2+ axons associate with PSD-95+, as also evident in the rendered 
image in the inset (solid arrowheads in large panel). Yet, sorne BDA+NGluT2+ 
varicosities did not show association with PSD-95+ profiles (small open 
arrowhead). Scale bar = 5 /lm in F, for aIl large panels and 2 /lm in F inset for aIl 
insets. 
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Fig. 5. BF cholinergie, GABAergic and glutamatergic axons in relation to 
pyramidal cens and interneurons in prefrontal cortex. A-C: Confocal3D 
rendered reconstruction (large panels) ofBDA-labeled axonal varicosities (in 
green) that are positive for the vesicular acetylcholine transporter protein YAChT 
(in red, arrowheads), which are shown in proximity (open arrowheads in A and B) 
or in apposition (solid arrowhead in C) to NPNF+ (A), PV+ (B) or CB+ (C) cens, 
as shown in the 3D reconstruction in the insets. D-F: Confocal3D rendered 
reconstruction (large panels) ofBDA-labeled axonal varicosities (in green) that 
are positive for the vesicular GABA transporter protein VGAT (in red, 
arrowheads), which are shown in apposition (solid arrowheads in D, E and F) to a 
NPNF+ dendrite (D), or a PV+ (E) or CB+ (F) neuron, as evident in the 3D 
reconstruction in the insets. Note in the inset D, the location ofthe VGA T 
staining inside the BDA + varicosity pointing to the dendritic NPNF+ process. 
Note in E, the conspicuous innervation of the soma by the BDA+NGAT+ 
varicosities. G-I: Confocal3D rendered reconstruction (large panels) ofBDA-
labeled axonal varicosities (in green) that are positive for the vesicular glutamate 
transporter protein VGluT2 (in red, arrowheads), which are shown in the 
proximity (open arrowheads in G and H) or in apposition (solid arrowheads in 1) 
to NPNF+ (G), PV+ (H) or CB+ (1) cens, as evident in the 3D reconstruction in 
the insets. Scale bar = 5 Jlm for large panels and 2 Jlm for insets. 
144 
A BDANAChT B BDA/VAChT C BDANAChT 
NPNF PV CB 
, 
J.-
= -- ;;;;;;;;;;;;;;; 
• __ f 
/..: 
a ·- -. 
. 
. 
0 BDANGAT E BDi\/VGAT F BDANGAT 
NPNF PV CB 
... 
p=. l- iiiiiiiiiiiiiii_ iiiiiiiiiiiiiii ~ 
l- , 
-'f 
iiiiiiiiiiiiiiil __ -,-
-'f 
• • 
t . 
~ t< 
G BDAiVGluT2 H BDA.VGluT2 1 BDA!VGluT2 
NPNF PV CB 
J.-
J.-
Iiiii- iiiiiiiiiiiiiii iiiiii--
Il - -
-
1 • . -
-
- -
- -- --
Fig. 5. BF cholinergie, GABAergic and glutamatergic axons in relation to 
pyramidal cells and interneurons in prefrontal cortex 
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PREFACE TO CHAPTER III 
In addition to the cortex, the BF sends descending projections to the LH, a 
region long known to be involved in the maintenance ofwakefulness as well as 
promotion of arousal and sympathetic activity. Retrograde tracing studies have 
determined that this projection is formed by an important number of GABAergic, 
few cholinergie and a large number of non-GABAergie non-cholinergie 
unidentified neurons, which may be glutamatergie. In order to establish whether 
the BF provides a glutamatergic innervation to the LH and whether this projection 
forms an independent contingent from that of GABAergic and cholinergie 
neurons, the presence ofVGluTs, as well as ofVGAT and YAChT was examined 
in anterogradely labeled BFaxon terminaIs. The proportion and the distribution 
ofaxon terminaIs that each contingent provided to LH, was also determined. 
Finally, the capacity to form excitatory and inhibitory synapses was assessed by 
examining the presence of post-synaptic markers. 
Based on the presence of state related neurons in the BF, inc1uding sleep-
active GABAergic and putative wake-active glutamatergic cells, the capacity of 
BF neurons to inhibit or excite LH neurons is discussed in the eontext of the LH 
role in maintenance of waking and promotion of arousal. 
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Chapter III 
Vesicular glutamate (VGluT), GABA (VGAT), and acetylcholine 
(V AChT) transporters in basal forebrain axon terminais 
innervating the lateral hypothalamus 
Pablo Henny and Barbara E. Jones 
Montreal Neurological Institute, McGill University, 
Montreal, Quebec, Canada H3A 2B4 
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ABSTRACT 
The basal forebrain (BF) is known to play important roles in cortical activation 
and sleep, which are like1y mediated by chemically differentiated cell groups 
including cholinergie, GABAergic and other unidentified neurons. One important 
target of these cells is the lateral hypothalamus (LH), which is critical for arousal 
and the maintenance ofwakefulness. In order to determine if chemica1ly specifie 
BF neurons provide an innervation to the LH, we employed anterograde transport 
of 10,000 MW biotinylated dextran amine (BDA) together with 
immunohistochemical staining of the vesicular transporter proteins (VTPs) for 
glutamate (VGluTl, 2 and 3), GABA (VGAT) or acetylcholine (ACh, YAChT). 
In addition, we applied triple staining for the postsynaptic proteins (PSPs), PSD-
95 with VGluT or Gephyrin (Geph) with VGAT, to examine whether the BDA-
labe1ed varicosities may form excitatory or inhibitory synapses in the LH. Axons 
originating from BDA-Iabeled neurons in the magnocellular preoptic nucleus 
(MCPO) and substantia innominata (SI) descended within the medial forebrain 
bundle and extended collateral varicose fibers to contact LH neurons. In the LH, 
the BDA -labeled varicosities were immunopositive (+) for V AChT (~1 0%), 
VGluT2 (25%) or VGAT (50%), revealing an important influence ofnewly 
identified glutamatergic together with GABAergic BF inputs. Moreover, in 
confocal microscopy, VGluT2+ and VGAT+ terminaIs were apposed to PSD-95+ 
and Geph+ profiles respectively, indicating that they formed synaptic contacts 
with LH neurons. The important inputs from glutamatergic and GABAergic BF 
cells could thus regulate LH neurons in an opposing manner to reciprocally 
stimulate vs. suppress cortical activation and behavioral arousal. 
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INTRODUCTION 
The basal forebrain (BF) plays an important role in the modulation of cortical 
activity and regulation of sleep-wake states. As known from early studies, it 
serves as the ventral extrathalamic relay to the cerebral cortex from the brainstem 
reticular activating and arousal systems (Starzl et al., 1951; Jones, 2005b). Yet, it 
is also importantly involved in sleep, since lesions of the BF are associated with 
insomnia (von Economo, 1931; Nauta, 1946; McGintyand Sterman, 1968; Jones, 
2005b). These opposing roles could be mediated by chemically differentiated cell 
groups in the BF that inc1ude cholinergic, GABAergic and non-cholinergic/non-
GABAergic, presumed glutamatergic, neurons (Gritti et al., 1993, 1994; Gritti et 
al., 1997; Manns et al., 2001). According to multiple lines of evidence, 
cholinergie neurons actively stimulate cortical activation during waking and 
paradoxical sleep (PS, also called rapid eye movement, REM, sleep) (Buzsaki et 
al., 1988; Metherate et al., 1992; Duque et al., 2000; Manns et al., 2000a; Jones, 
2004; Lee et al., 2005b). Sorne putative glutamatergic neurons can act in parallel 
with the cholinergie neurons in this process (Manns et al., 2003a). On the other 
hand, a majority of GABAergic BF neurons are minimally active during cortical 
activation (Manns et al., 2000b) and as reflected by c-Fos expression, many are 
maximally active during sleep (Modirrousta et al., 2004), indicating that they can 
promo te sleep, inc1uding slow wave sleep (SWS). In addition to projections to the 
cerebral cortex (Gritti et al., 1997), BF neurons give rise to projections to the 
posterior lateral hypothalamus (LH) (Gritti et al., 1994), a region long known to 
be crucial for waking (von Economo, 1931; Nauta, 1946; Hess, 1957; Swett and 
Hobson, 1968; Jones, 2005c). Recently, neurons have been localized in the LH 
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which contain the peptide orexin (Orx, also called hypocretin) that is critical for 
sustaining waking, since absence of the peptide, its receptor or the Orx neurons 
results in narcolepsy (Chemelli et al., 1999; Lin et al., 1999; Peyron et al., 2000; 
Thannickal et al., 2000). 
Although previous studies combining retro grade transport with 
immunohistochemical staining for neurotransmitter enzymes indicated that 
cholinergic, GABAergic and other BF neurons project to the LH (Gritti et al., 
1994), they did not reveal the efferent BF fibers projecting into the LH nor did 
they prove the use of acetylcholine (ACh), GABA or as proposed, glutamate as 
neurotransmitters by the projection neurons. Recently, proof of the uptake, 
storage and release of specific neurotransmitters has become possible by 
immunohistochemical staining for specific vesicular transporter proteins (VTPs), 
including those for ACh (V AChT) (Gilmor et al., 1996), GABA (VGAT) 
(Chaudhry et al., 1998) and glutamate (VGluTl, 2 and 3) (Fremeau et al., 2001; 
Fujiyama et al., 2001; Fremeau et al., 2002). We thus combined anterograde 
transport of 10,000 MW biotinylated dextran amine (BDA) with 
immunohistochemical staining for YAChT, VGluT (1,2 and 3) and VGAT to 
determine if cholinergic, glutamatergic or GABAergic neurons located in the 
magnocellular preoptic nucleus (MCPO) and substantia innominata (SI) project to 
the LH. To assess whether the VGluT+ and VGAT+ varicosities form synapses 
in the LH, we employed triple immunostaining for the postsynaptic proteins 
(PSPs) PSD-95, a marker for excitatory synapses (Sheng and Pak, 2000), or 
Gephryin (Geph), a marker for inhibitory synapses (Sassoe-Pognetto and Fritschy, 
2000; Sassoe-Pognetto et al., 2000). 
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MATERIALS AND METHODS 
AnimaIs and Surgery 
AlI procedures confonned to the guidelines of the Canadian Council on Animal 
Care and the U.S. NIH and were approved by the McGill University Animal Care 
committee. 
Long-Evans rats (200-250 g, Charles River Canada, St. Constant, Quebec, 
Canada) were anesthetized with ketamine/xylazine/acepromazine (65/5/1 mg/kg, 
i.p.) and placed in a stereotaxie frame (David KopfInstruments, Tujunga, CA, 
U.S.A.) for surgery. Anesthesia level was monitored during the experiment and 
augmented by boosters if necessary. Since previous studies based on retro grade 
as weIl as anterograde tracing showed no evidence of contralateraI projections 
from BF to LH (Swanson, 1976; Gritti et al., 1994), injections ofBDA were done 
on left and right sides of each brain. Holes were driIled in the skuIl and the dura 
mater removed on each side over the BF. Glass micropipettes (tip diameter 15 to 
25 J.lm) were back-fiIled with a 0.5 M NaCI solution containing 2% 10,000 MW 
BDA (BDA-lO,OOO, Molecular Probes, Eugene, Oregon, U.S.A.). With the aid of 
a micropositioner (Model660, David KopfInstruments), a BDA-fiIled pipette 
was lowered into the BF on each side aimed at the magnoceIlular preoptic nucleus 
(MCPO, from Bregma: anterior-posterior (AP), -0.5 mm; lateraI (L), +/- 2.5 mm; 
vertical (V), 8.5 mm). A holding CUITent of -300 nA was maintained (using a 
Microiontophoresis Dual CUITent Generator 260, World Precision Instruments 
(WPI), Sarasota, FL, U.S.A.) during the descent to avoid leakage ofthe solution. 
Once in the targeted site, microinjection ofBDA was perfonned by iontophoresis 
151 
applying positive CUITent pulses (5 to 10 ~A) in a dut y cycle of 1 sec (0.5 son, 0.5 
s off) for a period of25 to 30 min through a stimulator (Pulsemaster A300, WPI) 
and stimulus isolation unit (Iso-Flex, A.M.P.I., Israel). After the injection, the 
micropipette was held in place for 10 min and removed during renewed 
application of the holding CUITent. 
Rats were maintained for 5 or 6 days with food and water ad libitum to 
allow anterograde transport of the tracer. They were subsequently perfused 
transcardially under deep sodium pentobarbital anesthesia (100 mg/k:g, i.p.) with 
~500 ml 4% paraformaldehyde fixative solution. The brains were removed and 
put in a 30% sucrose solution for 2 to 3 days or until they sunk, after which they 
were frozen at -500 C and stored at -800 C for subsequent processing. 
Immunohistochemistry 
Sections were cut using a freezing microtome in 25 ~m thick coronal sections and 
collected in eight adjacent series at 200 ~m intervals through the forebrain, 
including the magnocellular BF area and the tuberal-posterior hypothalamus. 
Series were processed for evaluation of the BDA injection site in the BF and 
BDA-labeled fibers in the LH by light microscopy. For this purpose, the avidin-
biotin complex (ABC) procedure was performed using the Vectastain ABC Elite 
kit (Vector Laboratories, Burlingame, CA, V.S.A.) with nickel-intensified 
diaminobenzidine (DAB-Ni) and combined with a Nissl counterstain using neutral 
red (NR). 
Adjacent series containing the tuberal-posterior LH region were processed 
for double or triple fluorescent staining (see Table 1). Prior pilot studies were 
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perfonned to detennine the conditions necessary for antibody as weIl as 
streptavidin penetration through the full depth of the sections. As viewed through 
the z-axis under epifluorescent and confocal microscopy, we established that 0.1 
or 0.3% Triton X-100 (TX) allowed full penetration ofantibodies and streptavidin 
through 25 !-lm thick sections in double or triple stained series respectively. Free 
floating sections from each series were rinsed for 30 min in Trizma saline buffer 
(TS, 0.1 M, pH 7.4) followed by incubation for 30 min with a blocking solution of 
nonnal donkey serum (NDS, 6% in TS) containing TX (0.1 or 0.3%). Subsequent 
incubations and rinses (30 min between incubations) were done using TS 
containing NDS (1 %) and TX (0.1 or 0.3%). Incubations were perfonned at room 
temperature overnight with primary antibodies and for 3 hours with secondary 
antibodies or streptavidin. 
For double labeling ofBDA and one of the VTPs, sections were incubated 
(using 0.1 % TX) first with primary antibodies against V AChT, VGluT1, 2 or 3 or 
VGAT (from various species) and then with appropriate Cy3-conjugated 
secondary antibodies (from Donkey, Dky) followed by Cy2-conjugated 
streptavidin for reve1ation ofBDA (see Table 1, Double BDANTP). 
For double labeling oftwo VTPs, sections were incubated (using 0.1 % TX) 
with two primary antibodies against YAChT, VGluT2 and/or VGAT (from 
different species) and then with appropriate Cy2- and Cy3-conjugated secondary 
antibodies (from Dky) (see Table 1, Double VTP/VTP). 
For triple labe1ing ofBDA, the VTPs and the PSPs, sections were incubated 
(using 0.3% TX) with two primary antibodies against VGluT2 or VGAT and 
153 
PSD-95 or Geph, respectively (from different species) and then with appropriate 
Cy3 or Cy5 secondary antibodies (from Dky). They were subsequently incubated 
with Cy2-conjugated streptavidin for revelation ofBDA (see Table 1, Triple 
BDNVTP:PSP). 
AU sections were mounted out of Trizma water, and the mounted sections 
dehydrated through alcohols, cleared in xylene and coverslipped with Permount. 
Conventional microscopy, tracing and stereological analysis 
Sections were examined under light and epifluorescent microscopy with a Leica 
DMLB microscope or Nikon Eclipse E800 which were equipped with x-y-z 
motorized stages, video or digital camera and filters appropriate for FITC (or 
Cy2), Rhodamine (or Cy3) and (on the Nikon) Cy5 fluorescence. Single as weU 
as composite images were acquired and drawings performed using Neurolucida 
software (MicroBrightField, MBF, Colchester, VT, U.S.A.). CeUs and 
varicosities were counted using the Optical Fractionator probe of Stereo 
Investigator software (MBF). For tracing or counting, a computer resident atlas 
of the rat brain was employed that has been developed and applied in our 
laboratory using standardized procedures for tissue processing (see (Gritti et al., 
1993, 1994». For each application, series ofhistology sections are matched to 
appropriate levels of the atlas (at 400 Jlm intervals) under low magnification (5 or 
10x objective). At each level, the atlas image is then rotated ifnecessary, and the 
contours adjusted to optimally fit the relevant nuclei of the histology section. 
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Injection sites from 8 rats (BDA 14, 15, 16, 18, 19,20,21 and 22) were 
examined under brightfield illumination in DAB-Ni stained material. In 14 cases, 
the 1abe1ed cells were centered in the MCPO-SI (on the 1eft and/or right sides). 
From these, 5 injection sites ('cases' on 1eft and/or right sides) from 3 rats (BDA 
16, 18 and 19) were se1ected for quantitative estimate of the cells in the injection 
sites. From the latter 14 cases, the innervation of the LH was studied qualitatively 
and quantitatively in DAB-Ni and fluorescent stained material (see text and Table 
1). 
Under brightfield illumination, unbiased estimates of the total number of 
DAB-Ni stained, BDA-Iabeled nerve cell bodies were performed using the 
Optical Fractionator probe of Stereo Investigator. Cells were counted within 
contours of the BF and surrounding nuclei, including the MCPO, SI, nucleus of 
the diagonal band of Broca (DBB), olfactory tubercle (OTu), lateral preoptic area 
(LPO), fundus of the striatum (FS), piriform cortex (Pir), nucleus ofthe lateral 
olfactory tract (LOT) and anterior amygdaloid area (AA). Counts were made 
under a 60x Oil objective (with 1.40 numerical aperture, NA) through 6 or 7 BF 
levels (at 200 /Jm intervals) using an x-y sampling grid size (of 120 /Jm x 120 /Jm) 
that was equal to the counting frame size, so as to sample 100% of each area. 
Counting was performed through 10 /Jm in the z-axis (starting 1 /Jm from the 
surface in mounted sections having an average of ~ 12 /Jm thickness following 
dehydration). Following the stereological procedures imposed in Stereo 
Investigator, cells were counted if their tops were contained within the defined 
counting block. 
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Projections of the DAB-Ni stained, BDA-Iabeled axons were examined 
through the tuberal-posterior LH and in relation to NR stained neurons viewed 
under brightfield illumination. The axons and neurons were drawn using a 100x 
Oil objective within a contour ofthe LH using Neurolucida software (MBF). 
Given evidence for contacts of BF fibers on LH neurons, the total number of 
NR stained neurons which were or were not contacted by one or more DAB-Ni 
stained, BDA+ varicosities (NR+:BDA+ or NR+:BDA-) was estimated using the 
Optical Fractionator probe through the LH (n = 3 cases). Counts were performed 
under a 100x Oil objective (1.4 NA) on the Nikon microscope. The cells were 
sampled in the LH, as defined in the computer resident atlas, through 3 levels 
separated by 400 Jlm intervals (5800, 6200 and 6600 Jlm anterior (A) to interaural 
zero (IAO)). The sampling grid size (210 Jlm x 210 Jlm) was set to be larger than 
the counting frame (70 Jlm x 70 Jlm) so as to sample -11 % of the LH area. 
Counting was performed through 16 Jlm of the section thickness (starting 1 Jlm 
from the surface of the mounted sections which had an average thickness of -19 
Jlm following their minimal dehydration and differentiation for NR). As above, 
cells were counted if their tops were contained within the defined counting block. 
Under epifluorescent illumination, fluorescent stained BDA-positive (+) 
varicosities were examined for double labeling with the VTPs in the LH. After 
finding double labeling with YAChT, VGluT2 and VGAT, unbiased estimates of 
the total numbers of single BDA+ and double-Iabeled BDA+N AChT+, 
BDA+NGluT2+ or BDA+NGAT+ varicosities were estimated in the LH for 
each series using the Optical Fractionator probe of Stereo Investigator. In five 
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cases analyzed per series in stereology, all VTPs were stained using antibodies 
raised in Rabbit (Rb, YAChT, VGluT2 and VGAT, see Table 1). Counts were 
perfonned under a 100x Oil objective (with 1.40 NA) on the Leica microscope. 
The varicosities were sampled in the LH, as defined in the computer resident 
atlas, through 3 levels separated by 400 J.lm intervals (A 5800, A 6200 and A 
6600) of the tuberal-posterior LH (in 4 cases per series, Table 2). The sampling 
grid size (180 J.lm x 180 J.lm) was set to be larger than the counting frame (90 J.lm 
x 90 J.lm) so as to sample 25% of the LH area. Counting was perfonned through 8 
J.lm of the section thickness (starting 1 J.lm from the surface ofthe mounted 
sections having an average thickness of ~12 J.lm following dehydration). In each 
counting block and frame, all BDA+ varicosities (in green, Cy2) were counted, 
including those which were and were not double-Iabeled for the VTP (in red, 
Cy3) to obtain an estimate ofthe proportion of double-labeled varicosities for 
each VTP. 
Double labeling for YAChT, VGluT2 and/or VGAT was assessed under 
epifluorescent illumination on the Leica microscope (in 4 cases per series, Table 
1). In absence of any double labeling, no quantification was undertaken. 
Confocal microscopy and image processing 
To examine the presence ofPSPs in association with BDA+NTP+ varicosities, 
triple stained sections were analyzed by confocal microscopy with a Zeiss LSM 
510 laser scanning microscope equipped with Argon 488 nm, helium-neon 543 
nm and helium-neon nm 633 lasers for Cy2, Cy3 and Cy5 excitation as well as 
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with appropriate filters for detection of Cy2 (bandpass 500 to 530 nm, green), Cy3 
(bandpass 565 to 615 nm, red) and Cy5 (bandpass 697 to 719 nm, infrared). 
Scanning was perfonned through a Plan-Apochromat 100x (with 1.4 NA) 
objective and pinhole size of 1 (Airy Units) for each of the three channels. 
Images were acquired for the three chromo gens using the resident LSM 510 
software and consisted of stacks taken through the z-axis in optical slices of -0.33 
Jlm. Rendered 3D views of the image stacks were obtained using the image 
software Volocity 3.5.1 (Improvision Inc, Lexington, MA, U.S.A., 
www.improvision.com) which allowed interactive visualization, magnification 
and rotation of the 3D images in order to detennine the relative location of each of 
the elements from the three channels. In sorne images, a deconvolution procedure 
or iterative restoration in Volocity was applied using a 95% confidence level in 
order to maximize signal to noise ratio and better assess relationships among 
elements in the triple stained material. As assessed in 3 cases per series (Table 1), 
contacts between VTP+/BDA + varicosities and PSP+ profiles were evaluated in 
the rotated images and validated by lack of separation between the pre- and 
postsynaptic elements. 
Adjustments for brightness and contrast in brightfield images and tonal 
range for each individual RGB channel ("Adjustllevels" command in Photoshop) 
in fluorescent images were perfonned with Adobe Photoshop Creative Suite 
edition (Adobe System, San Jose, CA, U.S.A). 
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RESULTS 
BDA injection site and cellular labeling 
Iontophoretic application ofBDA-10,000 into the region of the magnocellular 
preoptic area and substantia innominata (MCPO-SI, Fig. lA) produced a smaIl 
and well restricted, spherical injection site (Fig. lB) containing labeled ceIl bodies 
and dendrites (Fig. 1 C). The injection sites ranged in size from 300 to 500 J.lm in 
diameter and were consistently located primarily within the MCPO and 
secondarily in the overlying SI (n = Il injection sites). 
To appraise the number of ceIls labeled and their precise location in BF 
nuclei, stereological estimates were obtained through the BF. The average 
number ofBDA-labeled neurons per injection was -1400 (mean ± SEM, 1430.6 ± 
315, n = 5 injection sites). The labeled ceIls were almost exclusively (96.2% ± 
1.7%; range, 90 to 100%) located within the MCPO (90.2%) and SI (6.0%). A 
few scattered ceIls were variably found in immediately adjacent regions including 
the olfactory tubercle, lateral olfactory tract nucleus or anterior amygdaloid area 
(3.5% ± 1.8%). Isolated ceIls were found in the nearby fundus ofthe striatum or 
piriform cortex in sorne cases. No labeled ceIls were seen in the more rostral 
DBB. No labeled ceIls were seen in distant regions known to project to MCPO-
SI, including the prefrontal cortex or importantly, the LH, indicating a lack of 
retro grade transport ofthe BDA-I0,000 in these afferent systems. 
BDA was found within axons in the diencephalon (n = 14 cases) and in 
cortical and subcortical telencephalic regions where different MCPO-SI neurons 
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are known to project from retro grade (Gritti et al., 1994; Gritti et al., 1997) and 
other anterograde tracing studies (Luiten et al., 1987; Grove, 1988). 
BDA-labeled fibers and varicosities in the LB 
In the diencephalon, thick fascicles of fibers were evident in the ventrolateral 
posterior LH (Fig. 2A). From these coarse fibers, collateral fine fibers extended 
out through the LH. Sorne fibers continued sparsely into the perifomical area but 
most remained within the LH. The fine fibers bore varicosities along their axons 
(boutons en passant, Fig. 2B') or occasionally at the end oftheir axons (boutons 
terminaux, Fig. 2B"). Although many varicose axons did not appear to contact 
nerve cell bodies in the region (Fig. 2B'), a significant number did appear to do 
so, innervating either small (Fig. 2B") or large (Fig. 2B"') neurons by varicose 
processes that could entirely envelop the soma. To better visualize the fiber 
distribution and innervation of nerve cell bodies within the LH, high 
magnification tracing of the DAB-Ni stained axons and neutral red (NR+) stained 
cells was performed. As seen in Fig. 2e, the major axon fascicles were seen to 
course within the ventrolateral part ofthe medial forebrain bundle (MFB) from 
which they extended fine varicose fibers to contact and sometimes entirely 
surround cells in ventral, central and dorsal portions of the LH (Fig. 2D', 2D" and 
2D"'). 
To appraise the extent of the innervation of neurons in the LH, stereological 
estimates were obtained of the number and proportion of LH cells ostensibly 
contacted by BDA-Iabeled varicosities in the light microscope images. In three 
cases, the NR+ cells which were contacted (NR+:BDA+) together with those 
160 
which were not contacted (NR+:BDA-) were counted in randorn sampling 
through three levels of the LH (~A 5800, A 6200 and A 6600). The nurnber of 
contacted cells (NR+:BDA+ = 8,027 ± 3,639 neurons) corresponded to ~14% 
(14.4 ± 5.3%) of the total nurnber ofNR+ cells (NR+:BDA+ plus NR+:BDA- = 
52,495 ± 5,611 neurons) estirnated in the LH. 
YAChT, VGluT and VGAT within BDA-labeled varicosities in the LH 
Series that were double stained for BDA and the VTPs were examined to 
determine if BFaxonal varicosities in the LH were immunopositive (+) for 
V AChT, VGluT or VGAT. 
VAChT+ varicosities were relatively sparse in the LH. Nonetheless, sorne 
BDA-labeled terminaIs were double-labeled for V AChT (Fig. 3A). The 
BDA+N AChT+ varicosities were rnost often located along axons (Fig. 3A', A" 
and A"'). 
Both VGluTl + (not shown) and VGluT2+ varicosities were densely 
distributed through the LH, though the VGluT2 rnost densely so. VGluT3+ 
varicosities were also present though sparse (not shown). In adjacent series 
processed for BDA and VGluTl, 2 or 3, only VGluT2 was found to be present in 
BDA-labeled varicosities (Fig. 3B). The BDA+NGluT2+ varicosities rnost 
frequently appeared to be boutons en passant (Fig. 3B', B" and B"'), although 
sorne appeared to be boutons terminaux. 
Varicosities that were VGAT+ were densely distributed within the LH area. 
Many of the BDA-labeled axonal varicosities were VGAT+ (Fig. 3C). The 
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BDA +NGAT + varicosities were most commonly boutons en passant (Fig. 3C', 
C" and C"'), though sorne appeared to be boutons terminaux. 
Double staining for different VTPs was subsequently examined (n = 4 
cases per series) to determine if they might be colocalized in the BF terminaIs. 
Double-Iabeling for VAChTNGluT2, VAChTNGAT or VGluT2NGAT was not 
detected in varicosities of the LH (not shown). These negative results indicated 
that multiple VTPs are not colocalized in the same BFaxonal varicosities 
innervating the LH. 
Proportion and distribution ofVAChT+, VGluT2+ and VGAT+ BDA-
labeled varicosities 
To determine the proportions of cholinergie, glutamatergic and GABAergic BF 
axon terminal s, stereological analysis was used for estimation of the total numbers 
ofBDA+ and BDA+NTP+ varicosities in the tuberal-posterior LH (~A 5800, A 
6200 and A 6600, Table 2). In the double stained V AChT series, ~ 10% of the 
BDA+ varicosities were BDA+N AChT+. In the VGluT2 series, ~23% ofBDA+ 
varicosities were BDA+/VGluT2+. In the VGAT series, ~47% of the BDA+ 
varicosities were BDA+NGAT+. 
As evident in plots of the sampled BDA+N AChT+, BDA+NGluT2+ and 
BDA+NGAT+ (Fig. 4, representing ~25% of the estimated total number of 
varicosities), the three types ofterminals were codistributed across the LH. The 
three were commonlymost dense within the ventral and central portions of the 
LH, though also scattered through more dorsal portions of the LH. 
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PSD-95 or Geph in relation to BDA+NGluT2+ or BDA+NGAT+ terminaIs 
To assess whether PSPs were present in association with the numerous 
BDA+NGluT2+ or BDA+NGAT+ varicosities, triple fluorescent staining for 
BDA (Cy2), VGluT2 or VGAT (Cy3) and PSD-95 or Geph (Cy5) was performed 
in LB sections and analyzed by confocal microscopy using 3D reconstruction and 
rotation of the images (in 3 cases per series). 
In the series stained for BDA, VGluT2 and PSD-95, the PSD-95 staining 
appeared punctate and smaller in size than VGluT2+ varicosities. As judged from 
magnified and rotated 3D images, PSD-95+ puncta were often seen close1y 
associated with VGluT2+ varicosities (Fig. 5A, B and C, pointers). 
BDA+NGluT2+ varicosities were commonly seen in close association with one 
or more PSD-95+ puncta (BDA+NGluT2+:PSD-95+, Fig. 5 A and B, pointers 
opposite filled arrowheads). As confirmed in 3D rotations, the BDA+NGluT2+ 
varicosities were apposed to the PSD-95+ profiles (Fig. 5A and B, insets). 
BDA+NGluT2- varicosities were generally seen unassociated with PSD-95+ 
puncta (Fig. 5C), although sorne BDA+NGluT2-:PSD-95+ profiles were 
admittedly seen (not shown). 
In series stained for BDA, VGAT and Geph, Geph staining appeared 
punctate. The Geph+ puncta were generally larger that the PSD-95+ puncta. As 
judged from magnified and rotated 3D images, Geph+ puncta were frequently 
seen in close association with VGAT+ varicosities, and converselyVGAT 
varicosities were frequently seen in close association with Geph+ puncta (Fig. 5D, 
E and F, pointers). BDA+NGAT+ axonal varicosities were apposed to Geph+ 
puncta (BDA+NGAT+:Geph+), usually with one Geph+ profile per 
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BDA+NGAT+ varicosity (Fig. 5D and E). Occasionally, unlabeled LH cells 
appeared to be surrounded by VGAT+ varicosities, including BDA+NGAT+ 
ones that were apposed to Geph+ puncta, located on the inner side of the 
varicosities and thus presumably in the cell membrane ofthe innervated cell body 
(Fig. 5 D). BDA+NGAT- varicosities were not seen in apposition to Geph+ 
profiles (Fig. 5F). 
164 
DISCUSSION 
The present study provides evidence that cholinergic, glutamatergic and 
GABAergic BF neurons project to the LH. The quantitatively most important, 
glutamatergic and GABAergic fibers also appear to form excitatory and inhibitory 
synapses respectively on LH neurons. Through this projection, BF neurons can 
thus have a dual influence in the LH to excite or inhibit neurons involved in 
promoting cortical activation and behavioral arousal. 
Technical considerations 
Confirming its documented utility as an anterograde tracer (Veenman et al., 1992; 
Wouterlood and Jorritsma-Byham, 1993; Lanciego et al., 2000; Reiner et al., 
2000), we found that BDA-I0,000 provided discrete labeling ofBF cell bodies 
and reliable anterograde labeling of BF fibers and varicosities. Although we 
noticed sorne labeled cells in areas surrounding the injection site in the MCPO-SI, 
which might have been retrogradely labeled, we did not find cells retrogradely 
labeled at a distance in the prefrontal cortex or LH, confirming that BDA -10,000, 
in contrast to BDA-3000 MW, results in neglible retrograde labeling (Wouterlood 
and Jorritsma-Byham, 1993; Reiner et al., 2000). Here from the labeled cells 
located predominantly (>90% on average) in the MCPO of the BF, the BDA-
labeled axons were seen to course within the ventrolateral, "a" subdivision of the 
MFB, which has been known to carry descending fibers from the MCPO 
(Veening et al., 1982). In the posterior LH, the axons sent collateral branches 
through the LH region in a manner also previously described from the MCPO by 
application of other anterograde tracers, including Phaseolus vulgaris 
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leucoagglutinin (PHA-L) (Grove, 1988) and proteins synthesized from tritiated 
amino acids (Swanson, 1976). This distribution of efferent fibers to the LH from 
MCPO-SI fits within a lateral to medial topographie organization of projections to 
the tuberal-posterior hypothalamus from forebrain structures (Veening et al., 
1982). Moreover, the BDA-Iabe1ed varicose fibers extended through a region in 
the LH from which neurons in the MCPO and SI had previously been retrograde1y 
labeled with cholera toxin in large numbers in our laboratory (Gritti et al., 1994). 
Here, we labe1ed only a small proportion of these afferent neurons, according to 
their numbers and distribution (Gritti et al., 1993, 1994; Gritti et al., 2003), since 
our injection site was intentionally discrete so as to be maximally restricted to the 
MCPO and overlying sr. With this relatively small proportion ofprojection 
neurons labeled, we found nonethe1ess that an estimated ~22,000 terminaIs were 
labe1ed with BDA in the LH and ~8,000 cells (~15% of the estimated total LH 
cell population) were contacted by BDA + terminaIs, thus providing a good 
sample of the basalo-hypothalamic projection to the LH. 
Confirming the utility of BDA as an anterograde tracer that can be readily 
used along with immunostaining for e1ucidating complex neural circuits 
(Lanciego et al., 2000), we were able to apply double staining for BDA and the 
VTPs in order to identify the neurotransmitters utilized by the BF neurons 
projecting to the LH. We found that with use of Triton (0.1 %), we obtained 
complete penetration in double stained material for VTP antibodies and 
streptavidin (through 25 !J.m thick sections). Such re1iable, homogeneous staining 
thus permitted the application of stereological analysis to assess the proportions of 
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the different VTP+ tenninals in the LH. We were moreover able to apply triple 
staining for BDA, the VTPs and PSPs (using 0.3% TX). 
Double staining with the VTPs allowed unequivocal identification of the 
neurotransmitter utilized by the projecting neurons (Chaudhry et al., 1998; 
Bellocchio et al., 2000). VTP proteins fonn, together with other elements 
necessary for recycling, docking and fusion of synaptic vesic1es, a critical 
component of the machinery for neurotransmitter release at presynaptic sites (Liu 
et al., 1999; Fremeau et al., 2004). Particularly in the case ofVGAT and VGluT2, 
they have been found to be concentrated at symmetrical and asymmetrical 
synapses respectively, to co-purify with other synaptic proteins and to colocalize 
with synaptophysin and/or synaptobrevin in synaptic tenninals (Chaudhry et al., 
1998; Takamori et al., 2000; Gualix et al., 2003; Fremeau et al., 2004). 
Triple staining with PSPs here confinned that the BDA-Iabeled VGluT+ and 
VGAT+ tenninals abutted excitatory and inhibitory postsynaptic elements, 
respectively. The PSPs, PSD-95 and Geph, fonn part of the postsynaptic 
scaffolding of excitatory (Komau et al., 1995; O'Brien et al., 1999; Sheng and 
Pak, 2000) and inhibitory (Pfeiffer et al., 1984; Sassoe-Pognetto et al., 1995; 
Sassoe-Pognetto and Fritschy, 2000; Sassoe-Pognetto et ai., 2000) synapses, 
respectively. Indeed, PSD-95 colocalizes with glutamate receptors by interacting 
directly with the C-tenninus of synaptic NMDA receptor subunits (Komau et al., 
1995) and indirectly through the protein stargazin with AMP A receptors (Chen et 
al., 2000). Although not binding GABAA receptors directly, Geph colocalizes 
with the most common and synaptically located GABAA receptor subunits as well 
as the glycine receptor (Pfeiffer et al., 1984; Sassoe-Pognetto et al., 2000). We 
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employed laser scanning confocal microscopy and state-of-the-art 3D rendering 
technology to visualize appositions between BDA +NTP+ terminaIs and PSP+ 
profiles, an approach that has been proposed to be suitable for judging the 
existence of synaptic contacts by confocal microscopy (Wouterlood et al., 2002b; 
Wouterlood et al., 2003), while recognizing that absolute proof of such contacts 
necessitates electron microscopy. Thus, we believe that the presynaptic 
enrichment ofVTPs for glutamate and GABA in BDA+ terminaIs and their 
apposition with PSPs associated with excitatory and inhibitory synapses 
respectively, represents strong evidence for the synaptic contacts of glutamatergic 
and GABAergic BF terminaIs on LH neurons. 
BF cholinergie, glutamatergic and GABAergic fibers in the LH 
The immunohistochemicallocalization ofVAChT, VGluT2 and VGAT in 
anterogradely labeled BF varicosities demonstrates that BF neurons have the 
capacity, endowed by the VTPs, to release ACh, glutamate or GABA respectively 
(Gilmor et al., 1996; Chaudhry et al., 1998; Bellocchio et al., 2000; Fremeau et 
al., 2001). Their neurotransmitter phenotypes would appear to be unambiguous, 
since in contrast to previous evidence for the presence of multiple mRNAs or 
proteins for synthetic enzymes of ACh, glutamate or GABA in BF cell bodies 
(Manns et al., 2001; Sotty et al., 2003), no evidence for colocalization ofthe VTP 
proteins was found here in terminaIs within the LH. BF neurons innervating the 
LH can thus be phenotypically identified as cholinergic, glutamatergic or 
GABAergic. 
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By demonstrating the presence ofVGluT2 proteins in BF terminaIs, the 
present results provide the tirst proof for the existence of BF neurons that utilize 
glutamate as a neurotransmitter and can thus be considered glutamatergic. 
Another recent report showed by in situ hybridization that cortically projecting BF 
neurons contain mRNA for VGluT2 and accordingly have the capacity to 
synthesize the VGluT2 protein (Hur and Zaborszky, 2005). Previous results had 
also suggested the existence of glutamatergic BF neurons based upon the presence 
ofphosphate-activated-glutaminase (PAG) (Manns et al., 2001), the enzyme 
utilized for the synthesis of glutamate from glutamine, yet possibly also used for 
the synthesis of GABA from the same substrate in sorne cells (Fujiyama et al., 
2001). The presence of glutamatergic BF neurons that utilize VGluT2 follows the 
principle that in the forebrain, VGluT2 neurons are localized predominantly in 
subcortical structures, whereas VGluT1 neurons are localized predominantly in 
cortex (Fremeau et al., 2001). A third type ofvesicular transporter for glutamate 
(VGluT3) has more recently been visualized in cell bodies within sorne cortical 
and subcortical neurons, inc1uding notably BF neurons (Fremeau et al., 2002; 
Schafer et al., 2002; Harkanyet al., 2003; Herzog et al., 2004). In the present 
analysis, we did not tind evidence for concentration ofVGluT3 in BF varicosities 
within the LH. It would thus appear that BF neurons might contain VGluT3 in 
their cell bodies but not transport it to their terminaIs or altematively that BF 
neurons which do transport VGluT3 to their terminaIs do not project caudally to 
the LH. 
Of the total number of BFaxonal varicosities in the LH, the smallest 
proportion was VAChT+ «10%), a medium proportion VGluT2+ (~25%) and the 
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largest proportion VGAT+ (~50%). Previous studies employing retro grade 
transport with immunostaining for the synthetic enzymes of ACh (choline 
acetyltransferase, ChAT) and GABA (glutamic acid decarboxylase, GAD) found 
that of the BF cells within the MCPO projecting to LH, <5% were ChAT+, ~20% 
were GAD+ and up to ~75% were neither and thus presumed to be glutamatergic 
(Gritti et al., 1994). The higher proportions of anterogradely labeled V AChT+ 
and VGAT+ varicosities relative to retrogradely labeled ChAT+ and GAD+ cell 
bodies might be due to more axonal collateralization per neuron or more 
varicosities per axon length in GABAergic and cholinergic than non-
GABAergic/non-cholinergic neurons, which would include the glutamatergic 
neurons. Irrespective ofthese possible differences, only 25% of the varicosities 
were found to be glutamatergic, and another ~ 15% of varicosities could not be 
accounted for as glutamatergic, cholinergic, or GABAergic. It is possible that this 
contingent might use another type of excitatory neurotransmitter, such as 
aspartate, which is not recognized as a substrate by the vesicular glutamate 
transporters (Bellocchio et al., 2000; Fremeau et al., 2001; Fremeau et al., 2002). 
Indeed, aspartate has been found in axon terminaIs forming asymmetric synapses 
in the hypothalamus (van den Pol, 1991). Or, this proportion might simply reflect 
negative immunohistochemical staining due to insufficient amounts of sorne or aIl 
of the VTPs in terminaIs. 
By showing the presence ofPSD-95 and Geph in apposition to BF identified 
glutamatergic and GABAergic terminaIs respectively in the LH, the results 
substantiate the synaptic nature of this projection and also corroborate the 
principle that glutamate and GABA terminaIs generally form synapses with 
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postsynaptic target neurons (Edwards, 1995). Given the small number and 
proportion ofBDA+N AChT+ varicosities in the LH and the less weIl known 
association of cholinergie tenninals with specifie PSPs (Parker et al., 2004) or 
synaptic specializations (Descarries et al., 1997), we did not examine the 
relationship of the BDA+N AChT+ boutons to PSPs. ACh might act 
predominantly by diffuse transmission through ectopie release and extrasynaptic 
receptors (Levey et al., 1995; Coggan et al., 2005). 
Functional signifie an ce of the cholinergie, glutamatergic and GABAergic BF 
projections to LH 
Neurons in the LH project to brainstem arousal systems and/or spinal cord 
sympathetic and motor systems as weIl as forebrain limbic areas and the cerebral 
cortex (Saper et al., 1979; Saper, 1985; Holstege, 1987). By means ofthese 
multiple projections, the LH is weIl suited to play a central role in arousal. 
Indeed, the LH has been shown to positively influence several arousal-related 
pro cesses such as sympathetic tone, locomotion and exploratory behavior, 
including food seeking, reward and cortical activation (Olds and Milner, 1954; 
Hess, 1957; Berthoud, 2002; Di Leone et al., 2003; Jones, 2005b). Recently, the 
diffusely projecting neurons have been identified in the LH that contain the 
peptide Orx (de Lecea et al., 1998; Peyron et al., 1998; Sakurai et al., 1998), 
which appears to be critical for arousal and postural muscle tone since in absence 
of the peptide or its receptor, narcolepsy with cataplexy occurs (Chemelli et al., 
1999; Lin et al., 1999; Peyron et al., 2000; Thannickal et al., 2000; Gerashchenko 
et al., 2001b; Hara et al., 2001). Physiologically as weIl as anatomically and 
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chemicaIly, the LH is comprised by different cell types, the vast majority ofwhich 
discharge at high rates during active waking with behavioral arousal (Szymusiak 
et al., 1989; Sakai et al., 1990; Steininger et al., 1999; Koyama et al., 2003). 
Sorne discharge in association with cortical activation during both waking and PS. 
Identified Orx neurons have recently been found to discharge maximally during 
active wakefulness and to virtually cease firing during SWS and PS (Lee et al., 
2005a; Mileykovskiy et al., 2005). 
In the present study, we found that the LH received input from cholinergie 
BF terminaIs, which represented <10% of all BF varicosities. Since cholinergie 
BF neurons have been found to discharge in association with cortical activation 
during both waking and PS (Manns et al., 2000a; Lee et al., 2005b), they could 
possibly influence similar neurons in the LH which project selectively to the 
cerebral cortex and discharge with cortical activation during both waking and PS 
(Szymusiak et al., 1989; Sakai et al., 1990; Steininger et al., 1999; Koyama et al., 
2003). 
Glutamatergic terminaIs accounted for up to 25% of the total BF innervation 
of the LH, indicating that glutamatergic BF neurons can exert an important 
excitatory influence upon the LH. This influence could be exerted upon LH 
neurons which discharge in association with cortical activation and presumably 
project to the cerebral cortex (above) or upon LH neurons which discharge in 
association with motor activity and presumably project to the brainstem or spinal 
cord (Szymusiak et al., 1989; Steininger et al., 1999; Alam et al., 2002). 
Glutamatergic BF neurons could also act upon Orx LH neurons, which project 
172 
diffusely to aIl targets and could thus simultaneously promote cortical activation 
along with motor activity and behavioral arousal that occur during waking. Such 
an excitatory influence could originate from as yet chemically unidentified but 
possibly glutamatergic BF neurons that are maximally active during waking and 
minimally active during SWS and PS (Szymusiak and McGinty, 1986b; Manns et 
al., 2003a; Lee et al., 2004; Jones, 2005a). 
Approximately 50% of BFaxon terminaIs innervating the LH were 
GABAergic, indicating that a major influence of the BF in this region is 
inhibitory. Given that the vast majority of neurons in the LH discharge during 
waking (Steininger et al., 1999; Alam et al., 2002) and that inhibition ofthese 
neurons by injections of the GABAA receptor agonist muscimol into the LH 
suppresses waking (Lin et al., 1989), it can be concluded that the GABAergic 
inhibitory influence from the BF in the LH would suppress waking and promote 
sleep. This inhibitory influence could be upon multiple LH neurons, including 
Orx neurons, whose inhibition by GABAergic input would accordingly provide a 
very powerful impetus for sleep. We propose that this innervation originates from 
particular GABAergic BF neurons that are sleep-active (Modirrousta et al., 2004) 
and discharge during SWS or SWS and PS when muscle hypotonia and atonia 
occur (Szymusiak and McGinty, 1986b; Manns et al., 2000b; Lee et al., 2004; 
Jones, 2005a). 
In conclusion, the present study reveals the presence of three phenotypically 
distinct BF cell groups that must according to their neurotransmitters, 
differentially modulate the LH. As a minor contingent, cholinergie BF neurons 
can act to facilitate LH neurons involved in cortical activation. As a larger 
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contingent, newly identified glutamatergic BF neurons can act to promo te both 
cortical and behavioral arousal ofwaking. As the largest contingent, GABAergic 
BF neurons can act to suppress arousal and promote sleep. 
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Table l. List ofprimary and secondary antibodies used for fluorescence staining ofbiotinylated dextran amine (BDA), vesicular 
transporter proteins (VTPs) and post-synaptic proteins (PSPs). 
1" AB !overni,hl} 2" AB !l hours} SAIl houn} 
Stries Antilen Host Dilution Source Cat# Immunolen S~dficl!l: Il2m9.f'·· Dilution SAIT Dilution n" 
Double YAChT GI 1:5000 Chemicon l ABl578 S)11thetic peptide By WB the AB recognizes a Anti-GI.cy3 1:800 SA.cy2 1:800 
BDA corresponding to C-terminus -65-70 kD band 
YTP of cloned rat YAChT' (CSPP corresponding to YAChT 
GPFlXiCEDDYNYYSRS)' protein4 
YAChT Rh 1:1000 Sigma2 Y5387 Synthetic peptide By WB the AB rccognizcs a Anti·Rb·Cy3 
corresponding 10 AA 512- -67·70 kD band, 
530 orC-tenninus ofcloned com::sponding to YAChT 
rat YAChT (K-SPPGPFlXiC protein7 
EDDYNYYSRS)' 
YGluTi Rh 1:1000 GiftRHE' Synthetic peptide By WB the AB rccognizcs a Anti·Rb-Cy3 
corresponding 10 68 Iast AA 
-62 kD band from rat brain9 
of C-terminus of rat BNPi 
(YGluTl)' 
YGluTI Rh 1:5000 GiftRHE Synthetic peptide By WB the AB l<COgnizes a Anti·Rh·Cy3 14 
corresponding to 64 last AA -50-62 kD band front rat 
of C-terminus of rat ONPi brain10 
(YGluTI)" 
YGluT3 GP 1:1000 Chemicon AB542 1 Synthetic peptide &am The AB labels YGluT3+ ceU, Anti-GP·Cy3 
cloned rat VGluD protein l1 and fiben, in agrccmeut with 
(AFEGEEPL'iYQNEEDFSE other VGluT3 antiserall 
TS)' 
YGAT Rh 1:250 Chemicon AB5062P Synthetic peptide By WB the AB recognizc::s a Anti·Rb-Cy3 14 
corn::sponding to a 17 AA band at-55-60 kD12 
peptide ncar C-terminus 
regioo of rat YGAT" (VHS 
lEGLIEA YRTNAED)' 
Double YAChT/ Gt 1:5000 Chemicon ABI578 (above) (above) Anti·Gt·Cy3 1:800 
YTP YGiuTI Rh 1:5000 GiftRHE (above) (above) Anti.Rb-Cy2 1:200 
YTP 
YAChT/ Gt 1:5000 Chemicon ABI578 (above) (above) Anti·Gt·Cy3 1:800 
YGAT Rh 1:250 Chemicon AB5062P (above) (above) Anti.Rb-Cy2 1:200 
YGAT/ Rh 1:250 Chemicon AB5062P (above) (above) Anti·Rh·Cy2 1:800 
YGiuTI GP 1:5000 Chemicon AB5907 Synthctic peptide from The AB givcs labeling in Anti·GP·Cy3 1:200 
cloncd rat VGluT2 protein13 agreement with otha- antiscra 
(YQESAQDAYSYKDRDD toVGlunu 
YS)' 
Triple YGiuTI/ Rh 1:5000 GiftRHE (above) (above) Anti·Rh-Cy5 1:800 SA·Cy2 1:800 
BOA PSo..95 M, 1:100 ABR' MAI·045 Purifio:l recombinant of rat The AB dctc:cts post synaptic Anli.M,·Cy3 1:800 
YTP PSD-9S 14 density 95kD in rat brain. By 
PSP WB it rccognizcs a -95 kDa 
bandl4 
YGAT/ Rh 1:250 Chemicon AB5062P (above) (above) Anti·Rh-Cy5 
Geph M, 1:100 SY·Sv' 147011 Purificd rat gcphyrinu By WB the AB r<eognizes a Anli·M,·Cy3 
-.93 kD band. ft detects aN-
tenninus cpitopel6 
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1 Chemicon: Chemicon International, Temecula, CA, U.S.A. 
2 Sigma: Sigma, St. Louis, Missouri, U.S.A. 
3 Gift from Edwards, R.H. and Fremeau, R. T.Jr. 
4 ABR: Affinity BioReagents, Golden, CO, U.S.A. 
5 SV-SV: Synaptic Systems, Gôttingen, Germany. 
6 http://www.chemicon.com/ProductIProductDataSheet.asp ?ProductItem~ AB 15 78 
7 Supplied by Chemicon on request 
8 http://www.sigmaaldrich.comlsigmaldatasheetlv5387dat.pdf 
9 Bellocchio et al., 1998 
10 Fremeau et al., 2001 
Il http://www.chemicon.comlProductIProductDataSheet.asp?Productltem~AB5421 
12 http://www.chemicon.com/ProductIProductDataSheet.asp?Productltem~AB5062P 
13 http://www.chemicon.comlproductlproductdataSheel.asp?Productltem~AB5907 
14 http://www.bioreagents.comlindex.cfrnlfuseactionlproducts.printIProductlMAI-045 
15 http://www.sysy.comlgephyrinlgephy_fs.html 
16 Pfeiffer et al., 1984 
17 Jackson Immuno Research Laboratories, West Grove, PA, U.S.A. 
18 For multiple labeling (ML) with minimal cross-reactivity (min X) to other species. 
19 n: number of cases (each case referring to an injection site and series from the same side of the brain, thus 1 or 2 per brain). 
Abbreviations: AA, amino acid; AB, antibody; BNPi, brain specifie Na +-dependent phosphate transporter; Cal., catalog; Cy2, 
cyanine; Cy3, indocaIbocyanine; Cy5, indodicarbocyanine; Dky, donkey; DNPi, differentiation-associated Na +-dependent phosphate 
transporter; Geph, gephyrin; GP, guinea pig; Gt, goat; Ms, mouse (monoclonal); Rb, rabbit; SA, streptavidin; WB, western blol. 
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Table 2. Proportion ofVAChT +, VGIuT2+ and VGAT + BDA-labeled BFaxonal varicosities in the LH region based on 
stereological estimates l . 
VACIIYserles VGluTIseries VGATHria ~ 
c .... BDA+var. BDA+/ ~. VACbT+ BDA+var. BDA+/ ".VGluTI+ BDA+var. BDA+/ e;.VGAT+ ANOVA VAChT+var. VGluT2+ var. VGAT+var. F-ratio 
BDAI5·L 38,080 4,640 12.2 
BDAI5·R 17,920 1,040 5.8 
BDAI6-L 18,800 2,640 14.0 27,040 5,600 20.7 23,440 Il,280 48.1 
BDAI8·L 17,840 2,000 11.2 10,800 2,080 19.3 17,680 8,240 46.6 
BDAI8·R 15,120 960 63 Il,680 2,640 22.6 17,120 8,160 47.7 
BDAI9-L 18,824 6,136 32.6 20,176 10,504 52.1 
BDAI9·R 19,032 3.432 18.0 16,536 6,864 41.5 
M ... ±SEM 21,5S2±4,178 2,256± 673 9.9:1:: 1.6 17,475± 2,946 J.!J7lz 806 22.6:1:: 2.6 11I,!I9O±1,274 ',010:1::'16 47.2:1:: 1.7 17.3"· 
IData for individual cases (1 or 2 sides from 4 rat brains) is presented together with the mean ± SEM. Estimated numbers of 
varicosities were obtained by sampling from 3 sections (at levels, A 5800, A 6200 and A 6600), per series per case. The proportions 
of the three VTP+ varicosities differed significantly (***, p < 0.001 according to one-way ANOVA) across and between VTP+ 
varicosities (with p < 0.05 according to post-hoc Bonferroni-corrected multiple-comparisons). Abbreviations: Est., estimated; var., 
varicosities; VTP, vesicular transporter protein. 
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Fig. 1. BF site ofBDA injection. A: Atlas section through the cholinergic cell 
area (MCPO-SI) where iontophoretic applications ofBDA were placed. B: 
Composite image oftypical BDA injection site (case BDAI8-R, processed using 
ABC with DAB-Ni and counterstained with neutral red). Note the small size and 
restricted location ofBDA-labe1ed cells in the MCPO. C: High magnification 
image oftwo BDA-Iabeled neurons (from B, arrowheads). Brightness and 
contrast was adjusted in Band C. Abbreviations: ac, anterior commissure; FS, 
fundus striatum; LPO, lateral preoptic area; MCPO, magnocellular preoptic 
nucleus; MPO, medial preoptic nucleus; oc, optic chiasm; Pir, piriform cortex; SI, 
substantia innominata; sa, supraoptic nucleus. Scale bars: in B, 1 mm; in C, 20 
Jlm. 
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Fig. 1. BF site of BDA injection 
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Fig. 2. BDA-Iabeled fibers in the LH. A: Low magnification composite image of 
BDA+ axons (in black, DAB-Ni) and neutral red stained (NR+) cells in the LH 
(case BDA19-L). B: High magnification images showing BDA+ axons and 
terminaIs within the LH area. Varicosities appeared most commonly along axons 
as boutons en passant (solid arrowhead in B') but also at the end of axons as 
boutons terminaux (open arrowhead in B"). Many axonal varicosities (stained 
with DAB-Ni) were seen in the neuropil (B') or in close proximity to small (solid 
arrowhead in B") or large (solid arrowhead in B"') nerve cell bodies (stained 
with NR, B' and B", case BDA15-L; B''', case BDA19-L). C: Tracing of 
BDA+ axons and NR+ neurons in the LH at -A 6200 Jlm (from IAO, case 
BDA19-L). Although concentrated more ventrally, fibers extended through the 
LH area and formed appositions with neurons therein (D). D: High magnification 
tracing of elements in C showing the relationship ofBDA+ axons with dorsally 
(solid arrowheads in D'), as well as more ventrally (D" and D''') located NR+ 
neurons. (The neuron in D'" corresponds to that pictured in B"'.) Tonal range 
for each RGB channel as well as brightness and contrast adjustment were made 
for pictures in A and B. Abbreviations: cp, cerebral peduncle; DMH, dorsomediai 
hypothalamus; f, fomix; LH, lateral hypothalamus; ot, optic tract; VMH, 
ventromedial hypothalamic nucleus; ZI, zona incerta. Scaie bars: in A, 100 Jlm; 
in B and D, 10 Jlm. 
182 
cp 
ot 
/' ) ~, .~ 
c D" 1 
Fig. 2. BDA-Iabeled fibers in the LH 
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Fig. 3. BDA-Iabeled axons in LH contain YAChT, VGluT2 or VGAT. High 
magnification epifluorescent images illustrating anterogradely labeled BDA+ 
axons (left A', B' and C', green fluorescent Cy2) that are double-Iabeled for 
vesicular transporter proteins (VTPs) as shown in single (middle A", B" and C" , 
red fluorescent Cy3) and merged (right A''', B'" and C"', yeIlow) images and 
indicated by white arrowheads for those which are in focus. A: BDA+ varicose 
fiber (A') whose varicosities are positive for YAChT (A" and A"'). B: BDA+ 
varicose axon (B') whose varicosities are positive for VGluT2 (B" and B"'). C: 
BDA+ axon (C') whose varicosities are positive for VGAT (C" and C"'). Tonal 
range in red and green channels was adjusted individually (see methods). Scale 
bar in C'" for aIl images, 10 Ilm. 
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Fig. 4. Distribution ofVAChT+, VGluT2+ and VGAT+ BDA-Iabeled 
varicosities in the LH. Plotted together are the BDA+N AChT+ (blue circles), 
BDA+NGluT2+ (green squares) and BDA+NGAT+ (red triangles) that were 
marked and counted by stereological analysis from double stained fluorescent 
sections at the three levels through the LH (case BDA16-L). The BDA+NTP-
negative terminaIs, which were counted in each series, are not included. The 
stereological analysis was performed by sampling ~ ofthe total area (using a 
counting frame of 90 x 90 /-lm within a grid of 180 x 180 /-lm, see Methods), and 
each figure thus reflects ~~ of the total number ofvaricosities in a 25 /-lm thick 
section. Note the concentration ofBDA+NTP+ varicosities within the ventral 
and central portion of the LH, with scattered varicosities in other portions, 
especially at the most posterior level (A 5800). Abbreviations: f, fomix. 
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Fig. 4. Distribution ofVAChT +, VGluT2+ and VGAT + BDA-Iabeled 
varicosities in the LH 
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Fig. 5. Relationship ofPSD-95+ puncta to VGluT2+ and Geph+ puncta to 
VGAT+ BDA-Iabeled varicosities in 3D rendered confocal images. A and B: 
Large images (8 and 12 seriaI 0.33 !lm thick optical sections) ofBDA-labeled 
axons and varicosities (solid arrowheads, pseudo-color green, Cy2) that are 
immunopositive for VGluT2 (pseudo-color blue, Cy3) and face PSD-95+ profiles 
(facing pointers, pseudo-color red, Cy5) and featured in the zoomed images on the 
right (5 and 12 seriaI 0.33 !lm thick optical sections). Note also in the large 
images, the frequent association ofVGluT2+ varicosities with PSD-95+ puncta 
(pointers). C: Image (8 seriaI sections) of a BDA+ varicosity (open arrowhead, 
pseudo-color green, Cy2) that is immunonegative for VGluT2 (pseudo-color blue, 
Cy3) and do es not face a PSD-95+ profile, as also evident in the zoom images on 
the right (10 seriaI sections). Note VGluT2+ varicosities in the vicinity that are 
associated with PSD-95+ puncta (pointer in large image). D and E: Images (8 
and 7 seriaI sections, respectively) ofBDA-labeled axons and varicosities (solid 
arrowheads, pseudo-color green, Cy2) that are positive for VGAT (pseudo-color 
blue, Cy3) and face Geph+ profiles (facing pointers, pseudo-color red, Cy5), as 
featured in the zoomed images on right (9 and 7 seriaI sections). In the large 
image of D, VGAT+/Geph+ elements appear to surround the unlabeled soma ofa 
neuron with the VGAT+ varicosities outside and the Geph+ puncta (pointers) 
inside, presumably on the cell membrane. Note in the large panels that many 
VGAT+ varicosities are associated with Geph+ puncta (pointers). F: Image (7 
seriaI sections) ofa BDA+ varicosity (open arrowhead, pseudo-color green, Cy2) 
that is immunonegative for VGAT (pseudo-color blue, Cy3) and is not associated 
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Fig. 5. Relationship of PSD-95+ puncta to VGluT2+ and Geph+ puncta to 
VGAT + BDA-Iabeled varicosities in 3D rendered confocal images 
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with any Geph+ puncta, as also evident in the zoomed images on the right (5 
seriaI sections). Note, in contrast, other VGAT+ varicosities in the vicinity are 
associated with Geph+ puncta (pointer). Deconvolution was applied to aIl images 
with a confidence limit of95% (see Methods). Scale bar for large images on left 
(shown for aIl panels in F) = 5 Ilm; for zoom images on right (shown for aIl 
panels in F) = 1 Ilm. 
190 
191 
PREFACE TO CHAPT ER IV 
Hypothalamic neurons which contain the peptide orexin (also called 
hypocretin) and distribute in the LH, the perifomical area (PF) and dorsomedial 
hypothalamus (DMH) have been recently described. These neurons have been 
shown to play a cardinal role in the maintenance ofwakefulness, since their 
absence, or that of the Orx peptide or its receptor, leads to narcolepsy, a syndrome 
characterized by excessive sleepiness, sudden loss of muscle tone and intrusions 
of PS phenomena into W. 
Given the role of the BF in the appearance ofbehavioral quiescence and 
sleep and, as described in the last chapter, the prominent projections of the BF to 
the LH, the possibility that these afferents may innervate, and therefore control 
the activity of Orx neurons, was examined. 
In order to determine whether Orx neurons are innervated by BF neurons, 
we first mapped and quantified the Orx neurons in the hypothalamus in relation to 
BF afferents, using double stained material for BDA and Orx. Upon presence of 
significant numbers of appositions between BFaxon terminaIs and Orx neurons, 
the neurochemical phenotype of those appositions and the proportions of neurons 
innervated by them were determined in triple stained fluorescent material for 
BDA, VTPs and Orx. Finally, the presence of synaptic contacts was examined by 
using triple stained material for BDA, PSPs and Orx. 
Given the critical role of Orx neurons in the maintenance ofW, the 
influence that GABAergic and glutamatergic BF neurons may have on Orx 
neuronal activity is discussed in relation to the role of the BF neurons in sleep and 
cortical activation. 
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Chapter IV 
Innervation of OrexinIHypoeretin Neurons by GABAergie, 
Glutamatergie or Cholinergie Basal Forebrain Terminais 
Evideneed by Immunostaining for Presynaptie Vesieular 
Transporter and Postsynaptie Seaffolding Proteins 
Pablo Henny and Barbara E. Jones 
Montreal Neurological Institute, McGill University, 
Montreal, Quebec, Canada H3A 2B4 
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Abbreviations: 
ABC avidin-biotin-peroxidase complex 
ac anterior commissure 
AHA anterior hypothalamic area 
AMCA aminomethylcoumarin acetate 
ANPB alpha-naphthol pyronin B 
Arc arcuate nucleus 
BDA biotinylated dextran amine 
BF basal forebrain 
cp cerebral peduncle 
Cy2 cyanme 
Cy3 indocarbocyanine 
Cy5 indodicarbocyanine 
DAB diaminobenzidine 
DAB-Ni nickel-intensified diaminobenzidine 
DMH dorsomedial hypothalamic nucleus 
f fornix 
FS fundus striatum 
Geph gephyrin 
IC internaI capsule 
LH lateral hypothalamus 
LPO lateral preoptic area 
--, MCPO magnocellular preoptic nucleus 
MFB medial forebrain bundle 
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MPO medial preoptic nucleus 
mt mammillothalamic tract 
oc optic chiasm 
Orx orexin or hypocretin 
ot optic tract 
Pe periventricular hypothalamic nucleus 
PF perifomical area 
Pir piriform cortex 
PSD-95 95-kD postsynaptic density protein 
PSP postsynaptic protein 
SI substantia innominata 
SO supraoptic nucleus 
STh subthalamic nucleus 
YAChT vesicular transporter for acetylcholine 
VGAT vesicular transporter for GABA 
VGluT2 vesicular transporter for glutamate 2 
VMH ventromedial hypothalamic nucleus 
VTP vesicular transporter protein 
ZI zona incerta 
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ABSTRACT 
Orexinlhypocretin (Orx) neurons are critical for the maintenance ofwaking in 
association with behavioral arousal and postural muscle tone, since with their loss, 
narcolepsy with cataplexy occurs. Given that basal forebrain (BF) neurons 
project to the hypothalamus and play important diverse roles in sleep-wake states, 
we sought to determine whether acetylcholine (ACh), glutamate (Glu) and/or 
GABA releasing BF neurons innervate and could thereby differentially regulate 
the Orx neurons. From discrete injections ofbiotinylated dextran amine (BDA, 
10,000 MW) into the magnocellular preoptic nucleus (MCPO) and substantia 
innominata (SI) in the rat, BDA-labeled fibers projected to the lateral 
hypothalamus (LH), perifomical area (PF) and dorsomedial hypothalamus 
(DMH), where ~41 %, ~ Il % and 9% of Orx-positive (+) neurons were 
respectively contacted in each region. Employing triple fluorescent staining for 
Orx, BDA and presynaptic vesicular (V) transporters (T), we found that only 4% 
of the innervated Orx+ neurons in the LH were contacted by BDA+[VAChT+] 
terminaIs, whereas ~31 % and ~67% were respectively contacted by 
BDA+[VGluT2+] and BDA+[VGAT+] terminaIs. In 3D rendered and rotated 
confocal images, we confirmed the latter contacts and examined staining for 
postsynaptic proteins PSD-95, a marker for glutamatergic synapses, and gephyrin, 
a marker for GABAergic synapses, that were located on Orx+ neurons facing 
BDA-labe1ed terminaIs in ~20% and ~50% of contacts, respectively. With such 
synaptic input, BF glutamatergic neurons can excite Orx neurons and thus act to 
maintain behavioral arousal with muscle tone, whereas GABAergic neurons can 
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inhibit Orx neurons and thus promote behavioral quiescence and sleep along with 
muscle atonia. 
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INTRODUCTION 
Neurons containing the peptide orexin (Orx, also called hypocretin) play a critical 
role in maintaining wakefulness and associated postural muscle tone, since in 
their absence or that of the peptide or receptor, narcolepsy with cataplexy occurs 
in humans and animaIs (Chemelli et al., 1999; Lin et al., 1999; Peyron et al., 
2000; Thannickal et al., 2000; Yamanaka et al., 2003b). The Orx neurons are 
located within the tuberaI hypothalamus where they are broadly distributed across 
the lateral hypothalamic area (Broberger et al., 1998; Peyron et al., 1998; 
Modirrousta et al., 2005; Swanson et al., 2005), a region long known to play an 
important role in arousal (see for review, (Jones, 2005b )). Lying there within the 
path of the medial forebrain bundle (MFB) (Millhouse, 1969; Veening et al., 
1982), the Orx neurons have recently been shown to receive inputs from multiple 
forebrain and brainstem cell groups (Sakurai et al., 2005; Yoshida et al., 2006), 
which project through the MFB and are involved in sleep-wake state regulation 
(Jones, 2005b). The sources of afferent input might include the basal forebrain 
(BF) (Sakurai et al., 2005), which, from lesion, stimulation and recording studies 
is known to play diverse roI es in sleep-wake state regulation through its different 
constituent cell groups (Szymusiak et al., 2000; Jones, 2005a; Jones, 2005b). 
The BF is known particularly for the cholinergic neurons residing there 
within multiple nuclei and projecting to the cerebral cortex where they stimulate 
cortical activation during waking and paradoxical sleep (PS, also called rapid eye 
movement, REM, sleep) see for review (Jones, 2004). However, the BF also 
contains more numerous non-cholinergic neurons, including GABAergic and 
glutamatergic neurons which appear to play different roI es in sleep-wake state 
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regulation, including the promotion of slow wave sleep (SWS) or conversely, 
waking (Lee et al., 2004; Jones, 2005a). From retrograde tracing studies, we 
previously found that few cholinergie neurons, but many GABAergic and other 
unidentified BF neurons, project caudally to the lateral hypothalamus (LH) (Gritti 
et al., 1994). Most recently using anterograde transport ofbiotinylated dextran 
amine (BDA) together with immunohistochemistry for the vesicular transporter 
proteins (VTPs), we established that a minor proportion ofterminals projecting 
into the LH from the BF contained the VTP for acety1choline (ACh, V AChT) , 
whereas a major proportion contained that for GABA (VGAT) and a remaining 
proportion contained the VTP for glutamate (VGluT2 and not VGluT1 or 
VGluT3), proving an important glutamatergic in addition to GABAergic 
contingent of the BF inputs to the LH (Henny and Jones, 2006a). We also 
established in that study that the cholinergie, GABAergic and glutamatergic 
projecting neurons were phenotypically distinct, since the VTPs were not co-
localized in the same terminaIs. The BF afferents would thus release ACh, 
GABA or glutamate. The aim of the present study was thus to examine if the Orx 
neurons in the hypothalamus are innervated by BF terminaIs and, if so, whether 
they might be selectively or preferentially innervated by cholinergie, 
glutamatergic or GABAergic terminaIs and thereby influenced in a particular 
manner by BF neurons across the sleep-waking cycle. 
Using anterograde transport of 10,000 MW BDA in rats (Henny and Jones, 
2006a), we examined in the present study the innervation of Orx neurons by 
neurons ofthe magnocellular preoptic nucleus (MCPO) and substantia innominata 
(SI) of the BF cholinergie cell area from where significant hypothalamic as well 
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as neocortical projections originate (Gritti et al., 1994; Gritti et al., 1997) and can 
influence behavioral in addition to cortical components of sleep-wake states 
(Szymusiak et al., 2000; Jones, 2004, 2005a; Jones, 2005b). First, using single or 
dual staining, we studied and estimated quantitatively with stereological analysis 
the distribution of Orx neurons in the hypothalamus and their contact by BDA-
labeled terminaIs in light microscopy. Second, using triple staining for Orx, BDA 
and the VTPs, we examined and estimated quantitatively with stereological 
analysis the contacts on the Orx neurons by BDA-Iabeled terminaIs containing 
YAChT, VGluT2 or VGAT in fluorescence microscopy. Third, given evidence of 
prominent VGluT2 and VGAT containing terminals apposing the Orx neurons, 
we further studied their contacts by confocallaser scanning microscopy and 3D 
reconstruction with rotation. Lastly, to as certain whether such varicosities might 
form excitatory or inhibitory synapses on the Orx neurons, we similarly examined 
sections triple-stained for BDA, Orx and the scaffolding postsynaptic proteins 
(PSPs), PSD-95 as a marker for asymmetric, glutamatergic synapses (Sheng and 
Pak, 2000; Sassoe-Pognetto et al., 2003) or Gephyrin (Geph) as a marker for 
symmetric, GABAergic synapses (Pfeiffer et al., 1984; Giustetto et al., 1998; 
Sassoe-Pognetto and Fritschy, 2000; Sassoe-Pognetto et al., 2000). Using 3D 
reconstruction with rotation ofhigh-resolution confocal images, we document 
important glutamatergic and GABAergic BF inputs onto Orx neurons. 
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MATERIALS AND METHODS 
AnimaIs and Surgery 
AlI procedures conformed to the guidelines of the Canadian Council on Animal 
Care and the U.S. NIH and were approved by the McGill University Animal Care 
committee. 
As previously described in detail (Henny and Jones, 2006a), Long Evans 
rats (200-250 g, Charles River Canada, St. Constant, Quebec, Canada) were 
anesthetized and placed in a stereotaxic frame (David Kopf Instruments, Tujunga, 
CA) for surgery. Glass micropipettes (tip diameter 15 to 25 f.lm) were back-fiIled 
with a 0.5 M NaCI solution containing 2% 10,000 MW BDA (BDA-l 0,000, 
Molecular Probes, Eugene, OR). Since previous studies using anterograde as weIl 
as retro grade tracing methods showed no evidence for contralateral projections 
from BF to the posterior hypothalamus (Swanson, 1976; Gritti et al., 1994), 
bilateral injections ofBDA were performed. The pipettes were lowered into the 
region of the MCPO on each si de (from Bregma: anterior-posterior (AP), -0.5 
mm; Lateral (L), +/- 2.5 mm; Vertical (V), 8.5 mm) (Paxinos and Watson, 1986) 
with the aid of a micropositioner (Mode1 660, David Kopf Instruments). Once in 
the targeted site, microinjection ofBDA was performed by iontophoresis (using a 
Microiontophoresis Dual CUITent Generator 260, World Precision Instruments 
(WPI), Sarasota, FL) applying positive CUITent pulses (5 to 10 f.lA) in a dut y cycle 
of 1 sec (0.5 son, 0.5 s off) for a period of25 to 30 min through a stimulator 
(Pulsemaster A300, WPI) and stimulus isolation unit (Iso-Flex, A.M.P.I., 
J erusalem, Israel). 
201 
Rats were maintained for 5 or 6 days with food and water ad libitum and 
subsequently perfused transcardially under deep sodium pentobarbital anesthesia 
(100 mg/kg, i.p.) with ~500 ml 4% paraformaldehyde fixative solution. The 
brains were removed and put in a 30% sucrose solution for 2 to 3 days, after 
which they were frozen at -500 C and stored at -800 C for subsequent processing. 
Immunohistochemistry 
Sections were cut using a freezing microtome in 25 Jlm thick coronal sections and 
collected in eight adjacent series at 200 Jlm intervals through the forebrain, 
including the magnocellular basal forebrain and the tuberaI hypothalamus. To 
visualize BDA-Iabeled neurons in the BF as weIl anterogradely-Iabeled axons in 
the tuberaI hypothalamus, the avidin-biotin-peroxidase complex (ABC) protocol 
was used with diaminobenzidine (DAB) intensified with Nickel (DAB-Ni). 
Sections were subsequently counterstained for Nissl substance using Neutral Red. 
For the mapping, distribution and quantitative estimates of Orx+ cells in 
the hypothalamus, seriaI sections were incubated ovemight with goat (Gt)-Anti-
Orx-A (1 :500, see Table 1) and stained with DAB following incubation with 
donkey (Dky) anti-Gt IgG and Gt peroxidase-antiperoxidase (P AP, both from 
Jackson Immuno Research Laboratories, West Grove, PA). 
For evaluation of the injection sites, description ofBDA-labeled fibers in 
the tuberaI hypothalamus and examination of the innervation of Orx+ cells in the 
region, series were processed for dual-staining ofBDA using the ABC procedure 
with DAB-Ni and Orx-A (above) using PAP with alpha-naphthol pyronin B 
(ANPB, Sigma, St. Louis, MI). Injection sites on one or two sides from 9 rats 
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were selected according to their placement in the MCPO and SI (n = 16 cases) for 
subsequent processing and analysis in peroxidase or fluorescent stained material. 
For triple fluorescent staining of Orx with the VTPs (V AChT, VGluT2 or 
VGAT) and BDA (see Tables 1 and 2), free floating sections from each series 
were rinsed for 30 min in Trizma saline buffer (TS, 0.1 M, pH 7.4) followed by 
incubation for 30 min with a blocking solution of normal donkey serum (NDS, 
6% in TS) containing 0.3% Triton X-100 (TX). Sections were subsequently co-
incubated ovemight at room temperature with VTP and Orx-A primary antibodies 
(in TS containing NDS 1 % and TX 0.3%). Prior pilot studies determined that 
incubation in TX 0.3% allowed full penetration of the antibodies and streptavidin, 
as viewed through the z-axis under epifluorescent and confocal microscopy. The 
next day, sections were incubated for 3 hours in indocarbocyanine (Cy3)- and 
aminomethylcoumarin acetate (AMCA) or indodicarbocyanine (Cy5)-conjugated 
secondary antibodies, followed by three hours in cyanine (Cy2)-conjugated-
streptavidin (SA) for BDA revelation. For triple fluorescent staining ofBDA with 
the PSPs, PSD-95 or Geph, and Orx, the same protocol was used by co-incubation 
with the PSP and Orx antibodies ovemight (see Tables 1 and 2). 
AU sections were mounted out of Trizma water, and the mounted sections 
dehydrated through alcohols, cleared in xylene and coverslipped with Permount. 
Conventional microscopy, tracing and stereological analysis 
Sections were examined under light and epifluorescent microscopy with a Leica 
DMLB or Nikon E800 microscope equipped with an x-y-z motorized stage, video 
or digital camera and filters appropriate for FITC or Cy2, Rhodamine or Cy3, 
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DAPI-AMCA and/or Cy5 fluorescence. Single as weIl as composite images were 
acquired on the Nikon or Leica microscopes using Neurolucida software from 
MicroBrightField (MBF, Colchester, VT), which was also used for plotting cells 
and tracing fibers. In light or fluorescent material, ceIls and varicosities were 
counted using the Optical Fractionator probe of Stereolnvestigator software 
(MBF) on the Nikon microscope. For tracing or counting, a computer resident 
atlas of the rat brain was employed that has been developed and applied in our 
laboratory using standardized procedures for tissue processing. For each 
application, series ofhistology sections are matched to appropriate levels of the 
atlas (at 400 Jlm intervals) under low magnification (5 or 10x objective). At each 
level, the atlas image is then rotated if necessary, and the contours adjusted to 
optimally fit the relevant nuclei of the histology section. In the BF, the number of 
BDA labeled cells was counted through the injection site within the MCPO and SI 
(Gritti et al., 1993; Henny and Jones, 2006a). Through the hypothalamus, Orx 
neurons were plotted and counted through their full distribution across three AP 
levels (in mm from Interaural (A) zero), ~A6.6, A6.2 and A5.8 (Paxinos and 
Watson, 1986), and within three contours, the LH, comprising the region lateral to 
the fornix through which the MFB passes and present at levels ~A6.6, A6.2 and 
A5.8, and the perifornical area (PF), comprising the area surrounding and 
extending medial to the fornix, and the dorsomedial hypothalamic nucleus (DMH) 
and present at levels ~A6.2 and ~A5.8 (Veening et al., 1982; Modirrousta et al., 
2005). BDA-Iabeled fibers were plotted and analyzed using the same atlas 
sections and contours. 
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For representation of the distribution of the Orx population, Orx+ neurons 
(stained with DAB) were plotted under brightfield illumination with a 40x 
objective at three levels (above) using Neurolucida. In the same material, 
stereological estimates of the total number of Orx+ cells across three levels in the 
LH, and two levels in the PF and DMH were obtained using Stereolnvestigator. 
Within the Optical Fractionator probe, cells were counted with a 60x Oil objective 
(1.40 numerical aperture, NA) using a counting frame of 120 flm x 120 flm and a 
sampling grid size of240 flm x 240 flm to sample 25% of the x-y area of each 
nucleus. Within each counting frame or block, all cells whose tops came into 
focus beneath the surface of the section were counted through a 10 flm dissector 
height in the z-axis, which corresponded to the average thickness of the mounted 
(dehydrated, cleared and coverslipped) sections in this series. 
To examine the relationship ofBFaxons to the Orx neurons in the 
hypothalamus, BDA-Iabeled fibers (stained black with DAB-Ni) and Orx+ cell 
bodies (stained fuchsia with ANPB) were traced under brightfield illumination 
using the Neurolucida software (MBF). Axons and cell bodies were drawn using 
a lOOx Oil objective within contours ofthe LH, PF and DMH. Unbiased 
estimates of the number and proportion of Orx+ neurons receiving contacts from 
BF varicosities were obtained in the LH, where both the Orx+ cells and BF 
varicosities were most numerous, as well as in PF and DMH. An Orx+ cell was 
considered to be contacted if a BDA+ varicosity was seen in direct apposition to 
the cell, with no obvious space observed between them and at a point where both 
were located at the approximately same focal plane. Stereological counts were 
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obtained ofOrx+ cens that were (Orx+:BDA+) or were not (Orx+:BDA-) 
contacted by one or more BDA+ varicosities through the LH, PF and DMH (n = 
3). Counts were performed under a lOOx Oil objective (1.40 NA) at three leve1s 
(above) within the LH contour and two levels (above) within PF and DMH 
contours. Within the Optical Fractionator probe, a counting frame of 70 J.lm x 70 
J.lm was employed with a sampling grid size of 140 J.lm x 140 J.lm so as to sample 
25% of the area. Within each counting frame or block, an cens whose tops came 
into focus beneath the surface of the section were counted through 15 J.lm in the z-
axis, which was the average thickness of the mounted sections in this series. 
To examine the re1ationship ofBDA+ terminaIs containing different VTPs 
[VTP+] to Orx+ cens, triple-stained sections were viewed under epifluorescent 
microscopy to determine if BDA+[VAChT+] , BDA+[VGluT2+] or 
BDA+[VGAT+] varicosities appeared to come into contact with Orx+ cens 
stained with AMCA or Cy5 (see Table 2). Additional series were used for 
stereology in which Orx cens were stained with Cy5 (using the antibody from Gt 
in combination with anti-VTP antibodies from Rb, Table 2). Unbiased estimates 
were obtained of the total number and proportion of innervated Orx+ cens which 
were contacted by each of the BDA+[VTP+] type ofvaricosityby counting 
Orx+:BDA+[VTP+] along with Orx+:BDA+[VTP-] cens through three levels of 
the LH contour in each series (n = 3). In addition, estimates ofthe total number 
and proportion of contacting varicosities were computed for each of the 
BDA+[VTP+] type ofvaricosity by using counts ofBDA+[VTP+]:Orx+ and 
BDA +[VTP-] :Orx+ varicosities (n = 3). The presence of BDA + contacts on the 
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counted cells was assessed online by sequential observation of the material 
through the different filters at the same focal plane and multiple planes through 
the z axis. Counts were performed under a 100x Oil objective (with 1.40 NA) 
within a counting frame of 70 Jlm x 70 Jlm and using a sampling grid of 120 Jlm x 
120 Jlm so as to sample -33% of the LH area. Within each counting frame or 
block, aIl cells whose tops came into focus beneath the surface of the section were 
counted through 8 Jlm in the z-axis, which corresponded to the average thickness 
of the mounted sections in these series. 
Confocal microscopy and image processing 
Material triple-stained for BDANTP/Orx or BDAlPSP/Orx was examined in a 
Zeiss LSM 510 laser scanning confocal microscope equipped with Argon 488 nm, 
helium-neon 543 nm and he1ium-neon 633 nm lasers for Cy2, Cy3 and CyS 
excitation, respectively. Appropriate filters were used for detection of Cy2 
(bandpass 500 to 530 nm, green), Cy3 (bandpass 565 to 615 nm, red) and CyS 
(bandpass 697 to 719 nm, infrared, color coded in blue). Scanning was performed 
through a Plan-Apochromat 100x (with 1.4 NA) objective and pinhole size of 
-0.8 (0.6 to 1, Airy Units) for the three channe1s. Acquisition was performed with 
the resident LSM 510 software and consisted of stacks of images taken through 
the z-axis in optical slices of -0.5 Jlm for VTPs, or -0.33 Jlm for PSPs series. 
Additional high resolution stack images (optical slices of -0.05 to 0.1 Jlm) were 
acquired for the PSP series. 
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Rendered 3D views of the stacks were obtained using the fluorescence 
rendering mode from the image software Volocity 3.7 (Improvision Inc, 
Lexington, MA, www.improvision.com). which provides a semi-transparent 3D 
view of the different elements based on the degree of intensity of each voxel (i.e., 
the more intense, the less transparent). The different elements could then be 
examined simultaneously and interactively from different angles and 
magnifications. Thus, varicosities could be judged to be in contact with a 
postsynaptic cell or process, as assessed by the absence of space between the 
presynaptic and postsynaptic element from any of the angles observed 
(Wouterlood et al., 2002b). High resolution image stacks (see above) were 
analyzed in the fluorescent rendering mode as well as in the isosurface rendering 
mode, which provides a 3D solid, non-transparent view of the element surface. 
Channels in which the signal was low or the noise was relatively high were 
restored using a deconvolution procedure (iterative restoration in Volocity). 
Adjustment for brightness and contrast for all pictures, in addition to 
adjustment of tonal range for each individual ROB channel ("AdjustfLevels" 
command in Photoshop) for fluorescent images were performed with Adobe 
Photoshop Creative Suite edition (Adobe System, San Jose, CA, V.S.A). Figure 
preparation and final montage were done with Adobe Illustrator Creative Suite 
edition (Adobe). 
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RESULTS 
BDA injection site and anterograde labeling in the hypothalamus 
Iontophoretic application ofBDA-10,000 into the region ofthe MCPO-SI (Fig. 
lA) on 2 sides in 9 rats produced small and well restricted, spherical injection 
sites (Fig. lB) of <500 /-lm diameter and containing (sorne ~ 1400) labe1ed nerve 
cell bodies, as previously described (Henny and Jones, 2006a). Injection sites 
were positioned primarily within the MCPO and SI (in n = 16 cases se1ected for 
analysis), where ~90% and ~6% of labe1ed cells were located, respectively. 
BDA-Iabe1ed fibers coursed through the MFB to reach the tuberaI hypothalamus 
where multiple neurons, particularly in the LH, were contacted by varicosities 
(Fig. 1C) (Henny and Jones, 2006a). 
Number and distribution of Orx+ neurons in the hypothalamus 
The distribution and numbers of Orx+ neurons were examined in P AP (OAB) 
stained material. Orx+ cells were distributed across the tuberaI hypothalamus in 
moderate numbers from rostral to caudalleve1s (~A6.6, A6.2 and A5.8, Fig. 2). 
Although most concentrated in the area immediately surrounding and dorsal to the 
fomix, cells were distributed through the LH, PF and DMH. According to 
stereological estimates of total numbers of cells (mean ± SEM, n = 3), ~1800 
Orx+ cells were located within the LH, ~500 in the PF and ~900 in the DMH with 
a total of ~3200 neurons per side (Table 3). The proportions of Orx neurons were 
thus ~56% in the LH, ~15% in the PF and ~29% in the DMH contours as 
delineated here. 
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BDA-Iabeled axons in relation to Orx+ neurons 
The relation ofBFaxon terminaIs to Orx cells was examined in material dual-
stained using peroxidase for BDA (in black with DAB-Ni following ABC 
procedure) and Orx (in fuchsia with ANPB following PAP procedure) (n = 7, Fig. 
3). Multiple BDA-Iabeled fibers were evident in the regions where Orx+ cell 
bodies and proximal dendrites were present, particularly in the LH (Fig. 3A). 
Moreover, BDA-Iabeled axonal boutons en passant (Fig. 3B') or boutons 
terminaux (Fig. 3B" and B''') appeared to contact Orx+ cell bodies as well as 
dendrites. In tracings of aIl BDA+ fibers along with Orx+ cells at high 
magnification using Neurolucida, multiple fine collaterals of the coarse fibers 
within the MFB appeared to extend dorsally and medially to reach Orx+ neurons 
within the central and dorsal regions of the LH (Fig. 3C, level A 6.0, 
approximately intermediate to those seen in Fig. 2B and C). Here, BDA-Iabeled 
varicosities appeared to contact Orx+ soma or proximal dendrites in the LH (Fig. 
3D', D" and D"'). Sorne BDA-Iabeled fibers also extended medially to reach 
into the PF or DMH, although these were few in number. As determined by 
stereological analysis, the proportion of Orx+ neurons that were contacted by at 
least one BDA+ varicosity (Orx+:BDA+) within the LH, PF and DMH, was 
estimated to be ~41 %, ~ Il % and ~9%, respectively (Table 3). Overall, ~ 28% of 
the total population of Orx+ neurons was contacted by BFaxonal varicosities. 
Given that the maximal incidence of Orx+ neurons contacted occurred in 
the LH and that the majority of Orx+ neurons were also contained within the LH 
(above), subsequent analyses of the BF innervation were focused upon the Orx+ 
neurons within the contour of the LH. 
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YAChT, VGluT2 and VGAT in BDA-Iabeled varicosities in relation to Orx+ 
neurons in the LH 
To determine ifBF terminaIs contacting Orx neurons are cholinergie, 
glutamatergic or GABAergic, sections which were triple-stained for BDA (with 
Cy2), the VTPs (VAChT, VGluT2 or VGAT with Cy3) and Orx-A (with AMCA 
or Cy5) were examined under epifluorescent microscopy (see number of cases, n, 
for each series in Table 2). In these sections, sparse VAChT+ varicosities were 
evident (Fig. 4A"), whereas multiple VGluT2+ (Fig. 4B") and VGAT+ (Fig. 
4C") varicosities were present in the vicinity of the Orx+ neurons. 
BDA+[VAChT+] (Fig. 4A"'), BDA+[VGluT2+] (Fig. 4B"') and 
BDA+[VGAT+] (Fig. 4C"') BFaxons were aH present in the immediate surround 
ofthe Orx+ neurons as weil. However, only BDA+[VGluT2+] (Fig. 4B"') and 
BDA+[VGAT+] varicosities (Fig. 4C"') appeared to contact the Orx+ neurons in 
substantial numbers. 
Stereological estimates of contacts between VAChT+, VGluT2+ or VGAT+ 
BDA-Iabeled varicosities and Orx+ neurons in the LH 
To determine the proportions of Orx+ neurons innervated by cholinergie, 
glutamatergic or GABAergic BFaxon terminaIs, stereological analysis was used 
for estimation of the total numbers of Orx+ neurons contacted by each of the 
BDA+[VTP+] types ofvaricosities in the LH through the three leveIs studied 
(~A6.6, A6.2 and A5.8, n = 3 cases, Table 4). In the YAChT series, less than 4% 
of the Orx+:BDA + neurons were contacted by BDA +[V AChT +] varicosities. In 
the VGluT2 series, ~31 % ofthe Orx+:BDA+ neurons were contacted by 
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BDA+[VGluT2+] varicosities. In the VGAT series, -67 % of the Orx+:BDA+ 
neurons were contacted by BDA+[VGAT+] varicosities. 
The number of BDA +[VTP+] varicosities contacting Orx+ neurons 
(BDA+[VTP+]:Orx+) was also determined (n = 3, Table 4). As estimated from 
each series, the proportions of varicosities in contact with Orx+ neurons were 
respectively: -2% for BDA+[VAChT+], -17 % for BDA+[VGluT2+] and -58% 
for BDA+[VGAT+] varicosities. Across series, the numbers of terminais detected 
per Orx+ cell were: one for BDA+[VAChT+], one to two for BDA+[VGluT2+] 
and one to four for BDA+[VGAT+] varicosities. Given the minimal number of 
contacts by BDA+[VAChT+] varicosities and the substantiai number of contacts 
by BDA+[VGluT2+] and BDA+[VGAT+] varicosities on the Orx+ neurons, 
confocal analysis was pursued for the latter terminaIs. 
Confocal analysis ofVGluT2 or VGAT inside and ofPSD-95 or Gephyrin 
opposite BDA+ terminais on Orx+ neurons 
To examine in detail the nature of the BDA+ contacts observed on Orx+ neurons, 
confocal microscopie analysis was performed on material triple-stained for BDA 
(with Cy2), Orx (with Cy5 or Cy3) and markers for the presynaptic, VTP 
(VGluT2 or VGAT with Cy3) or postsynaptic, PSP (PSD-95 or Geph withCy5) 
(see Table 2 for number of cases processed and examined for each series). 
Confocal images were further viewed using 3D reconstruction and rotation with 
magnification to confirm that the pre- and postsynaptic elements were in contact 
through three spatial axes. 
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In series triple-stained for BDA, VGluT2 and Orx, the Orx+ neurons were 
seen to be surrounded by numerous VGluT2+ varicosities. In this material, many 
BDA-Iabeled VGluT2+ varicosities were apposed to Orx+ soma (Fig. 5A) or 
proximal dendrites (not shown). As judged from examination and rotation of 3D 
images from such cases, the BDA+[VGluT2+] varicosity appeared to be in 
contact with the Orx+ ceIl, since no space could be observed between the two 
(Fig. 5A, small images) with rotation through three axes. 
In series triple-stained for BDA, PSD-95 and Orx, staining for PSD-95 
appeared punctate and could be seen on the surface ofOrx+ neurons (Fig. 5B). In 
sorne BDA+:Orx+ contacts (Fig. 5B), PSD-95+ puncta could be detected opposite 
the BDA+ varicosity and associated with the Orx+ cell (Fig. 5B, small images). 
From 93 acquired images of appositions (from n = 3 cases), 74 BDA+:Orx+ 
contacts (~80%) were confirmed in rotated and magnified 3D images, and 16 of 
these or 21.6 % showed staining for PSD-95 opposite the BDA + varicosity and 
associated with the Orx+ cell. 
To further assess the spatial relationship among the BDA+ terminaIs, PSD-
95+ puncta and Orx+ ceIls, image stacks with high z-axis resolution (0.05 to 0.10 
/lm optical slices) were acquired of23 appositions (from n = 3 cases) and 
analyzed in 3D rotations. Contacts were confirmed between BDA+ varicosities 
and Orx+ neurons, as shown from three different, orthogonal 3D angles of semi-
transparent fluorescence images (Fig. 6A1, BI and Cl). PSD-95+ profiles were 
observed in apposition to BDA + varicosities (Fig. 6A2, B2 and C2) and in 
association with the surface ofOrx+ neurons (Fig. 6A3 and B3), being localized 
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between BDA+ and Orx+ e1ements (Fig. 6A4 and B4). Opaque isosurface 
rendering of the three elements further evidenced the localization of PSD-95+ 
puncta, which appear tucked in or hidden between the BDA+ varicosity and the 
Orx+ neuron (Fig. 6A5, B5 and C5). 
In series triple-stained for BDA, VGAT and Orx, Orx+ neurons were also 
seen to be surrounded by VGAT+ varicosities. Many BDA-Iabeled VGAT+ 
varicosities were in close apposition to Orx+ soma or dendrites (Fig. 5C). As 
judged from the rotated and magnified 3 D images of such cases, the 
BDA+[VGAT+] varicosity was in contact with the Orx+ cell (Fig. 5C, small 
images) through three axes. 
In series triple-stained for BDA, Geph and Orx, Geph staining (Cy5) 
appeared punctate, generally in larger puncta than PSD-95 and frequently 
associated with Orx+ soma and dendrites (Fig. 5D). In multiple BDA+:Orx+ 
contacts (Fig. 5D), Geph+ puncta were seen facing the BDA+ varicosity and 
associated with the Orx+ cell (Fig. 5D, top small images), such that they appeared 
to be located between the terminal and cell in merged images (Fig. 5D lower 
small image). From 112 acquired images of appositions (from n = 3 cases), 93 
BDA+:Orx+ contacts (>80%) were confirmed in rotated and magnified 3D 
images, and 44 or 47.3 % showed Geph+ puncta between the BDA+ varicosity 
and the Orx+ cell. 
For further analysis, image stacks with high z-axis resolution (0.05 to 0.10 
Jlm optical slices) were acquired of 19 (from n = 3 cases) BDA, Geph and Orx 
appositions, and examined. Contacts were seen between BDA+ varicosities and 
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Orx+ neurons, as evidenced from 3D orthogonal views (Fig. 6DI, El and FI). 
Geph+ profiles were observed in apposition to BDA+ varicosities (Fig. 6E2 and 
F2) and in association with the surface ofOrx+ neurons (Fig. 6D3, E3 and F3), 
located between BDA+ and Orx+ e1ements (Fig. 6E4 and F4). Opaque isosurface 
rendering of the three elements evidenced the localization of Geph+ puncta 
between the BDA+ varicosity and the Orx+ neuron (Fig. 6D5, E5 and F5). 
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DISCUSSION 
The present study presents qualitative and quantitative evidence that Orx neurons 
are innervated by afferents from the BF cholinergie cell area. Yet, from this 
cholinergie cell area, the afferents were predominantly comprised of 
noncholinergic terminaIs. Numerous glutamatergic and GABAergic varicosities 
contacted Orx neurons in the LH and could thus respectively exert excitatory and 
inhibitory influences on their activity during wake and sleep states. 
BF projections to Orx neurons 
We show here that anterogradely labeled fibers from the MCPO-SI of the BF 
cholinergie cell area extend into the region of the Orx cells in the tuberaI 
hypothalamus. As shown and discussed in our previous study (Henny and Jones, 
2006a), the fibers reached the caudal hypothalamus through the ventrolateral 
portion of the MFB, which has long been known to carry fibers from this 
forebrain area (Swanson, 1976; Veening et al., 1982; Grove, 1988). From this 
component, collaterals fan out through the LH and extend dorsomedially though 
less numerously through the PF and sparsely into the DMH. 
We estimated here using stereology that Orx neurons are most numerous 
within the LH, numbering -1800, less numerous within the PF, numbering -500 
and intermediate in the DMH numbering -900 for a total of -3200 neurons per 
side. The total number (in Long Evans rats) is similar to that previously estimated 
by us as -3400 Orx+ neurons per side (in Wistar rats) (Modirrousta et al., 2005) 
and to one other published number estimated by stereological analysis as -2900 
Orx+ neurons per side (in Wistar rats) (Allard et al., 2004). According to 
216 
conventional delineation as the region lateral to the fomix through which the 
MFB fiber systems travel, >50% (or ~ 1800) of the Orx cells are located in the LH. 
We show here that BF terminaIs, which would originate from a relatively 
small number of caudally projecting cells in the MCPO-SI labeled by the BDA 
injections, contact a significant proportion (~28%) of all Orx+ cells. This input 
was topographically arranged, as the proportions of Orx+ cells contacted were 
substantial (~41 %) in the LH and small in the more medial PF (~11 %) and DMH 
(~9%). Notably, from similar injection sites, BF terminals contact only ~15% of 
the total LH cell population (estimated at ~50,000 through the tuberaI 
hypothalamus) (Henny and Jones, 2006a), suggesting a selective enrichment of 
BF terminaIs upon the Orx neurons relative to all other chemically unidentified 
neurons of the LH. According to a recent extensive survey of afferents to the Orx 
neurons using both anterograde and retro grade tracing (Y oshida et al., 2006), the 
overall proportion of Orx neurons contacted by BF afferents (~28%, from the 
present study) would be comparable to that originating from the adjacent 
ventrolateral preoptic area (31 %). In the former work, the BF was not considered 
to be among the major afferent sources to the Orx neurons, though it contained a 
moderate number of afferent cells (Y oshida et al., 2006). In that study, the 
afferents were identified by injections of retro grade tracers into the region where 
the Orx+ neurons are most concentrated, immediately surrounding the fomix 
within the dorsal PF, the lateral DMH and the dorsomedial region of the LH, and 
thus highlighted major sources of input from the more medial basal telencephalic 
afferent systems. From our present and previous (Gritti et al., 1994; Henny and 
Jones, 2006a), as well as other early tracing studies (Swanson, 1976; Veening et 
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al., 1982; Grove, 1988), the MCPO-SI would fit within a lateral-to-medial as weIl 
as ventral-to-dorsal topographically organized system offibers coursing within 
the MFB and serving as afferents to the hypothalamus and notably, as the present 
results indicate, the Orx neurons therein. 
Predominant innervation by noncholinergic, glutamatergic and GABAergic, 
BF terminaIs of Orx neurons 
In the LH, of the total number of Orx neurons contacted by BFaxonal varicosities 
(~41 %, see above), only a minimal proportion (~4%) was innervated by 
cholinergie varicosities, whereas the major proportion was innervated by 
glutamatergic or GABAergic varicosities. Similarly, only 2% of the varicosities 
on Orx+ cells were VAChT+ in this material. These results are in line with our 
previous study showing that cholinergie BF terminaIs in the LH comprise less 
than 10%, whereas glutamatergic and GABAergic terminaIs comprise the vast 
majority of the BF terminaIs in the LH (Henny and Jones, 2006a). They are not in 
agreement with the recent results of Sakurai and colleagues using a transgene for 
a tetanus toxin tracer (tetanus toxin C fragment fused to green fluorescent protein, 
TTC::GFP), which is believed to be transported transynaptically and retrogradely, 
linked to an orexin promoter together with fluorescent staining for choline 
acetyltransferase (ChAT) (Sakurai et al., 2005). In those studies, essentially aIl 
retrogradely labeled neurons in the cholinergie cell area of the BF were judged to 
be immunostained for ChAT. We recognize the possibility that the TTC::GFP 
tracer could be taken up by terminaIs on distal dendrites which were not evident 
in our fluorescent material. On the other hand, previous results from our lab and 
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from other groups utilizing retro grade transport oftraditional tracers also found 
minimal proportions of descending projections from cholinergic BF neurons 
«5%) to the brainstem or hypothalamus and the region of the Orx cell bodies and 
dendrites (Grove, 1988; Semba et al., 1989; Gritti et al., 1994; Bayer et al., 1999). 
As discussed by Sakurai and colleagues, retro grade labeling by TTC::GFP could 
be due to transynaptic transport along with retro grade transport that could result in 
labeling of a large number and proportion of cholinergic BF cells as higher order 
afferent neurons. Such an indirect, multisynaptic influence of cholinergic BF 
neurons upon Orx neurons might be expected to exist as a feedback upon the Orx 
neurons which project into the region of the cholinergic cells (Espana et al., 2005) 
and would exert an excitatory effect through Orx on the cholinergic neurons 
(Eggermann et al., 2001). On the other hand, from electrophysiological studies, it 
appears that cholinergic input can have an important influence on Orx neurons, 
since cholinergic agonists can depolarize and excite the Orx neurons (Bayer et al., 
2005; Sakurai et al., 2005). Although the BF cholinergic cells may participate in 
this influence, the pontomesencephalic cholinergic neurons likely play a more 
dominant role given previous evidence of their more substantial projections into 
the region ofthe Orx cells (Ford et al., 1995; Bayer et al., 1999). 
We found that a substantial proportion ofBF-innervated Orx neurons were 
contacted by VGluT2 containing BDA-Iabeled terminaIs (~31 %), and that a 
substantial proportion of the BDA-Iabeled terminaIs contacting Orx neurons were 
VGluT2+ (~17%). Glutamate has been shown to depolarize Orx neurons through 
both NMDA and AMPA receptors in vitro (Li et al., 2002; Yamanaka et al., 
2003a). Orx neurons have been described as receiving a relatively high density of 
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VGluT2+ varicosities and asymmetric, presumed excitatory synapses (Horvath 
and Gao, 2005). From the present results, one source of these multiple 
glutamatergic inputs can be attributed to BF neurons. 
The major proportion ofBF-innervated Orx neurons were contacted by 
VGAT containing BDA-Iabeled terminaIs (~67%), and a major proportion of the 
BDA-Iabeled varicosities were VGAT+ (~58%), indicating that GABAergic BF 
neurons can have a potent influence upon Orx neurons. GABA has been shown to 
hyperpolarize and inhibit Orx neurons which are otherwise spontaneously active 
in vitro (Li et al., 2002; Eggermann et al., 2003; Yamanaka et al., 2003a). 
Interestingly, Orx neurons are considered to have a relatively sparse GABAergic 
input, particularly in relation to the glutamatergic input, with a ratio of inhibitory 
to excitatory synapses estimated as 1 to 10 (Horvath and Gao, 2005). In light of 
the latter results, it would appear that the BF GABAergic neurons may play a 
particularly important role in providing this inhibitory input and influence to the 
Orx cells. 
BF glutamatergic and GABAergic synaptic input onto Orx neurons 
We confirmed by confocallaser scanning microscopy and 3D image rendering 
and rotation that BDA-Iabeled BF varicosities appeared to contact Orx neurons in 
the LH. By continuous rotation through three axes, we were thus able to establish 
for large numbers of varicosities that there appeared to be no space between the 
varicosity and the Orx+ cell. Such confirmation has been considered by others to 
represent strong evidence for synaptic contacts (Wouterlood et al., 2002b). Yet, it 
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is weIl recognized that only the resolution of the electron microscope provides 
absolute proof of such contacts by presynaptic elements with postsynaptic targets. 
More specific evidence is provided for the synaptic nature of glutamatergic 
and GABAergic terminaIs by the presence of the presynaptic vesicular 
transporters. VGluT2 and VGAT, which were demonstrated in the BDA-Iabeled 
varicosities apposed to Orx ceIls, confer the capacity to release glutamate and 
GABA and are concentrated in the presynaptic terminal at asymmetric and 
symmetric synapses, respectively (Gilmor et al., 1996; Chaudhry et al., 1998; 
Bellocchio et al., 2000; Takamori et al., 2000; Fremeau et al., 2001; Gualix et al., 
2003; Fremeau et al., 2004). 
Lastly, we show that in confirmed contacts ofBDA-labeled varicosities 
with Orx ceIls, postsynaptic pro teins of PSD-95 and Geph are situated facing the 
varicosity and in association with the Orx+ cell. Similar to proportions ofBDA-
labeled varicosities ostensibly contacting Orx+ neurons that were VGluT2+ and 
VGAT+ (above), the proportions of confirmed contacts by BDA-Iabeled 
varicosities upon Orx+ neurons which showed PSD-95 or Geph puncta between 
the terminal and cell were ~22% and ~47% respectively. Postsynaptic proteins, 
PSD-95 and Geph are constituent parts of the postsynaptic scaffolding of 
asymmetric, excitatory (Sheng and Pak, 2000) and symmetric, inhibitory synapses 
(Sassoe-Pognetto and Fritschy, 2000) respectively. At excitatory synapses, PSD-
95 colocalizes by direct and indirect association with NMDA and AMP A 
receptors (Sassoe-Pognetto et al., 2003). At inhibitory synapses, Geph is 
colocalized with the most common synaptic subtypes of GABAA receptors and is 
suggested to participate in their anchoring to the postsynaptic membrane (Sassoe-
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Pognetto et al., 1995; Giustetto et al., 1998). The location ofpostsynaptic 
proteins sandwiched between presynaptic and postsynaptic elements has been 
considered as strong evidence for synaptic contacts in 3D rendered confocal 
images (Wouterlood et al., 2003). We thus believe that the present results 
showing both pre- and postsynaptic elements for glutamatergic and GABAergic 
synapses in association with BDA-Iabeled terminaIs contacting Orx neurons 
provide compelling evidence for BF glutamatergic and GABAergic synaptic input 
to the Orx cells. 
Functional significance of the cholinergie, glutamatergic and GABAergic BF 
input to Orx neurons 
Orx neurons play a key role in stimulating and maintaining arousal by excitatory 
influences upon multiple systems, induding the cerebral cortex, hypothalamic and 
brainstem arousal systems, as well as sympathetic and motor circuits in the spinal 
cord (Peyron et al., 1998; van den Pol, 1999; Saper et al., 2001; Taheri et al., 
2002; Krout et al., 2003; Siegel, 2004; Jones and Muhlethaler, 2005; Sakurai, 
2005). As now shown by recent studies, they are in tum influenced by afferent 
input from multiple forebrain and brainstem systems (Sakurai et al., 2005; 
y oshida et al., 2006). Here we show that neurons of the BF cholinergie cell area, 
which themselves are importantly involved in regulating sleep-wake states, 
contribute significantly to that afferent input. The BF input was particularly dense 
onto the Orx neurons in the LH, which despite daims ofbeing selectively 
activated with reward seeking (Harris et al., 2005), have also dearly been shown 
to discharge and express c-Fos in association with simple waking, arousal or 
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stress (Espana et al., 2003; Lee et al., 2005a; Mileykovskiyet al., 2005; 
Modirrousta et al., 2005). 
In contrast to recent c1aims (above, (Sakurai et al., 2005)), the cholinergie 
BF cells appear to contribute minimally to the innervation ofthe Orx neurons in 
the LH. Cholinergie BF neurons discharge in a manner (Lee et al., 2005b) that 
differs fundamentally from that of recently identified Orx neurons across sleep-
wake states (Lee et al., 2005a). Whereas cholinergie neurons discharge 
maximally during both waking and PS in association with cortical activation, Orx 
neurons discharge maximally during waking in association with movement and 
muscle tone and cease firing during PS sleep with muscle atonia (Jones, 2005a). 
It is thus not surprising that Orx neurons are not under direct control of 
cholinergie BF neurons. To the contrary, the silence of Orx neurons during PS 
sleep is the condition under which cholinergie neuronal discharge stimulates 
cortical activation in association with the muscle atonia of that state. 
The Orx neurons receive a substantial glutamatergic input from BF neurons 
indicating that these glutamatergic neurons can exert a significant excitatory 
influence upon Orx cells. In single unit recording studies, many noncholinergic 
BF neurons have been identified that discharge maximally during active waking 
and are virtually silent during sleep including PS sleep (Szymusiak and McGinty, 
1986b; Lee et al., 2004; Lee et al., 2005b). The discharge ofthese neurons is 
positively correlated with postural muscle tonus or neck e1ectromyographic 
(EMG) activity (Lee et al., 2004), like that of the Orx neurons (Jones, 2005a; Lee 
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et al., 2005a). We propose that such noncholinergic neurons are glutamatergic 
and could facilitate behavioral arousal in part by exciting the Orx cells. 
The major input to the Orx neurons from BF is GABAergic. Given the 
purportedly small inhibitory input relative to excitatory input onto Orx neurons 
(Horvath and Gao, 2005), this GABAergic input from BF neurons might be of 
critical importance in inhibiting the discharge of Orx neurons during periods of 
behavioral quiescence, sleep and/or muscle atonia (Lee et al., 2005a). Although 
we have identified GABAergic neurons which discharge in association with 
cortical activation (Manns et al., 2000b), we propose that the innervation of the 
Orx neurons originates from the particular GABAergic BF neurons that are active 
during sleep (Modirrousta et al., 2004) and discharge during SWS and/or PS sleep 
in negative correlation with muscle tonus or EMG (Szymusiak and McGinty, 
1986b; Manns et al., 2000b; Lee et al., 2004; Jones, 2005a). 
Orexin has been attributed a particularly important role in maintaining 
arousal since in its absence in knockout mice or that of its receptor in dogs or Orx 
neurons in humans, narcolepsy occurs (Chemelli et al., 1999; Lin et al., 1999; 
Peyron et al., 2000; Thannickal et al., 2000; Hara et al., 2001). In humans, 
narcolepsy is characterized by excessive daytime sleepiness, short onset of REM 
sleep and/or loss of postural muscle tone, known as cataplexy. Accordingly, the 
excitation of Orx neurons by presumed wake-active, glutamatergic BF neurons 
could normally serve to prevent sleep onset and loss of postural muscle tone, 
whereas the inhibition of Orx neurons by presumed sleep-active GABAergic BF 
neurons could promote sleep onset and the loss of postural muscle tone. It could 
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be due in part to withdrawal of the major BF GABAergic input to Orx neurons 
that neurotoxic lesions of the BF result in a severe disruption ofSWS and PS 
(Szymusiak and McGinty, 1986a). Moreover, chemical stimulation ofthe BF 
with cholinergie agonists or agents exciting cholinergie neurons can elicit PS with 
atonia in cats and rats (Hemandez-Peon et al., 1963; Cape et al., 2000; Jones, 
2004) and/or cataplexy in dogs (Nishino et al., 1995). Cholinergie agonists and 
ACh, which is released in the BF maximally during PS (Vazquez and Baghdoyan, 
2001), cou1d excite noncholinergic, presumed GABAergic BF neurons (Fort et al., 
1998; Wu et al., 2000), including those which innervate the Orx neurons and 
thereby elicit PS and/or muscle atonia. 
In conclusion, the present study reveals an important glutamatergic and 
GABAergic input to Orx neurons from BF neurons. Glutamatergic BF neurons 
can excite Orx neurons to stimulate behavioral arousal and waking. GABAergic 
BF neurons can inhibit Orx neurons to diminish behavioral arousal along with 
muscle tone and thereby promote sleep, including PS with muscle atonia. 
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Table 1. Primary antibodies (AB) for immunostaining of orexin (Orx), vesicular transporter proteins (VTPs) 
or postsynaptic proteins (PSPs) 
Antigen Host sp Source Cat. # Immunogen Specificity 
Orx 
Orx-A Rb 
Orx-A Gt 
VTPs 
YAChT Gt 
YAChT Rb 
VGluT2 Rb 
VGAT Rb 
PSPs 
PSD-95 Ms 
Geph Ms 
Phoenix 1 H-003-30 Full 33 AA Orx-A peptide 
sequence from rat 
(EPLPDCCRQKTCSCRLYELLH 
GAGNHAAGILTL)2 
By WB the AB recognizes a -3.5 
kD band from rat brain, 
corresponding to the Orx-A 
peptidé 
Santa Cruz3 sc-8070 Peptide mapping at the C-terminus AB reacts with Orx-A ofmouse, 
ofhuman Orx-A (AA 48-66 of the rat and human by WB, 
Chemicon6 AB1578 
V5387 
Gift RHE 11 -
Orx precursor, identical to immunostaining blocked with 
corresponding mouse sequence)4 antigen peptide (sc-8070 P) and 
pattern of staining identical to that 
with Orx-A (Rb) H-003-30 
(Phoenix)5 
Peptide corresponding to C-
terminus ofcloned rat VAChT7 
(CSPPGPFDGCEDDYNYYSRS)8 
Peptide corresponding to AA 512-
530 ofC-terminus ofcloned rat 
YAChT (K-
SPPGPFDGCEDDYNYYSRS)IO 
By WB the AB recognizes a -65-
70 kD band corresponding to 
YAChT protein7 
By WB the AB recognizes a -67-
70 kD band, corresponding to 
V AChT protein 10 
GST fusion protein containing AA By WB the AB recognizes a -50-
519-582 of rat DNPi (VGluT2)12 62 kD band from rat brain l2 
Chemicon AB5062P Peptide corresponding to 17 AA 
near C-terminus region ofrat 
VGAT 
By WB the AB recognizes a band 
at -55-60 kD I3 
Sy_Sy16 
(VHSLEGLIEA YRTNAED)I3 
MA 1-045 Purified recombinant of rat PSD- By WB the AB recognizes a -95 
95 15 kDa protein and a slightly larger 
species from rat brain extracts 15 
147011 Purified rat gephyrin 17 
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By WB the AB recognizes a -93 
kD band. It detects aN-terminus 
epitopel8 
1 Phoenix: Phoenix Phannaeeuticals Ine., Belmont, CA. 
2 http://www.phoenixpeptide.comlCatalog%20Files/Orexins%20SectioniOrexinsHypocretinspage.htm 
3 Santa Cruz: Santa Cruz Biotechnology Inc., Santa Cruz, CA. 
4 Infonnation provided by Santa Cruz data sheet and technical service. 
5 Infonnation on WB provided by Santa Cruz data sheet and technical service, blocking experiments earried out in 
our lab with the Santa Cruz antigen peptide and immunostaining of Orx cell population eompared for two antibodies 
in our lab in this and previous studies (Modirrousta et al., 2005). 
6 Chemicon: Chemicon International, Temecula, CA. 
7 http://www.chemieon.eomIProduetIProduetDataSheet.asp?ProduetItem= AB 1578 
8 Supplied by Chemieon on request. 
9 Sigma: Sigma, St. Louis, MO. 
10 http://www.sigmaaldrich.comlsigma/datasheetJv5387dat.pdf 
Il Gift from Edwards, R.H. and Fremeau, R.T.Jr. 
12 Fremeau et al., 2001. 
13 http://www.chemicon.comIProductIProductDataSheet.asp?ProductItem=AB5062P 
14 ABR: Affinity BioReagents, Golden, CO. 
15 http://www.bioreagents.comlindex.cfmlfuseaetioniproducts.printIProductJMA 1-045 
16 SY-SY: Synaptic Systems, Gottingen, Gennany. 
17 http://www.sysy.comlgephyrinigephyJs.html 
18 Pfeiffer et al., 1984. 
Abbreviations: AA, amino acid; AB, antibody; DNPi, differentiation-associated Na + -dependent phosphate 
transporter; Geph, gephyrin; Gt, goat; Ms, mouse (monoclonal); Rb, rabbit; sp, species; WB, western blot. 
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Table 2. Combination and sequential processing ofprimary and secondary antibodies along with streptavidin (SA) 
used for triple fluorescent staining of orexin (Orx), vesicular transporter proteins (VTPs) or postsynaptic proteins 
(PSPs) and biotinylated dextran amine (BDA) 
l'Y AB {ovemightll 2'Y AB (3 hoursl SA p hours) 
Series Antigen Host sI! Dilution IgG {Dk:ll2.3 Dilution SA Dilution n 4 
BDAIVTP/Orx 
BDAIV AChT/Orx YAChT Gt 1:1000 Anti-Gt-Cy3 1:800 SA-Cy2 1:800 4 Orx-A Rb 1:200 Anti-Rb-AMCA 1:100 
BDA/VAChT/Orx YAChT Gt 1:1000 Anti-Gt-Cy3 1:800 2 Orx-A Rb 1:200 Anti-Rb-Cy5 1:800 
BDA/VAChT/Orx YAChT Rb 1:5000 Anti-Rb-Cy3 1:800 5 Orx-A Gt 1:200 Anti-Gt-Cy5 1:800 
BDAIVGluT2/0rx VGluT2 Rb 1:5000 Anti-Rb-Cy3 1:800 4 Orx-A Gt 1:200 Anti-Gt-AMCA 1:100 
BDAIVGluT2/0rx VGluT2 Rb 1:5000 Anti-Rb-Cy3 1:800 Il Orx-A Gt 1:200 Anti-Gt-Cy5 1:800 
BDAIVGAT/Orx VGAT Rb 1:250 Anti-Rb-Cy3 1:800 4 Orx-A Gt 1:200 Anti-Gt-AMCA 1:100 
BDAIVGAT/Orx VGAT Rb 1:250 Anti-Rb-Cy3 1:800 Il Orx-A Gt 1:200 Anti-Gt-Cy5 1:800 
BDA/PSP/Orx 
BDA/PSD-95/0rx PSD-95 Ms 1:100 Anti-Ms-Cy5 1:800 SA-Cy2 1:800 3 Orx-A Gt 1:200 Anti-Gt-Cy3 1:800 
BDA/Geph/Orx Geph Ms 1:100 Anti-Ms-Cy5 1:800 3 Orx-A Gt 1:200 Anti-Gt-C~3 1:800 
1 For sources and specificity ofprimary antibodies from different species refer to Table 1. 
2 Jackson Immuno Research Laboratories, West Grove, PA. 
3 For multiple labe\ing (ML) with minimal cross-reactivity (min X) to other species. 
4 n: number of cases (each case referring to an injection site and series from the same side of the brain, thus 1 or 2 
per brain from 9 rats for a total of 16 injection sites selected for their placement in the MCPO/SI). 
Abbreviations: AB, antibody; AMCA, aminomethylcoumarin acetate; Cy2, cyanine; Cy3, indocarbocyanine; Cy5, 
indodicarbocyanine; Dky, donkey; Geph, gephyrin; Gt, goat; Ms, mouse (monoclonal); Rb, rabbit; sp, species. 
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Table 3. Numbers and proportions of Orx cens and Orx+ cens contacted 
by BDA+ varicosities estimated across hypothalamic regions l 
Hypothalamic region LH PF DMH 
Single-immunostained Orx series2 
N° Orxcells 1770.7 ± 182.3 469.3 ± 21.3 917.3 ± 149.3 
% Orx cells of Total across regions 56.0 ± 3.0 % 15.2 ± 2.0 % 28.8 ± 2.9 % 
Dual-immunostained BDNOrx series] 
N° Orx+cells 1216.0 ± 97.8 320.0 ± 37.0 576.0± 97.8 
N° Orx+ cells contacted bya BDA+ var. 512.0 ± 110.9 42.7 ± 42.7 42.7 ± 21.3 (Orx+:BDA+) 
% Orx+ cells contacted by a BDA+ var. in 41.4 ± 7.1 % 1l.l ± 1l.l % 8.9 ± 4.8 % 
each region 
Total 
3157.3 ± 259.5 
100 ± 0.0 % 
2122.0 ± 97.8 
597.3 ± 166.6 
27.7 ± 6.6 % 
IEstimated numbers of cens and BDA-contacted cens were obtained by random systematic sampling of the 
hypothalamus at levels A6.6, A6.2 and A5.8 for LH, and levels A6.2 and A5.8 for PF and DMH using 
StereoInvestigator. 
2Series from 3 different brains processed for single-immunostaining of Orx cens with DAB (see Methods). 
3Series from 3 individual cases (injection sites) processed for dual-immunostaining ofBDA (with DAB-Ni) and 
Orx (with ANPB, see Methods). 
Data are presented as means ± SEM. Abbreviations: DMH, dorsomedial hypothalamic nucleus; LH, lateral 
hypothalamus; PF, perifornical area; var., varicosity. 
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Table 4. Numbers and proportions ofOrx+ cells contacted by BDA+ varicosities positive for vesicular 
transporter proteins (VTP+), and numbers and proportions ofBDA+[VTP+] varicosities in contact with Orx+ 
cells in the lateral hypothalamus (LH) 1 
Triple-immunostained BDNVTP/Orx series YAChT YGluT2 YGAT 
N° Orx+ cells contacted by BDA+ var. 548.3 ± 68.3 532.7± 109.7 595.3 ± 109.7 (Orx+:BDA+) in each series 
N° Orx+ cells contacted by BDA+[VTP+] var. 
15.7 ± 15.7 188.0 ± 8 \.4 376.0 ± 27.1 (Orx+:BDA+[VTP+ ])2 
% Orx+ cells contacted by BDA+[VTP+) var. 2 3.7±3.7 % 31.4 ± 9.4 % 66.7± 11.2 % 
N° BDA+ var. in contact with Orx+ cells 908.6 ± 122.4 1096.7 ± 180.7 1457.0 ± 204.9 (BDA+:Orx+) in each series 
N° BDA+[VTP+) var. in contact with an Orx+ cell 
15.7 ± 15.7 203.7 ± 95.3 814.7± 87.2 (BDA+[VTP+):Orx+)2 
% BDA+[VTP+) var. in contact with Orx+ celll 2.2±2.2 % 16.6±6.2 % 57.8±8.7 % 
lEstimated numbers of cells were obtained by random systematic sampling of the LH area at levels A6.6, A6.2 
and A5.8 using Stereolnvestigator from three individual cases (injection sites). 
2According to a non-parametric Kruskal-Wallis test, the different VTP+ varicosities differed significantly 
according to the numbers (H = 6.587, p = 0.037) and proportions (H = 7.261, p = 0.027) of Orx+ neurons 
contacted by BDA+[VTP+] and to the numbers (H = 6.587, p = 0.037) and proportions (H = 6.938, p = 0.031) 
ofBDA+[VTP+] varicosities contacting Orx+ neurons. 
Data are presented as means ± SEM. Abbreviations: var., varicosity. 
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Fig. 1. BDA injection site in BF and anterogradely labeled BF tenninals in the 
LH. A: Atlas section through the cholinergie cell area (MCPO-SI) where 
iontophoretic applications of BDA were placed. B: Composite image of typical 
BDA injection site (processed using ABC with DAB-Ni and counterstained for 
Nissl with neutral red). Note the small size and restricted location ofBDA 
injection site in the MCPO. C: High magnification images showing BDA+ 
axonal varicosities (arrowheads) contacting Nissl-stained cell bodies located in 
dorsal (C'), middle (C") and ventral (C"') portions of the LH area. Scale bars = 1 
mm in B; 10 Jlm in C", also for C' and C"'. 
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A 
Fig. 1. BOA injection site in BF and anterogradely labeled BF 
terminais in the LH 
233 
Fig. 2. Distribution of Orx+ neurons at three levels through the tuberaI 
hypothalamus. A, Band C: Mapping ofOrx+ neurons within contours of the 
LH, PF and DMH at A6.6 (A), A6.2 (B) and A5.8 (C) levels, based on the 
material presented in D, E and F, respectively. Sorne few scatlered Orx+ neurons 
within contours of the AHA, Pe and ZI are not shown in the mapping. D, E and 
F: Composite images of sections immunostained for Orx-A (with DAB) 
showing the distribution of Orx+ neurons in the hypothalamus at A6.6 (D), A6.2 
(E) and A5.8 (F). Scale bar = 1 mm in F for D-F. 
234 
01 
B 
Fig.2. Distribution of Orx+ neurons at three levels through the tuberai 
hypothalamus 
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Fig. 3. Distribution ofBDA-labeled fibers in relation to Orx+ neurons. A: Low 
magnification composite image ofBDA+ axons (in black, DAB-Ni) and Orx+ 
cells (in fuchsia, ANPB) in the LH at ~A6.0. B: High magnification images 
showing BDA+ varicosities (arrowheads) in contact with Orx+ neurons in the LH 
(B', B" and B"'). C: Tracing and mapping ofall BDA+ fibers and Orx+ neurons 
in the tuberaI hypothalamus at ~A6.0 ~m (from IAO). From coarse fibers within 
the ventrolateral MFB, fine varicose collaterals extended dorsally and medially to 
reach Orx+ cells through the LH. Sorne fibers also extended medially into the PF 
and DMH. D: High magnification of elements depicted in C, showing contacts of 
BDA + axons by varicosities on proximal dendrites or soma of Orx+ cells located 
in the dorsal (D') or central (D" and D"') region ofthe LH. Tonal range for each 
ROB channel as well as brightness and contrast adjustment were made for 
pictures in A and B. Scale bars = 100 ~m in A; 10 ~m in Band D. 
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Fig. 3. Distribution of BDA-Iabeled fibers in relation to Orx+ neurons 
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Fig. 4. VAChT+, VGluT2+ or VGAT+, BDA-Iabeled varicosities in relation to 
Orx+ neurons viewed by epifluorescent microscopy. In each case, BDA is green 
(Cy2), the VTP red (Cy3) and Orx blue (AMCA in A or Cy5 in B and C). A: 
BDA+[VAChT+] terminaIs in the vicinity of an Orx+ neuron. BDA+ terminaIs 
(sol id arrowheads in A') located in the vicinity yet not close to an Orx+ neuron 
(left) are positive for the V AChT protein (solid arrowheads in A"), as evident in 
the merged image (in yellow, solid arrowheads in A'''). A VAChT+ terminal that 
is not BDA+ (open arrowhead) is closer to the Orx+ cell body. Note also the 
sparse number ofVAChT+ varicosities in the vicinity ofOrx+ neurons. B: 
BDA +[VGluT2+] terminaIs in close proximity to Orx+ neurons. Two small 
BDA+ terminaIs (solid arrowheads in B') over an Orx+ cell body are positive for 
the VGluT2 protein (solid arrowheads in B"), as evident in the merged image (in 
yellow, solid arrowheads in B"'). Note also the relatively large number of 
VGluT2+ varicosities in close proximity to the Orx+ neurons. C: 
BDA+[VGAT+] terminaIs over Orx+ neurons. Two BDA+ terminaIs (solid 
arrowheads in C') in close proximity to an Orx+ neuron are positive for VGAT 
(solid arrowheads in C"), as evident in the merged image (in yellow, solid 
arrowheads in C"'). In all images, tonal range was adjusted for each RGB 
channel individually. Scale bar in C'" = 1 0 /-lm for A - C. 
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Fig. 5. Presence ofpresynaptic VGluT2 or VGAT and postsynaptic PSD-95 or 
Gephyrin (Geph) proteins in contacts between BDA-Iabeled varicosities and Orx+ 
neurons. A: Rendered 3D confocal image (16 seriaI 0.50 /lm thick optical 
sections) of a BDA-Iabeled axon (in green, Cy2), whose varicosities (in yellow) 
are positive for VGluT2 (in red, Cy3). One ofthese varicosities is in apposition 
(arrowhead) to an Orx+ neuron (in pseudo-color blue, Cy5), as evident in the 
rendered zoom images on the right (6 seriaI 0.5 /lm thick optical sections) 
depicting in detail the relation between the BDA+ varicosity (top) or the 
contained VGluT2 (middle) with the Orx+ neuron surface and showing the three 
elements together in the merged image (bottom). Note also on the left, other 
VGluT2+ varicosities in contact with the Orx+ neuron. B: Rendered 3D confocal 
image (9 seriaI 0.33 /lm thick optical sections) of a BDA+ varicosity (arrowhead, 
in green, Cy2) facing a PSD-95+ profile (opposite pointer, in pseudo-color red, 
Cy5) located between the varicosity and the surface of the Orx+ neuron (in 
pseudo-color blue, Cy3). As evident in the zoom rendered images on the right (13 
seriaI 0.33 /lm thick optical sections), the BDA+ varicosity is apposed to the Orx+ 
process (top image), opposite the PSD-95+ punctum which is on the surface of the 
Orx+ process (pointer, middle image) and between the BDA+ varicosity and the 
Orx+ process (pointer in the merged image, bottom). Note the presence of other 
PSD-95+ puncta over the Orx+ neuron (upper pointer) at the left panel. C: 
Rendered 3D confocal image (28 seriaI 0.5 /lm thick optical sections) of a BDA-
labeled axon (in green, Cy2), from which most varicosities (in yellow) are 
positive for VGAT (in red, Cy3) and come into contact (large arrowhead) with the 
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Fig. 5. Presence of presynaptic VGluT2 or VGAT and postsynaptic PSD-95 or Gephyrin 
(Geph) proteins in contacts between BDA-Iabeled varicosities and Orx+ neurons 
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dendrites and soma of the Orx+ neuron. As seen in the rendered zoom images on 
the right (8 seriaI 0.5 !lm thick optical sections), the BDA+ varicosity (top image) 
containing VGAT (middle image) appears to be in contact with the surface of the 
Orx+ neuron (merged image, bottom). Note in the left image other VGAT+ 
varicosities also appear to appose the Orx+ neuron. D: Rendered 3D confocal 
image (14 seriaI 0.33 !lm thick optical sections) ofBDA-labeled axonal 
varicosities (arrowhead, green, Cy2) facing Geph+ puncta (facing pointer, 
pseudo-color red, Cy5) over an Orx+ neuron (pseudo-color blue, Cy3). As 
evident in the zoom rendered images at the right (12 seriaI 0.33 !lm thick optical 
sections), the apposition of the BDA+ varicosity with the Orx+ neuron (top 
image) is associated with a Geph+ punctum on the surface of the Orx+ neuron 
(pointer, middle image) and between the BDA+ varicosity and the Orx+ neuron ( 
merged image, pointer, bottom). Note the presence of other Geph+ puncta over 
the Orx+ neuron (upper pointers) in the left panel. Deconvolution iterative 
restoration (see Methods) was applied to the Cy5 channel (in Band C left panels 
and in A, B, C and D right panels), the Cy3 channel (in C left panel and in C and 
D right panels) and the Cy2 channel (in B, C and D). Tonal range adjustments for 
each individual RGB channel were made for aH pictures. Scale bars = 10 !lm in 
left large panel in D, also for large left panels in A, B and C; 1 !lm in D zoom 
bottom image, also for zoom images in A, B and C. 
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Fig. 6. Three-dimensionallocalization of postsynaptic pro teins PSD-95 or 
Gephyrin (Geph) between BDA+ terminaIs and Orx+ neurons. A-C: Orthogonal 
views (see be1ow) of a high resolution rendered confocal 3D image (40 seriaI 
~0.06 ~m thick optical sections) in semi-transparent fluorescence rendering 
(columns 1-4) or opaque isosurface (column 5) views of a single contact between 
a BDA+ varicosity (in green, Cy2) and an Orx+ proximal dendrite (in blue, Cy3), 
with presence of PSD-95+ puncta (in red, Cy5) between the varicosity and 
dendrite. The BDA+ varicosity is in contact with the Orx+ process (Al-Cl), and 
in c1ear apposition to a PSD-95+ profile (solid arrowheads in A2-C2,), which is in 
tum located on the surface of the Orx+ neuron (sol id arrowheads in A3 and B3). 
The localization of the PSD-95+ profile between the two structures is evident in 
the triple merged fluorescent image (solid arrowheads in A4 and B4) as well as in 
the triple merged isosurface rendering image, where the punctum appears almost 
complete1y occ1uded (dotted arrowheads in A5-C5). The PSD-95+ punctum is 
complete1y occ1uded in certain ofthe orthogonal views (dotted arrowheads in C3, 
C4 and C5). (A6-C6): Representation of the three orthogonal views with 
orientation markers showing the X, Y, Z axes. D-F: Orthogonal views of a high 
resolution rendered confocal 3D image (38 seriaI ~0.08 ~m thick optical sections) 
in semi-transparent fluorescence rendering (columns 1-4) or opaque isosurface 
rendering (column 5) views ofa single contact between a BDA+ varicosity (in 
green, Cy2) and an Orx+ soma (in blue, Cy3), with the presence of Geph+ puncta 
(in red, Cy5) between the terminal and soma. The BDA + varicosity is in contact 
with an Orx+ soma (Dl-FI) and in c1ear apposition to a Geph+ profile (solid 
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Fig. 6. Three-dimensionallocalization of postsynaptic proteins PSD-95 or Gephyrin (Geph) 
between BDA+ terminais and Orx+ neurons 
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arrowheads in E2-F2,), which is in tum located on the surface of the Orx+ neuron 
(solid arrowheads in D3-F3). The localization of the Geph+ profile between the 
two structures is evident in the triple merged fluorescent image (solid arrowheads 
in E4-F4) as weIl as in the triple merged isosurface image (sol id arrowheads in E5 
and F5). Note the relative occlusion ofthe Geph+ profile in the rendered 
isosurface images, evidencing its location between the two structures. Due to the 
orthogonal views, the Geph+ puncta are completely occluded in sorne ofthem 
(dotted arrowheads in D2, D4 and D5). (D6-F6): Representation ofthe three 
orthogonal views with orientation markers showing the X, Y, Z axes. 
Deconvolution iterative restoration (see Methods) was applied to Cy5, Cy3 and 
Cy2 channels. Scale bars: 1 Jlm in C5 for A, Band C, and in F5 for D, E and F. 
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GENERAL DISCUSSION 
The present thesis work provides evidence for the existence of neurons in 
the BF that have the capacity to synthesize and re1ease glutamate. By the 
presence ofVGluT3 in the cell bodies ofChAT+, GAD+ or PAG+ neurons, it 
appears that a pool of synthesized glutamate may be re1eased from the soma or 
dendrites of BF neurons to regulate, as proposed, synaptic inputs and neuronal 
excitability. By the presence of VGluT2, another pool of synthesized glutamate 
may be used by neurons to release glutamate from axon terminaIs. By projections 
to cerebral cortex, these as weIl as other prominent cholinergie and GABAergic 
contingents may influence cortical neurons to modulate cortical activity in 
association with different states. By descending projections to the LH, 
predominant glutamatergic and GABAergic neurons innervate LH and Orx 
neurons to provide reciprocal influences to promote either behavioral arousal or 
behavioral quiescence and sleep. 
Cholinergie, GABAergie and glutamatergie phenotypes of basal forebrain 
neurons 
Along with previous results (Manns et al., 2001), the results ofthis thesis allow 
the parceling of the BF into groups of neurons according to synthetic enzymes and 
VTPs. A hypothetical, although reasonable sketch ofthis parcelation is depicted 
in Figure 4. The main group of neurons is constituted by those able to synthesize 
glutamate (PAG+) (Chapter 1). This group also includes neurons that synthesize 
ACh (ChAT +/P AG+), as weIl as an important proportion of those that synthesize 
GABA (GAD+/PAG+) (Manns et al., 2001). As evident from the absence of 
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P AG in sorne GAD neurons, a proportion of GABA-synthesizing neurons would 
fall out ofthis category (GAD+/PAG-). A majority of the neurons that contain 
PAG also contains VGluT3 (VGluT3+) (Chapter I). This group would include 
neurons that synthesize ACh (ChAT+/PAG+NGluT3+), as well as those that 
synthesize GABA and contain PAG (GAD+/PAG+NGluT3+), but not those that 
do not contain P AG (GAD+/PAG-NGluT3-) (Chapter 1). Based on the absence 
of co-Iocalization ofVTPs (Chapters II and III), it is assumed that only V AChT 
would be contained in axon terminals of neurons that synthesize ACh 
(ChAT +/P AG+NGluT3+). Similarly, oruy VGAT would be contained in axons 
of neurons that synthesize GABA, irrespective of whether they express or not 
P AG or VGluT3 (GAD+/P AG+NGluT3+ or GAD+/P AG-NGluT3-). Finally, it 
is assumed that VGluT2 would oruy be contained in the axon terminals of neurons 
that contain P AG and only in those that do not synthesize ACh or GABA 
(P AG+/ChA T -/GAD-). Whether this group may or may not have VGluT3 in their 
cell bodies is uncertain. Finally, a group of neurons of unknown axon terminal 
phenotype, and therefore unidentifiable somatic phenotype, is assumed to exist 
based on the proportion ofaxon terminaIs not accountable for VAChT+, VGAT+ 
or VGluT2+ BF terminaIs (Chapters II and III). 
This division reveals the dual role that glutamate may have in the 
organization ofBF circuits. As shown in the cortex, the dendritic release of 
glutamate via VGluT3 by pyramidal cells is involved in the depression of 
inhibitory input from intemeoums via activation of glutamate metabotropic 
receptors located presynaptically (Zilberter, 2000; Harkany et al., 2004). As 
proposed, this depression could maintain pyramidal cell excitability and temporal 
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pattern of discharge. It is like1y that the re1ease of glutamate from the somato-
dendritic domain ofBF neurons may serve a similar role (Harkany et al., 2003), as 
BF neurons, like pyramidal neurons, are strongly innervated by GABAergic 
terminaIs and thus provide a prominent inhibitory influence (Ingham et al., 1988; 
Khateb et al., 1992; Gritti et al., 1993), which as explained may be attenuated by 
somato-dendritic release of glutamate. This regulation may he1p BF neurons to 
maintain their intrinsic discharge pattern (Khateb et al., 1992; Fort et al., 1998), 
which as discussed previously may play a critical role in the modulation of 
cortical activity (Manns et al., 2000a, b, 2003a; Lee et al., 2005b). On the other 
hand, the VGluT2-mediated release of glutamate from the axon terminal domain 
ofBF glutamatergic neurons, may act to modulate the activity ofpost-synaptic 
cells in a more c1assical manner, by direct depolarization through 
postysynaptically located AMPA and NMDA receptors (Fremeau et al., 2004). 
The basal forebrain as a region involved in the coordination of cortical 
activity and behavioral states 
The BF projection to cortex is comprised by three neurochemically 
differentiated neuronal contingents that, as discussed extensively, may have 
different influences over cortical activity. Similarly, the descending projections to 
LH may be involved in reciprocal promotion and attenuation ofbehavioral 
arousal. Given the concurrent changes in cortical activity that occur in association 
with different behavioral states, it is possible to conceive the BF as a region 
involved in the coordination ofboth processes. 
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As discussed previously, cholinergic neurons innervating PFC appear to 
have a critical role in attention (Sarter et al., 2003), which in tum may be 
associated with a relative attenuation ofbehavioral arousal as shown by the 
increase in parasympathetic activity during attention to conditioned stimuli (Hunt 
and Campbell, 1997). Interestingly, selective activation ofBF cholinergic 
neurons by injections of neurotensin in the BF provoke bursting of cholinergic 
neurons, prominent cortical theta and gamma activity and yet no increase in motor 
activity but instead the appearance of a quiescent waking state, shortly followed 
by PS (Cape et al., 2000). As cholinergic neurons with projections to frontal 
cortex have been found to provide extensive local collateralization and 
innervation to PV+, likely GABAergic BF neurons (Zaborszky and Duque, 2000), 
it is plausible to hypothesize that activation of cholinergic neurons, while 
promoting cortical theta activity in association with attention, may lead to 
excitation ofBF GABAergic neurons involved in the attenuation ofbehavioral 
arousal, such as those seen here to provide innervation to the LH. 
Sleep active neurons in the BF may participate in the cortical correlates of 
sleep, such as SW A during SWS (Sterman and Clemente, 1962a; Manns et al., 
2000b). Concurrently, sleep active neurons may inhibit arousal regions such as 
the LH (Sterman and Clemente, 1962b; Manns et al., 2003; Modirrousta et al., 
2004). Given that cortically projecting neurons form a different group than those 
projecting caudally (Semba et al., 1989), it is unlikely that the simultaneous 
promotion of SW A and behavioral quiescence originate from the same population 
of neurons. Thus, their simultaneous activation may be mediated through other 
mechanisms. As also discussed previously, SWA-active GABAergic neurons, 
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which discharge phasically and project to PFC may promo te the appearance of 
cortical SW A (Manns et al., 2000b) through direct innervation of pyramidal cells 
(Chapter II). Interestingly, it has been shown that the output ofPFC to BF, 
carried out by layer V pyramidal cells, is also directed to PV+ neurons (Zaborszky 
et al., 1997), which as pointed out in the previous paragraph likely correspond to 
GABAergic neurons. Again, it is possible to hypothesize that these BF 
GABAergic neurons with descending projections to LH and Orx neurons and 
involved in the attenuation ofbehavioral arousaI, may act under these 
circumstances in synergism with cortically projecting GABAergic neurons to 
promote and maintain sleep. 
Finally, neurons in the BF have been recorded that discharge maximally 
during W and decrease their activity as sleep appears and progresses (Lee et al., 
2004). Given the positive correlation oftheir discharge rate with the amplitude of 
muscle tone, these neurons are hypothesized to be involved in promotion of 
behavioral arousal along with facilitation of motor activity (Jones, 2005a) and, as 
proposed in Chapter IV, to correspond to those neurons that provide an excitatory 
input to Orx neurons. It is conceivable that neurons with similar characteristics 
may provide innervation to PFC, as proposed in Chapter II. Indeed, it has been 
shown that glutamate in PFC promotes increases in sympathetic activity (Resstel 
and Correa, 2005, 2006), supporting a role in behavioral arousal. Consonantly, 
acute stress elicited either by a restraint procedure or forced swimming are 
associated with increases in the release of glutamate in PFC, again suggesting a 
role in mediating arousal (Moghaddam, 1993). Mechanisms through which both 
populations may be co-activated during behavioral arousal may involve reciprocal 
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innervation through local axon collaterals, or altematively, glutamatergic 
intemeurons suggested to populate the BF (Hur et al., 2002). 
The major output of the basal forebrain is GABAergic 
The majority of BF terminaIs in the cortex and hypothalamus presented a 
GABAergic phenotype, outnumbering cholinergic terminaIs by a factor of two 
and five, respectively (Chapters II and III). Overall, these results agree with 
previous reports indicating that in both cortical as well as subcortical projections, 
BF GABAergic neurons represent a larger contingent than those with a 
cholinergic phenotype (Gritti et al., 1994; Gritti et al., 1997). They also agree 
with the quantitative estimations provided in Chapter l, where the GABAergic 
population outnumbers by several folds that comprised by cholinergic neurons. 
In relation to the functional role of GABAergic terminaIs in the cortex, 
these results also suggest a prominent role of this projection in neuropathologies 
associated with dysfunction of the basalo-cortical system, such as Alzheimer' s 
disease (Rossor et al., 1982). lndeed, this disease is associated with the 
degeneration ofboth cholinergic and non-cholinergic cells in the BF (Rasool et 
al., 1986) as well as decreases in the activity ofboth cholinergic and GABAergic 
markers in the cortex (Rossor et al., 1982). The involvement of the GABAergic 
system may be particularly relevant in the decrease of cortical high frequency 
activity observed in Alzheimer's patients (Jeong, 2004), which may be due to the 
dysfunction of tonically discharging GABAergic neurons that discharge at high 
frequencies and may promote gamma activity in the cortex (Manns et al., 2000b, 
2003a). 
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Regarding the descending projections to the LH, the predominant influence 
of the BF could be considered inhibitory. Thus, it is likely that the activation of 
caudally projecting neurons may be responsible for the generation ofbehavioral 
quiescence, decreases in sympathetic activity and promotion of sleep seen after 
BF stimulation (Hess, 1957; Sterman and Clemente, 1962b). Conversely, the 
chemical inactivation of neurons involved in these projections may be responsible 
for increases in W and insomnia (Satoh et al., 2003). It is thus plausible to 
conceive and hypothesize that treatments involving specific stimulation of 
caudally projecting BF neurons (by as yet unknown mechanism) may be 
beneficial in ameliorating excessive arousal and hyperactivity that are observed in 
cases of severe insomnia (Lugaresi et al., 1998). EquaIly, inactivation of the BF 
descending projecting system may be relevant in the treatment of those symptoms 
such as excessive somnolence or incapacity to maintain appropriate muscle 
activity seen in the disorder narcolepsy (Nishino et al., 1995; Nishino and Mignot, 
1997). 
Final conclusion (Figure 5) 
In conclusion, the BF comprises populations of neurons that have the capacity to 
synthesize and release ACh, GABA or glutamate. The three types ofneurons 
project and innervate the PFC and yet in different proportions, the LH. 
Contingent upon the their discharge profile across sleep-wake states, as weIl as 
upon the function of ACh, GABA and glutamate in these regions, it is concluded 
that: 1) BF cholinergic neurons may promote theta activity in PFC during certain 
waking states and PS. This influence would contribute synergistically to aspects 
253 
ofPFC cognitive and autonomie function, such as attention and working memory, 
along with atlenuation of motor and sympathetic output; 2) Cortically projecting 
GABAergic neurons may have a dual influence on PFC activity. Whereas sorne 
GABAergic neurons may facilitate cortical activation through promotion ofhigh 
frequency activity during wakefulness and PS, others may promote the 
appearance of rhythmic SW A during SWS. Akin sIeep-active neurons wouid 
provide an innervation of the LH and particularly Orx neurons to dampen 
behavioral arousal and promote behavioral quiescence and sleep; 3) By direct 
innervation of PFC, BF glutamatergic neurons may contribute to cortical 
activation and function, though their influence would be more related to those 
aspects mediating behaviorai arousal. This wouid aiso be the case for the 
prominent innervation they pro vide to the LH and Orx neurons. Through this 
influence, glutamatergic BF neurons may support behaviorai arousai of waking by 
promoting motor and sympathetic activation (Figure 5). 
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Figure 4: Proposed division of basal forebrain neuronal groups. A hypothetical 
partition ofbasal forebrain neurons according to the presence of synthetic 
enzymes and vesicular transporter proteins is provided. The major contingent of 
BF neurons is constituted by those neurons that synthesize glutamate (in green) as 
containing phosphate activated glutaminase (P AG). The vast majority of the 
neurons that synthesize ACh (in blue) as containing choline acetyltransferase 
(ChAT), and a large proportion ofthose that synthesize GABA (in red) as 
containing glutamic acid decarboxylase (GAD) are part ofthis group 
(ChAT+/PAG+ and GAD+/PAG+). A large proportion ofneurons that contain 
PAG also contain VGluT3 (PAG+NGluT3+). This population would also 
include most ofChAT+ (ChAT+/PAG+NGluT3+) and a majority ofGAD+ 
(GAD+/PAG+NGluT3+) cells. GAD+ neurons that do not contain PAG would 
correspond to those that do not contain VGluT3 either (GAD+/P AG-NGluT3-). 
ChAT + neurons would only be able to release ACh, as only containing the 
vesicular ACh transporter (VAChT) in their axon terminaIs (VAChT+). GAD+ 
neurons, irrespective of their P AG or VGluT3 content, would contain and only 
contain the vesicular GABA transporter (VGAT) in their axonal terminaIs 
(VGAT) to release GABA. Accordingly, glutamate would be only released by 
those PAG+ neurons that do not contain ChAT nor GAD (PAG+/ChAT-/GAD-) 
and would express the vesicular glutamate transporter 2 (VGluT2) in their axon 
terminaIs (VGluT2+). Axon terminaIs that do not contain YAChT, VGAT or 
VGluT2 would comprise a still unidentified population of (aspartergic?) neurons 
(in violet). As a result, while displaying complex neurochemical phenotypes in 
their cell bodies, which may underlie complex mechanisms for regulation of cell 
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Figure 4. Proposed division of basal forebrain neuronal groups 
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excitability, BF neurons display simpler phenotype in their axon terminaIs to 
regulate through independent mechanisms postsynaptic neurons. 
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Figure 5: Ascending and descending projections ofthe basal forebrain. The basal 
forebrain innervates cortical and hypothalamic regions through axonal efferents 
that, as indicated by the presence of vesicular transporter proteins (VTPs) would 
not only contain, but have the mechanisms to release ACh, GABA or glutamate. 
In the prefrontal cortex (PFC), these contingents may independently promote 
cortical activity in association with different waking and sleep states through 
innervation of cortical populations. In the lateral hypothalamus (LH) and through 
direct innervation of LH and Orx neurons, BF glutamatergic neurons may provide 
excitatory influences to promote wakefulness (W) together with behavioral 
arousal and muscle tone. Reciprocally, BF GABAergic may promote behavioral 
quiescence and sleep along with disfacilitation and suppression of muscle tone. 
By modulation and control of cortical activity and behavioral states, the BF may 
be seen as a key piece in the complex neuronal machinery that coordinates 
concurrent changes in cortical, somatomotor and autonomie function through 
sleep-wake states. Other abbreviations: ac, anterior commissure; ChAT, choline 
acetyltransferase; CPu, caudate putamen; EMG, electromyographic activity; 
GAD, glutamic acid decarboxylase; Gi, gigantocellular reticular formation; GiA, 
gigantocellular reticular formation, alpha part; GiV, gigantocellular reticular 
formation, ventral part; GP, globus pallidus; Hi, hippocampus; LC, locus 
coeruleus; LDTg, laterodorsal tegmental nucleus; LH, lateral hypothalamus; Mes 
RF, mesencephalic reticular formation; opt, optic tract; PAG, phosphate activated 
glutaminase PnC, pontine reticular formation, caudal part; PnO, pontine reticular 
formation, oral part; POA, preoptic area; PPTg, pedunculopontine tegmental 
nucleus; PS, paradoxical sleep; Rt, reticular thalamic nucleus; SWS, slow wave 
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sleep; SN, substantia nigra; Sol, solitary tract nucleus; Th, thalamus; TM, 
tuberomammillary nucleus; VTA, ventral tegmental area; W, wakefulness. 
Modified with permission from Jones BE (2005a), Figure 1. 
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SUMMARY 
Wakefulness (W), slow wave sleep (SWS) and paradoxical sleep (PS) are 
the three main behavioral states that occur in mammals. The generation and 
maintenance of these states, as well as the physiological changes that concur with 
them, are controlled by different regions in the central nervous system (CNS). 
Among those, the basal forebrain (BF) has been shown to play an important role 
in promoting the appearance of cortical activation, a phenomenon characterized 
by the presence ofhigh frequency activity and associated with cortical processing, 
which occurs during W and PS. Yet, the BF has also been shown to play a role in 
the generation of cortical slow wave activity (SW A) that occurs during SWS, as 
well as on the direct promotion ofbehavioral quiescence and sleep. 
In order to understand the mechanisms by which the BF participates in these 
processes, a project was carried out to identify and study the neuronal groups that 
populate the BF and participate in the projections that the BF sends to the cortex, 
and through which it controls cortical activity, and those that participate in the 
projections to the lateral hypothalamus (LH), a region involved in the promotion 
of arousal and W, and through whose inhibition BF sleep active neurons may 
promote sleep. 
We found that, in addition to neurons that synthesize ACh or GABA, which 
are known to populate the BF, a large number of neurons in the BF have the 
capacity to synthesize glutamate. In the BF, these three groups represented -6% 
(-22,000 neurons), -35% (-120,000 neurons) and -90% (-310,000 neurons) of 
the total number ofneurons in the BF, respectively. We also found that most of 
glutamate-synthesizing neurons had also the mechanisms to release glutamate 
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from their somato-dendritic compartments, which may represent a mechanism to 
regulate the strength of inhibitory inputs that they receive from other neurons and 
thus maintain their excitability. 
By labe1ing BF neurons and their axonal processes with anterograde tracers, 
we were also able to identify BFaxons innervating cortical regions and examine 
whether they had the capacity to re1ease ACh, GABA or glutamate, by detecting 
the presence of presynaptic markers specifie for each neurotransmitter. In the 
prefrontal cortex (PFC) we found that different contingents of BFaxons have the 
capacity to release ACh, GABA or glutamate, and they respective1y accounted for 
-19%, -52% and -15% of the total number of BF terminaIs in this cortical region. 
These axonal contingents innervated deep layers of the PFC and appeared to 
provide innervation to pyramidal or intemeuronal cell types. By these means, the 
BF could modulate cortical activity through cholinergie, GABAergic and 
glutamatergic mechanisms and thus promotes changes in cortical activity and in 
association with different behavioral states. In addition, by innervating deep 
layers ofPFC, the BF may also influence the corticofugal output to thalamus and 
other subcortical regions known to be involved in the regulation ofbehavioral 
states, such as the LH. 
In the LH we also found BFaxons which presented cholinergie, GABAergic 
and glutamatergic phenotypes, representing -10%, -25% and -50% of the total 
BFaxonal terminaIs in the LH, respectively. As providing the major proportions, 
glutamatergic and GABAergic axon terminaIs were found to provide synaptic 
innervation to hypothalamic neurons, inc1uding those that express the peptide 
orexin (Orx, or hypocretin), neurons that have been shown to be critical for the 
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maintenance ofW, as their absence is cause ofnarcolepsy. Ofthose Orx neurons 
innervated by BFaxons, ~30% received glutamatergic inputs and ~65% received 
GABAergic ones. Thus, through a prominent inhibitory projection to the LH and 
to wake-active Orx neurons, the BF may suppress wakefulness and promote sleep. 
Reciprocally, glutamatergic BF neurons may participate in the maintenance ofW 
through excitation of Orx neurons. 
By providing multiple influences to cortex and LH, the BF may not only 
fulfill its multiple roles in modulation of cortical activity and behavioral states, 
but also to play a key role in the coordination of the concurrent changes at cortical 
and behaviorallevels that occur across sleep-wake states. 
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Vesicular Glutamate (VGluT), GABA 
(VGAT), and Acetylcholine (VAChT) 
Transporters in Basal Forebrain Axon 
TerminaIs Innervating the Lateral 
Hypothalamus 
PABLO HENNY AND BARBARA E. JONES* 
Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada 
ABSTRACT 
The basal forebrain (BF) is known to play important roles in cortical activation and sleep, 
which are likely mediated by chemically differentiated cell groups including cholinergic, 
-y-aminobutyric acid (GABA)ergic and other unidentified neurons. One important target of 
these cells is the lateral hypothalamus (LH), which is critical for arousal and the mainte-
nance of wakefulness. To determine whether chemically specific BF neurons provide an 
innervation to the LH, we employed anterograde transport of 10,000 MW biotinylated 
dextran amine (BDA) together with immunohistochemical staining of the vesicular trans-
porter proteins (VTPs) for glutamate (VGluTl, -2, and -3), GABA (VGAT), or acetylcholine 
(ACh, YAChT). In addition, we applied triple staining for the postsynaptic proteins (PSPs), 
PSD-95 with VGluT or Gephyrin (Geph) with VGAT, to examine whether the BDA-Iabeled 
varicosities may form excitatory or inhibitory synapses in the LH. Axons originating from 
BDA-Iabeled neurons in the magnocellular preoptic nucleus (MCPO) and substantia innomi-
nata (SI) descended within the medial forebrain bundle and extended collateral varicose 
fibers to contact LH neurons. In the LH, the BDA-Iabeled varicosities were immunopositive 
(+) for YAChT (~lO%), VGluT2 (~25%), or VGAT (~50%), revealing an important influence 
of newly identified glutamatergic together with GABAergic BF inputs. Moreover, in confocal 
microscopy, VGluT2+ and VGAT+ terminaIs were apposed to PSD-95+ and Geph+ profiles 
respectively, indicating that they formed synaptic contacts with LH neurons. The important 
inputs from glutamatergic and GABAergic BF cells could thus regulate LH neurons in an 
opposing manner to stimulate vs. suppress cortical activation and behavioral arousal recip-
rocally. J. Comp. Neurol. 496:453-467, 2006. © 2006 Wiley-Liss, Ine. 
Indexing terms: glutamatergic; GABAergic; cholinergic; BDA; PSD-95; Gephyrin; rat; sleep-wake 
states 
The basal forebrain (BF) plays an important role in the 
modulation of cortical activity and regulation of sleep-
wake states. As known from early studies, it serves as the 
ventral extrathalamic relay to the cerebral eortex from the 
brainstem reticular activating and arousal systems 
(Starzl et al., 1951; Jones, 2005a). Yet, it is also impor-
tantly involved in sleep, because lesions of the BF are 
associated with insomnia (von Economo, 1931; Nauta, 
1946; McGinty and Sterman, 1968; Jones, 2005a). These 
opposing roles could be mediated by chemically differen-
tiated cell groups in the BF that include cholinergie, 
-y-aminobutyric acid (GABA)ergic, and non-cholinergid 
non-GABAergic, presumed glutamatergic, neurons (Gritti 
© 2006 WILEY-LISS, INC. 
et al., 1993, 1994, 1997; Manns et al., 2001). Aceording to 
multiple lines of evidence, cholinergie neurons actively 
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stimulate cortical activation during waking and paradox-
ical sleep (PS, also called rapid eye movement [REM] 
sleep; Buzsaki et al., 1988; Metherate et al., 1992; Duque 
et al., 2000; Manns et al., 2000b; Jones, 2004; Lee et al., 
2005b). Sorne putative glutamatergic neurons can act in 
parallel with the cholinergic neurons in this process 
(Manns et al., 2003). In contrast, most GABAergic BF 
neurons are minimally active during cortical activation 
(Manns et al., 2000a), and, as reflected by c-Fos expres-
sion, many are maximally active during sleep (Modir-
rousta et al., 2004), indicating that they can promote 
sleep, including slow wave sleep (SWS). 
In addition to projections to the cerebral cortex (Gritti et 
al., 1997), BF neurons give rise to projections to the pos-
terior lateral hypothalamus (LH; Gritti et al., 1994), a 
region long known to be crucial for waking (von Economo, 
1931; Nauta, 1946; Hess, 1957; Swett and Hobson, 1968; 
Jones, 2005c). Recently, neurons have been localized in 
the LH that contain the peptide orexin (Orx, also called 
hypocretin), which is critical for sustaining waking, be-
cause absence of the peptide, its receptor, or the Orx 
neurons results in narcolepsy (Chemelli et al., 1999; Lin et 
al., 1999; Peyron et al., 2000; Thannickal et al., 2000). 
Although previous studies combining retrograde trans-
port with immunohistochemical staining for neurotrans-
mitter enzymes indicated that cholinergic, GABAergic, 
and other BF neurons project to the LH (Gritti et al., 
1994), they did not reveal the efferent BF fibers projecting 
into the LH nor did they prove the use of acetylcholine 
(ACh), GABA, or, as proposed, glutamate as neurotrans-
mitters by the projection neurons. Recently, proof of the 
uptake, storage, and release of specific neurotransmitters 
has become possible by immunohistochemical staining for 
specific vesicular transporter proteins (VTPs), including 
those for ACh (VAChT; Gilmor et al., 1996), GABA (VGAT; 
Chaudhry et al., 1998) and glutamate (VGluT1, -2, and -3; 
Fremeau et al., 2001, 2002; Fujiyama et al., 2001). We 
thus combined anterograde transport of 10,000 MW bio-
tinylated dextran amine (BDA) with immunohistochemi-
cal staining for YAChT, VGluT 0,2, and 3), and VGAT to 
determine whether cholinergic, glutamatergic, or 
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GABAergic neurons located in the magnocellular preoptic 
nucleus (MCPO) and substantia innominata (SI) project to 
the LH. To assess whether the VGluT+ and VGAT+ var-
icosities form synapses in the LH, we employed triple 
immunostaining for the postsynaptic proteins (PSPs) 
PSD-95, a marker for excita tory synapses (Sheng and Pak, 
2000), or Gephryin (Geph), a marker for inhibitory syn-
apses (Sassoe-Pognetto and Fritschy, 2000; Sassoe-
Pognetto et al., 2000). 
MATERIALS AND METHODS 
AnimaIs and Surgery 
AlI procedures conformed to the guidelines of the Cana-
dian Council on Animal Care and the U.S. National Insti-
tutes of Health and were approved by the McGill Univer-
sity Animal Care Committee. 
Long-Evans rats (200-250 g, Charles River Canada, St. 
Constant, Quebec, Canada) were anesthetized with 
ketamine/xylazine/acepromazine (65/511 mglkg, i.p.) and 
placed in a stereotaxic frame (David Kopf Instruments, 
Tujunga, CA) for surgery. Anesthesia level was monitored 
during the experiment and augmented by boosters if nec-
essary. Because previous studies based on retrograde as 
weIl as anterograde tracing showed no evidence of con-
tralateral projections from the BF to the LH (Swanson, 
1976; Gritti et al., 1994), injections of BDA were done on 
left and right sides of each brain. Holes were drilled in the 
skull, and the dura mater was removed on each side over 
the BF. Glass micropipettes (tip diameter 15-25 ILm) were 
back-fiIled with a 0.5 M NaCI solution containing 2% 
10,000 MW BDA (BDA-10,000, Molecular Probes, Eugene, 
OR). With the aid of a micropositioner (model 660, David 
Kopf Instruments), a BDA-filled pipette was lowered into 
the BF on each side aimed at the magnocellular preoptic 
nucleus (MCPO; from Bregma: anterior-posterior [AP], 
-0.51ateral [L], :t2.5 mm; vertical [V] , 8.5 mm). A holding 
current of -300 nA was maintained (using a Microionto-
phoresis Dual Current Generator 260, World Precision 
Instruments [wpI], Sarasota, FL) during the descent to 
avoid leakage ofthe solution. Once the pipette was in the 
targeted site, microinjection of BDA was performed by 
iontophoresis applying positive current pulses (5-10 ~) 
in a dut y cycle of 1 second (0.5 seconds on, 0.5 seconds oft) 
for a period of 25-30 minutes through a stimulator (Pulse-
master A300, WPI) and stimulus isolation unit (Iso-Flex, 
A.M.P.I., Jerusalem, Israel). Mer the injection, the mi-
cropipette was held in place for 10 minutes and removed 
during renewed application of the holding current. 
Rats were maintained for 5 or 6 days with food and 
water ad libitum to allow anterograde transport of the 
tracer. They were subsequently perfused transcardially 
under deep sodium pentobarbital anesthesia (100 mglkg, 
i.p.) with -500 ml 4% paraformaldehyde fixative solution. 
The brains were removed and put in a 30% sucrose solu-
tion for 2-3 days or until they sank, after which they were 
frozen at -50·C and stored at -80·C for subsequent pro-
cessing. 
IImnunohistochemistry 
Sections were cut by using a freezing microtome in 
25-lLm-thick coronal sections and collected in eight adja-
cent series at 200-lLm intervals through the forebrain, 
including the magnocellular BF area and the tuberal-
posterior hypothalamus. Series were processed for evalu-
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ation of the BDA injection site in the BF and BDA-Iabeled 
fibers in the LH by light microscopy. For this purpose, the 
avidin-biotin complex (ABC) procedure was performed by 
using the Vectastain ABC Elite kit (Vector, Burlingame, 
CA) with nickel-intensified diaminobenzidine (DAB-Ni) 
and combined with a Nissl counterstain using neutral red 
(NR). 
Adjacent series containing the tuberal-posterior LH re-
gion were processed for double or triple fluorescent stain-
ing (Table 1). Prior pilot studies were performed to deter-
mine the conditions necessary for antibody as well as 
streptavidin penetration through the full depth of the 
sections. As viewed through the z-axis under epifluores-
cent and confocal microscopy, we established that 0.1 or 
0.3% Triton X-IOO (TX) allowed full penetration of anti-
bodies and streptavidin through 25-fLm-thick sections in 
double- or triple-stained series, respectively. Free-floating 
sections from each series were rinsed for 30 minutes in 
Trizma saline buffer (TS; 0.1 M, pH 7.4) followed by incu-
bation for 30 minutes with a blocking solution of normal 
donkey serum (NDS; 6% in TS) containing TX (0.1 or 
0.3%). Subsequent incubations and rinses (30 minutes 
between incubations) were done by using TS containing 
NDS (1%) and TX (0.1 or 0.3%). Incubations were per-
formed at room temperature overnight with primary an-
tibodies and for 3 hours with secondary antibodies or 
streptavidin. 
For double labeling of BDA and one of the VTPs, sec-
tions were incubated (by using 0.1% TX) first with pri-
mary antibodies against YAChT, VGluT1, -2, or -3, or 
VGAT (from various species) and then with appropriate 
Cy3-conjugated secondary antibodies (from donkey [Dky]) 
followed by Cy2-conjugated streptavidin for revelation of 
BDA (see Table 1, Double BDANTP)' 
For double labeling of two VTPs, sections were incu-
bated (by using 0.1% TX) with two primary antibodies 
against YAChT, VGluT2, and/or VGAT (from different 
species) and then with appropriate Cy2- and Cy3-
conjugated secondary antibodies (from Dky) (see Table 1, 
Double VTPNTP). 
For triple labeling of BDA, the VTPs, and the PSPs, 
sections were incubated (by using 0.3% TX) with two pri-
mary antibodies against VGluT2 or VGAT and PSD-95 or 
Geph, respectively (from different species) and then with 
appropriate Cy3 or Cy5 secondary antibodies (from Dky). 
They were subsequently incubated with Cy2-conjugated 
streptavidin for revelation of BDA (see Table 1, Triple 
BDANTP:PSP). 
AlI sections were mounted out of Trizma water, and the 
mounted sections were dehydrated through alcohols, 
cleared in xylene, and coverslipped with Permount. 
Conventional microscopy, tracing, and 
stereological analysis 
Sections were examined under light and epifluorescent 
microscopy with a Leica DMLB microscope or Nikon 
Eclipse E800 equipped with x-y-z motorized stages, a 
video or digital camera, and filters appropriate for fluo-
rescein isothiocyanate (FITC) (or Cy2), Rhodamine (or 
Cy3), and (on the Nikon) Cy5 fluorescence. Single as weil 
as composite images were acquired, and drawings were 
made by using Neurolucida software (MicroBrightField 
[MBFl, Colchester, VT). Cells and varicosities were 
counted by using the Optical Fractionator probe of Stereo 
Investigator software (MBF). For tracing or counting, a 
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computer resident atlas of the rat brain was employed 
that was developed and applied in our laboratory by using 
standardized procedures for tissue processing (Gritti et 
al., 1993, 1994). For each application, series of histology 
sections are matched to appropriate levels of the atlas (at 
400-fLm intervals) under low magnification (5 or 10x ob-
jective). At each level, the atlas image is then rotated if 
necessary, and the contours are adjusted to fit the rele-
vant nuclei of the histology section optimally. 
Injection sites from eight rats (BDA 14, 15, 16, 18, 19, 
20, 21, and 22) were examined under brightfield illumina-
tion in DAB-Ni-stained material. In 14 cases, the labeled 
cells were centered in the MCPO-SI (on the left and/or 
right sides). From these, five injection sites ("cases" on the 
left and/or right sides) from three rats (BDA 16, 18, and 
19) were selected for quantitative estimate of the cells in 
the injection sites. From the 14 cases, innervation of the 
LH was studied qualitatively and quantitatively in 
DAB-Ni and fluorescent stained material (see text and 
Table 1). 
Under brightfield illumination, unbiased estimates of 
the total number of DAB-Ni-stained, BDA-Iabeled nerve 
cell bodies were performed by using the Optical Fractiona-
tor probe of Stereo Investigator. Cells were counted within 
contours of the BF and surrounding nuclei, including the 
MCPO, SI, nucleus of the diagonal band of Broca (DBB), 
olfactory tubercle (OTu), lateral preoptic area (LPO), fun-
dus of the striatum (FS), piriform cortex (Pir), nucleus of 
the lateral olfactory tract (LOT), and anterior amygdaloid 
area (AA). Counts were made under a 60x oil objective 
(with 1.40 numerical aperture [NA]) through six or seven 
BF levels (at 200-fLm intervals) by using an x-y sampling 
grid size (of 120 X 120 fLm) that was equal to the counting 
frame size, so as to sample 100% of each area. Counting 
was performed through 10 fLm in the z-axis (starting 1 fLm 
from the surface in mounted sections having an average of 
-12-fLm thickness following dehydration). Following the 
stereological procedures imposed in Stereo Investigator, 
cells were counted iftheir tops were contained within the 
defined counting block. 
Projections of the DAB-Ni-stained, BDA-Iabeled axons 
were examined through the tuberal-posterior LH and in 
relation to NR stained neurons viewed under brightfield 
illumination. The axons and neurons were drawn by using 
a 100x oil objective within a contour of the LH using 
Neurolucida software (MBF). 
Given evidence for contacts ofBF fibers on LH neurons, 
the total number ofNR stained neurons that were or were 
not contacted by one or more DAB-Ni-stained, BDA + var-
icosities (NR+:BDA+ or NR+:BDA-) was estimated by 
using the Optical Fractionator probe through the LH (n = 
3 cases). Counts were performed under a 100x oilobjec-
tive (1.4 NA) on the Nikon microscope. The cells were 
sampled in the LH, as defined in the computer resident 
atlas, through three levels separated by 400-fLm intervals 
(5,800, 6,200, and 6,600 fLm anterior [A) to interaural zero 
[lAO)). The sampling grid size (210 x 210 fLm) was set to 
be larger than the counting frame (70 X 70 /Lm) so as to 
sample -11% of the LH area. Counting was performed 
through 16 fLm of the section thickness (starting 1 fLm 
from the surface of the mounted sections, which had an 
average thickness of -19 fLm following their minimal de-
hydration and differentiation for NR). As above, cells were 
counted if their tops were contained within the defined 
counting block. 
TABLE 1. List ofPrimary and Secondary Antibodies Used for Fluorescence StainingofBiotinylated Dextran Amine (EDA), Vesicular Transporter Proteins (VTPs) and Postsynaptic Proteins (PSPs) .... I:n 
c:l) 
l'Y AB (overnight) 2'Y AB (3 hours) SA (3 hours) 
Series Antigen Host Dilution Source Cat. # Immunogen Specificity IgG (Dky)17.18 Dilution SAl7 Dilution n l9 
DoubieBDA YAChT Gt 1:5000 Chemicon1 AB1578 Synthetic peptide corresponding to By WB the AB recognizes a Anti·Gt-Cy3 1:800 SA-Cy2 1:800 
vrp C-tcnninus of cloncd rat -65-70 kD band 
YAChT" (CSPP corresponding to YAChT 
GPFDGCEDDYNYYSRS)' protein4 
YAChT Rb 1:1000 Sigma2 V5387 Synthetic peptide corresponding to By WB the AB recob'Ilizes a Anti.Rb·Cy3 1:800 SA·Cy2 1:800 
AA 512-530 of C·terminus of -67-70 kD band, 
cloned rat V AChT (K· corresponding to V AChT 
SPPGPFDGCEDDYNYYSRS)8 protcin7 
VGJuTl Rb 1:1000 Gift RHE3 Synthetic peptide corresponding to By WB the AB recognizes a Anti.Rb·Cy3 1:800 SA.Cy2 1:800 
68 last AA of C·terminus of rat -62 kD band from rat 
BNPi (VGJuTl)" brain9 
VGJuT2 Rb 1:5000 Gilt RHE Synthetic peptide corresponding to By WB the AB recognizes a Anti·Rb·Cy3 1:800 SA·Cy2 1:800 14 
64 last AA of C·terminus of rat -50-52 kD band from 
DNPi CVGluT2)'o rat brain10 
VGJuT3 GP 1:1000 Chemicon AB5421 Synthetic peptide from cloned rat The AB labels VGJuT3 j Anti·GP·Cy3 1:800 SA.Cy2 1:800 
VGluT3 protein" cells and fibers. in 
(AFEGEEPLSYQNEEDFSETS)7 agreement with otheT 
VGluT3 antisera11 
VGAT Rb 1:250 Chemicon AB5062P Synthetic peptide corresponding to By WB the AB recogoizes a Anti·Rb·Cy3 1:800 SA.Cy2 1:800 14 
a 17 AA peptide near C· band at ~55-60 kD12 
tenninus region of rat VGAT12 
(VHSLEGLIEAYRTNAED)7 
Double vrp YAChT! Gt 1:5000 Chemicon AB 1578 (above) (above) Anti.Gt.Cy3 1:800 
vrp VG\uT2 Rb 1:5000 Gilt RHE (above) (above) Anti·Rb·Cy2 1:200 
YAChT! Gt 1:5000 Chemicon AB1578 (above) (above) Anti-Gt·Cy3 1:800 
VGAT Rb 1:250 Chemicon AB5062P (above) (above) Anti-Rb.Cy2 1:200 
VGAT! Rb 1:250 Chemicon AB5062P (above) (above) Anti.Rb·Cy2 1:200 4 
VGluT2 GP 1:5000 Chemicon AB5907 Synthetic peptide from cloned rat The AB gives labeling in Anti.GP.Cy3 1:800 
VGluT2 protein" agreement with other 
CVQESAQDA YSYKDRDDYS)' antisera to VGluT2 13 
Triple BDA VG\uT2I Rb 1:5000 Gift RHE (above) (above) Anti-Rb-Cy5 1:800 SA-Cy2 1:800 
o-,l Vl'PPSP PSD·95 Ms 1:100 ABR' MA1·045 Purified recombinant of rat PSD· The AB detects post Anti.Ms·Cy3 1:800 SA.Cy2 1:800 
=-95'4 synaptic density 95kD in ." 
rat brain. By WB it ~ 
recognizes a -95 kDa 0 
band'" 3 VGAT/ Rb 1:250 Chemicon AB5062P (above) (above) Anti·Rb·Cy5 1:800 SA.Cy2 1:800 e:. Geph M. 1:100 SY·Sv" 147011 Purilied rat gephyrin 15 By WB the AB recognizes a Anti·Ms·Cy3 1:800 SA.Cy2 1:800 
-93 kD band. It deteet. 0 
.... 
aN-terminus epitope16 C"J 
0 
lChemicon: Chemicoll International. Temecula, CA 51 
"Sigma: Sigma, St. Louis, MO '1:1 po 
3Gift from Edwards, R.H. and Fremeau, R.T. Jr. ~. 'ABR: Affinity BioReagents, Golden, CO. ;= 5SY.SY: Synaptic Systems, Gottingen, Germany. 
6http://www.chemicon.comlProductlProductDataSheet.asp?Productltem-ABI578 ;] ~ 7Supplied by Chemicon on request 8http://www.sigmaaldrich.comlsigma/datasheet/v5387dat.pdf ~ ea "Bellocchio et al., 1998 0 
'''Fremeau et al., 2001 
-< Q 
''http://www.chemicon.comlProductfProductDataSheet.asp ?Productltem -AB5421 ~ ~ 12http://www.chemicon.comlProduct/ProductDataSheet.asp?Productltem=AB5062P ~ 13http://www.chemicon.comiproductJproductdataSheet.asp?Productltem - AB5907 ~ t:' 
'4http://www.bioreagents.comlindex.cfmlfuseactioniproducts.print/Product/MA1.045 0 
15http://www.sysy.com/gephyrinlgephy_fs.html t= .... 
'"pfeiffer et al., 1984 ~ .... 0 17Jackson Immuno Research Laboratories, West Grove, PA. 
~ ~ "For multiple labeling (ML) with minimal cross·reactivity (min X) to other speeies. 8 19n, number of cases (each case referring to an injection site and series from the sarne side of the brain, thus 1 or 2 per brain). 0 
AA, amino aeid; AB, antibody; BNPi, brain specifie Na + -dependent phosphate transporter; eat., catalog; Cy2, (.'Yanine; cya, indocarbocyanine; Cy5, indodicarbocyanine; Dky, donkey; DNPi. differentiation-associated Na + ~dependent ~ ~ phosphate transporter; Geph, gephyrin; GP, guinea pig; Gt, goat; Ms, mouse <monoclonal); Rb, rabbit; SA, streptavidin; WB, western blot. =:s CIl ." 
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Under epifluorescent illumination, fluorescent stained 
BDA-positive (+) varicosities were examined for double 
labeling with the VTPs in the LH. Mter double labeling 
with YAChT, VGluT2, and VGAT was found, unbiased 
estima tes of the total numbers of single BDA + and 
double-Iabeled BDA+NAChT+, BDA+NGluT2+, or 
BDA +NGAT+ varicosities were estimated in the LH for 
each series by using the Optical Fractionator probe of 
Stereo Investigator. In five cases analyzed per series in 
stereology, all VTPs were stained by using antibodies 
raised in rabbit (Rb; YAChT, VGluT2, and VGAT; see 
Table 1). Counts were performed under a 100x oilobjec-
tive (with 1.40 NA) on the Leica microscope. The varicos-
ities were sampled in the LH, as defined in the computer 
resident atlas, through three levels separated by 400-lJ.m 
intervals (A 5,800, A 6,200, and A 6,600) of the tuberal-
posterior LH (in four cases per series; Table 2). The sam-
pling grid size (180 x 180 flm) was set to be larger than 
the counting frame (90 X 90 IJ.m) so as to sample 25% of 
the LH area. Counting was performed through 8 IJ.m of the 
section thickness (starting 1 IJ.m from the surface of the 
mounted sections having an average thickness of -12 IJ.m 
following dehydration). In each counting block and frame, 
aIl BDA + varicosities (in green, Cy2) were counted, in-
cluding those that were and were not double-Iabeled for 
the VTP (in red, Cy3) to obtain an estimate of the propor-
tion of double-Iabeled varicosities for each VTP. 
Double labeling for YAChT, VGluT2, and/or VGAT was 
assessed under epifluorescent illumination on the Leica 
microscope (in four cases per series; Table 1). In the ab-
sence of any double labeling, no quantification was under-
taken. 
Confocal microscopy and image processing 
To examine the presence of PSPs in association with 
BDA+NTP+ varicosities, triple-stained sections were an-
alyzed by confocal microscopy with a Zeiss LSM 510 laser 
scanning microscope equipped with Argon 488 nm, 
helium-neon 543 nm, and helium-neon 633 nm lasers for 
Cy2, Cy3, and Cy5 excitation as weIl as with appropriate 
filters for detection of Cy2 (bandpass 500-530 nm, green), 
Cy3 (bandpass 565-615 nm, red), and Cy5 (bandpass 697-
719 nm, infrared). Scanning was performed through a 
Plan-Apochromat 100X (with 1.40 NA) objective and pin-
hole size of 1 (Airy Units) for each of the three channels. 
Images were acquired for the three chromogens by using 
the resident LSM 510 software and consisted of stacks 
taken through the z-axis in optical slices of -0.33 IJ.m. 
Rendered 3D views of the image stacks were obtained by 
using the image software Volocity 3.5.1 (Improvision, Lex-
ington, MA, www.improvision.com). which allowed inter-
active visualization, magnification, and rotation of the 3D 
images in order to determine the relative location of each 
of the elements from the three channels. 
In some images, a deconvolution procedure or iterative 
restoration in Volocity was applied by using a 95% confi-
dence level in order to maximize the signal-to-noise ratio 
and assess relationships among elements better in the 
triple-stained material. As assessed in three cases per 
series (Table 1), contacts between VTP+/BDA+ varicosi-
ties and PSP+ profiles were evaluated in the rotated 
images and validated by lack of separation between the 
pre- and postsynaptic elements. 
Adjustments for brightness and contrast in brightfield 
images and tonal range for each individual RGB channel 
457 
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("Adjustllevels" command in Photoshop) in fluorescent im-
ages were performed with Adobe Photoshop Creative 
Suite edition (Adobe Systems, San Jose, CA). 
RESULTS 
BDA injection site and cellular labeling 
Iontophoretic application ofBDA-10,000 into the region 
of the magnocellular preoptic area and substantia innomi-
nata (MCPO-SI, Fig. lA) produced a small and well-
restricted, spherical injection site (Fig. lB) containing la-
beled cell bodies and dendrites (Fig. 1C). The injection 
sites ranged in size from 300 to 500 J.l.m in diameter and 
were consistently located primarily within the MCPO and 
secondarily in the overlying SI (n = 11 injection sites). 
To appraise the number of cells labeled and their precise 
location in BF nuclei, stereological estimates were ob-
tained through the BF. The average number of BDA-
labeled neurons per injection was -1,400 (mean :t SEM, 
1,430.6 :t 315, n = 5 injection sites). The labeled cells were 
almost exclusively (96.2 :t 1.7%; range, 90-100%) located 
within the MCPO (90.2%) and SI (6.0%). A few scattered 
cells were variably found in immediately adjacent regions 
including the olfactory tubercle, lateral olfactory tract nu-
cleus, or anterior amygdaloid area (3.5 :t 1.8%). Isolated 
cells were found in the nearby fundus of the striatum or 
piriform cortex in sorne cases. No labeled cells were seen 
in the more rostral DBB. No labeled cells were seen in 
distant regions known to project to the MCPO-SI, inc1ud-
ing the prefrontal cortex or, importantly, the LH, indicat-
ing a lack of retrograde transport of the BDA-10,OOO in 
these afferent systems. 
BDA was found within axons in the diencephalon (n = 
14 cases) and in cortical and subcortical telencephalic 
regions where different MCPO-SI neurons are known to 
project from retrograde (Gritti et al., 1994, 1997) and 
other anterograde tracing studies (Luiten et al., 1987; 
Grove, 1988). 
BDA-labeled fibers and varicosities 
in the LH 
In the diencephalon, thick fascic1es of fibers were evi-
dent in the ventrolateral posterior LH (Fig. 2A). From 
these coarse fibers, collateral fine fibers extended out 
through the LH. Sorne fibers continued sparsely into the 
perifornical area, but most remained within the LH. The 
fine fibers bore varicosities along their axons (boutons en 
passant, Fig. 2B') or occasionally at the end oftheir axons 
(boutons terminaux, Fig. 2B"). Although many varicose 
axons did not appear to contact nerve cell bodies in the 
region (Fig. 2B'), a significant number did appear to do so, 
innervating either small (Fig. 2B") or large (Fig. 2B''') 
neurons by varicose processes that could entirely envelop 
the soma. To visualize the fiber distribution and innerva-
tion of nerve cell bodies better within the LH, high-
magnification tracing of the DAB-Ni-stained axons and 
neutral red (NR+) stained cells was performed. As seen in 
Figure 2C, the major axon fascic1es were seen to course 
within the ventrolateral part of the medial forebrain bun-
dIe (MFB) from which they extended fine varicose fibers to 
contact and sometimes entirely surround cells in ventral, 
central, and dorsal portions of the LH (Fig. 2D' ,D",D'''). 
To appraise the extent of the innervation of neurons in 
the LH, stereological estimates were obtained of the num-
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Fig. 1. BF site of BDA injection. A: Atlas section through the 
cholinergic cell area (MCPO-Sn where iontophoretic applications of 
BDA were placed. B: Composite image of typical BDA injection site 
(case BDA18-R, processed by using ABC with DAB-Ni and counter-
stained with neutral red). Note the small size and restricted location 
of BDA-labeled cells in the MCPO. C: High-magnification image of 
two BDA-labeled neurons (from B, arrowheadsl. Brightness and con-
trast were adjusted in B and C. For abbreviations, see Hst. Scale bar = 
1 mm in B; 20 .... m in C. 
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Fig. 2. BDA-Iabeled fibers in the LH. A: Low-magnification com-
posite image of BDA + axons (in black, DAB-Ni) and neutral red 
stained (NR+) cells in the LH (case BDA19-L). B: High-magnification 
images showing BDA + axons and terminais within the LH area. 
Varicosities appeared most co=only along axons as boutons en 
passant (solid arrowhead in B') but also at the end of axons as boutons 
terminaux (open arrowhead in BH). Manyaxonal varicosities (stained 
with DAB-Ni) were seen in the neuropil (B') or in close proximity to 
small (solid arrowhead in BH) or large (solid arrowhead in B"') nerve 
cel! bodies (stained with NR, B' and BH, case BDA15-L; W', case 
ber and proportion of LH cells ostensibly contacted by 
BDA-Iabeled varicosities in the light microscope images. 
In three cases, the NR+ cells that were contacted (NR+: 
BDA + ) together with those that were not contacted (NR +: 
BDA - ) were counted in random sampling through three 
levels of the LH (-A 5,800, A 6,200, and A 6,600). The 
number of contacted cells (NR+:BDA+ = 8,027 ::':: 3,639 
neurons) corresponded to -14% (14.4 :!: 5.3%) of the total 
number of NR+ cells (NR+:BDA+ plus NR+:BDA-
52,495 ::':: 5,611 neurons) estimated in the LH. 
VAChT, VGluT, and VGAT within BDA-
labeled varicosities in the LB 
Series that were double stained for BDA and the VTPs 
were examined to determine whether BFaxonal varicos-
ities in the LH were immunopositive (+) for YAChT, 
VGluT, or VGAT. 
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BDA19-L). C: Tracing ofBDA+ axons and NR+ neurons in the LH at 
-6,200 j.Lm (from lAO, case BDA19-L). Although coneentrated more 
ventrally, fibers extended through the LH area and formed apposi-
tions with neurons therein (D). D: High-magnifieation tracing of ele-
ments in C showing the relationship of BDA+ axons with dorsally 
(solid arrowheads in D'), as well as more ventrally (DH and DH') located 
NR + neurons. (The neuron in D''' corresponds to that pictured in Bm .) 
Tonal ranges for each RGB channel as weil as brightness and contrast 
adjustments were made for pictures in A and B. For abbreviations, see 
list. Seale bar = 100 !Lm in A; 10 !Lm in B,D. 
VAChT+ varicosities were relatively sparse in the LH. 
Nonetheless, some BDA-Iaheled terminals were double-
laheled for YAChT (Fig. 3A). The BDA+NAChT+ varicosi-
ties were most often located along axons (Fig. 3N ,A" ,Nif). 
Both VGluTl + (not shown) and VGluT2+ varicosities 
were densely distributed through the LH, although the 
VGluT2 most densely so. VGluT3+ varicosities were also 
present although sparse (not shown). In adjacent series 
processed for BDA and VGluTl, -2, or -3, only VGluT2 was 
found to he present in BDA-labeled varicosities (Fig. 3B). 
The BDA+NGluT2+ varicosities most frequently ap-
peared to he boutons en passant (Fig. 3B' ,B",B'''), al-
though some appeared to be boutons terminaux. 
Varicosities that were VGAT+ were densely distributed 
within the LH area. Many of the BDA-Iaheled axonal 
varicosities were VGAT+ (Fig. 3C). The BDA +NGAT+ 
varicosities were most commonly boutons en passant (Fig. 
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Fig. 3. BDA-labeled axons in LH contain YAChT, VGluT2, or 
VGAT. High-magnification epifluorescent images illustrating antero-
gradely labeled BDA+ axons (N, B', and C', green fluorescent Cy2) 
that are double-Iabeled for vesicular transporter proteins (VTPs) as 
shown in single (N, B", and C", red fluorescent Cy3) and merged (right 
Am, B''', and C", yellow) images and indicated by white arrowheads 
for those that are in focus. A: BDA+ varicose fiber (N) whose vari-
3C' ,C",C"'), although sorne appeared to be boutons termi-
naux. 
Double staining for different VTPs was subsequently 
examined (n = 4 cases per series) to determine whether 
they might he colocalized in the BF terminaIs. Double 
labeling for VAChTNGluT2, VAChTNGAT, or VGluT2/ 
VGAT was not detected in varicosities of the LH (not 
shown). These negative results indicated that multiple 
VTPs are not colocalized in the same BFaxonal varicosi-
ties innervating the LH. 
Proportion and distribution of VAChT+, 
VGluT2+, and VGAT+ BDA-Iabeled 
varicosities 
To determine the proportions of cholinergie, glutama-
tergic, and GABAergic BFaxon terminaIs, stereological 
analysis was used for estimation of the total numbers of 
BDA+ and BDA+NTP+ varicosities in the tuberal-
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cosities are positive for YAChT (A" and A"'). B: BDA+ varicose axon 
(B') whose varicosities are positive for VGluT2 (B" and B"'). C: BDA+ 
axon (C') whose varicosities are positive for VGAT (C' and C"'). Tonal 
range in red and green channels was adjusted individually (see Ma-
terials and Methods). For abbreviations, see list. Scale bar = 10 .. m in 
C" (applies to A'-C'''). 
posterior LH (-A 5,800, A 6,200, and A 6,600; Table 2). In 
the double-stained YAChT series, -10% of the BDA + 
varicosities were BDA +N AChT+. In the VGluT2 series, 
-23% ofBDA+ varicosities were BDA+NGluT2+. In the 
VGAT series, -47% of the BDA+ varicosities were BDA+/ 
VGAT+. 
As evident in plots of the sampled BDA +N AChT+, 
BDA+NGluT2+, and BDA+NGAT+ (Fig. 4, represent-
ing -25% of the estimated total number of varicosities), 
the three types of terminaIs were codistributed across the 
LH. The three were commonly most dense within the 
ventral and central portions of the LH, although they were 
also scattered through more dorsal portions of the LH. 
PSD-95 or Geph in relation to BDA +1 
VGluT2+ or BDA+NGAT+ terminaIs 
To assess whether PSPs were present in association 
with the numerous BDA+NGluT2+ or BDA+NGAT+ 
The Journal of Comparative Neurology. DOl IO.lOO2lcne 
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A 5800 
Fig. 4. Distribution of VAChT+, VGluT2"', and VGAT+ BDA-
labeled varicosities in the LH. Plotted together are the BDA ... / 
VAChT+ (blue circles), BDA+NGluT2+ (green squares), and BDA+/ 
VGAT+ (red triangles) that were marked and counted by stereological 
analysis from double-stained fluorescent sections at the three levels 
through the LH (case BDAI6-L). The BDA+IVTP-negative terminais, 
which were counted in each series, are not included. The stereological 
analysis was performed by sampling one-fourth of the total area 
(using a counting frame of 90 x 90 /Lm within a grid of180 x 180/Lm; 
see Materials and Methods), and each figure thus reflects about one-
fourth of the total number of varicosities in a 25-/Lm-thick section. 
Note the concentration ofBDA +IVTP+ varicosities within the ventral 
and central portion of the LH, with scattered varicosities in other 
portions, especially at the most posterior level (A 5800). For abbrevi-
ations, see Hst. 
varicosities, triple fluorescent staining for BDA (Cy2), 
VGluT2 or VGAT (Cy3), and PSD-95 or Geph (Cy5) was 
performed in LH sections and analyzed by confocal mi-
croscopy by using 3D reconstruction and rotation of the 
images (in three cases per series). 
In the series stained for BDA, VGluT2, and PSD-95, the 
PSD-95 staining appeared to be punctate and smaller in 
size than VGluT2+ varicosities. Asjudged from magnified 
and rotated 3D images, PSD-95+ puncta were often seen 
closely associated with VGluT2+ varicosities (Fig. 5A-C, 
pointers). BDA+NGluT2+ varicosities were commonly 
seen in close association with one or more PSD-95+ 
puncta (BDA+NGluT2+:PSD-95+, Fig. 5A,B, pointers 
opposite filled arrowheads). As confirmed in 3D rotations, 
the BDA+NGluT2+ varicosities were apposed to the 
PSD-95+ profiles (Fig. 5A,B, insets). BDA+NGluT2-
varicosities were generally seen unassociated with PSD-
461 
95+ puncta (Fig. 5C), although sorne BDA+NGluT2-: 
PSD-95+ profiles were seen (not shown). 
In series stained for BDA, VGAT, and Geph, Geph stain-
ing appeared to be punctate. The Geph+ puncta were 
generally larger that the PSD-95 + puncta. As judged from 
magnified and rotated 3D images, Geph+ puncta were 
frequently seen in close association with VGAT+ varicos-
ities, and conversely VGAT varicosities were frequently 
seen in close association with Geph+ puncta (Fig. 5D-F, 
pointers). BDA+NGAT+ axonal varicosities were ap-
posed to Geph+ puncta (BDA+NGAT+:Geph+), usually 
with one Geph+ profile per BDA+NGAT+ varicosity 
(Fig. 5D,E). Occasionally, unlabeled LH cells appeared to 
be surrounded by VGAT+ varicosities, including BDA+I 
VGAT+ ones that were apposed to Geph+ puncta, located 
on the inner side of the varicosities and thus presumably 
in the cell membrane ofthe innervated cell body (Fig. 5D). 
BDA+NGAT- varicosities were not seen in apposition to 
Geph + profiles (Fig. 5F). 
DISCUSSION 
The present study provides evidence that cholinergic, 
glutamatergic, and GABAergic BF neurons project to 
the LH. The quantitatively most important, glutama-
tergic and GABAergic, fibers also appear to form exci-
tatory and inhibitory synapses, respectively, on LH neu-
rons. Through this projection, BF neurons can thus 
have a dual influence in the LH to excite or inhibit 
neurons involved in promoting cortical activation and 
behavioral arousai. 
Technical considerations 
Confirming its documented utility as an anterograde 
tracer (Veenman et al., 1992; Wouterlood and Jorritsma-
Byham, 1993; Lanciego et al., 2000; Reiner et al., 2000), 
we found that BDA-I0,000 provided discrete labeling of 
BF cell bodies and reIiable anterograde labeling of BF 
fibers and varicosities. Although we noticed sorne labeled 
cells in areas surrounding the injection site in the MCPO-
SI, which might have been retrogradely labeled, we did 
not find cells retrogradely labeled at a distance in the 
prefrontal cortex or LH, confirming that BDA-I0,OOO, in 
contrast to BDA-3000 MW, results in neglible retrograde 
labeling (Wouterlood and Jorritsma-Byham, 1993; Reiner 
et al., 2000). Here, from the labeled cells located predom-
inantly (>90% on average) in the MCPO of the BF, the 
BDA-labeled axons were seen to course within the ventro-
lateral, a, subdivision of the MFB, which has been known 
to carry descending fibers from the MCPO (Veening et al., 
1982). In the posterior LH, the axons sent collateral 
branches through the LH region in a manner also previ-
ously described from the MCPO by application of other 
anterograde tracers, including Phaseolus vulgaris leuco-
agglutinin (PHA-L; Grove, 1988) and proteins synthesized 
from tritiated amino acids (Swanson, 1976). 
This distribution of efferent fibers to the LH from 
MCPO-SI fits within a lateral to medial topographic orga-
nization of projections to the tuberal-posterior hypothala-
mus from forebrain structures (Veening et al., 1982). 
Moreover, the BDA-labeled varicose fibers extended 
through a region in the LH from which neurons in the 
MCPO and SI had previously been retrogradely labeled 
with cholera toxin in large numbers in our laboratory 
(Gritti et al., 1994). Here, we labeled only a small propor-
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tion of these afferent neurons, according to their numbers 
and distribution (Gritti et aL, 1993, 1994, 2003), because 
our injection site was intentionally discrete so as to be 
maximally restricted to the MCPO and overlying SI. With 
this relatively small proportion of projection neurons la-
beled, we found nonetheless that an estimated -22,000 
terminais were laheled with BDA in the LH and -8,000 
cells (-15% of the estimated total LH cell population) 
were contacted by BDA + terminais, thus providing a good 
sample of the basalo-hypothalamic projection to the LH. 
Confirming the utility of BDA as an anterograde tracer 
that can he readily used along with immunostaining for 
elucidating complex neural circuits (Lanciego et aL, 2000), 
we were able to apply double staining for BDA and the 
VTPs in order to identifY the neurotransmitters utilized 
by the BF neurons projecting to the LH. We found that 
with the use of Triton (0.1%), we obtained complete pen-
etration in material double stained for VTP antibodies and 
streptavidin (through 25-llm-thick sections). Such reli-
able, homogeneous staining thus permitted the applica-
tion of stereological analysis to assess the proportions of 
the different VTP+ terminais in the LH. We were also 
able to apply triple staining for BDA, the VTPs, and PSPs 
(by using 0.3% TX). 
Double staining with the VTPs allowed unequivocal 
identification of the neurotransmitter utilized by the pro-
jecting neurons (Chaudhry et al., 1998; Bellocchio et al., 
2000). Together with other elements necessary for recy-
ding, VTPs form docking and fusion of synaptic vesides, a 
critical component of the machinery for neurotransmitter 
release at presynaptic sites (Liu et aL, 1999; Fremeau et 
aL, 2004). Particularly in the case ofVGAT and VGluT2, 
Fig. 5. Relationship of PSD-95 + puncta to VGluT2+ and Geph+ 
puncta to VGAT+ BDA·labeled varicosities in 3D rendered confocal 
images. A,B: Large images (8 and 12 seriai 0.33·~m·thick optical 
sections) of BDA·labeled axons and varicosities (solid arrowheads, 
pseudo-color green, Cy2) that are immunopositive for VGluT2 
(pseudo-color blue, Cy3), face PSD-95+ profiles (facing pointers, 
pseudo-color red, Cy5) and featured in the zoomed images on the right 
(5 and 12 seriai 0.33-~m-thick opticaI sections). Note aIso, in the large 
images, the Frequent association ofVGluT2+ varicosities with PSD-
95+ puncta (pointers). C: Image (eight seriai sections) of a BDA+ 
varicosity (open arrowhead, pseudo-color green, Cy2) that is immu-
nonegative for VGluT2 (pseudo-color blue, Cy3) and does not face a 
PSD-95+ profile, as is also evident in the zoom images on the right (10 
seriai sections). Note VGluT2+ varicosities in the vicinity that are 
associated with PSD-95+ puncta (pointer in large image). D,E: lm· 
ages (eight and seven seriaI sections, respectively) of BDA-Iabeled 
axons and varicosities (solid arrowheads, pseudo-color green, Cy2) 
that are positive for VGAT (pseudo-color blue, Cy3) and face Geph + 
profiles (facing pointers, pseudo-color red, Cy5), as featured in the 
zoomed images on the right (nine and seven seriaI sections). In the 
large image of D, VGAT+/Geph+ elements appear to surround the 
unlabeled soma ofa neuron with the VGAT+ varicosities outside and 
the Geph+ puncta (pointers) illside, presumably on the cell mem-
brane. Note in the large panels that many VGAT+ varicosities are 
associated with Geph+ puncta (pointers). F: Image (seven seriai 
sections) of a BDA + varicosity (open arrowhead, pseudo-color green, 
Cy2) that is immunonegative for VGAT (pseudo-color blue, Cy3) and 
is Ilot associated with any Geph + puncta, as is also evident in the 
zoomed images 011 the right (five seriaI sections). Note, in contrast, 
that other VGAT+ varicosities in the vicinity are associated with 
Geph+ puncta (pointer). Deconvolution was applied to aIl images with 
a confidence limit of95% (see Materials and Methods). For abbrevia-
tions. see list. Scale bar = 5 ~m in F (applies to A-F, large images; 1 
~m in F, lower right corner (applies to A-F, smaIl images). 
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they have been found to be concentrated at symmetrical 
and asymmetrical synapses, respectively, to co-purify with 
other synaptic proteins and to colocalize with synaptophy-
sin and/or synaptobrevin in synaptic terminais (Chaudhry 
et aL, 1998; Takamori et aL, 2000; Gualix et al., 2003; 
Fremeau et aL, 2004). 
Triple staining with PSPs here confirmed that the BDA-
labeled VGluT+ and VGAT+ terminaIs abutted excita-
tory and inhibitory postsynaptic elements, respectively. 
The PSPs, PSD-95 and Geph, form part of the postsynap-
tic scaffolding of excitatory (Kornau et aL, 1995; O'Brien et 
aL, 1999; Sheng and Pak, 2000) and inhibitory (Pfeiffer et 
aL, 1984; Sassoe-Pognetto et aL, 1995, 2000; Sassoe-
Pognetto and Fritschy, 2000) synapses, respectively. In-
deed, PSD-95 colocaIizes with glutamate receptors by in-
teracting directly with the C-terminus of synaptic NMDA 
receptor subunits (Kornau et aL, 1995) and indirectly 
through the protein stargazin with AMPA receptors (Chen 
et aL, 2000). Although not binding GABAA receptors di-
rectly, Geph colocaIizes with the most common and syn-
aptically located GABAA receptor subunits as weIl as the 
glycine receptor (Pfeiffer et aL, 1984; Sassoe-Pognetto et 
aL, 2000). 
We employed laser scanning confocal microscopy and 
state-of-the-art 3D rendering technology to visualize ap-
positions hetween BDA+NTP+ terminais and PSP+ pro-
files, an approach that has been proposed to he suitable for 
judging the existence of synaptic contacts by confocal mi-
croscopy (Wouterlood et al., 2002, 2003), while recognizing 
that absolute proof of such contacts necessitates electron 
microscopy. Thus, we helieve that the presynaptic enrich-
ment of VTPs for glutamate and GABA in BDA + termi-
nais and their apposition with PSPs associated with exci-
tatory and inhibitory synapses respectively, represents 
strong evidence for the synaptic contacts of glutamatergic 
and GABAergic BF terminais on LH neurons. 
BF cholinergie, gIutamatergic, and 
GABAergic fibers in the LH 
The immunohistochemical localization of YAChT, 
VGluT2, and VGAT in anterogradely labeled BF varicos-
ities demonstrates that BF neurons have the capacity, 
endowed by the VTPs, to release ACh, glutamate, or 
GABA, respectively (Gilmor et aL, 1996; Chaudhry et aL, 
1998; Bellocchio et aL, 2000; Fremeau et aL, 2001). Their 
neurotransmitter phenotypes would appear to he unam-
biguous, hecause, in contrast to previous evidence for the 
presence of multiple mRNAs or proteins for synthetic en-
zymes of ACh, glutamate, or GABA in BF cell bodies 
(Manns et aL, 2001; Sotty et aL, 2003), no evidence for 
colocaIization of the VTP proteins was found here in ter-
minaIs within the LH. BF neurons innervating the LH can 
thus be phenotypically identified as cholinergie, glutama-
tergic, or GABAergic. 
By demonstrating the presence of VGluT2 proteins in 
BF terminaIs, the present results provide the first proof 
for the existence ofBF neurons that utilize glutamate as a 
neurotransmitter and can thus be considered glutamater-
gic. Another recent report showed by in situ hybridization 
that cortically projecting BF neurons contain mRNA for 
VGluT2 and accordingly have the capacity to synthesize 
the VGluT2 protein (Hur and Zaborszky, 2005). Previous 
results had also suggested the existence of glutamatergic 
BF neurons based on the presence ofphosphate-activated-
glutaminase (PAG; Manns et aL, 2001), the enzyme uti-
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lized for the synthesis of glutamate from glutamine, yet 
possibly also used for the synthesis of GABA from the 
same substrate in sorne cells (Fujiyama et al., 2001). The 
presence of glutamatergic BF neurons that utilize VGluT2 
follows the principle that in the forebrain, VGluT2 neu-
rons are localized predominantly in subcortical structures, 
whereas VGluTl neurons are localized predominantly in 
the cortex (Fremeau et al., 2001). A third type ofvesicular 
transporter for glutamate (VGluT3) has more recently 
been visualized in cell bodies within sorne cortical and 
subcortical neurons, notably inc1uding BF neurons 
(Fremeau et al., 2002; Schafer et aL, 2002; Harkany et al., 
2003; Herzog et aL, 2004). In the present analysis, we did 
not find evidence for concentration of VGluT3 in BF var-
icosities within the LH. It would thus appear that BF 
neurons might contain VGluT3 in their cell bodies but not 
transport it to their terminais or, alternatively, that BF 
neurons that do transport VGluT3 to their terminais do 
not project caudally to the LH. 
Ofthe total numher of BFaxonal varicosities in the LH, 
the smallest proportion was VAChT+ (-10%), a medium 
proportion was VGluT2+ (-25%), and the largest propor-
tion was VGAT+ (-50%). Previous studies employing ret-
rograde transport with immunostaining for the synthetic 
enzymes of ACh (choline acetyltransferase [ChAT]) and 
GABA (glutamic acid decarboxylase [GAD]) found that of 
the BF cells within the MCPO projecting to the LH, <5% 
were ChAT+, -20% were GAD+ and up to -75% were 
neither and thus presumed to he glutamatergic (Gritti et 
aL, 1994). The higher proportions of anterogradely labeled 
VAChT+ and VGAT+ varicosities relative to retrogradely 
labeled ChAT+ and GAD+ cell bodies might be due to 
more axonal collateralization per neuron or more varicos-
ities per axon length in GABAergic and cholinergic than 
non-GABAergidnon-cholinergic neurons, which would in-
c1ude the glutamatergic neurons. 
Irrespective of these possible differences, only 25% of the 
varicosities were found to he glutamatergic, and another 
-15% ofvaricosities could not he accounted for as glutama-
tergic, cholinergic, or GABAergic. It is possible that this 
contingent might use another type of excitatory neurotrans-
mitter, such as aspartate, which is not recognized as a sub-
strate by the vesicular glutamate transporters (Bellocchio et 
aL, 2000; Fremeau et aL, 2001, 2002). Indeed, aspartate has 
heen found in axon terminals forming asymmetric synapses 
in the hypothalamus (van den Pol, 1991). Another possibility 
is that this proportion might simply reflect negative immu-
nohistochemical staining due to insufficient amounts of 
sorne or all of the VTPs in terminals. 
By showing the presence of PSD-95 and Geph in appo-
sition to BF identified glutamatergic and GABAergic ter-
minaIs, respectively, in the LH, the results substantiate 
the synaptic nature ofthis projection and also corroborate 
the principle that glutamate and GABA terminais gener-
ally form synapses with postsynaptic target neurons (Ed-
wards, 1995). Given the small numher and proportion of 
BDA+NAChT+ varicosities in the LH and the less well-
known association of cholinergic terminaIs with specifie 
PSPs (Parker et aL, 2004) or synaptic specializations (Des-
carries et aL, 1997), we did not examine the relationship of 
the BDA+NAChT+ boutons to PSPs. ACh might act pre-
dominantly by diffuse transmission through ectopie re-
lease and extrasynaptic receptors (Levey et aL, 1995; Cog-
gan et aL, 2005). 
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Functional significance of the cholinergie, 
glutamatergic, and GABAergic BF 
projections to LH 
Neurons in the LH project to brainstem arousal systems 
and/or spinal cord sympathetic and motor systems as weIl 
as forebrain limbic areas and the cerebral cortex (Saper et 
al., 1979; Saper, 1985; Hoistege, 1987). By means ofthese 
multiple projections, the LH is weIl suited to play a central 
role in arousaI. Indeed, the LH has been shown to influ-
ence positively several arousal-related processes such as 
sympathetic tone, locomotion, and exploratory behavior, 
inc1uding food seeking, reward, and cortical activation 
(OIds and Milner, 1954; Hess, 1957; Berthoud, 2002; DiLe-
one et aL, 2003; Jones, 2005a). Recently, diffusely project-
ing neurons have heen identified in the LH that contain 
the peptide Orx (de Lecea et aL, 1998; Peyron et aL, 1998; 
Sakurai et al., 1998), which appears to be critical for 
arousal and postural muscle tone because in absence of 
the peptide or its receptor, narcolepsy with cataplexy oc-
curs (Chemelli et al., 1999; Lin et al., 1999; Peyron et al., 
2000; Thannickal et al., 2000; Gerashchenko et aL, 2001; 
Hara et al., 2001). Physiologically as weIl as anatomicaUy 
and chemically, the LH is comprised of different cell types, 
the vast majority of which discharge at high rates during 
active waking with hehavioral arousal (Szymusiak et aL, 
1989; Sakai et al., 1990; Steininger et aL, 1999; Koyama et 
aL, 2003). Sorne discharge in association with cortical 
activation during both waking and PS. Identified Orx neu-
rons have recently been found to discharge maximally 
during active wakefulness and to virtuaUy cease firing 
during SWS and PS (Lee et aL, 2005a; Mileykovskiy et al., 
2005). 
In the present study, we found that the LH received 
input from cholinergic BF terminais, which represented 
-10% of aU BF varicosities. Because cholinergic BF neu-
rons have been found to discharge in association with 
cortical activation during both waking and PS (Manns et 
aL, 2000b; Lee et al., 2005b), they could possibly influence 
similar neurons in the LH that project selectively to the 
cerebral cortex and discharge with cortical activation dur-
ing both waking and PS (Szymusiak et aL, 1989; Sakai et 
aL, 1990; Steininger et al., 1999; Koyama et aL, 2003). 
Glutamatergic terminais accounted for up to 25% of the 
total BF innervation of the LH, indicating that glutama-
tergic BF neurons can exert an important excitatory in-
fluence on the LH. This influence could he exerted on LH 
neurons that discharge in association with cortical activa-
tion and presumably project to the cerebral cortex (see 
above) or on LH neurons that discharge in association 
with motor activity and presumably project to the brain-
stem or spinal cord (Szymusiak et al., 1989; Steininger et 
aL, 1999; Alam et aL, 2002). Glutamatergic BF neurons 
could also act on Orx LH neurons, which project diffusely 
to aIl targets and could thus simultaneously promote cor-
tical activation along with motor activity and behavioral 
arousal that occur during waking. Such an excitatory in-
fluence could originate from as yet chemically unidentified 
but possibly glutamatergic BF neurons that are maxi-
mally active during waking and minimally active during 
SWS and PS (Szymusiak and McGinty, 1986; Manns et 
aL, 2003; Lee et al., 2004; Jones, 2005b). 
Approximately 50% of BFaxon terminaIs innervating 
the LH were GABAergic, indicating that a major influence 
of the BF in this region is inhibitory. Given that the vast 
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majority of neurons in the LH discharge during waking 
(Steininger et al., 1999; Alam et al., 2002) and that inhi-
bition of these neurons by injections of the GABAA recep-
tor agonist muscimol into the LH suppresses waking (Lin 
et al., 1989), it can be conc1uded that the GABAergic 
inhibitory influence from the BF in the LH would suppress 
waking and promote sleep. This inhibitory influence could 
be on multiple LH neurons, including Orx neurons, whose 
inhibition by GABAergic input would accordingly provide 
a very powerful impetus for sleep. We propose that this 
innervation originates from particular GABAergic BF 
neurons that are sleep-active (Modirrousta et al., 2004) 
and discharge during SWS or SWS and PS when muscle 
hypotonia and atonia occur (Szymusiak and McGinty, 
1986; Manns et al., 2000a; Lee et al., 2004; Jones, 2005b). 
In conclusion, the present study reveals the presence of 
three phenotypically distinct BF cell groups that, accord-
ing to their neurotransmitters, differentially modulate the 
LH. As a minor contingent, cholinergic BF neurons can act 
to facilitate LH neurons involved in cortical activation. As 
a larger contingent, newly identified glutamatergic BF 
neurons can act to promote both cortical and behavioral 
arousal of waking. As the largest contingent, GABAergic 
BF neurons can act to suppress arousal and promote 
sleep. 
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Innervation of OrexinIHypoeretin 
Neurons by GABAergie, Glutamatergie 
or Cholinergie Basal Forebrain TerminaIs 
Evideneed by Immunostaining for 
Presynaptie Vesieular Transporter and 
Postsynaptie Seaffolding Proteins 
PABLO HENNY AND BARBARA E. JONES* 
Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada 
ABSTRACT 
Orexinlhypocretin (Orx) neurons are critical for the maintenance of waking in associa-
tion with behavioral arousal and postural muscle tone, since with their loss narcolepsy with 
cataplexy occurs. Given that basal forebrain (BF) neurons project to the hypothalamus and 
play important diverse roles in sleep/wake states, we sought to determine whether acetyl-
choline (ACh), glutamate (Glu), and/or GABA-releasing BF neurons innervate and could 
thereby differentially regulate the Orx neurons. From discrete injections of biotinylated 
dextran amine (BDA, 10,000 MW) into the magnocellular preoptic nucleus (MCPO) and 
substantia innominata (SI) in the rat, BDA-Iabeled fibers projected to the lateral hypothal-
amus (LH), perifornical area CPF), and dorsomedial hypothalamus (DMH), where -41%, 
-11 %, and 9% of Orx-positive (+) neurons were respectively contacted in each region. 
Employing triple fluorescent staining for Orx, BDA, and presynaptic vesicular (V) transport-
ers (T), we found that only 4% of the innervated Orx+ neurons in the LH were contacted by 
BDA+[VAChT+l terminaIs, whereas -31% and -67% were respectively contacted by 
BDA+[VGluT2+1 and BDA+[VGAT+l terminaIs. In 3D-rendered and rotated confocal im-
ages, we confirmed the latter contacts and examined staining for postsynaptic proteins 
PSD-95, a marker for glutamatergic synapses, and gephyrin, a marker for GABAergic 
synapses, that were located on Orx+ neurons facing BDA-labeled terminaIs in -20% and 
-50% of contacts, respectively. With such synaptic input, BF glutamatergic neurons can 
excite Orx neurons and thus act to maintain behavioral arousal with muscle tone, whereas 
GABAergic neurons can inhibit Orx neurons and thus promote behavioral quiescence and 
sleep along with muscle atonia. J. Comp. Neurol. 499:645-661, 2006. © 2006 Wiley·Liss, Ine. 
Indexing tenns: BDA; gephyrin; narcolepsy; PSD-95; rat; paradoxical sleep; REM sleep; sleepl 
wake states; stereology; VAChT; VGAT; VGluT2 
Neurons containing the peptide orexin (Orx, also called 
hypocretin) play a critical role in maintaining wakefulness 
and associated postural muscle tone, since in their ab-
sence or that of the peptide or receptor, narcolepsy with 
cataplexy occurs in humans and animaIs (Chemelli et al., 
1999; Lin et al., 1999; Peyron et al., 2000; Thannickal et 
al., 2000; Yamanaka et al., 2003a). The Orx neurons are 
located within the tuberaI hypothalamus, where they are 
broadly distributed across the lateral hypothalamic area 
(Broberger et al., 1998; Peyron et al., 1998; Modirrousta et 
al., 2005; Swanson et al., 2005), a region long known to 
play an important role in arousal (see, for review, Jones, 
2005a). Lying there within the path of the medial fore-
© 2006 WlLEY-LISS, INC. 
brain bundle (MFB) (Millhouse, 1969; Veening et al., 
1982), the Orx neurons have recently been shown to re-
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ceive inputs from multiple forebrain and brainstem cell 
groups (Sakurai et al., 2005; Yoshida et al., 2006), which 
project through the MFH and are involved in sleep/wake 
state regulation (Jones, 2005a). The sources of afferent 
input might include the basal forebrain (HF) (Sakurai et 
al., 2005), which, from lesion, stimulation, and recording 
studies is known to play diverse roles in sleeplwake state 
regulation through its different constituent cell groups 
(Szymusiak et al., 2000; Jones, 2005a,b). 
The HF is known particularly for the cholinergie neu-
rons residing there within multiple nuclei and projecting 
to the cerebral cortex, where they stimulate cortical acti-
vation during waking and paradoxical sleep (PS, also 
called rapid eye movement, REM, sleep; see, for review, 
Jones, 2004). However, the HF also contains more numer-
ous noncholinergic neurons, including GABAergic and 
glutamatergic neurons that appear to play different roles 
in sleeplwake state regulation, including the promotion of 
slow wave sleep (SWS) or, conversely, waking (Lee et al., 
2004; Jones, 2005b). From retrograde tracing studies, we 
previously found that few cholinergic neurons, but many 
GABAergic and other unidentified HF neurons, project 
caudally to the lateral hypothalamus (LH) (Gritti et al., 
1994). Most recently, using anterograde transport of bio-
tinylated dextran amine (BDA) together with immunohis-
tochemistry for the vesicular transporter proteins (VTPs), 
we established that a minor proportion of terminaIs pro-
jecting into the LH from the BF contained the VTP for 
acetylcholine (ACh, YAChT), whereas a major proportion 
contained that for GABA (VGAT) and a remaining propor-
tion contained the VTP for glutamate (VGluT2 and not 
VGluT1 or VGluT3), proving an important glutamatergic 
in addition to GABAergic contingent of the HF inputs to 
the LH (Henny and Jones, 2006). We also established in 
that study that the cholinergic, GABAergic, and glutama-
tergic projecting neurons were phenotypically distinct, 
since the VTPs were not colocalized in the same terminaIs. 
The HF afferents would thus release ACh, GABA, or glu-
tamate. The aim of the present study was thus to examine 
ifthe Orx neurons in the hypothalamus are innervated by 
BF terminaIs and, if so, whether they might he selectively 
or preferentially innervated by cholinergie, glutamatergic, 
or GABAergic terminaIs and thereby influenced in a par-
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ticular manner by BF neurons across the sleeplwaking 
cycle. 
Using anterograde transport of 10,000 MW BDA in rats 
(Henny and Jones, 2006), we examined in the present 
study the innervation of Orx neurons by neurons of the 
magnocellular preoptic nucleus (MCPO) and substantia 
innominata (SI) of the HF cholinergie cell area from where 
significant hypothalamic as weIl as neocortical projections 
originate (Gritti et al., 1994, 1997) and can influence be-
havioral in addition to cortical components of sleeplwake 
states (Szymusiak et al., 2000; Jones, 2004, 2005a,b). 
First, using single or dual-staining, we quantitatively 
studied and estimated with stereological analysis the dis-
tribution of Orx neurons in the hypothalamus and their 
contact by BDA-Iaheled terminaIs in light microscopy. 
Second, using triple-staining for Orx, BDA, and the VTPs, 
we quantitatively examined and estimated with stereo-
logical analysis the contacts on the Orx neurons by HDA-
laheled terminals containing V AChT, VGluT2, or VGAT in 
fluorescence microscopy. Third, given evidence of promi-
nent VGluT2 and VGAT-containing terminals apposing 
the Orx neurons, we further studied their contacts by 
confocallaser scanning microscopy and 3D reconstruction 
with rotation. Lastly, to ascertain whether such varicosi-
ties might form excitatory or inhibitory synapses on the 
Orx neurons, we similarly examined sections triple-
stained for BDA, Orx, and the scaffolding postsynaptic 
proteins (PSPs), PSD-95 as a marker for asymmetric, glu-
tamatergic synapses (Sheng and Pak, 2000; Sassoe-
Pognetto et al., 2003) or gephyrin (Geph) as a marker for 
symmetric, GABAergic synapses (Pfeiffer et al., 1984; Gi-
ustetto et al., 1998; Sassoe-Pognetto and Fritschy, 2000; 
Sassoe-Pognetto et al., 2000). Using 3D reconstruction 
with rotation of high-resolution confocal images, we doc-
ument important glutamatergic and GABAergic BF in-
puts onto Orx neurons. 
MATERIALS AND METHODS 
AnimaIs and surgery 
AlI procedures conformed to the guidelines of the Cana-
dian Council on Animal Care and the US NIH and were 
Abbreviations 
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Cy2 
Cy3 
Cy5 
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Geph 
ic 
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LPO 
Avidin-biotin-peroxidase eomplex 
Anterior commissure 
Anterior hypothalamie area 
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Arcuate nucleus 
Biotinylated dextran amine 
Basal forebrain 
Cerebral peduncle 
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Indocarboeyanine 
Indodicarboeyanine 
Diaminobenzidine 
Nickel-intensified diaminobenzidine 
Dorsomedial hypothalamic nucleus 
Fornix 
Fundus striatum 
Gephyrin 
Internai capsule 
Lateral hypothalamus 
Lateral preoptic area 
MCPO 
MFB 
MPO 
mt 
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Orx 
ot 
Pe 
PF 
Pir 
PSD-95 
PSP 
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SO 
STh 
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VGluT2 
VMH 
VTP 
ZI 
Magnocellular preoptie nucleus 
Medial forebrain bundle 
Medial preoptie nucleus 
Mammillothalamic tract 
Optie ehiasm 
Orexin or hypocretin 
Optic tract 
Periventricular hypothalamic nucleus 
Perifornical area 
Piriform cortex 
95-kD postsynaptic density protein 
Postsynaptic protein 
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Vesicular transporter for acetylcholine 
Vesicular transporter for GABA 
Vesicular transporter for glutamate 2 
Ventromedial hypothalamic nucleus 
Vesicular transporter protein 
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TABLE 1. Primary Antibodies (AB) for Immunostaining of Orexin (Orx), Vesicular Transporter Proteins (VTPs) or Postsynaptic Proteins (PSPs) 
Antigen Host sp Source Cat. # Immunogen Specificity 
Orx 
Orx·A Rb Phoenix1 H·003-30 Full 33 AA Orx-A peptide sequence from rat 
(EPLPDCCRQKTCSCRL YELLHGAGNHAAGIL TL)2 
By WB the AB recognizes a -3.5 kD band 
from rat brain, corresponding to the 
Orx-A peptide' 
Orx-A Gt Santa Cruz3 sc-8070 Peptide mapping at the C-terminus ofhuman Orx-A AB reacts with Orx-A of mouse, rat and 
(AA 48--66 of the Orx precursor. identical to human by \VB, immun08taining 
corresponding mouse sequence)4 blacked with antigen peptide (sc-8070 
P) and pattern of staining identical to 
that with Orx-A <Rb) H-003-30 
(Phoenild 
VTPs 
YAChT Gt Chemicon6 ABI578 Peptide corresponding to C-terminus of c10ned rat By WB the AB recognizes a -65-70 kD 
YAChT' (CSPPGPFDGCEDDYNYYSRS)8 band corresponding to YAChT protein' 
YAChT Rb Sigma" V5387 Peptide corresponding to AA 512--530 of C-terminus of 
cloned rat YAChT (K-SPPGPFDGCEDDYNYYSRS)lO 
By WB the AB recognizes a -67-70 kD 
band, corresponding to YAChT 
protein1O 
VGluT2 Rb Gift RHE" GST fusion protein containing AA 519-582 of rat DNPi By WB the AB recognizes a -50-62 kD 
(VGluT2)12 band from rat brain12 
VGAT Rb Chemicon AB5062P Peptide corresponding to 1 ï AA near C~terminus region By WB the AB recognizes a band at -55-
of rat VGAT (VHSLEGLIEAYRTNAED)13 60kDI' 
PSP. 
PSD-95 Ms ABRI' MAI-045 Purified recombinant of rat PSD_9515 By WB the AB recognizes a c,,'95 kDa 
protein and a slightly larger speri ... 
from rat brain extracts 15 
Geph Ms Sy-Syl" 147011 Purified rat gephyrin 17 By WB the AB recognizes a -93 kD band. 
It detects aN-terminus epitope18 
lIA, amino aeid; AB, antibody; DNPi, differentiation-associatoo Na' -dependent phosphate transporter; Geph. gephyrin; Gt, goat; Ms, mouse (monoclonal); Rb, rabbi!; sp. speries; 
WB, western blot. 
Iphoenix Phannaceuticals, Belmont, CA 
2http1lwww.phoenixpeptide.comlCatalog%20FilesiOrexins%20SectioniOrexiosHypocretinspage.htm 
"Santa Cruz Biotecbnology, Santa Cruz, CA. 
'Information provided by Santa Cruz data sheet and technica\ service. 
sInfonnation on WB provided by Santa Cruz data sheet and technical service, blocking experiments carried out io our lab with the Santa Cruz antigen peptide and immunostaining 
of Orx œil population compared for two antibodies io our lab io !his and previous studies (Modirrousta et al., 2005). 
6Chemicon International, Temecula, CA. 
·http11www.chemicon.com/ProductlProductDataSheet.asp?ProductItem=ABI578 
"supplied by Chemicon on request. 
·Sigma. St. Louis. MO. 
l..http://www.sigmaaldrich.comlsigmaidatasheetJv5387 dat.pdf 
llOift from R.H. Edwards and R.T. Fremeau Jr. 
12Fremeau et al., 2001. 
13http://www.chemicon.com/ProductlProductDataSheet.a.p?ProductItem~AB5062P 
14ABR: Affinity BioReagents, Golden. CO. 
15http://www.bioreagents.comJindex.cfmlfuseactionlproducts.prinUProductJMAI-045 
16SY_SY: Synaptic Systems. Goettiogen, Gennany. 
11http1/www.sysy.comlgephyrinlgephyjs.html 
18Pfeiffer et al., 1984. 
approved by the McGiIl University Animal Care Commit-
tee. 
As previously described in detail (Henny and Jones, 
2006), Long Evans rats (200-250 g, Charles River Can-
ada, St. Constant, Quebec, Canada) were anesthetized 
and placed in a stereotaxic frame (David Kopf Instru-
ments, Tujunga, CA) for surgery. Glass micropipettes (tip 
diameter 15-25 !-lm) were back-filled with a 0.5 M NaCI 
solution containing 2% 10,000 MW BDA (BDA-10,000, 
Molecular Probes, Eugene, OR). Since previous studies 
using anterograde as weIl as retro grade tracing methods 
showed no evidence for contralateral projections from BF 
to the posterior hypothalamus (Swanson, 1976; Gritti et 
al., 1994), bilateral injections ofBDA were performed. The 
pipettes were lowered into the region ofthe MCPO on each 
side (from bregma: anterior-posterior (AP), -0.5 mm; lat-
eral (L), ± 2.5 mm; vertical (V), 8.5 mm) (Paxinos and 
Watson, 1986) with the aid of a micropositioner (Model 
660, David Kopf Instruments). Once in the targeted site, 
microinjection of BDA was performed by iontophoresis 
(using a Microiontophoresis Dual Current Generator 260, 
World Precision Instruments (WPI), Sarasota, FL) apply-
ing positive current pulses (5-10 f.!Â.) in a dut y cycle of 1 
second (0.5 seconds on, 0.5 seconds off) for a period of 
25-30 minutes through a stimulator (Pulsemaster A300, 
WPI) and stimulus isolation unit (Iso-Flex, A.M.P.I., 
Jerusalem, Israel). 
Rats were maintained for 5 or 6 days with food and 
water ad libitum and subsequently perfused transcardi-
aIly under deep sodium pentobarbital anesthesia (100 mg! 
kg, intraperitoneaIly, i.p.) with -500 mL 4% paraformal-
dehyde fixative solution. The brains were removed and 
put in a 30% sucrose solution for 2-3 days, after which 
they were frozen at -50·C and stored at -80·C for sub-
sequent processing. 
Immunohistochemistry 
Sections were cut using a freezing microtome in 25 
!-lm-thick coronal sections and collected in eight adjacent 
series at 200-!-lm intervals through the forebrain, includ-
ing the magnocellular basaI forebrain and the tuberaI 
hypothalamus. To visualize BDA-Iabeled neurons in the 
BF as weIl anterogradely labeled axons in the tuberaI 
hypothalamus, the avidin-biotin-peroxidase complex 
(ABC) protocol was used with diaminobenzidine (DAB) 
intensified with Nickel (DAB-Ni). Sections were subse-
quently counterstained for Nissl substance using Neutral 
Red. 
For the mapping, distribution, and quantitative estimates 
of Orx+ cells in the hypothalamus, seriaI sections were in-
cubated overnight with goat (Gt)-Anti-Orx-A (1:500, see Ta-
ble 1) and stained with DAB following incubation with don-
key (Dky) anti-Gt IgG and Gt peroxidase-antiperoxidase 
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TABLE 2. Combination and Sequential Processing of Primary and Secondary Antibodies along with Streptavidin (SA) Used for Triple Fluorescent Staining 
of Orexin (Orx), VesicuIar Transporter Proteins (VTPs), or Postsynaptic Proteins (PSPs) and Biotinylated Dextran Amine (BDA) 
lry AB (overnight)' 2ry AB (3 hours) SA (3 hourg) 
Series Antigen Hostsp Dilution IgG (Dky)2,3 Dilution SA Dilution n 4 
BDNVTP/Orx 
BDAIV AChT/Orx YAChT Gt 1:1000 Aoti-Gt-Cy3 1:800 SA-Cy2 1:800 4 Orx-A Rb 1:200 Aoti-Rb-A...'II:CA 1:100 
BDAIV AChT/Orx YAChT Gt 1:1000 Aoti-Gt-Cy3 1:800 2 Orx-A Rb 1:200 Aoti-Rb-Cy5 1:800 
BDAIV AChT/Orx YAChT Rb 1:5000 Aoti-Rb-Cy3 1:800 5 Orx-A Gt 1:200 Aoti-Gt-Cy5 1:800 
BDAlVGluT210rx VGluT2 Rb 1:5000 Aoti-Rb-Cy3 1:800 4 Orx-A Gt 1:200 Aoti-Gt-AMCA 1:100 
BDAlVGluT210rx VGluT2 Rb 1:5000 Aoti-Rb-Cy3 1:800 11 Orx-A Gt 1:200 Aoti-Gt-Cy5 1:800 
BDAlVGA T/Orx VGAT Rb 1:250 Aoti-Rb-Cy3 1:800 4 Orx-A Gt 1:200 Aoti-Gt-AMCA 1:100 
BDAlVGA T/Orx VGAT Rb 1:250 Aoti-Rb-Cy3 1:800 11 Orx-A Gt 1:200 Aoti-Gt-Cy5 1:800 
BDNPSP/Orx 
BDA/PSD-9510rx PSD-95 Ms 1:100 Aoti-Ms-Cy5 1:800 SA-Cy2 1:800 3 Orx-A Gt 1:200 Aoti-Gt-Cy3 1:800 
BDNGephlOrx Geph Ms 1:100 Aoti-Ms-Cy5 1:800 3 Orx-A Gt 1:200 Aoti-Gt-Cy3 1:800 
AB, antibody; AMCA. aminomethylooumarin acetate; Cy2, cyanine; Cy3, indocarbocyanine; Cy5, indodicarbocyanine; Dky, donkey; Geph. gephyrin; Gt, goat; Ms, mouse 
(monoclonal); Rb, rabbit; sp, species. 
'For sources and specificity of primary antibodies from different species, refer to Table l. 
'Jackson ImmunoResearch Laboratories, West Grove, PA. 
'For multiple labeling (ML) with minimal crossreactivity (min X) to other species. 
4n: numher of cases (each case referring to an injection site and series from the same side of the brain, thus 1 or 2 per brain from 9 rats for a total of 16 injection sites selected 
for their placement in the MCPO/SI). 
(PAP, both from Jackson ImmWloResearch Laboratories, 
West Grove, PA). 
For evaluation of the injection sites, description ofBDA-
labeled fibers in the tuberaI hypothalamus, and examina-
tion of the innervation of Orx+ cells in the region, series 
were processed for dual-staining of BDA using the ABC 
procedure with DAB-Ni and Orx-A (above) using PAP 
with alpha-naphthol pyronin B (ANPB, Sigma, St. Louis, 
MO). Injection sites on one or two sides from nine rats 
were selected according to their placement in the MCPO 
and SI (n = 16 cases) for subsequent processing and anal-
ysis in peroxidase or fluorescent stained material. 
For triple fluorescent staining of Orx with the VTPs 
(VAChT, VGluT2, or VGAT) and BDA (see Tables 1 and 2), 
free-floating sections from each series were rinsed for 30 
minutes in Trizma saline buffer (TS, 0.1 M, pH 7.4) fol-
lowed by incubation for 30 minutes with a blocking solu-
tion of normal donkey serum (NDS, 6% in TS) containing 
0.3% Triton X-100 (TX). Sections were subsequently coin-
cubated overnight at room temperature with VTP and 
Orx-A primary antibodies (in TS containing NDS 1% and 
TX 0.3%). Prior pilot studies determined that incubation 
in TX 0.3% allowed full penetration of the antibodies and 
streptavidin, as viewed through the z-axis under epifluo-
rescent and confocal microscopy. The next day sections 
were incubated for 3 hours in indocarbocyanine (Cy3)- and 
aminomethylcoumarin acetate (AMCA) or indodicarbocya-
nine (Cy5)-conjugated secondary antibodies, followed by 3 
hours in cyanine (Cy2)-conjugated-streptavidin (SA) for 
BDA revelation. For triple fluorescent staining of BDA 
with the PSPs, PSD-95 or Geph, and Orx, the same pro-
tocol was used by coincubation with the PSP and Orx 
antibodies overnight (see Tables 1 and 2). 
AlI sections were mounted out of Trizma water and the 
mounted sections dehydrated through alcohols, c1eared in 
xylene, and coverslipped with Permount. 
Conventional microscopy, tracing, and 
stereological analysis 
Sections were examined under light and epifluorescent 
microscopy with a Leica DMLB or Nikon E800 microscope 
equipped with an x-y-z motorized stage, video or digital 
camera, and filters appropriate for FITC or Cy2, Rhoda-
mine or Cy3, DAPI-AMCA, and/or Cy5 fluorescence. Sin-
gle as weIl as composite images were acquired on the 
Nikon or Leica microscopes using Neurolucida software 
from MicroBrightField (MBF, Colchester, VT), which was 
also used for plotting cells and tracing fibers. In light or 
fluorescent material, cells and varicosities were counted 
using the Optical Fractionator probe ofStereolnvestigator 
software (MBF) on the Nikon microscope. For tracing or 
counting, a computer-resident atlas of the rat brain was 
employed that was developed and applied in our labora-
tory using standardized procedures for tissue processing. 
For each application, series of histology sections are 
matched to appropriate levels of the atlas (at 400-j.l.m 
intervals) under low magnification (5 or 10X objective). At 
each level the atlas image is then rotated, if necessary, 
and the contours adjusted to optimally fit the relevant 
nuc1ei of the histology section, In the BF, the number of 
BDA-Iabeled cells was counted through the injection site 
within the MCPO and SI (Gritti et al., 1993; Henny and 
Jones, 2006). Through the hypothalamus, Orx neurons 
were plotted and counted through their full distribution 
across three AP levels (in mm from Interaural (A) zero): 
-A6.6, A6.2, and A5.8 (paxinos and Watson, 1986), and 
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within three contours, the LH, comprising the region lat-
eral to the fornix through which the MFB passes and 
present at levels ~A6.6, A6.2, and A5.8; the perifornical 
area (PF), comprising the area surrounding and extending 
medial to the fornix; and the dorsomedial hypothalamic 
nucleus (DMH) and present at levels ~A6.2 and ~A5.8 
(Veening et al., 1982; Modirrousta et al., 2005). BDA-
labeled fibers were plotted and analyzed using the same 
atlas sections and contours. 
For representation of the distribution of the Orx popu-
lation, Orx+ neurons (stained with DAB) were plotted 
under brightfield illumination with a 40X objective at 
three levels (above) using Neurolucida. In the same ma-
terial, stereological estimates of the total number of Orx + 
ceIls across three levels in the LH, and two levels in the PF 
and DMH, were obtained using Stereolnvestigator. 
Within the optical fractionator probe, cells were counted 
with a 60X oil objective (1.40 numerical aperture, NA) 
using a counting frame of 120 X 120 !lm and a sampling 
grid size of 240 X 240 !lm to sample 25% ofthe x-y area of 
each nucleus. Within each counting frame or block, aIl 
ceIls whose tops came into focus beneath the surface of the 
section were counted through a 10-!lm dissector height in 
the z-axis, which corresponded to the average thickness of 
the mounted (dehydrated, cleared, and coverslipped) sec-
tions in this series. 
To examine the relationship of BFaxons to the Orx 
neurons in the hypothalamus, BDA-labeled fibers (stained 
black with DAB-Ni) and Orx+ cell bodies (stained fuchsia 
with ANPB) were traced under brightfield illumination 
using the Neurolucida software (MBF). Axons and cell 
bodies were drawn using a 100X oil objective within con-
tours ofthe LH, PF, and DMH. Unbiased estimates of the 
number and proportion of Orx+ neurons receiving con-
tacts from BF varicosities were obtained in the LH, where 
both the Orx+ cells and BF varicosities were most numer-
ous, as well as in PF and DMH. An Orx+ cell was consid-
ered to be contacted if a BDA + varicosity was seen in 
direct apposition to the cell, with no obvious space ob-
served between them and at a point where both were 
located at the approximately same focal plane. Stereologi-
cal counts were obtained of Orx+ cells that were (Orx+: 
BDA +) or were not (Orx + :BDA -) contacted by one or 
more BDA + varicosities through the LH, PF, and DMH 
(n = 3). Counts were performed under a 100X oil objective 
(1.40 NA) at three levels (above) within the LH contour 
and two levels (above) within PF and DMH contours. 
Within the optical fractionator probe, a counting frame of 
70 X 70 !lm was employed with a sampling grid size of 
140 X 140 !lm so as to sample 25% of the area. Within 
each counting frame or block, aIl cells whose tops came 
into focus beneath the surface of the section were counted 
through 15 !lm in the z-axis, which was the average thick-
ness of the mounted sections in this series. 
To examine the relationship of BDA + terminaIs con-
taining different VTPs [VTP+J to Orx+ ceIls, triple-
stained sections were viewed under epifluorescent micros-
copy to determine if BDA+ [V AChT+], BDA+[VGluT2+], 
or BDA + [VGAT+ J varicosities appeared to come into con-
tact with Orx+ cells stained with AMCA or Cy5 (see Table 
2). Additional series were used for stereology in which Orx 
cells were stained with Cy5 (using the antibody from Gt in 
combination with anti-VTP antibodies from Rb; Table 2). 
Unbiased estimates were obtained of the total number and 
proportion of innervated Orx+ cells that were contacted 
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by each ofthe BDA + [VTP+ J type ofvaricosity by counting 
Orx+:BDA+[VTP+J alongwith Orx+:BDA+[VTP-J cells 
through three levels of the LH contour in each series (n = 
3). In addition, estimates of the total number and propor-
tion of contacting varicosities were computed for each of 
the BDA+[VTP+J type of varicosity by using counts of 
BDA+[VTP+]:Orx+ and BDA+[VTP-]:Orx+ varicosities 
(n = 3). The presence of BDA + contacts on the counted 
cells was assessed online by sequential observation of the 
material through the different filters at the same focal 
plane and multiple planes through the z-axis. Counts were 
performed under a 100x oil objective (with 1.40 NA) 
within a counting frame of 70 X 70 !lm and using a 
sampling grid of 120 X 120 !lm so as to sample -33% of 
the LH area. Within each counting frame or block, aIl cells 
whose tops came into focus beneath the surface of the 
section were counted through 8 !lm in the z-axis, which 
corresponded to the average thickness of the mounted 
sections in these series. 
Confocal microscopy and image processing 
Material triple-stained for BDAlVTP/Orx or BDAlPSP/ 
Orx was examined in a Zeiss LSM 510 laser scanning 
confocal microscope equipped with Argon 488 nm, helium-
neon 543 nm, and helium-neon 633 nm lasers for Cy2, 
Cy3, and Cy5 excitation, respectively. Appropriate filters 
were used for detection of Cy2 (bandpass 500-530 nm, 
green), Cy3 (bandpass 565-615 nm, red), and Cy5 (band-
pass 697-719 nm, infrared, color-coded in blue). Scanning 
was performed through a Plan-Apochromat 100x (with 
1.4 NA) objective and pinhole size of -0.8 (0.6-1, Airy 
Units) for the three channels. Acquisition was performed 
with the resident LSM 510 software and consisted of 
stacks of images taken through the z-axis in optical slices 
of -0.5 !lm for VTPs, or -0.33 !lm for PSPs series. Addi-
tional high-resolution stack images (optical slices of 
-0.05-0.1 !lm) were acquired for the PSP series. 
Rendered 3D views of the stacks were obtained using 
the fluorescence rendering mode from the image software 
Volocity 3.7 (Improvision, Lexington, MA, www.improvi-
sion.com), which provides a semitransparent 3D view of 
the different elements based on the degree of intensity of 
each voxel (i.e., the more intense, the less transparent). 
The different elements could then be examined simulta-
neously and interactively from different angles and mag-
nifications. Thus, varicosities could be judged to be in 
contact with a postsynaptic cell or process, as assessed by 
the absence of space between the presynaptic and postsyn-
aptic element from any of the angles observed (Wouterlood 
et al., 2002). High-resolution image stacks (see above) 
were analyzed in the fluorescent rendering mode as weIl 
as in the isosurface rendering mode, which provides a 3D 
solid, nontransparent view of the element surface. Chan-
nels in which the signal was low or the noise was rela-
tively high were restored using a deconvolution procedure 
(iterative restoration in Volocity). 
Adjustment for brightness and contrast for aIl pictures, 
in addition to adjustment of tonal range for each individ-
ual RGB channel ("AdjustlLevels" command in Photoshop) 
for fluorescent images were performed with Adobe Photo-
shop Creative Suite edition (Adobe System, San Jose, CA). 
Figure preparation and final montage were done with 
Adobe Illustrator Creative Suite edition. 
650 
RESULTS 
BDA injection site and anterograde labeling 
in the hypothalamus 
Iontophoretic application ofBDA-10,000 into the region 
of the MCPO-SI (Fig. lA) on two sides in nine rats pro-
duced small and well-restricted, spherical injection sites 
(Fig. lB) of <500 !Lm diameter and containing (sorne 
~ 1,400) labeled nerve cell bodies, as previously described 
(Henny and Jones, 2006). Injection sites were positioned 
primarily within the MCPO and SI (in n = 16 cases 
selected for analysis), where ~90% and ~6% of labeled 
cells were located, respectively. BDA-Iabeled fibers 
coursed through the MFB to reach the tuberaI hypothal-
amus, where multiple neurons, particularly in the LH, 
were contacted by varicosities (Fig. 1C) (Henny and Jones, 
2006). 
Number and distribution of Orx+ neurons 
in the hypothalamus 
The distribution and numbers of Orx+ neurons were 
examined in PAP (DAB)-stained material. Orx+ cells 
were distributed across the tuberaI hypothalamus in mod-
erate numbers from rostral to caudallevels (~A6.6, A6.2, 
and A5.8, Fig. 2). Although most concentrated in the area 
immediately surrounding and dorsal to the fornix, cells 
were distributed through the LH, PF, and DMH. Accord-
ing to stereologicaI estimates of total numbers of cells 
(mean :t SEM, n = 3), ~ 1,800 Orx+ cells were located 
within the LH, ~500 in the PF, and ~900 in the DMH 
with a total of ~3,200 neurons per side (Table 3). The 
proportions of Orx neurons were thus ~56% in the LH, 
~ 15% in the PF, and ~29% in the DMH contours as 
delineated here. 
BDA-Iabeled axons in relation to Orx+ 
neurons 
The relation of BFaxon terminaIs to Orx cells was 
examined in material dual-stained using peroxidase for 
BDA (in black with DAB-Ni following ABC procedure) and 
Orx (in fuchsia with ANPB following PAP procedure) (n = 
7, Fig. 3). Multiple BDA-Iabeled fibers were evident in the 
regions where Orx+ cell bodies and proximal dendrites 
were present, particularly in the LH (Fig. 3A). Moreover, 
BDA-Iabeled axonal boutons en passant (Fig. 3B') or bou-
tons terminaux (Fig. 3B",B IU) appeared to contact Orx+ 
cell bodies as well as dendrites. In tracings of aIl BDA + 
fibers along with Orx+ cells at high magnification using 
Neurolucida, multiple fine collaterais of the coarse fibers 
within the MFB appeared to extend dorsally and medially 
to reach Orx+ neurons within the central and dorsal re-
gions of the LH (Fig. 3C, level A6.0, approximately inter-
mediate to those seen in Fig. 2B,C). Here, BDA-Iabeled 
varicosities appeared to contact Orx+ soma or proximal 
dendrites in the LH (Fig. 3D' ,D",D"'). Sorne BDA-Iabeled 
fibers also extended medially to reach into the PF or DMH, 
although these were few in number. As determined by 
stereological analysis, the proportion of Orx+ neurons 
that were contacted by at least one BDA + varicosity 
(Orx+:BDA+) within the LH, PF, and DMH, was esti-
mated to be ~41 %, -11%, and -9%, respectively (Table 
3). Overall, -28% of the total population of Orx + neurons 
was contacted by BFaxonal varicosities. 
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Fig. 1. BDA injection site in BF and anterogradely labeled BF 
terminais in the LH. A: Atlas section through the cholinergie cell area 
(MCPO-SIl where iontophoretic applications of BDA were placed. 
B: Composite image of typical BDA injection site (processed using 
ABC with DAB-Ni and counterstained for Nissl with neutral red). 
Note the small size and restricted location of BDA injection site in the 
MCPO. C: High-magnification images showing BDA + axonal varicos-
ities (arrowheads) contacting Nissl-stained cell bodies located in dor-
sal (C'), middle (C"), and ventral (Cm) portions of the LH area. Scale 
bars = 1 mm in B; 10 /Lm in ail C. 
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Fig. 2. Distribution of Orx+ neurons at three levels through the 
tuberaI hypothalamus. A-C: Mapping of Orx+ neurons within con· 
tours of the LH, PF, and DMH at A6.6 (A), A6.2 (B), and A5.8 (C) 
levels, based on the material presented in D-F, respectively. Sorne 
few scattered Orx+ neurons within contours of the AHA, Pe and ZI 
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are not shown in the mapping. D-F: Composite images of sections 
immunostained for Orx-A (with DAB) showing the distribution of 
Orx+ neurons in the hypothalamus at A6.6 (D), A6.2 (E), and A5.8 
(F). Scale bar = 1 mm in F (applies ta D-F). 
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TABLE 3. Numbers and Proportions of Orx Cells and Orx+ Cells Contacted by BDA+ Varicosities Estirnated across Hypothalarnic Regions' 
Hypothalamic region LH PF DMH Total 
Single-immunostained Orx series2 
N° Orx cells 1770.7 ± 182.3 469.:3 ± 21.3 917.3 ± 149.3 3157.3 ± 259.5 
% Orx cells of Total across regions 56.0 ± 3.0% 15.2 ± 2.0% 28.8 ± 2.9% 100 ± 0.0% 
Dual-immunostained BDAlOrx series3 
W Orx+ cells 1216.0 ± 97.8 320.0 ± 37.0 576.0 ± 97.8 2122.0 ± 97.8 
W Orx+ cells contacted by a BDA + 512.0 ± 110.9 42.7 ± 42.7 42.7 ± 21.3 597.3 ± 166.6 
var. (Orx + :BDA+ ) 
% Orx+ cells contacted by a BDA+ 41.4 ± 7.1 % 11.1 ± 11.1 % 8.9 ± 4.8% 27.7 ± 6.8% 
var. in each region 
Data are presented as rneans :: SEM. DMH, dorsomedial hypothalamic nucleus; LH, lateral hypothalamus; PF, perifornical area; var., varicosity. 
'Estimated number. of cells and BDA-contacted cells were obtained by random systematic sampling of the hypothalamllB at levels A6.6, A6.2 and AS.8 for LH, and level. A6.2 
and AS.8 for PF and DMH using Stereolnvestigator. 
28eries from 3 different brains processed for single-immunostaining of Orx cells with DAB (see Methodsl. 
3Series from 3 individua) cases (injection sites) processed for dual-immunostaining of BDA (with DAB-Ni) and Orx (with ANPB, see Materials and Methods). 
Fig. 3. Distribution of BDA-Iabeled libers in relation to Orx+ 
neurons. A: Low-magnilication composite image of BDA+ axons (in 
black, DAB-Ni) and Orx+ cells (in fuchsia, ANPBl in the LH at --A6.0. 
B: High-magnilication images showing BDA+ varicosities (arrow-
heads) in contact with Orx+ neurons in the LH Œ', B", and B'"). 
C: Tracing and mapping of ail BDA + libers and Orx + neurons in the 
tuberai hypothalamus at -A6.0 J.Lm (from IAO). From coarse libers 
within the ventrolateral MFB, line varicose collaterals extended dor-
Given that the maximal incidence of Orx+ neurons 
contacted occurred in the LH and that the majority of 
Orx+ neurons were also contained within the LH 
sally and medially to reach Orx+ cells through the LH. Some libers 
also extended medially into the PF and DMH. D: High magnification 
of elements depicted in C, showing contacts of BDA + axons by vari-
cosities on proximal dendrites or soma of Orx+ cells located in the 
dorsal (D') or central (D" and 0"') region of the LH. Tonal range for 
each RGB channel as weil as brightness and contrast adjustment 
were made for pictures in A and B. Scale bars = 100 J.Lm in A; 10 J.Lm 
inB,D. 
(above), subsequent analyses of the BF innervation 
were focused on the Orx+ neurons within the contour of 
the LH. 
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Fig. 4. VAChT+, VGluT2+ or VGAT+, BDA-Iabeled varicosities 
in relation to Orx+ neurons viewed by epifluorescent microscopy. In 
eaeh case, BDA is green (Cy2), VTP red (Cy3), and Orx blue (AMCA in 
A or Cy5 in B and Cl. A: BDA + IV AChT+ 1 terminais in the vicinity of 
an Orx+ neuron. BDA+ terminais (solid arrowheads in A') located in 
the vicinity, yet not close to an Orx+ neuron Oeft), are positive for the 
YAChT protein (solid arrowheads in A"), as evident in the merged 
image (in ye\low, solid arrowheads in Am). A VAChT+ terminal that is 
not BDA+ (open arrowheadl is closer to the Orx+ ee\l body. Note also 
the sparse number of VAChT+ varicosities in the vieinity of Orx+ 
neurons. B: BDA+IVGluT2+1 terminais in close proximity to Orx+ 
YAChT, VGluT2, and VGAT in BDA-Iabeled 
varicosities in relation to Orx + neurons in 
the LB 
To determine if BF terminaIs contacting Orx neurons are 
cholinergie, glutamatergic, or GABAergic, sections that were 
triple-stained for BDA (with Cy2), the VTPs (VAChT, 
VGluT2, or VGAT with Cy3), and Orx-A (with AMCA or Cy5) 
were examined under epifluorescent microscopy (see num-
ber of cases, n, for each series in Table 2). In these sections, 
sparse VAChT+ varicosities were evident (Fig. 4A"), 
whereas multiple VGluT2+ (Fig. 4B") and VGAT+ <Fig.4C") 
varicosities were present in the vicinity ofthe Orx+ neurons. 
BDA+[VAChT+l (Fig. 4A"'), BDA+[VGluT2+1 (Fig. 4B"'), 
and BDA + [VGAT+ 1 (Fig. 4C"') BFaxons were ail present in 
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neurons. Two small BDA + terminais (solid arrowheads in B') over an 
Orx+ ce\l body are positive for the VGluT2 protein (solid arrowheads 
in B"), as evident in the merged image (in yellow, solid arrowheads in 
Bm ). Note also the relatively large number ofVGluT2+ varicosities in 
close proximity to the Orx+ neurons. C: BDA+IVGAT+1 terminais 
over Orx+ neurons. Two BDA+ terminais (solid arrowheads in C') in 
close proximity to an Orx+ neuron are positive for VGAT (solid 
arrowheads in C"), as evident in the merged image (in yellow, solid 
arrowheads in cm). In ail images, tonal range was adjusted for each 
RGB channel individually. Seale bar = 10 I1m in cm (applies to A-Cl. 
the immediate surround of the Orx+ neurons as weil. How-
ever, only BDA+[VGluT2+] (Fig. 4B'") and BDA+[VGAT+] 
varicosities (Fig. 4C"') appeared ta contact the Orx+ neurons 
in substantial numbers. 
Stereological estimates of contacts between 
VAChT+, VGluT2+, or VGAT+ BDA-Iabeled 
varicosities and Orx+ neurons in the LB 
To determine the proportions of Orx+ neurons inner-
vated by cholinergie, glutamatergic, or GABAergic BF 
axon terminaIs, stereological analysis was used for esti-
mation of the total numbers of Orx + neurons contacted by 
each of the BDA + [VTP+ 1 types of varicosities in the LH 
through the three levels studied (~A6.6, A6.2, and A5.8, 
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TABLE 4. Numbers and Proportions of Orx + Cells Conta~ied by BDA+ Varicosities Positive for Vesicular Transporter Proteins (VTP+ J, and Numbers and 
Proportions of BDA+ IVTP+l Varicosities in Contact with Orx+ CeUs in the Lateral Hypothalamus (LH)l 
Triple·immunostained BDNVTP/Orx series YAChT VGluT2 VGAT 
W Orx + œlls contacted by BDA + var. 548.3:': 68.3 532.7:': 109.7 595.3 :': 109.7 
IOrx+ :BDA + ) in each series 
W Orx+ œlls contacted by BDA+ IVTP+! var. 15.7:': 15.7 188.0:': 81.4 376.0:': 27.1 
(Orx+:BDA+!VTP+!r-
'Jf. Orx+ cells contacted by BDA'!VTP+ 1 var.2 3.7±3.7% 31.4 ± 9.4% 66.7 ± 11.2% 
W BDA + var. in contact with Orx+ cells IBDA +: 908.6 :': 122.4 1096.7:': 180.7 1457.0:': 204.9 
Orx + ) in each series 
W BDA+IVTP+! var. in contact with an Orx+ 15.7:': 15.7 203.7:': 95.3 814.7:': 87.2 
cells <BDA+IVTP+!:Orx+)2 
% BDA+!VTP+ 1 var. in contact with Orx+ cells' 2.2 ± 2.2 % 16.6 ± 6.2% 57.8 ± 8.7% 
Data are presented as means ± SEM. var., varicosity. 
'Estimated numbers of colis were obtained by randOID syst"matie sampling of the LH area at levels A6.6, A6.2 and AS.8 using Stereolnvestigatar from three individual cases 
(injection sites). 
zAccording ta a non-parametric KruskaJ-Wallis test, the different VTP+ varicosities differed signilieantly aceording ta the numbers Œ = 6.587, P = 0.037) and proportions Œ = 
7.261, P = 0.027) ofOrx+ neurons contacted by BDA+!VTP+! and ta the numbers (H = 6.587, P = 0.037) and proportions Œ = 6.938, P = 0.031) of BDA+ !VTP+l varieositi .. 
contacting Orx+ neurons. 
n = 3 cases, Table 4). In the YAChT series, less than 4% 
of the Orx+:BDA+ neurons were contacted by 
BDA + [V AChT+ 1 varicosities. In the VGluT2 series, 
-31% of the Orx+:BDA+ neurons were contacted by 
BDA+[VGluT2+1 varicosities. In the VGAT series, -67% 
of the Orx+:BDA+ neurons were contacted by 
BDA + [VGAT+ 1 varicosities. 
The numher of BDA+[VTP+l varicosities contacting 
Orx+ neurons (BDA + [VTP+ 1 :Orx + ) was also determined 
(n = 3, Table 4). As estimated from each series, the pro-
portions of varicosities in contact with Orx+ neurons 
were, respectively: -2% for BDA+[VAChT+l, -17% for 
BDA+[VGluT2+l, and -58% for BDA+[VGAT+l varicos-
ities. Across series, the numhers ofterminals detected per 
Orx+ cell were: one for BDA+[VAChT+l, one to two for 
BDA+[VGluT2+l, and one to four for BDA+[VGAT+l 
varicosities. Given the minimal number of contacts by 
BDA+[VAChT+l varicosities and the substantial number 
of contacts by BDA+[VGluT2+1 and BDA+[VGAT+l var-
icosities on the Orx+ neurons, confocal analysis was pur-
sued for the latter terminaIs. 
ConfocaI anaIysis of VGluT2 or VGAT inside 
and of PSD-95 or gephyrin opposite BDA + 
terminaIs on Orx+ neurons 
To examine in detail the nature of the BDA + contacts 
observed on Orx+ neurons, confocal microscopic analysis 
was performed on material triple-stained for BDA (with 
Cy2), Orx (with Cy5 or Cy3) and markers for the presyn-
aptic, VTP (VGluT2 or VGAT with Cy3) or postsynaptic, 
PSP (PSD-95 or Geph with Cy5) (see Table 2 for numher of 
cases processed and examined for each series). Confocal 
images were further viewed using 3D reconstruction and 
rotation with magnification to confirm that the pre- and 
postsynaptic elements were in contact through three spa-
tial axes. 
In series triple-stained for BDA, VGluT2, and Orx, the 
Orx+ neurons were seen to he surrounded by numerous 
VGluT2+ varicosities. In this material, many BDA-
labeled VGluT2+ varicosities were apposed to Orx+ soma 
(Fig. 5A) or proximal dendrites (not shown). As judged 
from examination and rotation of 3D images from such 
cases, the BDA+[VGluT2+1 varicosity appeared to be in 
contact with the Orx+ cell, since no space could he ob-
served between the two (Fig. 5A, small images) with ro-
tation through three axes. 
In series triple-stained for BDA, PSD-95, and Orx, 
staining for PSD-95 appeared punctate and could be seen 
on the surface ofOrx+ neurons (Fig. 5B). In sorne BDA+: 
Orx+ contacts (Fig. 5B), PSD-95+ puncta could be de-
tected opposite the BDA + varlcosity and associated with 
the Orx+ cell (Fig. 5B, small images). From 93 acquired 
images of appositions (from n = 3 cases), 74 BDA+:Orx+ 
contacts (-80%) were confirmed in rotated and magnified 
3D images, and 16 of these, 21.6%, showed staining for 
PSD-95 opposite the BDA + varicosity and associated with 
the Orx+ cell. 
To further assess the spatial relationship among the 
BDA+ terminals, PSD-95+ puncta, and Orx+ celIs, image 
stacks with high z-axis resolution (0.05-0.10 f.lIll optical 
slices) were acquired of 23 appositions (from n = 3 cases) and 
analyzed in 3D rotations. Contacts were confirmed between 
BDA + varicosities and Orx+ neurons, as shown from three 
different, orthogonal 3D angles of semitransparent fluores-
cence images (Fig. 6A1,B1,Cl). PSD-95+ profiles were ob-
served in apposition to BDA+ varicosities (Fig. 6A2,B2,C2) 
and in association with the surface of Orx+ neurons (Fig. 
6A3,B3), being localized between BDA + and Orx+ elements 
(Fig. 6A4,B4). Opaque isosurface rendering of the three ele-
ments further evidenced the localization ofPSD-95+ puncta, 
which appear tucked in or hidden hetween the BDA + vari-
cosity and the Orx+ neuron (Fig. 6A5,B5,C5). 
In series triple-stained for BDA, VGAT, and Orx, Orx+ 
neurons were also seen to be surrounded by VGAT+ var-
icosities. Many BDA-Iabeled VGAT+ varicosities were in 
close apposition to Orx+ soma or dendrites (Fig. 5C). As 
judged from the rotated and magnified 3D images of such 
cases, the BDA+[VGAT+l varicosity was in contact with 
the Orx+ cell (Fig. 5C, small images) through three axes. 
In series triple-stained for BDA, Geph, and Orx, Geph 
staining (Cy5) appeared punctate, generally in larger 
puncta than PSD-95 and frequently associated with Orx+ 
soma and dendrites (Fig. 5D). In multiple BDA+:Orx+ 
contacts (Fig. 5D), Geph + puncta were seen facing the 
BDA + varicosity and associated with the Orx+ cell (Fig. 
5D, top small images), such that they appeared to he 
located between the terminal and cell in merged images 
(Fig. 5D, lower small image). From 112 acquired images of 
appositions (from n = 3 cases), 93 BDA+:Orx+ contacts 
(>80%) were confirmed in rotated and magnified 3D im-
ages, and 44 or 47.3% showed Geph+ puncta between the 
BDA + varicosity and the Orx+ cell. 
BDANGluT2/0rx BDAiOrx 
"" 
'" VGiuT2/0rx 
'" 
Merged 
"" 
A 
BDA/VGAT /Orx BDNOrx 
~ 
~ 
VGi\T,Orx 
~ 
~ Merg~d 
C ~ 
Fig. 5. The presence ofpresynaptic VGluT2 or VGAT and postsyn-
aptic PSD-95 or Gephyrin (Geph) proteins in contacts between BDA-
labeled varicosities and Orx+ neurons. A: Rendered 3D confocal im-
age (16 seriaI 0.50-j.Lm thick optical sections) of a BDA-Iabeled axon 
(in green, Cy2), whose varicosities (in yellow) are positive for VGluT2 
(in red, Cy3). One ofthese varicosities is in apposition (arrowhead) to 
an Orx + neuron (in pseudocolor blue, Cy5), as evident in the rendered 
zoom images on the right (6 seriaI 0.5-j.Lm thick optical sections) 
depicting in detail the relation between the BDA+ varicosity (top) or 
the contained VGluT2 (middle) with the Orx+ neuron surface and 
showing the three elements together in the merged image (bottom). 
Note also on the left other VGluT2+ varicosities in contact with the 
Orx+ neuron. B: Rendered 3D eonfocal image (9 seriaI 0.33-j.Lm thick 
optical sections) of a BDA+ varicosity (arrowhead, in green, Cy2) 
facing a PSD-95+ profile (opposite pointer, in pseudocolor red, Cy5) 
located between the varicosity and the surface of the Orx+ neuron (in 
pseudocolor blue, Cy3). As evident in the zoom rendered images on the 
right (13 seriaI 0.33-j.Lm thiek optical sections), the BDA + varicosity is 
apposed to the Orx+ proeess (top image), opposite the PSD-95+ 
punctum, which is on the surface of the Orx + process (pointer, middle 
image) and between the BDA+ varicosity and the Orx+ process 
(pointer in the merged image, bottom). Note the presence of other 
PSD-95+ puncta over the Orx+ neuron (upper pointer) at the left 
panel. C: Rendered 3D eonfocal image (28 seriai 0.5-j.Lm thick optical 
sections) of a BDA-Iabeled axon (in green, Cy2), from which most 
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varicosities (in yellow) are positive for VGAT (in red, Cy3) and come 
into contact (large arrowhead) with the dendrites and soma of the 
Orx+ neuron. As seen in the rendered zoom images on the right (8 
seriaI 0.5-j.Lm thick optical sections), the BDA+ varicosity (top image) 
containing VGAT (middle image) appears to be in contact with the 
surface of the Orx+ neuron (merged image, bottom). Note in the left 
image other VGAT+ varicosities also appear to appose the Orx+ 
neuron. D: Rendered 3D confocal image (14 seriaI 0.33-j.Lm thick 
optical sections) of BDA-Iabeled axonal varicosities (arrowhead, 
green, Cy2) facing Geph+ puncta (facing pointer, pseudocolor red, 
Cy5) over an Orx+ neuron (pseudocolor blue, Cy3). As evident in the 
zoom rendered images at the right (12 seriaI 0.33-j.Lm thick optical 
sections), the apposition of the BDA+ varicosity with the Orx+ neu-
ron (top image) is associated with a Geph+ punctum on the surface of 
the Orx+ neuron (pointer, middle image) and between the BDA+ 
varicosity and the Orx+ neuron (merged image, pointer, bottom). 
Note the presence of other Geph+ puncta over the Orx+ neuron 
(upper pointers) in the left panel. Deconvolution iterative restoration 
(see Materials and Methods) was applied to the Cy5 channel (in B and 
C, left panels, and in A-D, right panels), the Cy3 channel (in C, left 
panel, and in C,D, right panels) and the Cy2 channel (in B-D)_ Tonal 
range adjustments for each individual RGB channel were made for ail 
pictures. Seale bars = 10 j.Lm in left large panel in D (applies to large 
left panels in A-C); 1 j.Lm in D, zoom bottom image (applies to zoom 
images in A-C)_ 
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Fig. 6. 3D localization of postsynaptic proteins PSD-95 or gephy· 
rin (Geph) between BDA+ terminaIs and Orx+ neurons. A-C: Or-
thogonal views (see below) of a high-resolution rendered confocaI 3D 
image (40 seriaI -O.06-f.Lm thick opticaI sections) in semitransparent 
fluorescence rendering (columns 1-4) or opaque isosurface (column 5) 
views of a single contact between a BDA + varicosity (in green, Cy2) 
and an Orx+ proximaI dendrite {in bIue, Cy3}, with the presence of 
PSD-95+ puncta (in red, Cy5) between the varicosity and dendrite. 
The BDA+ varlcosity is in contact with the Orx+ process (Al-Cl), 
and in clear apposition to a PSD-95+ profile (solid arrowheads in 
A2-C2,), which is in turn located on the surface of the Orx+ neuron 
(solid arrowheads in A3,B3). The 10caIization of the PSD-95+ profile 
between the two structures is evident in the triple merged fluorescent 
image (solid arrowheads in A4,B4) as weIl as in the triple merged 
isosurface rendering image, where the punctum appears aImost com-
pletely occluded (dotted arrowheads in A5-C5). The PSD-95+ punc-
tum is completely occluded in certain of the orthogonal views (dotted 
arrowheads in C3-C5). A6-C6: Representation of the three orthogo-
nal views with orientation markers showing the X, Y, Z axes. D-F: 
Orthogonal views of a high-resolution rendered confocaI3D image (38 
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seriaI -0.08-f.Lm thick optical sections) in semitransparent fluores-
cence rendering (columns 1-4) or opaque isosurface rendering (col-
umn 5) views of a single contact between a BDA + varicosity (in green, 
Cy2) and an Orx+ soma (in blue, Cy3), with the presence of Geph+ 
puncta (in red, Cy5) between the terminal and soma. The BDA + 
varicosity is in contact with an Orx+ soma (Dl-Fl) and in clear 
apposition to a Geph + profile (solid arrowheads in E2,F2), which is in 
turn located on the surface of the Orx+ neuron (solid arrowheads in 
D3-F3). The 10caIization of the Geph+ profile between the two struc-
tures is evident in the triple merged fluorescent image (solid arrow-
heads in E4,F4) as weIl as in the triple merged isosurface image (solid 
arrowheads in E5,F5). Note the relative occlusion ofthe Geph + profile 
in the rendered isosurface images, evidencing its location between the 
two structures. Due to the orthogonal views, the Geph + puncta are 
completely occluded in sorne of them (dotted arrowheads in 
D2,D4,D5J. D6-F6: Representation ofthe three orthogonal views with 
orientation markers showing the X, Y, Z axes. Deconvolution iterative 
restoration (see Materials and Methods) was applied to the Cy5, Cy3, 
and Cy2 channels. ScaIe bars = 1 f.Lm in C5 (applies to A-C), and in 
F5 (applies to D-F). 
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For further analysis, image stacks with high z-axis res-
olution (0.05-0.10 f.1m optical slices) were acquired of 19 
(from n = 3 cases) BDA, Geph, and Orx appositions and 
examined. Contacts were seen between BDA + varicosities 
and Orx+ neurons, as evidenced from 3D orthogonal 
views (Fig. 6D1,E1,F1). Geph + profiles were observed in 
apposition to BDA + varicosities (Fig. 6E2,F2) and in as-
sociation with the surface of Orx+ neurons (Fig. 
6D3,E3,F3), located between BDA+ and Orx+ elements 
(Fig. 6E4,F4). Opaque isosurface rendering of the three 
elements evidenced the localization of Geph + puncta be-
tween the BDA + varicosity and the Orx+ neuron (Fig. 
6D5,E5,F5). 
DISCUSSION 
The present study presents qualitative and quantitative 
evidence that Orx neurons are innervated by afferents 
from the BF cholinergic cell area. Yet from this cholinergic 
cell area the afferents were predominantly comprised of 
noncholinergic terminaIs. Numerous glutamatergic and 
GABAergic varicosities contacted Orx neurons in the LH 
and could thus respectively exert excitatory and inhibitory 
influences on their activity during wake and sleep states. 
BF projections to Orx neurons 
We show here that anterogradely labeled fibers from the 
MCPO-SI of the BF cholinergic cell area extend into the 
region of the Orx cells in the tuberaI hypothalamus. As 
shown and discussed in our previous study (Henny and 
Jones, 2006), the fibers reached the caudal hypothalamus 
through the ventrolateral portion of the MFB, which has 
long heen known to carry fibers from this forebrain area 
(Swanson, 1976; Veening et al., 1982; Grove, 1988). From 
this component, collaterals fan out through the LH and 
extend dorsomedially, although less numerously, through 
the PF and sparsely into the DMH. 
We estimated here using stereology that Orx neurons 
are most numerous within the LH, numbering -1,800, 
less numerous within the PF, numbering -500, and in-
termediate in the DMH numbering -900 for a total of 
-3,200 neurons per side. The total number (in Long 
Evans rats) is similar to that previously estimated by us 
as -3,400 Orx+ neurons per side (in Wistar rats) (Modir-
rousta et al., 2005) and to one other published number 
estimated by stereological analysis as -2900 Orx+ neu-
rons per side (in Wistar rats) (Allard et al., 2004). Accord-
ing to conventional delineation as the region lateral to the 
fornix through which the MFB fiber systems travel, >50% 
(or -1,800) ofthe Orx cells are located in the LH. 
We show here that BF terminaIs, which would originate 
from a relatively small number of caudally projecting cells 
in the MCPO-SI labeled by the BDA injections, contact a 
significant proportion (-28%) of aIl Orx+ cells. This input 
was topographically arranged, as the proportions of Orx + 
cells contacted were substantial (-41%) in the LH and 
small in the more medial PF (-11%) and DMH (-9%). 
Notably, from similar injection sites, BF terminals contact 
only -15% of the total LH cell population (estimated at 
-50,000 through the tuberaI hypothalamus) (Henny and 
Jones, 2006), suggesting a selective enrichment of BF 
terminaIs upon the Orx neurons relative to aIl other chem-
ically unidentified neurons of the LH. According to a re-
cent extensive survey of afferents to the Orx neurons 
using both anterograde and retro grade tracing (Yoshida et 
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al., 2006), the overall proportion of Orx neurons contacted 
by BF afferents (-28%, from the present study) would be 
comparable to that originating from the adjacent ventro-
lateral preoptic area (31%). In the former work, the BF 
was not considered to be among the major afferent sources 
to the Orx neurons, although it contained a moderate 
number of afferent cells (Yoshida et al., 2006). In that 
study the afferents were identified by injections of retro-
grade tracers into the region where the Orx+ neurons are 
most concentrated, immediately surrounding the fornix 
within the dorsal PF, the lateral DMH, and the dorsome-
dial region of the LH, and thus highlighted major sources 
of input from the more medial basal telencephalic afferent 
systems. From our present and previous (Gritti et al., 
1994; Henny and Jones, 2006), as weIl as other early 
tracing studies (Swanson, 1976; Veening et al., 1982; 
Grove, 1988), the MCPO-SI would fit within a lateral-to-
medial as well as ventral-to-dorsal topographically orga-
nized system of fibers coursing within the MFB and serv-
ing as afferents to the hypothalamus and, notably, as the 
present results indicate, the Orx neurons therein. 
Predominant innervation by noncholinergic, 
glutamatergic, and GABAergic BF terminaIs 
of Orx neurons 
In the LH, ofthe total number of Orx neurons contacted 
by BFaxonal varicosities (-41%, see above), only a min-
imal proportion (-4%) was innervated by cholinergic var-
icosities, whereas the major proportion was innervated by 
glutamatergic or GABAergic varicosities. Similarly, only 
2% of the varicosities on Orx+ cells were VAChT+ in this 
material. These results are in line with our previous study 
showing that cholinergic BF terminaIs in the LH comprise 
less than 10%, whereas glutamatergic and GABAergic 
terminaIs comprise the vast majority of the BF terminaIs 
in the LH (Henny and Jones, 2006). These are not in 
agreement with the recent results of Sakurai et al. (2005) 
using a transgene for a tetanus toxin tracer (tetanus toxin 
C fragment fused to green fluorescent protein, TTC::GFP), 
which is believed to be transported transynaptically and 
retrogradely, linked to an orexin promoter together with 
fluorescent staining for choline acetyltransferase (ChAT). 
In those studies, essentially aIl retrogradely labeled neu-
rons in the cholinergie cell area of the BF were judged to 
he immunostained for ChAT. We recognize the possibility 
that the TTC::GFP tracer could be taken up by terminaIs 
on distal dendrites that were not evident in our fluores-
cent material. On the other hand, previous results from 
our lab and from other groups utilizing retrograde trans-
port of traditional tracers also found minimal proportions 
of descending projections from cholinergie BF neurons 
«5%) to the brainstem or hypothalamus and the region of 
the Orx cell bodies and dendrites (Grove, 1988; Semba et 
al., 1989; Gritti et al., 1994; Bayer et al., 1999). As dis-
cussed by Sakurai et al. (2005), retrograde labeling by 
TTC::GFP could be due to transynaptic transport along 
with retrograde transport that could result in labeling of a 
large number and proportion of cholinergic BF cells as 
higher-order afferent neurons. Such an indirect, multisyn-
aptic influence of cholinergic BF neurons upon Orx neu-
rons might be expected to exist as a feedback on the Orx 
neurons that project into the region of the cholinergie cells 
(Espana et al., 2005) and would exert an excitatory effect 
through Orx on the cholinergic neurons (Eggermann et al., 
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2001). On the other hand, from electrophysiological stud-
ies it appears that cholinergic input can have an impor-
tant influence on Orx neurons, since cholinergic agonists 
can depolarize and excite the Orx neurons (Bayer et al., 
2005; Sakurai et al., 2005). Although the BF cholinergic 
cells may participate in this influence, the pontomesence-
phalic cholinergic neurons likely play a more dominant 
role, given previous evidence of their more substantial 
projections into the region of the Orx cells (Ford et al., 
1995; Bayer et al., 1999). 
We found that a substantial proportion of BF-
innervated Orx neurons were contacted by VGluT2 con-
taining BDA-Iabeled terminaIs (-31%), and that a sub-
stantial proportion of the BDA-Iabeled terminaIs 
contacting Orx neurons were VGluT2+ (-17%). Gluta-
mate has been shown to depolarize Orx neurons through 
both NMDA and AMPA receptors in vitro (Li et al., 2002; 
Yamanaka et al., 2003b). Orx neurons have been de-
scribed as receiving a relatively high density ofVGluT2+ 
varicosities and asymmetric, presumed excitatory syn-
apses (Horvath and Gao, 2005). From the present results, 
one source of these multiple glutamatergic inputs can be 
attributed to BF neurons. 
The major proportion of BF -innervated Orx neurons 
were contacted by VGAT containing BDA-Iabeled termi-
naIs (-67%), and a major proportion of the BDA-Iabeled 
varicosities were VGAT+ (-58%), indicating that 
GABAergic BF neurons can have a potent influence on 
Orx neurons. GABA has been shown to hyperpolarize and 
inhibit Orx neurons that are otherwise spontaneously ac-
tive in vitro (Li et al., 2002; Eggermann et al., 2003; 
Yamanaka et al., 2003b). Interestingly, Orx neurons are 
considered to have a relatively sparse GABAergic input, 
particularly in relation to the glutamatergic input, with a 
ratio ofinhibitory to excitatory synapses estimated as 1 to 
10 (Horvath and Gao, 2005). In light of the latter results, 
it would appear that the BF GABAergic neurons may play 
a particularly important role in providing this inhibitory 
input and influence to the Orx cells. 
BF glutamatergic and GABAergic synaptic 
input onto Orx neurons 
We confirmed by confocallaser scanning microscopy and 
3D image rendering and rotation that BDA-Iabeled BF 
varicosities appeared to contact Orx neurons in the LH. 
By continuous rotation through three axes, we were thus 
able to establish for large numbers of varicosities that 
there appeared to be no space between the varicosity and 
the Orx+ cell. Such confirmation has been considered by 
others to represent strong evidence for synaptic contacts 
(Wouterlood et al., 2002). Yet it is weIl recognized that 
only the resolution of the electron microscope provides 
absolute proof of such contacts by presynaptic elements 
with postsynaptic targets. 
More specific evidence is provided for the synaptic na-
ture of glutamatergic and GABAergic terminaIs by the 
presence of the presynaptic vesicular transporters. 
VGluT2 and VGAT, which were demonstrated in the BDA-
labeled varicosities apposed to Orx cells, confer the capac-
ity to release glutamate and GABA and are concentrated 
in the presynaptic terminal at asymmetric and symmetric 
synapses, respectively (Gilmor et al., 1996; Chaudhry et 
al., 1998; Bellocchio et al., 2000; Takamori et al., 2000; 
Fremeau et al., 2001, 2004; Gualix et al., 2003). 
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Lastly, we show that in confirmed contacts of BDA-
labeled varicosities with Orx cells, postsynaptic proteins 
ofPSD-95 and Geph are situated facing the varicosity and 
in association with the Orx+ cell. Similar to proportions of 
BDA-Iabeled varicosities ostensibly contacting Orx+ neu-
rons that were VGluT2+ and VGAT+ (above), the propor-
tions of confirmed contacts by BDA-Iabeled varicosities on 
Orx+ neurons that showed PSD-95 or Geph puncta be-
tween the terminal and cell were -22% and -47%, re-
spectively. Postsynaptic proteins, PSD-95, and Geph are 
constituent parts of the postsynaptic scaffolding of asym-
metric, excitatory (Sheng and Pak, 2000), and symmetric 
inhibitory synapses (Sassoe-Pognetto and Fritschy, 2000), 
respectively. At excitatory synapses, PSD-95 colocalizes 
by direct and indirect association with NMDA and AMPA 
receptors (Sassoe-Pognetto et al., 2003). At inhibitory syn-
apses, Geph is colocalized with the most common synaptic 
subtypes of GABAA receptors and is suggested to partici-
pate in their anchoring to the postsynaptic membrane 
(Sassoe-Pognetto et al., 1995; Giustetto et al., 1998). The 
location of postsynaptic proteins sandwiched between pre-
synaptic and postsynaptic elements has been considered 
strong evidence for synaptic contacts in 3D rendered con-
focal images (Wouterlood et al., 2003). We thus believe 
that the present results showing both pre- and postsynap-
tic elements for glutamatergic and GABAergic synapses in 
association with BDA-Iabeled terminaIs contacting Orx 
neurons provide compelling evidence for BF glutamatergic 
and GABAergic synaptic input to the Orx cells. 
Functional signiftcance of the cholinergie, 
glutamatergic, and GABAergic BF input to 
Orx neurons 
Orx neurons play a key role in stimulating and main-
taining arousal by excitatory influences on multiple sys-
tems, including the cerebral cortex, hypothalamic, and 
brainstem arousal systems, as weIl as sympathetic and 
motor circuits in the spinal cord (Peyron et al., 1998; van 
den Pol, 1999; Saper et al., 2001; Taheri et al., 2002; Krout 
et al., 2003; Siegel, 2004; Jones and Muhlethaler, 2005; 
Sakurai, 2005). As now shown by recent studies, they are 
in turn influenced by afferent input from multiple fore-
brain and brainstem systems (Sakurai et al., 2005; Yo-
shida et al., 2006). Here we show that neurons of the BF 
cholinergic cell area, which themselves are importantly 
involved in regulating sleeplwake states, contribute sig-
nificantly to that afferent input. The BF input was partic-
ularly dense onto the Orx neurons in the LH, which de-
spite claims of being selectively activated with reward 
seeking (Harris et al., 2005), have also clearly been shown 
to discharge and express c-Fos in association with simple 
waking, arousal, or stress (Espana et al., 2003; Lee et al., 
2005a; Mileykovskiy et al., 2005; Modirrousta et al., 2005). 
In contrast ta recent claims (above, Sakurai et al., 2005), 
the cholinergie BF cells appear to contribute minimally to 
the innervation orthe Orx neurons in the LH. Cholinergie 
BF neurons discharge in a manner (Lee et al., 2005b) that 
differs fundamentally from that ofrecently identified Orx 
neurons across sleeplwake states (Lee et al., 2005a). 
Whereas cholinergie neurons discharge maximally during 
both waking and PS in association with cortical activation, 
Orx neurons discharge maximally during waking in asso-
ciation with movement and muscle tone and cease firing 
during PS sleep with muscle atonia (Jones, 2005b). It is 
The Journal of Comparative Neurology. DOl lO.lOO2lcne 
INNERVATION OF OREXIN NEURONS 
thus not surprising that Orx neurons are not under the 
direct control of cholinergic BF neurons. To the contrary, 
the silence of Orx neurons during PS sleep is the condition 
under which cholinergic neuronal discharge stimulates 
cortical activation in association with the muscle atonia of 
that state. 
The Orx neurons receive a substantial glutamatergic 
input from BF neurons, indicating that these glutamater-
gic neurons can exert a significant excitatory influence on 
Orx cells. In single unit recording studies, many noncho-
linergic BF neurons have been identified that discharge 
maximally during active waking and are virtually silent 
during sleep, including PS sleep (Szymusiak and 
McGinty, 1986b; Lee et al., 2004, 2005b). The discharge of 
these neurons is positively correlated with postural mus-
cle tonus or neck electromyographic (EMG) activity (Lee et 
al., 2004), like that of the Orx neurons (Jones, 2005b; Lee 
et al., 2005b). We propose that such noncholinergic neu-
rons are glutamatergic and could facilitate behavioral 
arousal in part by exciting the Orx cells. 
The major input to the Orx neurons from BF is GABAer-
gic. Given the purportedly small inhibitory input relative 
to excitatory input onto Orx neurons (Horvath and Gao, 
2005), this GABAergic input from BF neurons might be of 
critical importance in inhibiting the discharge of Orx neu-
rons during periods ofbehavioral quiescence, sleep, and/or 
muscle atonia (Lee et al., 2005a). Although we have iden-
tified GABAergic neurons that discharge in association 
with cortical activation (Manns et al., 2000), we propose 
that the innervation of the Orx neurons originates from 
the particular GABAergic BF neurons that are active dur-
ing sleep (Modirrousta et al., 2004) and discharge during 
SWS and/or PS sleep in negative correlation with muscle 
tonus or EMG (Szymusiak and McGinty, 1986b; Manns et 
al., 2000; Lee et al., 2004; Jones, 2005b). 
Orexin has been attributed a particularly important 
role in maintaining arousal, since in its absence in knock-
out mice or that of its receptor in dogs or Orx neurons in 
humans, narcolepsy occurs (Chemelli et al., 1999; Lin et 
al., 1999; Peyron et al., 2000; Thannickal et al., 2000; 
Hara et al., 2001). In humans, narcolepsy is characterized 
by excessive daytime sleepiness, short onset of REM sleep, 
and/or loss of postural muscle tone, known as cataplexy. 
Accordingly, the excitation of Orx neurons by presumed 
wake-active, glutamatergic BF neurons could normally 
serve to prevent sleep onset and loss of postural muscle 
tone, whereas the inhibition of Orx neurons by presumed 
sleep-active GABAergic BF neurons could promote sleep 
onset and the loss of postural muscle tone. It could be due 
in part to withdrawal of the major BF GABAergic input to 
Orx neurons that neurotoxic lesions of the BF result in a 
severe disruption of SWS and PS (Szymusiak and 
McGinty, 1986a). Moreover, chemical stimulation of the 
BF with cholinergic agonists or agents exciting cholinergic 
neurons can elicit PS with atonia in cats and rats 
(Hernandez-Peon et al., 1963; Cape et al., 2000; Jones, 
2004) and/or cataplexy in dogs (Nishino et al., 1995). Cho-
linergic agonists and ACh, which is released in the BF 
maximally during PS (Vazquez and Baghdoyan, 2001), 
could excite noncholinergic, presumed GABAergic BF neu-
rons (Fort et al., 1998; Wu et al., 2000), including those 
that innervate the Orx neurons and thereby elicit PS 
and/or muscle atonia. 
In conclusion, the present study reveals an important 
glutamatergic and GABAergic input to Orx neurons from 
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BF neurons. Glutamatergic BF neurons can excite Orx 
neurons to stimulate behavioral arousal and waking. 
GABAergic BF neurons can inhibit Orx neurons to dimin-
ish behavioral arousal along with muscle tone and thereby 
promote sleep, including PS with muscle atonia. 
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